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Abstract 
Background/ aims: Bipolar disorder is associated with significant impairment in a broad range 
of neuropsychological processes in addition to hypothalamic-pituitary-adrenal (HPA) axis 
dysfunction and hypercortisolaemia. As both animal and human models have highlighted the 
role of cortisol in the modulation of memory processes, attempting to understand this link is 
of critical importance. The aims of this thesis are to first profile neuropsychological and HPA 
axis function in individuals with a diagnosis of bipolar disorder, before examining if these 
functions can be altered through an intervention with an antiglucocorticoid drug. The 
subsequent chapters of this thesis will report analyses designed to explore specific aspects of 
these changes in more detail, principally alterations in spatial memory processes.  
Method: The thesis reports two broad phases of research. The first is a study of 20 
participants diagnosed with bipolar disorder (with depressive symptoms) who first completed 
a broad neuropsychological assessment and profiling of afternoon cortisol and DHEA levels. 
These individuals then entered a randomised crossover study to examine the effects of 
mifepristone (RU-486), a glucocorticoid receptor antagonist, on neuropsychological functions 
and mood. A second cohort of 53 participants diagnosed with bipolar depression (BD) and 47 
healthy controls was recruited to explore aspects of the results in more detail, particularly the 
fractionation of spatial memory and the integration of neuropsychological processes and their 
relationship with measures of HPA axis function. 
Results: 1) BD participants exhibited broad neuropsychological impairment across a range of 
cognitive domains in addition to hypercortisolaemia. 2) Administration of an 
antiglucocorticoid drug significantly reduced cortisol levels and improved spatial working 
memory performance. 3) The underlying neuropsychological component structure of BD and 
controls differed. 4) BD participants exhibited impairments in fine-grain metric spatial memory 
which, unlike other spatial processes, could not be explained by other measures. 5) A unique 
profile of processes underpinning aspects of visuospatial memory was observed in BD, 
suggesting a form of cognitive ‘scaffolding’. 6) A simple link between neuropsychological 
processes and peripheral HPA axis measures was not observed. 
Conclusion: Spatial memory processes in bipolar depression can be altered by direct HPA axis 
manipulation. A number of interesting avenues for future research have been identified that 
will further our knowledge of the integration between the biological mechanisms underlying 
neuropsychological impairment in mood disorders and should develop our understanding of 
integration between cognitive processes in general. 
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1. General Introduction 
 
1.1 Outline and organization of the thesis 
The following thesis contains seven chapters: a general introduction, five empirical chapters, 
and a general discussion.  
 
Chapter one, the general introduction, presents an overview of bipolar disorder and a 
focussed review of neuropsychological and hypothalamic-pituitary-adrenal (HPA) axis 
abnormalities within the disorder. This provides the background to chapters two and three 
which contain data from the same cohort of patients from a program of research examining 
the effectiveness of antiglucocorticoid treatment in bipolar disorder. Chapter two examines 
the broad neuropsychological performance and peripheral cortisol levels in this group, while 
chapter three reports the effects of an antiglucocorticoid (mifepristone) on these measures. A 
discussion of these findings highlights several important areas for further study and identifies 
methodological improvements. 
 
The subsequent three empirical Chapters (Chapters four to six) are born out of the findings of 
the initial studies and explore in more depth specific hypotheses resulting from these. Chapter 
four examines the factor structure of neuropsychological measures in patients with bipolar 
disorder in comparison to that in healthy controls. Chapter five reports the findings of a more 
specific analysis of – and fractionation of  –  spatial memory processes in bipolar depression. 
Finally, as a result of the findings of Chapters four and five, Chapter six examines the 
relationship between specific spatial memory processes and broader neuropsychological 
factors and the relationship with other HPA axis measures. Chapter seven contains the general 
discussion of all of these findings. 
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1.2 Bipolar disorder: an overview 
In this section, a brief overview of bipolar disorder is presented, covering the historical 
conceptualisation, current diagnostic classification, clinical features and epidemiology. 
 
1.2.1 History 
The origins of the concept of bipolar disorder can be traced back to the classical period and 
are found in the writings of Greek physicians and philosophers. Hippocrates (460–337 BC) was 
the first to systematically describe mania and melancholia, supported by clinical observation 
and extended follow-up (Angst & Marneros, 2001). His theories were progressed by many 
scholars, such as Aretaeus of Cappadocia who, in the 1st century AD, published works such as 
‘On the Aetiology and Symptomatology of Chronic Diseases’ and ‘The Treatment of Chronic 
Diseases’ in which he described mental disorders in detail and was the first to link mania and 
melancholia (Angst & Marneros, 2001).  
 
Over the centuries many others explored and developed these ideas. The explicit 
conceptualisation of BD as a single distinct entity emerged in the 19th century with the work 
of Jean-Pierre Falret. In 1851 Falret published a statement in the Gazette des Hôpitaux in 
which he described a single disorder which he named ‘folie circulaire’, characterized by a 
continuous cycle of depression, mania and ‘well’ intervals of varying length (Falret, 1851; 
Angst & Marneros, 2001). This notion gained popularity throughout Europe (although not 
without some opposition). However, it is undoubtedly the work of the German psychiatrist 
Emil Kraepelin which laid the foundation for the concept of bipolar disorder as we know it 
today.  
 
Page | 20 
Kraepelin was the first to divide psychosis into two discrete disorders: dementia praecox 
(schizophrenia) and manic-depressive insanity (bipolar disorder). By 1913, in the eighth 
edition of Kraepelin’s text, virtually all of the major clinical forms of melancholia had been 
subsumed under “manic-depressive illness” – a state that he argued could be clearly 
differentiated from dementia praecox by its periodic or episodic course, a more benign 
prognosis and a family history of manic-depressive illness (Goodwin & Jamison, 2007).  
 
As with other significant periods in the development of the bipolar concept, there were some 
who did not support this system. For example, Carl Wernicke – and later Karl Kleist – both 
argued against the notion of unifying many conditions under the bipolar concept, which they 
saw as distinct, especially melancholia (Wernicke, 1900; Kleist, 1911). However, it has been 
noted that these detailed distinctions did not gain widespread acceptance because of their 
complexity (Angst & Marneros, 2001). The foundations laid down by Kraepelin were 
subsequently taken forward through the ‘research diagnostic criteria’ era and refined through 
the subsequent iterations of these to the formal diagnostic systems we have today. 
 
In the following section the current formal classification of bipolar disorder and its clinical 
features are discussed. While these are utilised in the context of the present study, they are 
far from objective and they are not uncritically accepted. The current edition of ICD-10 
describes the situation thus: “It seems likely that psychiatrists will continue to disagree about 
the classification of disorders of mood until methods of dividing the clinical syndromes are 
developed that rely at least in part upon physiological or biochemical measurement, rather 
than being limited as at present to clinical descriptions of emotions and behaviour. As long as 
this limitation persists, one of the major choices lies between a comparatively simple 
classification with only a few degrees of severity, and one with greater details and more 
subdivisions…. Options for specifying several aspects of affective disorders have been included 
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{in ICD-10}, which, although still some way from being scientifically respectable, are regarded 
by psychiatrists in many parts of the world as clinically useful. It is hoped that their inclusion 
will stimulate further discussion and research into their true clinical value” (WHO, 1992). 
 
1.2.2 Diagnosis and clinical features 
Bipolar disorder is recognised as a heterogeneous condition, typically characterised by 
extreme fluctuations in mood that cycle between (hypo)manic or mixed states and depressive 
episodes interspersed with periods of euthymia. Current formal diagnostic systems such as 
the ICD-10  and DSM-IV contain similar features of mania and depression although the specific 
diagnostic categories differ slightly.  
 
ICD-10 describes the disorder as being characterized by “repeated (i.e. at least two) episodes 
in which mood and activity levels are significantly disturbed, this disturbance consisting on 
some occasions of an elevation of mood and increased energy and activity (mania or 
hypomania), and on others of a lowering of mood and decreased energy and activity 
(depression)”.  
 
These disturbances of mood are specifically characterized – mania is described as a period (for 
at least 1 week; severe enough to disrupt ordinary work and social activities more or less 
completely) where mood is elevated “out of keeping with the individual's circumstances and 
may vary from carefree joviality to almost uncontrollable excitement. Elation is accompanied 
by increased energy, resulting in over activity, pressure of speech, and a decreased need for 
sleep. Normal social inhibitions are lost, attention cannot be sustained, and there is often 
marked distractibility. Self-esteem is inflated, and grandiose or over-optimistic ideas are freely 
expressed” (WHO, 1992). Within ICD-10 a with- or without- psychotic symptoms distinction is 
also made. 
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Hypomania is defined as a lesser degree of mania, in which “abnormalities of mood and 
behaviour are too persistent and marked to be included under cyclothymia but are not 
accompanied by hallucinations or delusions”. There is a persistent mild elevation of mood (for 
at least several days on end), increased energy and activity, and usually marked feelings of 
well-being and both physical and mental efficiency. Increased sociability, talkativeness, over-
familiarity, increased sexual energy, and a decreased need for sleep are often present but not 
to the extent that they lead to severe disruption of work or result in social rejection. 
Irritability, conceit, and boorish behaviour may take the place of the more usual euphoric 
sociability. Concentration and attention may be impaired, thus diminishing the ability to settle 
down to work or to relaxation and leisure, but this may not prevent the appearance of 
interests in quite new ventures and activities, or mild over-spending (WHO, 1992). 
 
As described above, within bipolar disorder depressive episodes also occur. ICD-10 includes a 
mild/moderate/severe distinction but characterises all as where an individual suffers from 
depressed mood, loss of interest and enjoyment, and reduced energy leading to increased 
fatigue and diminished activity. Marked tiredness after only slight effort is common. Other 
common symptoms are: reduced concentration and attention; reduced self-esteem and self-
confidence; ideas of guilt and unworthiness; bleak and pessimistic views of the future; ideas or 
acts of self-harm or suicide; disturbed sleep; diminished appetite. The lowered mood is noted 
to vary little from day to day, and is often unresponsive to circumstances, yet may show a 
characteristic diurnal variation as the day goes on. A duration of at least 2 weeks is typically  
required for diagnosis, but shorter periods may be reasonable if symptoms are unusually 
severe and of rapid onset. 
 
The DSM-IV shares many common features with the ICD-10, although includes a more formal 
distinction between bipolar-I (includes a history of mania) and bipolar-II (includes a history of 
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hypomania) (The bipolar-II sub-type is included under a sub-heading of ‘other bipolar affective 
disorders’ in ICD-10).  It is also specified that hypomania should last for at least 4 days (rather 
than ‘several days’ in ICD-10) for a diagnosis of bipolar-II disorder and that the overall 
diagnosis can be made on the basis of a single manic episode. The features of a major 
depressive episode are very similar to the ICD-10 and “require five (or more) of the following 
symptoms to have been present during the same 2-week period (and represent a change from 
previous functioning); at least one of the symptoms is either (i) or (ii)”:  
(i) depressed mood most of the day, nearly every day;  
(ii) markedly diminished interest or pleasure in all, or almost all, activities most of 
the day, nearly every day;  
 
(iii) significant weight loss when not dieting or weight gain, or decrease or increase 
in appetite nearly every day; (iv) insomnia or hypersomnia nearly every day; (v) 
psychomotor agitation or retardation nearly every day; (vi) fatigue or loss of energy 
nearly every day; (vii) feelings of worthlessness or excessive or inappropriate guilt 
nearly every day; (viii) diminished ability to think or concentrate, or indecisiveness, 
nearly every; (ix) recurrent thoughts of death (not just fear of dying), recurrent 
suicidal ideation without a specific plan, or a suicide attempt or a specific plan for 
committing suicide (APA, 1994). 
 
Other specifiers can also be added to these, including presence or absence of psychosis and 
rapid cycling (4 or more mood episodes in a one-year period). It should also be noted that 
these formal diagnostic criteria have been through some development and refinement by 
authors who see such illnesses as a much more detailed, incremental spectrum from bipolar-I: 
(full-blown mania) through to bipolar-VI (a late-onset, dementia-associated illness) (Akiskal & 
Pinto, 1999; Ng et al., 2008). These have not generally entered mainstream diagnostic 
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convention although the conceptualisation of many psychiatric illnesses as dimensional rather 
than categorical is increasing and may form an important part of formal diagnostic systems in 
the future.  
 
1.2.3 Epidemiology 
1.2.3.1 Prevalence and incidence 
Several epidemiological studies have examined the prevalence and incidence of bipolar 
disorder around the world. In a synthesis of ten population-based epidemiologic studies using 
similar methods from the United States, Canada, Puerto Rico, France, West Germany, Italy, 
Lebanon, Taiwan, Korea, and New Zealand, involving around 38,000 community-dwelling 
subjects, lifetime rates of bipolar disorder were between 0.3% and 1.5% with the sex ratios 
nearly equal (Weissman et al., 1996). Other European studies have arrived at similar 
estimates. In Florence, 1-year and point prevalence estimates for bipolar disorder were 1.7% 
and 0.6% respectively (Faravelli et al., 1990). In a review of data from fourteen studies 
(including the aforementioned) from a total of ten countries, the majority of studies reported 
12-month estimates of approximately 1% (range 0.5-1.1%), with little evidence of a gender 
difference (Pini et al., 2005).  
 
The cumulative lifetime incidence of bipolar disorder has been estimated at 1.5-2%, although 
when the wider range of bipolar spectrum disorders is considered, estimates increase to 
around 6% (Pini et al., 2005). Within the UK, incidence rates from the recent Aesop study were 
estimated as 4 per 100,000 per year, ranging from 1.7 in Nottingham to 6.2 in London (Lloyd 
et al., 2005).  
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1.2.3.2 Course and outcome 
Bipolar disorder has a typical age of onset before the age of thirty. The results of the National 
Comorbidity Survey from the US suggest that of the four age bands characterised (15 to 24, 25 
to 34, 35 to 44, 45 to 54yrs) the 25 to 34yrs group had a significantly greater lifetime odds of a 
psychiatric illness. For affective disorders specifically, the 12-month odds were greatest in the 
15 to 24yrs category and reduced monotonically over time (Kessler et al., 1994). This is 
consistent with other US studies, such as that by Weissman and colleagues over 10 countries. 
Here the average age of onset ranged from 17.1 yrs (Edmonton/Alberta) to 27.2 yrs (Puerto 
Rico) with the first peak between 15 and 19 yrs (Weissman et al., 1996).  
 
The course of the illness is severe and disabling for many patients. In a study conducted 
through the Stanley Bipolar Foundation Network, 261 patients were screened and completed 
comprehensive illness and symptom profiling. The average illness duration of those in the 
sample was 20 years. During the course of their illness, 71% had been hospitalised at least 
once, 29% had attempted suicide, and 59% had a history of psychosis. Co-morbidity was high 
with 67% having at least one additional axis-I disorder and 41% had a history of substance 
abuse. Other important characteristics of the sample were that 52% reported experiencing 
depressive symptoms first, compared to only 19% for mania/hypomania. Forty six percent 
reported a worsening of their symptoms over time with only 30% being entirely symptom-free 
between episodes (Suppes et al., 2001).  
 
As discussed above, although the disorder is characterised by the presence of mania or 
hypomania, it is depressive symptoms that are predominant. In two prospective natural 
history studies of weekly symptomatic status, Judd and colleagues performed a long-term 
follow-up of 146 patients with BP-I over 12.8 years (Judd et al., 2002) and 86 patients with BP-
II over 13.4 years (Judd et al., 1998). For patients with BP-I it was found that patients were 
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symptomatically ill about half of the time (mean, 47.3%) and asymptomatic for the remainder 
of follow-up (mean, 52.7%). When symptomatic, patients experienced 3 times more 
depressive symptoms (31.9% of total follow-up weeks) than manic symptoms (9.3% of weeks), 
and depressive symptoms were 5 times more frequent than cycling/mixed symptoms (5.9% of 
weeks). For patients with BP-II, again they were symptomatic for about half of the time of the 
follow-up (mean, 53.9%) however the predominance of depressive symptoms was even 
greater: patients experienced 39 times more depressive symptoms (50.3% of total follow-up 
weeks) than hypomanic symptoms (1.3% of weeks), and depressive symptoms were 22 times 
more frequent than cycling/mixed symptoms (2.3% of weeks).  
 
1.2.4 Summary 
From this overview it can clearly be seen that bipolar disorder can for many individuals be 
seen as a severe and enduring mental illness. One important feature of the illness that 
emerges is that while the disorder is characterised by (hypo)mania, of the time spent ill, the 
majority is spent in depression. Therefore it is bipolar depression (BD) that is the focus of this 
thesis.  
 
 
 
1.3 Neuropsychological impairment in bipolar disorder 
The following section of this introduction examines the evidence for neuropsychological 
dysfunction in mood disorders.  This will draw from the wider field and will include discussion 
of impairment in different phases of the illness as well as from depressive disorders in general 
in order to provide context to the focus on bipolar depression. 
 
Page | 27 
1.3.1 General background, methodological issues and clinical correlates relating to 
neuropsychological impairment in mood disorders 
 
A very brief overview is first presented of some of the broad issues surrounding the 
assessment of neuropsychological impairments in mood disorders in terms of the factors that 
have emerged in the literature as being associated with the general profile of impairment. The 
intention is not to exhaustively review these but to raise those that are relevant to the 
subsequent literature review and affect the general design of the empirical chapters in this 
thesis. 
 
1.3.1.1 Unipolar versus bipolar depression 
There is a large degree of overlap in the neuropsychological profiles of unipolar and bipolar 
depression, however in general it appears that there is greater severity of neuropsychological 
impairment in the latter (Wolfe et al., 1987; Deptula et al., 1991; Borkowska & Rybakowski, 
2001). For example, Borkowska and Rybakowski (2001) compared the performance of patients 
with bipolar or unipolar mood disorders during acute episodes of depression. A significantly 
greater severity of executive dysfunction – including poorer performance in non-verbal 
problem solving, response inhibition, verbal fluency and set-shifting –  was found in bipolar 
compared with unipolar depressed patients. Other studies have reported greater executive 
dysfunction in depressed patients with bipolar disorder (Calev et al., 1986; Martinez-Aran et 
al., 2004), although it should be noted that others have found only selective impairments in 
immediate spatial memory and ‘hot’ (i.e. emotionally-laden) cognition (Roiser et al., 2009) 
while some found no differences on any measure of attention, memory, executive function, 
and general intellectual functioning (Mojtabai et al., 2000; Sweeney et al., 2000). The 
discrepancy is probably due to the confounding effect of other clinical factors. For example, all 
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subjects in the Mojtabai study were psychotic. Also, it has been reported in one study that 
while bipolar depressed patients had statistically poorer neuropsychological function than 
first-episode MDD patients, there was no difference with recurrent patients (Fossati et al., 
2004). This highlights the importance of illness variables on performance and raises the 
question of whether the two disorders can ever be compared satisfactorily. For example, even 
if the groups could be matched for demographic profile and the severity of current episode, it 
would be impossible to equate overall illness characteristics such as medication, 
hospitalizations and previous affective episodes (of depression or mania) (Porter et al., 2007). 
 
1.3.1.2 State versus trait 
Neuropsychological impairments persist into euthymia in bipolar disorder (Bearden et al., 
2001; Robinson et al., 2006; Bora et al., 2009). There is a general consensus that both 
executive functions and declarative memory are impaired (van Gorp et al., 1998; Ferrier et al., 
1999; Martinez-Aran et al., 2000; El-Badri et al., 2001; Clark et al., 2002; Martinez-Aran et al., 
2002; Martinez-Aran et al., 2004; Torrent et al., 2006). However, a recent study suggested that 
the verbal declarative memory deficits in euthymia may be entirely accounted for by a general 
executive impairment (Thompson et al., 2009). As is the case with major depression, a number 
of demographic and clinical characteristics are associated with a more impaired 
neuropsychological profile in euthymic bipolar patients (Robinson & Ferrier, 2006). 
 
Several studies have compared neuropsychological functioning in euthymic and depressed 
bipolar patients. It would be logical to assume that the deficits and profile seen in euthymia 
should also be seen in depression, with the added effect of ‘depression’ overlaid. For example, 
Dixon and colleagues reported a similar profile of impairment in executive function between 
euthymic and depressed bipolar patients, although the error rate on one test of inhibition 
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(Hayling test; anomalous completion) was greater in the depressed (Dixon et al., 2004). 
Similarly, Martinez-Aran and colleagues found euthymic and depressed patients to be 
impaired on most executive and verbal list-learning tasks, but logical memory and visual 
reproduction was impaired only in the depressed (Martinez-Aran et al., 2004).  
 
However not all studies have found this pattern. Kerr and colleagues reported a similar profile 
of deficits on the Stroop test in euthymic, mania and depression compared to controls (Kerr et 
al., 2005). Similarly, in a study by Schneider and colleagues, depressed and euthymic patients 
did not differ significantly on any verbal or executive domain of the WAIS (Schneider et al., 
2008). It is unclear why this pattern emerges in some studies but not others. Subtle 
differences in clinical or demographic features may play a part but perhaps one important 
consideration is that it may be a statistical artefact resulting from, in most cases, presenting 
results in terms of statistical post hoc analysis without clarifying which differences represent a 
differential deficit (Crawford et al., 2000).  
 
1.3.1.3 Medication effects 
Due to the severity of the disorder it is extremely difficult to recruit patients with bipolar 
disorder who are depressed but drug-free. However, several studies from the USA (Wolfe et 
al., 1987; Brooks et al., 2006; Taylor Tavares et al., 2007; Roiser et al., 2009) have achieved 
this (see section 1.3.2). Deficits are seen in these studies although it is difficult to compare 
these with the overall pattern seen in the area as a whole as there are so few tests in 
common.  
 
Only one study to date has directly compared medicated and unmedicated bipolar depressed 
patients (Holmes et al., 2008) and found that there were no statistical differences between 
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the two, although numerically, accuracy was slightly worse in the unmedicated group, while 
reaction times were slower in the medicated group. In terms of effect sizes, the unmedicated 
group performed comparably to those in other studies of medication-free patients, on the 
tests in common (Roiser et al., 2009). Other studies from India examining neuropsychological 
performance in unmedicated euthymic patients also reported a similar profile compared to 
medicated patients (Goswami et al., 2009).  
 
In terms of general impact on neuropsychological functioning, the largest effect to be 
cognizant of seems to be the psychomotor slowing associated with lithium use (Pachet & 
Wisniewski, 2003) although even in this area there remains some debate (see Savitz et al., 
2005).  
 
1.3.1.4 Clinical and illness modifiers 
A number of clinical and demographic factors have been identified as affecting the severity or 
profile of neuropsychological impairment in mood disorders. Severity of depression, 
melancholic or psychotic features, co-morbidity, hospitalization, and treatment with ECT have 
all been associated with a broader and/or more severe impairment (Porter et al., 2007).  
 
In bipolar disorder, neuropsychological functioning has been found to be negatively related to 
illness features such as the number of episodes suffered, the number of hospital admissions 
and duration of illness. Episodes of both depression and mania also related negatively to 
neuropsychological function, although mania was reported to relate more consistently to 
delayed verbal memory and some measures of executive function, whereas depressive 
episodes were related less consistently and to a broader range of impairments (Robinson & 
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Ferrier, 2006). A number of studies have also suggested that the profile of impairment differs 
in patients with psychotic illness features (Glahn et al., 2006; Levy & Weiss, 2010). 
 
It is unlikely that many of these factors are independent of each other and may simply 
represent a greater likelihood of impairment the more severe or complex the illness. Also, 
some of these factors are more easily verified than others, for example, hospitalisation can be 
easily confirmed whereas precise dates for onset of illness or duration of episode are more 
difficult to accurately verify. Nevertheless, it is important to be mindful of these features 
when assessing the profile of impairment between individual studies. 
 
In the next section, the literature on neuropsychological impairment in bipolar depression is 
reviewed. 
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1.3.2 Bipolar depression – a review of the neuropsychology literature 
Relatively few studies have specifically focused on depression within bipolar disorder. One 
recent meta-analysis (Kurtz & Gerraty, 2009) which focussed on the neuropsychology of 
bipolar disorder in euthymia and in symptomatic states (the only one to do this to date) found 
only 5 papers that met inclusion criteria in the bipolar depression analysis. From these 5 
studies, the only tests for which data could be extracted – according to their criteria of 
requiring similar tests/procedures from at least three – were Trails A (attention/psychomotor 
speed) and Trails B (executive function), verbal fluency (language) and verbal memory (Rey-
AVLT or CVLT). The pooled effect sizes for each of these were d=0.80, 0.64, 0.93, and 1.20 
respectively indicate moderate to large effect sizes. A direct comparison with euthymic 
patients across these measures revealed significantly greater verbal learning and fluency 
deficits in depressed individuals.  
 
Due to the limited number of studies of sufficient methodological rigour or sharing common 
tests to permit inclusion in the above meta-analysis, the following section will describe the 
profile of neuropsychological impairment in bipolar depression in much broader terms. To 
that end, a database search was conducted in Medline, PubMed, EMBASE and Science Direct 
to identify suitable papers with a focus on bipolar depression. The terms: ‘bipolar disorder’ or 
‘manic-depression’ were combined with ‘depress*’ and ‘neuropsycholog*’, ‘neurocogniti*’, 
‘memory’, ‘attention’, and ‘executive’. These were limited to ‘English language’ and ‘Human’ 
studies and were selected from 1980 to present (coinciding with the release of DSM-III). This 
resulted in the identification of 914 papers. The abstracts of these were assessed to exclude 
any obviously not focussing on the area of interest. At this stage, review papers were retained 
to provide additional sources of potential references. Overall, 91 papers were found of 
interest which were read and assessed for general suitability and reduced to a final selection 
of 38. The last stage of this process (extraction of mean, s.d. and sample size) resulted in 19 
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papers being retained with sufficient data of use; of the remainder, five were general review 
papers and fourteen had issues with the data or methodology e.g. no control group, only mild 
depressive symptoms, pooled analysis with other diagnoses or insufficient data to calculate an 
effect size.  
 
The following section summarises the results of these studies. General information is also 
summarised alongside the neuropsychological data; specifically other groups included in the 
studies, demographic details, illness severity and diagnostic procedures, current 
hospitalisation and medication use, and inclusion/exclusion criteria. Primarily the focus is on 
the major broad domains of neuropsychological function; attention and executive function, 
immediate/ short-term memory, verbal memory, visuo-spatial memory, (psycho)motor speed. 
Results will be described on a study by study basis but where multiple studies have used the 
same or similar tasks, a meta-analytic approach will be taken to pool the effect sizes and give 
an overall estimate with confidence intervals 1. Where possible this will be done on an 
individual test-by-test basis and by a broader ‘process’ approach e.g. immediate verbal recall, 
delayed verbal recognition etc. The layout of the data is in a form where negative effect sizes 
always indicate lower/worse performance in patients compared to controls and similarly, 
significance of the pooled effects. Effect sizes included in the pooled analyses are indicated in 
the tables with an asterisk.  
  
                                                          
1 For the pooled estimate of effect size within a meta-analysis, both random and fixed-effects methods can be produced. As 
outlined in the Cochrane Collaboration methodology there is considerable debate as to the most appropriate to use. In the 
current data, in the majority of cases the fixed and random effects produced identical pooled effect estimates, however, when 
there were differences the fixed effect model tended to produce a marginally more conservative estimate. Therefore the fixed 
effect method is used throughout. 
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Table 1-1 Overview of the 19 studies identified.  
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Tabulated above are the 19 papers identified, including sample sizes, basic demographics, 
diagnostic and illness characteristics/ severity measures, inclusion and exclusion criteria, tests 
employed and a general summary of the outcome of the study. The average sample size in the 
studies is n=24 (range, n=8 to 65) for the bipolar depressed group and n=36 (range, n=14 to 
88) for controls. This slight disparity is due to some studies having additional experimental 
groups of interest e.g. MDD, manic/euthymic bipolar groups etc. Most groups are matched (or 
are at least non-statistically different) in age, sex and some measure of IQ or general 
educational attainment.  Due to the severe nature of the illness, most patients were receiving 
medication at the time or testing although some studies have been in individuals free of 
psychotropic medications (Wolfe et al., 1987; Brooks et al., 2006; Taylor Tavares et al., 2007; 
Roiser et al., 2009) or have been designed to directly test the differences between medicated 
and unmedicated patients (Holmes et al., 2008).  
 
One of the most striking issues with the studies listed is the heterogeneity in selection of 
neuropsychological tasks. As was suggested in the Kurtz & Gerray (2009) meta-analysis, there 
are very few studies that have used the same or similar measures within any one theoretical 
domain. For this reason, a less stringent criteria will be used for assessing and pooling data. If 
two or more studies have used the same or similar measures, these will be examined 
together. For clarity, this will be explained on a test by test basis in the subsequent sections.  
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1.3.3 Executive and attentional impairments 
Although it is noted that some theoretical models of human memory include the control of 
attention as an executive function (Baddeley & Hitch, 1974) the two will be considered 
separately in this section2. 
 
1.3.3.1 Attention 
Due to the nature of the task, the majority of studies have utilised computerised tests to 
assess aspects of sustained attention. In the Conner’s CPT, subjects view letters presented in 
the centre of a screen, one at a time, for varied presentation rates and intervals. Subjects are 
instructed to respond as fast and as accurately as possible every time a letter appears on the 
screen, except for the letter ‘X’. The entire test lasts approximately 15 minutes. The CANTAB 
RVIP (rapid visual information processing) task is analogous to this, with subjects viewing 
series of numbers on the screen and are required to respond each time they see one of three 
target sequences (3-5-7, 2-4-6, or 4-6-8). The overall test lasts 4 minutes. The cued target 
detection paradigm is a “Posner-style” pre-cuing task  in which subjects are required to detect 
the presence of an ‘x’ inside of one of two boxes whilst fixating on a central ‘+’. Just prior to 
the target appearing in one of the boxes, subjects were explicitly told to “watch for a cue 
which would correspond with the side of the screen in which the target would appear 80% of 
the time”. Subjects were then instructed to respond to the target as quickly as possible by 
pressing a key on the side of the keyboard corresponding with the side of the screen on which 
the target appeared. Cues were of varying types, including valid, invalid and neutral. Finally, 
the d2 task, the only pen-and-paper test requires subjects to cross out any letter ‘d’ that has 
two flankers (dashes) in any combination.  
 
                                                          
2
 For the purposes of these initial chapters, the attribution of tasks into neuropsychological domains is done 
according to common classification in the neuropsychological literature (for example, Lezak et al., 2004; Strauss et 
al., 2006). 
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Table 1-2. Summary of studies examining attentional tasks in bipolar depression 
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Within this domain there is a great deal of heterogeneity in the number of outcome measures 
that have been used, producing highly variable effect size estimates. The only measure used in 
two separate studies is the latency measure from the RVIP (Holmes et al., 2008; Roiser et al., 
2009). As the Holmes et al study involved the comparison of medicated and unmedicated 
patients, two separate comparisons are included from this study, although the same control 
group is included in both.  The pooled estimate of effect size for RVIP latency was d= -0.011 
(95%CI=0.231 to -0.254;  χ2=0.008, p=0.928; individual effect size plots are presented in 
appendix 9.1). However, it is of note that other single measures produced much greater effect 
sizes such as commission errors (d= -0.752) in Connor’s CPT (Brooks et al., 2006) and RVIP 
omission errors (d= -0.991) in medicated patients (Holmes et al., 2008). It is also notable that 
the largest single effect size in this domain was for the d2 task (d= -0.958), the only pen-and-
paper task employed, with a greater psychomotor/fine dexterity component than other 
measures.  
 
 
1.3.3.2 Executive functioning 
Due to the complexity of defining executive functions (Lezak et al., 2004; Strauss et al., 2006), 
this neuropsychological domain contains the greatest number of tests tapping many different 
theoretical executive processes. Those used here can fit generally into the domains of working 
memory monitoring; set-shifting/ rule formation and reversal; planning, reasoning and 
strategy; inhibition; and fluency.  Although tasks can often fit into multiple domains, for the 
purpose of obtaining a pooled estimate of effect size, each outcome measure is only used 
once.  
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Tests within the Working memory monitoring domain include: the digit span (reverse), where 
participants must immediately recall a string of numbers in the reverse order from how they 
were presented; the Sternberg memory scanning test, where participants are required to 
rapidly scan strings of letters and indicate the presence or absence of a target; and the 
CANTAB spatial working memory (SWM) test, in which participants must carry out a self-
ordered search for target ‘tokens’ hidden in an array of boxes. 
 
Tests within the Set shifting/ rule formation and reversal domain include: the Wisconsin Card 
Sorting Test (WCST) and the analogous CANTAB intra-dimensional/extra-dimensional (IDED) 
set-shifting task,  involve the formation and subsequent shifting of rules that change through 
the viewing or sorting of visual stimuli. Similarly, Big Circle/Little Circle (CANTAB) tests reaction 
time and the ability to follow and then reverse rule-based responses; Trails B, which requires 
participants to switch between letters and numbers, joining one to the other. 
 
Within the domain of Planning, reasoning and strategy the tests employed were: CANTAB 
Stockings of Cambridge or Tower of London (SOC/TOL), where participants must plan and 
execute a number of moves to rearrange a series of coloured disks into a given arrangement; 
the Cognitive Estimation Test, which requires participants to estimate the answers to 
questions using deductive reasoning; and the strategy score from the CANTAB SWM, which 
assesses the efficiency of the search strategy adopted. 
 
Tests of Inhibition included: the Stroop test, in which participants must inhibit the pre-potent 
response of reading the printed names of colours and instead must say the colour of the ink 
that the word is printed in; the Hayling Sentence Completion Test (HSCT), which requires 
participants to finish incomplete sentences using contextually relevant (part A: 
straightforward completion condition) or contextually irrelevant (part B: anomalous 
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completion condition) words i.e. inhibit the obvious response; the CANTAB go/no-go task, and 
perseverations from the WCST .  
 
Finally, the verbal fluency tests that were included were either phonological (i.e. words 
beginning with a given letter) or by category (e.g. animals).  
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Table 1-3. Summary of studies examining attentional tasks in bipolar depression 
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Data from six studies (Popescu et al., 1991; Fossati et al., 2004; Martinez-Aran et al., 2004; 
Glahn et al., 2006; Taylor Tavares et al., 2007; Holmes et al., 2008) was included in the analysis 
of working memory monitoring. The pooled estimate of effect size was d= -0.682 (95%CI= -
0.489 to -0.875; χ2=48.0, p<0.0001). As the majority of data was from either the digit span 
(reverse) or SWM tests, these were further examined in separate analyses. For Reverse digit 
span, the pooled estimate of effect size was d= -0.932 (95%CI= -0.630 to -1.234; χ2=36.5, 
p<0.0001) and for SWM was d= -0.410 (95%CI= -0.131 to -0.690; χ2=8.3, p=0.004).  
 
For the analysis of Set shifting/ rule formation and reversal, data from seven studies was 
included (Sweeney et al., 2000; Basso et al., 2002; Fossati et al., 2004; Martinez-Aran et al., 
2004; Rubinsztein et al., 2006; Taylor Tavares et al., 2007; Roiser et al., 2009), with 2 studies 
providing information from two tests (Sweeney et al., 2000; Martinez-Aran et al., 2004). The 
pooled estimate of effect size was d= -0.416 (95%CI= -0.245 to  -0.587; χ2=22.8, p<0.0001).  A 
number of these studies used the WCST and IDED tasks and therefore the pooled effect in 
these measures was examined separately. The pooled estimate of the effect size was 
d= -0.300 (95%CI = -0.093 to  -0.506; χ2= 8.1, p<0.005).  
 
For the analysis of Planning, reasoning and strategy, data from six studies was included 
(Sweeney et al., 2000; Dixon et al., 2004; Rubinsztein et al., 2006; Taylor Tavares et al., 2007; 
Holmes et al., 2008; Roiser et al., 2009), with one study providing data from 2 tests (Sweeney 
et al., 2000) and one providing two patient samples against the same control group (Holmes et 
al., 2008). The pooled estimate of the effect size was d= -0.359 (95%CI= -0.184 to -0.533; 
χ2=16.2, p<0.0001). In this analysis, most contrasts came from the SWM strategy score and 
therefore this analysis was repeated including only this data, producing a pooled estimated 
effect size of d= -0.335 (95%CI= -0.128 to  -0.542; χ2=10.0, p=0.0015). 
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For the analysis of Inhibition, data from five studies was included (Deptula et al., 1991; 
Popescu et al., 1991; Dixon et al., 2004; Martinez-Aran et al., 2004; Kerr et al., 2005), with two 
providing data from two tests each (Dixon et al., 2004; Martinez-Aran et al., 2004). The pooled 
estimate of effect size d= -1.074 (95%CI =-0.844 to  -1.305; χ2=83.6, p<0.0001).  As the 
majority of measures within this domain are from either the Stroop colour-word test or the 
corrected interference effect, the analysis was repeated including only these measures. The 
pooled estimate of effect size was d= -1.044 (95%CI= -0.769 to -1.319; χ2=55.4, p<0.0001).  
 
For the analysis of Fluency, data from four studies was included (Neu et al., 2001; Basso et al., 
2002; Dixon et al., 2004; Martinez-Aran et al., 2004), with two providing data from two tests 
each (Dixon et al., 2004; Martinez-Aran et al., 2004). The pooled estimate of effect size for 
these measures was d= -0.843 (95%CI= -0.616 to -1.069; χ2= 53.3, p<0.0001). The fluency tests 
used can be separated into those assessing phonological fluency (Basso et al., 2002; Dixon et 
al., 2004; Martinez-Aran et al., 2004) and those assessing semantic fluency (Neu et al., 2001; 
Dixon et al., 2004; Martinez-Aran et al., 2004). When analysed separately, the pooled estimate 
of effect for category fluency was d= -0.803 (95%CI= -0.490 to -1.116; χ2=25.3, p<0.0001) and 
for phonological fluency was d= -0.887 (95%CI= -0.559 to -1.215; χ2=28.1, p<0.0001). 
 
 
1.3.4 Immediate (short-term) memory impairment 
In one of the more homogeneous neuropsychological domains, immediate (or short-term) 
memory has been assessed using the digit span and CANTAB spatial span (SSP) tasks. These 
tasks involve the temporary maintenance of verbal/phonological and spatial information 
respectively and accord to current models of working memory  e.g. (Baddeley & Hitch, 1974).  
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Table 1-4. Summary of studies examining immediate memory tasks in bipolar depression 
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Three studies included measures of forwards digit span (Fossati et al., 2004; Martinez-Aran et 
al., 2004; Glahn et al., 2006) and spatial span (Sweeney et al., 2000; Taylor Tavares et al., 
2007; Roiser et al., 2009). The study by Glahn and colleagues examined patients with and 
without a history of psychosis and therefore there are 4 outcome measures for digit span, 
although the same control group is used in both comparisons.  
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For digit span (forwards) or immediate verbal memory the pooled estimate of the effect size is 
d= -0.622 (95%CI= -0.326 to - 0.917; χ2 =17.0, p<0.0001).  
 
For the spatial span task,  or immediate spatial memory, the pooled estimate of the effect size 
is d= -0.470 (95%CI= -0.192 to - 0.748; χ2 =17.0, p=0.0009). 
 
1.3.5 Verbal memory impairments 
The majority of tasks within this domain broadly follow the same format, with subjects being 
required to retain and recall or recognise verbal information either immediately or after a 
delay. Variations in procedures come in the number of items to be remembered, 
mode/frequency of presentation, and potential outcome measure. The Rey-Auditory Verbal 
Learning Test (Rey-AVLT) and California Verbal Learning Test (CVLT) have been used most 
frequently and require the participant to recall 15 or 16 words read by the experimenter over 
multiple presentations. After a delay period there are also measures of delayed recall and 
recognition (with the CVLT, some of these are cued or free). The remaining tasks differ slightly 
from these.  
 
The selective reminding task also tests episodic memory; here participants search an A4 
format card containing four verbal items, pointing to and naming each item (e.g. dentist) 
when its category cue (e.g. profession) is given verbally. After the search, cued recall is 
immediately tested and if one or more names is not recalled, the card is presented again for 
naming followed by cued recall, until all names are retrieved. This continues until all 16 items 
are identified and retrieved. The study phase is followed by three tests trials of free recall 
preceded by 20 s of interference by counting backward. Participants recall as many items as 
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possible and then are cued (using the category) for recall of the remainder. Following the last 
free and cued recall trials, a yes–no recognition memory for the items is administered.  
 
Deptula’s verbal memory test assesses recall and recognition of 20 words (all four-legged 
animals) which are read to the participant and repeated back to ensure attention. Recall is 
assessed over four trials of 150 seconds duration – only those items not recalled are 
subsequently read to the participant. On the second and fourth trials, forced choice 
recognition is also assessed.  
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Table 1-5. Summary of studies examining verbal memory tasks in bipolar depression 
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Finally, the last test employed is the Logical Memory subtest of the Wechsler Memory Scale, 
which assesses immediate and delayed recall of a word passage. 
 
A number of effect sizes can be extracted from the available data. A total immediate free-
recall measure is reported in 5 studies (Wolfe et al., 1987; Deptula et al., 1991; Basso et al., 
2002; Fossati et al., 2004; Martinez-Aran et al., 2004), although there is insufficient data to 
include the Wolfe data in the pooled analysis. The pooled estimate of this effect size is d= -
0.995 (95%CI = -0.736 to -1.254; χ2=56.8, p<0.0001). It was noted that all tasks with the 
exception of logical memory involve the acquisition of individual words rather than a structure 
paragraph therefore the analysis was repeated with this measure removed and the effect size 
was only marginally different (d= -0.938, 95%CI = -0.645 to -1.232; χ2=39.3, p<0.0001). 
 
Some studies also included a measure of initial immediate free-recall i.e. recall performance 
after the first, single presentation of the to-be-remembered list (Neu et al., 2001; Basso et al., 
2002; Fossati et al., 2004). The pooled estimate of effect size for this measure was d= -0.644 
(95%CI= -0.352 to -0.937; χ2=18.6, p<0.0001).    
 
Several studies also included measures of longer-term verbal memory through the inclusion of 
delayed recall (Neu et al., 2001; Basso et al., 2002; Martinez-Aran et al., 2004)and/or delayed 
recognition (Deptula et al., 1991; Basso et al., 2002; Martinez-Aran et al., 2004). The pooled 
estimate of effect size for delayed recall was d= -1.064 (95%CI= -0.796 to -1.332; χ2=60.6, 
p<0.0001) and for recognition d= -0.957 (95%CI= -0.604 to -1.310; χ2=28.3, p<0.0001).  
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1.3.6 Visuo-spatial memory impairments 
The majority of tasks included in this domain are from the CANTAB test battery. These can be 
broadly divided into those requiring the immediate or delayed recognition of visual patterns 
or spatial locations. Most follow a forced-choice recognition format. Within the visual domain, 
a number of studies have used the available variants of the simultaneous and delayed match-
to-sample tests. The Match to Sample - simultaneous (MTS) version requires subjects to select 
the correct pattern from one, two, four, or eight peripheral patterns that matches the pattern 
shown simultaneously at the centre of the screen. The Simultaneous/Delayed Match to 
Sample (S/DMTS) test requires participants to select from a choice of 4 stimuli the one that 
correctly matches a target stimulus. This is done either simultaneously, or after the target has 
disappeared from the screen for delays of 0 sec, 4 sec or 12 sec. Other CANTAB tests 
employed include Paired Associative Learning (PAL) in which subjects are sequentially shown 
between one and eight patterns in an equally-spaced ‘circle’ around the screen. After a brief 
delay, the individual patterns are presented in the centre of the screen and the participant 
must indicate the peripheral location where it was first presented. This can therefore be 
thought of as an object-location binding task. Also, Pattern and Spatial Recognition (SREC and 
PREC) tasks, where participants are presented with a series of patterns or spatial locations and 
must indicate the correct item or position from a choice of two, after a brief delay.  
 
The remaining tasks used include, the visual memory and reproduction sub-tests from the 
Wechsler Memory Scale, a non-verbal recall and recognition task (Deptula et al., 1991) and a 
novel Spatial Delayed Response Task (SDRT) in which participants view a target array of 1, 3, 
or 5 yellow circles, positioned pseudo-randomly around a central fixation, and after a fixed 
delay, are required to indicate whether a single green circle is in the same position as one of 
the target circles.  
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Table 1-6. Summary of studies examining visuo-spatial memory tasks in bipolar depression 
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Within the domain of visuo-spatial memory, the relative homogeneity of test selection allows 
a number of pooled effect sizes to be extracted from the available data. Simultaneous 
matching-to-sample tests (i.e. where the test stimuli and the target appear together and must 
be matched) provide both accuracy (Sweeney et al., 2000; Rubinsztein et al., 2006; Roiser et 
al., 2009) and latency (Sweeney et al., 2000; Rubinsztein et al., 2006) measures. The pooled 
estimate of effect size for accuracy was d= -0.207 (95%CI=0.063 to -0.477; χ2=2.26, p=0.133) 
and for latency d= -0.321 (95%CI= -0.012 to -0.629; χ2=4.16, p=0.041). 
 
For the delayed match-to-sample (DMTS) test, although accuracy was reported in several tests 
there was no common outcome measure used in all. The pooled estimate of effect size for 
latency (Sweeney et al., 2000; Rubinsztein et al., 2006; Taylor Tavares et al., 2007; Roiser et 
al., 2009) was d= -0.007 (95%CI=0.241 to -0.255; χ2=0.003, p=0.955). 
 
Tests assessing memory for visual/pattern stimuli fitted into those that required participants 
to recall or reproduce this information from memory (Deptula et al., 1991; Neu et al., 2001; 
Martinez-Aran et al., 2004), and those that required forced-choice recognition of the correct 
item (Deptula et al., 1991; Sweeney et al., 2000; Rubinsztein et al., 2006; Taylor Tavares et al., 
2007; Holmes et al., 2008; Roiser et al., 2009).  The pooled estimate of effect size for visual 
memory (immediate recall) was d= -0.769 (95%CI= -0.427 to -1.111; χ2=19.4, p<0.0001) and for 
visual memory (recognition) was d= -0.167 (95%CI=0.022 to -0.356; χ2=3.0, p=0.083).  
 
It is clear that the task used in one study (Deptula et al., 1991) produced a more pronounced 
effect that the other studies in this analysis which all used the CANTAB Pattern Recognition 
test (PRec), therefore the analysis was repeated using these studies and produced a pooled 
estimated effect size of d= -0.128 (95%CI=0.065 to -0.321; χ2=1.69, p=0.193) for accuracy. The 
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pooled estimate of the latency values from this measure was d= -0.068 (95%CI=0.155 
to -0.291;  χ2=0.358, p=0.550).  
 
Within the domain of spatial memory (recognition), all tasks included some measure of 
accuracy (Sweeney et al., 2000; Glahn et al., 2006; Rubinsztein et al., 2006; Taylor Tavares et 
al., 2007; Roiser et al., 2009). The pooled estimate of effect size was d= -0.222 (95%CI= -0.022 
to -0.423; χ2=4.71, p=0.030).  
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1.3.7 (Psycho)motor speed impairments 
Broadly, the tasks employed within this domain can be categorized as those that test fine 
motor skills or dexterity and those that assess reaction time to respond to an event 
(sometimes with a decision making component). 
 
The Trail Making Test (TMT) part A (Reiten, 1958) assesses simple motor dexterity, requiring 
participants to joint up the numbers 1 to 25 in order, as quickly as possible (Part B is used to 
assess set-shifting; executive function). The Finger Tapping Tests require participants to ‘tap’ 
as many times as possible within a given time period while in the Grooved Pegboard, 
participants must place as many small pegs in key-like slots as quickly as possible.  
 
Within the reaction time tests, the Five Stage Reaction Time task (CANTAB) assesses 
psychomotor speed. Subjects are asked to hold down a press pad and release it and touch a 
yellow dot on the screen as soon as it appears. Simple reaction time requires participants to 
respond as quickly as possible to a target, while choice reaction times are similar but 
responses are conditional on the nature of the probe (i.e. response to red not blue lights) or a 
different key must be pressed in response to the different probes (Choice Reaction Time; 
double).  
 
Other tests included, counting tasks and rate of articulation where participants are required to 
count as quickly as possible, or without pausing. 
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Table 1-7. Summary of studies examining (psycho)motor tasks in bipolar depression 
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For the fine motor and dexterity analysis, data were pooled from 3 types of test (Trails A, 
tapping tests, and grooved pegboard) taken from five studies (Popescu et al., 1991; Neu et al., 
2001; Basso et al., 2002; Martinez-Aran et al., 2004; Burdick et al., 2009). The pooled estimate 
of the effect size was d= -0.794 (95%CI= -0.588 to -1.001; χ2=56.9, p<0.0001).  
 
As there were a number of different studies that used the Trails A, the pooled effect size for 
this test was examined separately and resulted in an estimated effect size of d= -0.845 
(95%CI= -0.545 to -1.145; χ2=30.5, p<0.0001).  
 
Of the reaction time tests, these are taken from three studies only (Popescu et al., 1991; 
Sweeney et al., 2000; Burdick et al., 2009) therefore multiple measures/tests are from the 
same samples. The pooled estimate of effect size is d= -0.607 (95%CI= -0.380 to -0.833; 
χ2=27.6, p<0.0001).  
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1.3.8 Summary of effect size analysis 
Examining the methodological issues first, as discussed in the above sections, there are several 
instances where multiple ‘valid’ patient samples come from the same study and are therefore 
compared against the same control group. This occurs, for example, when comparing groups 
with and without psychosis or on and off medication. Using the same controls may reduce 
variance within the domains covered by these studies. Also, the effect sizes generated are 
simple estimated effects and are not adjusted for demographic differences (through 
covariates) as they are in many analyses. The estimated effects are consequently susceptible 
to inflating the true effect size and should be viewed as a method of general comparison only. 
Finally, some domains or processes examined are covered by a more limited and 
homogeneous set of tests than others (e.g. immediate memory using the digit span or spatial 
span tests). Consequently there is likely to be less variance in these areas than in instances 
where a more broad definition was used to pool effects. 
  
Overall, the analysis of pooled effect sizes yielded results largely consistent with the existing 
non-meta analytic reviews of the literature (Quraishi & Frangou, 2002; Malhi et al., 2004; 
Savitz et al., 2005) although some differences were noted. For example, it had been proposed 
that within the domain of verbal fluency, only semantic fluency was impaired in bipolar 
depression (Malhi et al., 2004) whereas the current analysis found similar effect sizes for both 
phonological and semantic fluency. The largest effect sizes were observed in the domains of 
verbal memory, as well as aspects of executive functioning (inhibition, fluency and working 
memory monitoring), psychomotor speed (fine motor and dexterity), and visuo-spatial 
memory (immediate visual recall). However, focusing on processes rather than domains it is 
clear that within memory functioning, measures that are assessed by recall rather than 
recognition and/or assess delayed rather than immediate recollection, yield the largest 
effects.  
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Figure 1-1. Summary of pooled effect sizes (with lower and upper 95%CI) for primary neuropsychological 
processes in bipolar depression 
 
 
 
 
 
 
 
 
 
 
 
 
 
Different colouring of bars is for clarity, to denote separate neuropsychological domains (i.e. 
psychomotor, visuo-spatial etc.). 
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Figure 1-2. Summary of pooled effect sizes (with lower and upper 95%CI) for individual tests in bipolar 
depression 
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The size of effects are summarised in Figure 1-1, where within the visuo-spatial memory tests, 
visual recall produces a pooled effect size around d= -0.8, with visual and spatial recognition 
being around d= -0.2 (unfortunately no study included a measure of spatial memory recall; 
See Chapter 5 of the thesis for a test that includes this measure). Within the verbal memory, 
immediate and delayed recall as well as delayed recognition produce effect sizes around 
d= -1.0. It is worth noting that the executive domain includes a wider range of estimated 
effect sizes for different processes, likely reflecting the complexity and heterogeneity of 
measures included in this domain. Again, it should be highlighted that some of these 
processes are pooled from very similar or the same measures e.g. inhibition is purely from 
Stroop colour-word or interference scores, while others are drawn from a variety of measures.  
 
Previous reviews of this area have produced conclusions attesting to the general, broad profile 
of memory impairment in bipolar depression: “…deficits are likely the consequence of reduced 
cognitive effort or inefficient encoding and retrieval strategies, which result in poor free recall” 
(Malhi et al., 2004). A similar conclusion can be drawn from the present review of the 
literature. This has relevance for the subsequent course of this thesis and leads directly to the 
selection tests in Chapter 2; the initial examination of neuropsychological functioning in 
bipolar depressed patients. It also leads to the need in Chapter 4 to assess the factor structure 
of neuropsychological functioning in a larger sample of participants, developing understanding 
of how these processes relate to one another.  Prior to this, the next section examines the 
background literature on HPA axis dysfunction in mood disorder and its inclusion in this thesis 
as a modulator of neuropsychological functioning.  
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1.4 HPA axis dysregulation in mood disorder 
In this section, a brief overview of the HPA axis is first presented followed by those studies 
which have examined dysregulation in mood disorders. Although pertinent literature of 
depressive disorders in general will be examined, there will be a focus on bipolar depression. 
 
1.4.1 The HPA axis 
The HPA axis is one of the major hormonal systems mediating physical and psychological 
stress responses. When activated, neurones in the paraventricular nucleus of the 
hypothalamus secrete corticotropin-releasing hormone which is transported via the 
hypothalamo-pituitary portal circulation to the anterior pituitary where adrenocorticotropic 
hormone (ACTH) is secreted through stimulation of pituitary corticotrophs. ACTH then 
stimulates the adrenal cortex to secrete glucocorticoids: corticosterone in rats and cortisol in 
humans (Feldman et al., 1995; Berne & Levy, 1998). 
 
1.4.1.1 Cortisol and corticosteroid receptors 
Under basal conditions, cortisol secretion exhibits a 24 hour circadian rhythm in which 
concentrations are highest at waking and slowly decline to a nocturnal trough (Weitzman et 
al., 1971). As with many hormones it is released in a pulsatile manner throughout this cycle 
(Young et al., 2004a). A great deal of individual variation exists in the secretion of both ACTH 
and cortisol, but spontaneously occurring cortisol peaks are preceded by increases in ACTH 
levels, although secretion of the two hormones are not quantitatively linked throughout the 
day (Follenius et al., 1987). Indeed, analysis of ultradian variations within healthy individuals 
has shown a predominant periodicity in the oscillations of both hormones of between 55 and 
140 minutes for ACTH and 95 and 180 minutes for cortisol, indicating that, on occasion, a 
single cortisol peak may be initiated by two ACTH peaks (Follenius et al., 1987). Levels also 
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appear to exhibit seasonal variation with plasma cortisol being higher in winter, but overall 
cortisol production rate reduced (Walker et al., 1997; King et al., 2000; Hansen et al., 2001).  
 
Cortisol is involved in the regulation of fat, protein and carbohydrate metabolism, electrolyte 
balance, body water distribution, blood pressure and immunosuppressant anti-inflammatory 
action (Berne & Levy, 1998). As discussed it is also a key regulator of the physiological stress 
response, through negative-feedback actions via corticosteroid receptors. Two distinct 
corticosteroid receptor subtypes have been identified; the mineralocorticoid receptor (MR; 
Type I) and the glucocorticoid receptor (GR; Type II). Both receptor types have been 
implicated in mediating glucocorticoid feedback (Reul & de Kloet, 1985), however there are 
several differences in the distribution, occupancy and binding properties of the two receptors 
that affects their role physiologically. The MR is highly expressed in the limbic system whereas 
the GR is ubiquitous, being present in both subcortical and cortical structures, with a 
preferential distribution in the prefrontal cortex (Patel et al., 2000).  
 
Glucocorticoids bind to the MR with around a 6- to 10- fold greater affinity than to GR (de 
Kloet et al., 1999). Consequently, at basal levels near complete occupation of MRs occurs. GRs 
are minimally occupied at this point and only during times of high cortisol secretion, such as 
the circadian peak or during stress, do MRs become saturated and GR occupancy increases 
(Reul & de Kloet, 1985; de Kloet & Reul, 1987). A growing body of evidence indicates that 
alterations in HPA axis function may be a core feature of mood disorders and may exert 
significant causal and exacerbating effects on symptoms and neuropsychological functioning 
(for a review see Anacker et al.; Gallagher et al., 2009).  
 
 
Page | 71 
1.4.1.2 DHEA 
Recently there has been increased interest in the role of other adrenal steroids such as 
dehydroepiandrosterone (DHEA) which, in its sulfated form (DHEAS) is the most abundant 
adrenal steroid in humans (Morfin, 2002). DHEA is a naturally occurring excitatory neuroactive 
steroid (or neurosteroid: a term first proposed by Baulieu and colleagues in 1981 (Baulieu, 
1981) that applies to the steroids, the accumulation of which occurs in the nervous system 
independently, at least in part, of supply by the steroidogenic endocrine glands and which can 
be synthesized de novo in the nervous system (Baulieu & Robel, 1998)). The 
neurosteroidogenesis in the brain is independent of the peripheral production; brain DHEAS 
was not influenced by adrenal stimulation or inhibition with adrenocorticotropic hormone 
(ACTH) or dexamethasone, respectively, and increased 2 days after the stressful event of 
adrenalectomy and orchiectomy (Corpechot et al., 1981). DHEA is a substrate for 
androstenedione and testosterone synthesis and may have a role as an adrenal androgen 
(Gurnell & Chatterjee, 2001). DHEA serves as a precursor of androstenedione, testosterone, as 
well as of approximately 50% of androgens in adult men, 75% of active estrogens in 
premenopausal women, and 100% of active estrogens after menopause (Regelson & Kalimi, 
1994).  
 
As with cortisol, DHEA levels have been shown to exhibit seasonal variation (Garde et al., 
2000) although other studies have not found such changes and results seem far less consistent 
(Bjornerem et al., 2006; Brambilla et al., 2007). The diurnal rhythm of DHEA also appears to be 
less pronounced than that of cortisol (Hucklebridge et al., 2005). Neurosteroids display 
multiple effects on the central nervous system (CNS) and may act as potential signalling 
molecules for neocortical organization during neuronal development (Baulieu & Robel, 1996; 
Mao & Barger, 1998). In particular, neurosteroids can interact with various neurotransmitter 
systems to promote neuronal remodelling; they regulate growth of neurons, enhance 
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myelinisation and synaptogenesis in the CNS, affect synaptic functioning, and show 
neuroprotective properties (Friess et al., 2000; Wen et al., 2001; Johnson et al., 2002). 
Furthermore, these neurosteroids have been found in the mammalian brain at considerably 
higher concentrations than typically detected in serum or plasma (Corpechot et al., 1981; 
Baulieu, 1997). There is evidence that neurosteroids may be involved in the vulnerability to 
developing neuropsychiatric disorders such as dementia, mood disorders, substance abuse 
and others (for reviews see; (Epperson et al., 1999; Sundstrom Poromaa et al., 2003; Eser et 
al., 2006; Girdler & Klatzkin, 2007; Ritsner et al., 2008). 
 
The precise mechanism of action of DHEA in the brain is less well known although it has been 
shown to have actions on membrane-bound receptors and is a gamma-aminobutyric acid type 
A (GABAA) receptor antagonist (Hansen et al., 1999) as well as a sigma-1 receptor agonist 
(Maurice et al., 1999; Maurice et al., 2006). Recently it has been confirmed that neuroactive 
steroids (pregnenolone, DHEA, DHEAS, allopregnanolone) are present in human post-mortem 
brain tissue at physiologically relevant concentrations in the nanomolar range and that levels 
of pregnenolone and DHEA in posterior cingulate and parietal cortex are higher in subjects 
with schizophrenia and bipolar disorder compared to control subjects (Marx et al., 2006). 
However, in addition to these neurosteroid properties, it is the putative role of DHEA(S) as a 
functional antagonist of the actions of cortisol which have generated most interest in the 
study of patients with psychiatric illness.  
 
1.4.1.3 Methods of assessment 
A number of methods are available for the assessment of basal steroid levels in humans. For 
example, for small, highly lipid-soluble molecules (such as cortisol) the unbound hormone can 
pass easily through the membranes of nucleated cells permitting ‘free’ steroid levels to appear 
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in bodily fluids (Kirschbaum & Hellhammer, 2000). Levels can reliably be measured in urine, 
plasma and saliva with each having potential strengths and weaknesses (Levine et al., 2007). 
 
1.4.1.3.1 Urine 
Urinary cortisol excretion results from glomerular filtration and is a useful index of integrated 
24-hour plasma free cortisol (Levine et al., 2007), but steroid output over any fixed period of 
time can be reliably assessed (Callies et al., 2000). Similarly reliable measurements of DHEA as 
well as many other steroid metabolites can be achieved (Poor et al., 2004). 
 
1.4.1.3.2 Saliva 
Saliva sampling has certain advantages over plasma sampling, especially in patients whose 
HPA axes may be sensitive to stressful interventions such as venepuncture (Kirschbaum & 
Hellhammer, 1989, 1994, 2000; Lac, 2001). Due to the relatively small samples required to 
obtain steroid measurements, sampling can also be performed relatively frequently if 
necessary and can allow the circadian profile to be determined (Lac, 2001). The analysis of the 
area-under-the-curve provides an estimate of the overall hormonal secretion over 24-hour 
and – although not as precise – is more convenient than 24-hour urine collection.  
 
Importantly, several studies have examined the relationship between steroid levels in saliva 
compared to those in plasma. Cortisol and DHEA levels measured in saliva closely agree with 
free levels in the blood, due to the fact that cellular access and entry to the oral cavity are by a 
method of passive diffusion and therefore independent of saliva flow-rate and transport 
mechanisms (Vining et al., 1983; Granger et al., 1999; Kirschbaum & Hellhammer, 2000). 
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However, it should be noted that the method of collection of saliva can have effects on the 
accuracy of this relationship (Granger et al., 1999; Shirtcliff et al., 2001; Gallagher et al., 2006).  
1.4.1.3.3 Plasma 
A relationship between central and peripheral steroid levels has been established (Carroll et 
al., 1976b). However, there are factors that can result in variability in this relationship, for 
example  degree of blood brain permeability, activity of the multidrug-resistance gene type-1 
P-glycoprotein, and steroid metabolising enzymes within the brain, such as 11β-
hydroxysteroid dehydrogenase type 1 (Pearson et al., 2010). Guazzo et al (1996) measured 
plasma and CSF levels of cortisol and DHEA(S) in a group of 62 subjects aged 3 to 85 years. 
Significant correlations in steroid-free subjects were observed between blood and CSF levels 
for DHEA (r = 0.65) and DHEAS (r = 0.88) but not for cortisol (r = 0.26). However, in the case of 
cortisol, there appeared to be some evidence of two distinct populations diverging at blood 
concentrations of 300 to 400 nmol, with a strong relationship evident in one of these. Also, a 
strong relationship between CSF and blood levels emerged in the in a sub-group of 
participants on exogenous steroid administration (Guazzo et al., 1996).  
 
Many studies have examined aspects of HPA axis dysfunction using the variety of 
methodologies described above. These are briefly discussed in the following section before 
reviewing the evidence for the utility of examining the ratio of adrenal steroid secretion. 
 
1.4.2 Peripheral and basal abnormalities in mood disorders 
The first systematic studies of the abnormalities in steroid hormone secretion in psychiatric 
illnesses were carried out by Board and colleagues over half a century ago (Board et al., 1956; 
Board et al., 1957). These initial findings were subsequently replicated by other groups and 
extended to show that levels reduced as patients recovered (Gibbons & McHugh, 1962; 
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Gibbons, 1964, 1966). Many studies have replicated these findings using a variety of 
methodologies and collection methods.  
 
1.4.2.1 Urinary levels 
In major depression, elevated urinary cortisol levels have been reported in many studies (e.g. 
Carroll et al., 1976a; Kathol et al., 1989; Maes et al., 1998; Scott & Dinan, 1998) and may 
persist in recovery in some patients (Kathol, 1985). Although this pattern may not be evident 
in some sub-groups of patients and may even reverse with age/ illness chronicity (Oldehinkel 
et al., 2001). Urinary DHEA levels have similarly been found to be elevated (Tollefson et al., 
1990). The psychotic sub-type of unipolar and bipolar disorders also appears to be associated 
with higher urinary cortisol levels (Wedekind et al., 2007).  
 
More recently, comprehensive analysis of multiple urinary steroid metabolites in medication-
free patients with recurrent unipolar major depression revealed sex differences in some 
metabolites (Poor et al., 2004). In male patients (compared to male controls) levels of DHEA, 
as well as tetrahydrocorticosterone (THB), allo-THB, beta-cortolone (beta-CL) were found to 
be significantly decreased. However, in female patients, DHEA levels did not significantly differ 
from their respective control group, although cortisol and allo-THB levels were significantly 
elevated, and etiocholanolone and beta-CL levels were significantly decreased (Poor et al., 
2004). Relationships between the ratio of cortisol and DHEA and their metabolites have also 
been examined in MDD in relation to symptom severity, with 11-beta-hydroxysteroid 
dehydrogenase (HSD) being correlated with severity in women, and 17-beta-HSD being 
positively correlated with severity in women but negatively correlated in men (Raven & Taylor, 
1998).  
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Few studies have directly compared groups of patients with different diagnoses, although of 
those that have it has been found that 24-hour urinary cortisol levels were higher in affective 
disorders compared with schizophrenia (Diebold et al., 1981; Yehuda et al., 1993).  
 
1.4.2.2 Saliva 
As discussed earlier, because of the ease with which samples can be collected, many studies 
have examined steroid levels in saliva (those assessing both cortisol and DHEA or the ratio in 
the same samples are presented in more detail subsequently in this chapter).  
 
Recently there has been interest in the measurement of cortisol levels in saliva for the first 
hour after waking when cortisol levels are known to sharply rise. Several studies have 
demonstrated that clear abnormalities can be observed in patients with mood disorders. 
Unmedicated depressed patients have been found to secrete up to 25% more cortisol in the 
first hour after waking than control subjects (Bhagwagar et al., 2005). This increased cortisol 
awakening response (CAR) has been found to persist in remitted depressed patients 
(Bhagwagar et al., 2003). Similarly, increased CAR has been observed in clinically well patients 
with bipolar disorder, with normal DST responses (Deshauer et al., 2003) and recently in 
young high-risk subjects who had never personally suffered from depression but who had a 
biological parent with a history of major depression (Mannie et al., 2007). However, it should 
be noted that the interpretation of results of the CAR can be complex as some authors have 
highlighted that a blunted CAR can also be assumed to be abnormal (Aas et al., 2010). 
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1.4.2.3 Plasma and CSF 
Plasma sampling has often been adopted to take point-estimates of adrenal steroid secretion 
although as discussed, the pulsatile nature of release limits interpretation of findings. Of 
greater interest are those studies that have sampled at multiple time-points throughout the 
day to accurately profile the pattern of steroid secretion. One method proposed by Halbreich 
–  sampling cortisol levels in plasma every half-hour (from 1pm to 4pm) correlates well with 
24-hr cortisol levels and provides a reliable estimate of hypercortisolaemia (Halbreich et al., 
1982).  
 
Other studies have used even more extended sampling periods. Wong and colleagues (Wong 
et al., 2000) performed a comprehensive assessment of plasma and CSF steroids every 30 
minutes over 30 hours in medication-free melancholic MDD patients. ACTH levels were not 
significantly different from healthy controls. However, cortisol levels were significantly 
elevated as was the cortisol/ACTH ratio suggesting a relatively greater plasma cortisol 
response to a given simultaneous level of plasma ACTH (Wong et al., 2000). CSF cortisol levels 
have been shown to be elevated in both unipolar and bipolar disorder, with even greater 
levels evident in patients with psychotic features (Carroll et al., 1976b).  
 
Those studies assessing DHEA(S) levels in affective disorders present a somewhat mixed 
picture (for an overview see (van Broekhoven & Verkes, 2003)), although many have looked at 
the effect on depressive symptoms rather than a clear diagnosis of mood disorder. Other 
differences likely arise due to methodological factors or through assessment of steroids in 
isolation rather than considering the relationship with other adrenal steroids (see below).  
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1.4.2.4 The Cortisol/DHEA ratio 
It has been suggested that the assessment of cortisol or DHEA(S) alone may not be as 
informative as calculating the ratio of the two steroids – the cortisol to DHEA or 
DHEAS/cortisol molar ratio (Hechter et al., 1997). The notion is that DHEA(S) may maintain 
cortisol homeostasis by acting as a cortisol antagonist, particularly during periods of prolonged 
glucocorticoid hyperactivity. Several lines of evidence have shown that a variety of stressors 
result in a shift in the balance of cortisol and DHEA(S), in that there is an increase in cortisol 
synthesis and a decrease in androgen synthesis. In critical illness it has been demonstrated 
that not only do plasma levels of cortisol increase and DHEA decrease, but sensitivity of both 
to ACTH-stimulation is also correspondingly altered (Parker et al., 1985). Similarly, during 
acute psychological stress, stimulation of adrenal steroid release is accompanied by a shift 
towards DHEA release (Oberbeck et al., 1998). This has also led to the recognition of the 
potent antiglucocorticoid properties of DHEA(S) (Kalimi et al., 1994) (and its active 
metabolites, see (Muller et al., 2006)). In animals it has been demonstrated that DHEA 
protects hippocampal neurons against neurotoxin-induced cell death, possibly by decreasing 
nuclear GR levels (Cardounel et al., 1999). DHEA(S) has also been shown to inhibit 
glucocorticoid-induced enzyme activity (Browne et al., 1992). In healthy humans, acute 
administration of DHEA has been shown to rapidly reduce circulating cortisol levels (Wolf et 
al., 1997) while reduction in 24 hour levels have been demonstrated with longer treatment 
trials in healthy older subjects (Kroboth et al., 2003).  
 
Since DHEA levels appear to have regulatory effects on glucocorticoid action in the brain, it 
has been argued that the ratio of cortisol to DHEA most accurately reflects the degree of 
‘functional’ hypercortisolaemia (Goodyer et al., 1998; Wolkowitz et al., 2001; Gallagher & 
Young, 2002). Together, these studies highlight the importance of considering the somewhat 
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symbiotic relationship between cortisol and DHEA(S) and suggests that examination of each in 
isolation may fail to be as informative as assessment of the ratio of the two. 
 
An extensive series of longitudinal studies examining risk factors for the development of mood 
disorders in adolescents by Goodyer and colleagues (Goodyer et al., 1996; Herbert et al., 
1996; Goodyer et al., 1998; Goodyer et al., 2000a, 2000b; Goodyer et al., 2001a; Goodyer et 
al., 2001b; Goodyer et al., 2003) showed that the secretion of adrenal steroids is altered and 
of predictive utility. In saliva samples collected over 48 hours it was found that elevated 
evening cortisol and lower morning DHEA secretion were significantly, and independently, 
associated with major depression (Goodyer et al., 1996). Different patterns of adrenal steroid 
secretion were associated with co-morbidity (Herbert et al., 1996). 
 
Young and colleagues (Young et al., 2002) assessed salivary cortisol to DHEA molar ratios over 
2 consecutive days (at 8 am and 8 pm) in 44 medication-free major depressed patients 
compared to their matched controls. All patients were drug-free for at least 6 weeks although 
most were entirely medication-naïve (n = 26/44) and of the 18 who had previously received 
psychotropic medication, the time drug-free ranged from 6 to 336 weeks (median = 48 
weeks). Depressive symptom scores in the patient group ranged from 15 to 30 (mean = 21) on 
the Hamilton Depression Rating Scale. Thirty patients (68%) were experiencing their first 
episode of depression. Although cortisol levels were elevated and DHEA levels decreased in 
the patient group, neither difference reached statistical significance however the molar 
cortisol/DHEA ratio was significantly elevated. It should be noted that saliva was collected 
using a salivette device which, as discussed previously, studies have shown can affect the 
accuracy of DHEA measurement (Granger et al., 1999; Shirtcliff et al., 2001; Gallagher et al., 
2006).  
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In a comparison of depressed and remitted patients with major depressive disorder (the 
majority of whom were taking antidepressant medication) and matched controls, Michael and 
colleagues reported that salivary cortisol to DHEA ratios were significantly elevated, both at 8 
am and 8 pm, compared to remitted patients and healthy controls who did not significantly 
differ. Furthermore, in a post hoc analysis, taking the 85th percentile morning (8 am) 
cortisol/DHEA ratio of the control group as a cut-off, 82.5% of the depressed group had 
cortisol/DHEA ratios that were equal to or greater than this value, while this occurred in only 
15% of healthy controls (Michael et al., 2000).  
 
Using an intensive sampling methodology, Heuser and colleagues collected blood samples 
every 30 minutes over 24 hours in 26 depressed patients and 33 controls for assessment of 
cortisol and DHEA levels. Mean cortisol and DHEA levels, and minimum DHEA level was found 
to be elevated over the 24 hour period compared to controls (Heuser et al., 1998). An 
elevation in both cortisol and DHEA was also observed in a smaller group of female depressed 
patients (Weber et al., 2000). However the cortisol to DHEA molar ratio was not calculated in 
either study. Interestingly, it was noted that these finding differed from a smaller earlier study 
which sampled blood at single time-points where cortisol levels were significantly elevated 
while DHEA did not differ (Osran et al., 1993). Here the cortisol to DHEA ratio was also 
calculated and was found to be elevated in the morning (8 am) samples but not at 4 pm 
(Osran et al., 1993). Elevated cortisol levels and cortisol to DHEA ratios have also been found 
in un-medicated female MDD patients with co-morbid borderline personality disorder (Kahl et 
al., 2006) and in elderly depressed patients (Ferrari et al., 2004) although ageing itself is noted 
to significantly reduce DHEAS secretion (Ferrari et al., 2001a; Ferrari et al., 2001b).  
 
More discrepant results have been found in studies adopting single plasma-sampling 
methodology. In medication-free subjects (>4 weeks), Scott and colleagues (Scott et al., 1999) 
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found evidence of increased ratios of both cortisol to DHEA, and cortisol to DHEAS. When 
assessed individually, neither cortisol nor DHEA levels differed significantly from controls 
although DHEAS levels were lower in the patients (Scott et al., 1999). However, lower levels of 
both DHEA and cortisol with no difference in DHEAS have also been reported (Jozuka et al., 
2003) although here the ratio was not calculated.  
 
Other studies measuring the sulfated form have found elevated salivary DHEAS levels, even in 
the absence of abnormal cortisol levels in medicated patients with MDD. Although the sample 
size was somewhat modest, discriminant analysis indicated that 77% of subjects could be 
correctly classified by evening DHEAS levels (Assies et al., 2004). In a preliminary study, 
Takebayashi and colleagues found DHEAS and cortisol levels to be significantly elevated 
compared to controls in plasma samples taken at baseline in an outpatient sample (aged <45 
years). Following treatment, DHEAS had significantly decreased. There were no differences in 
the DHEAS to cortisol ratio of patients and controls at any point (Takebayashi et al., 1998). In 
one study of older depressed patients (>60 years) compared with matched controls, no 
differences in DHEA(S) to cortisol ratios were reported (Fabian et al., 2001).  
 
Very little work has been carried out on assessing cortisol to DHEA ratios in patients with 
bipolar disorder. Using a repeated plasma sampling protocol, hypercortisolaemia has been 
observed in bipolar patients (with depressive symptoms) compared with controls (chapter 2), 
without alteration in DHEA levels or cortisol to DHEA molar ratio (Gallagher et al., 2007) 
 
1.4.3 Activating/integrated tests 
The most sensitive tests of HPA axis function, however, are ‘activating’ tests whereby 
neuroendocrine responses are measured following pharmacological challenge. These are 
preferred not only because of their increased sensitivity, but because they elucidate 
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functional changes in the HPA axis at the receptor level (Watson et al., 2006a). The GR agonist 
dexamethasone has been used widely to examine HPA axis negative feedback integrity (Rush 
et al., 1996). An abnormal (non-suppressed) cortisol response to dexamethasone 
administration has been described in patients with mood disorder (Rush et al., 1996) and may 
be more pronounced in those with psychotic features (Duval et al., 2000). The combined 
dexamethasone/corticotropin releasing hormone (dex/CRH) test (Heuser et al., 1994) is also 
abnormal during relapse (Heuser et al., 1994; Modell et al., 1997) and persists in recovery, 
particularly in bipolar disorder (Rybakowski & Twardowska, 1999; Watson et al., 2004; Watson 
et al., 2007). Furthermore, corticosteroid receptor  abnormalities have been observed in post-
mortem studies which show evidence of regionally-specific changes in MR and GR mRNA 
expression in post-mortem brain tissue samples from patients with mood disorders (Knable et 
al., 2001; Webster et al., 2002; Lopez et al., 2003). 
 
It has been suggested that raised cortisol is a marker of prognosis and that HPA axis 
dysfunction and persistent hypercortisolaemia are likely to identify those patients who are 
either not improving or are likely to be vulnerable to relapse. In a study of depressed patients 
treated with the SSRI fluoxetine (Young et al., 2004b), non-responders showed abnormal HPA 
axis reactivity, whilst responders did not differ from healthy controls. A meta-analysis of the 
dexamethasone suppression test (DST) as a predictor of treatment outcome concluded that 
although DST status at baseline was not predictive of response to antidepressant treatment, 
persistent non-suppression DST after treatment was associated with high risk of early relapse 
and poor outcome after discharge from hospital (Ribeiro et al., 1993). Several studies have 
examined neuroendocrine responses to the dex/CRH test in depression and have found 
relationships with relapse or treatment response (Ising et al., 2007). For example, it has been 
shown that in clinically remitted major depression, post-treatment responses to the dex/CRH 
were significantly higher among patients who relapsed (Appelhof et al., 2006; Aubry et al., 
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2007).  It has been argued that early improvement, early treatment response and beneficial 
treatment outcome are associated with a lower HPA axis activity (assessed using the dex/CRH) 
and that, in the longer-term, HPA axis dysregulation increases in parallel with the number of 
previous episodes (Hatzinger et al., 2002). 
 
 
1.5 Is there any evidence of a link between HPA axis dysregulation and 
neuropsychological impairment? 
 
In the following section evidence for the direct relationship between cortisol and cognition is 
examined. First the work from animal studies is discussed before focussing on the extension of 
this to healthy human subjects and clinical conditions, particularly mood disorders. It should 
be noted that this will broadly examine the topic as more detailed reviews are available 
elsewhere, such as the acute effects of glucocorticoids on cognition (Lupien & McEwen, 1997; 
Het et al., 2005), the effects of stress on cognitive function (Sauro et al., 2003), and the 
modulatory effects of emotional content on memory (Roozendaal et al., 2008). 
 
1.5.1 Animal work 
Much of the work from animal models brings together two lines of study – the known effects 
of corticosteroids on hippocampal function and the role of the hippocampal formation in 
learning and memory. Lupien and McEwen comprehensively reviewed the literature on the 
acute effects of corticosteroids on memory in animals and humans (Lupien & McEwen, 1997). 
The overall pattern of results highlight that there are clear dose-related effects that elicit 
either facilitation in memory, as doses rise from sub-optimal to optimal levels, or impairment 
at higher doses and therefore show an inverted “U”-shape relationship. The role of the 
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specific receptor sub-types in different stages of memory formation can be separated from 
the effects of glucocorticoids have on general arousal. The model proposes that the dose-
response relationship emerges because of differential activation of MR or GR, especially in the 
hippocampus, with MR being involved in the processes of sensory integration and GR with 
acquisition and consolidation of the memory trace (Lupien & McEwen, 1997). It is also 
noteworthy that some of these effects may occur via interaction with neurotransmitter/ 
hormone complexes, such as sex hormones (Symonds et al., 2004; Kuhlmann & Wolf, 2005) 
and noradrenergic (Quirarte et al., 1997; Roozendaal et al., 2006) or serotonergic (McAllister-
Williams et al., 1998; Porter et al., 2002; Pariante et al., 2004a; Porter et al., 2004) systems. 
For example, chronic elevation of glucocorticoid levels, by corticosterone administration or 
stress, causes functional desensitization of the 5-HT1A autoreceptor (Lanfumey et al., 1999; 
Fairchild et al., 2003). Functional 5-HT1A autoreceptor desensitization also occurs when 
corticosterone rhythm is flattened at a level around the mid-diurnal level (Gartside et al., 
2003; Leitch et al., 2003). Recently it has been noted that endocannabinoids in the amygdala 
enhance memory consolidation and that cannabinoid-receptor activity within this brain region 
may be required for enabling glucocorticoid effects on such memory processes (Campolongo 
et al., 2009). 
 
1.5.2 Healthy human work 
In humans it has been suggested that  a distinction be made between the effect of 
corticosteroids on general arousal or attention and their effect on specific memory processes, 
paralleling that described in the animal literature (Lupien & McEwen, 1997). Several studies 
have demonstrated verbal declarative memory deficits following administration of 
hydrocortisone (Wolkowitz et al., 1990; Newcomer et al., 1999). Those that have examined 
different stages of information processing have argued that this is specifically an effect on 
memory retrieval (de Quervain et al., 2000; de Quervain et al., 2003). This appears discrepant 
Page | 85 
from the findings in rodents where the effects are on acquisition and consolidation. However 
de Quervain and colleagues suggest that it is the delay interval (24 hours) that is crucial to this 
difference. Although memory is impaired in humans by pre-learning administration of cortisol 
(e.g. Newcomer et al., 1999) glucocorticoid levels may remain elevated at the time of testing 
in these experiments. Thus it is possible that such results actually reflect impaired memory 
retrieval rather than altered memory acquisition or consolidation. A recent review has also 
highlighted the effect of diurnal changes in cortisol levels on the memory effects of 
glucocorticoids (Het et al., 2005). It is worth noting that all of these studies have used 
declarative verbal recall to assess performance, although it has been proposed that verbal 
working memory may be more sensitive than declarative memory to the acute effects of 
glucocorticoids (Lupien et al., 1999). There is also evidence that after sub-chronic doses of 
hydrocortisone,  spatial working memory is also impaired (Young et al., 1999). This introduces 
interesting opportunities to parallel the work in animals which has a focus on spatial memory 
and the hippocampus. Including emotional content into the word lists can further affect the 
pattern of impairment and facilitation following cortisol elevation  (for more detailed primary 
data and reviews see for example Wolf et al., 2004; Smeets et al., 2008; Wolf, 2008).  
 
 A meta-analysis has suggested a more complex picture of the effects of stress on memory (i.e. 
when memory is assessed following acute laboratory stress or long term exposure to rising 
basal levels of glucocorticoids) compared with that found after pharmacological manipulation 
(Sauro et al., 2003). This highlights the difficulty of generalising results across differing 
methods of HPA axis manipulation, and an even greater degree of complexity when 
attempting to apply these models of glucocorticoid-cognition interactions to clinical 
conditions in which cortisol levels/receptor dysfunction may be present over long periods of 
time. Broadly, clinical studies can be separated into those that have looked for direct 
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associations between cortisol levels and cognitive performance and those that have used 
markers of the general magnitude of HPA disturbance and neuropsychological impairment.  
 
1.5.3 Clinical conditions 
That hypersecretion of cortisol may be causative in the development of depression is 
suggested by findings in patients with Cushing’s disease/syndrome (CD/CS). Typically, 
individuals have plasma cortisol levels that are three-fold those of healthy subjects, and within 
this group the prevalence of depression is higher than in the normal population (Cohen, 1980; 
Kelly et al., 1983). Furthermore, depressive symptoms resolve on treatment of the primary 
endocrine disorder (Cohen, 1980; Kelly et al., 1983). Importantly, there is also clear 
impairment in neuropsychological functioning in these individuals. A number of studies have 
now demonstrated impairments in learning and memory, delayed recall, and visual-spatial 
ability (Whelan et al., 1980; Mauri et al., 1993; Forget et al., 2000; Starkman et al., 2001).  
 
Particular focus has also been placed on the effects of hypercortisolaemia in CS/D on 
hippocampal structures, where volume reductions have been noted in a significant proportion 
of patients (Starkman et al., 1992). These reductions are noted to be strongly correlated with 
impairment on tasks of verbal learning and recall – tasks known to be sensitive to 
hippocampal complex/temporal lobe dysfunction – and also with the degree of 
hypercortisolaemia (Starkman et al., 1992). Multiple mechanisms by which glucocorticoids 
induce these morphological changes in the brain have been posited, including decreased 
glucose utilization, increased actions of excitatory amino acids, inhibition of long-term 
potentiation and decreased neurotrophic factors, and decreased neurogenesis (Patil et al., 
2007).  It should be noted that in CS/D, the temporal relationship between treatment and 
recovery of neuropsychological functioning is not always coincident (Forget et al., 2002).   
 
Page | 87 
 Zobel and colleagues found that antidepressant treatment-associated changes in the cortisol 
response to the dex/CRH test in patients with major depression were correlated with 
improvements in working memory but not with improvements in episodic memory, sustained 
attention or global severity of symptoms (Zobel et al., 2004). This is consistent with the results 
of studies in healthy subjects discussed above (Lupien et al., 1999). However this finding has 
not yet been replicated. In contrast, Reppermund and colleagues assessed neuropsychological 
performance and administered the dex/CRH test to a group of 75 depressed inpatients of 
which 51 (68%) were in remission at the point of discharge. Despite a significant reduction of 
depressive symptoms between admission and discharge, high rates of neuropsychological 
impairment were still observed. Selective attention did improve in remitted and non-remitted 
patients, while speed of information processing improved only in those who had remitted. The 
cortisol response to the dex/CRH test decreased significantly only in remitted patients, but 
this was not correlated with neuropsychological performance. In non-remitted patients, 
severity of depression was significantly correlated with information processing while 
improvement in short-term memory was negatively associated with the cortisol response at 
discharge. Thus, it appears that HPA axis dysregulation and symptom severity have differential 
effects on verbal short term memory and speed of information processing (Reppermund et al., 
2007). 
 
The potential importance of the association between the consequences of HPA axis 
dysregulation and neuropsychological performance was indirectly illustrated recently in a 
study by Gorwood and colleagues exploring the hypothesis of the ‘toxic’ effects of depression 
on the hippocampus. Using verbal declarative memory (the delayed paragraph recall index 
from the Wechsler Memory Scale-Revised) as a surrogate marker of hippocampal function,  
8,229 patients were assessed twice over an average 42 day period and Structural Equation 
Modelling used to assess the clinical and demographic factors predicting performance. At 
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presentation, current illness severity was an important determinant of performance, while 
previous depressive history (the number and length of past episodes) was not. At the follow-
up after significant clinical response, the intensity of previous depressive history was more 
significant than current symptoms. Crucially, an inverse relationship was found between 
performance and recurrence whereby each additional episode (up to 4 episodes) impaired 
verbal declarative memory performance by 2% to 3% (Gorwood et al., 2008). The direct 
relationship of this finding to measures of HPA axis dysregulation and hypercortisolaemia 
requires further study.  
 
Higher levels of morning salivary cortisol have been shown to be associated with post-
encoding memory retrieval and storage deficits and executive dysfunction in major 
depression, in the absence of any relationship with symptoms (Egeland et al., 2005). This is 
consistent with the findings of Reppermund and colleagues described above. In psychotic 
major depression, relationships between elevated mean cortisol levels (1800 to 0100 hours) 
and poorer verbal memory and psychomotor speed performance have been found, while the 
cortisol slope over this period significantly correlated with both verbal memory and working 
memory (Gomez et al., 2006). In contrast, one recent study in first-episode psychosis, a 
blunted CAR response3 was found to be was associated with a more severe deficit in verbal 
memory and processing speed (Aas et al., 2010). Inverse relationships between peripheral 
cortisol levels and general intellectual functioning, but not verbal declarative memory have 
also been reported in major depression (van Londen et al., 1998).  
 
 
 
                                                          
3
 It is noted by the authors that this blunted response is assumed to be abnormal.  
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1.6 General summary and implications for the current thesis 
The preceding chapter outlines the literature surrounding the main research themes for the 
present thesis and the subsequent three empirical chapters. In this chapter a general 
introduction to the illness was presented (1.2) followed by a review of neuropsychological 
impairments in bipolar depression (1.3) and one of the potential neurobiological 
underpinnings of this phenomenon, that is, HPA axis dysfunction (1.4,1.5). As has been 
discussed, of the time that patients are symptomatic, the majority of this time is in depression 
and therefore this is the focus of the current research. When depressed, individuals present 
with a broad range of neuropsychological impairments, with the largest effect sizes seen in 
aspects of executive functioning, verbal and visual free-recall and delayed recall/ recognition, 
and psychomotor fine-motor control. A significant proportion of individuals also exhibit HPA 
axis dysfunction and consequent hypercortisolaemia, which animal and human studies have 
implicated in the modulation of neuropsychological functions. Exploring these features of the 
illness is not only important from a treatment perspective, but in bipolar disorder itself we 
may have a clinical condition in which we have the opportunity to examine the link between 
corticosteroids and memory. 
 
Therefore, in Chapter 2, the first empirical study is presented which assesses 
neuropsychological functioning and hypercortisolaemia in individuals with bipolar disorder 
with depressive symptoms. In Chapter 3, the results of a study of the use of an 
antiglucocorticoid adjunctive treatment in the same participants are presented. The aim of 
this latter study is to examine the specific neuropsychological changes that occur as a result of 
modulating the HPA axis, specifically through GR antagonism and the potential amelioration of 
hypercortisolaemia.  
  
Page | 90 
 
Chapter II 
 
Neuropsychological functioning and the 
HPA axis in bipolar depression  
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2. Neuropsychological functioning and the HPA axis in bipolar 
depression 
 
2.1 Introduction to Chapter 2 
As discussed previously (General introduction, section 1.3.2) there are relatively few studies 
which have specifically examined neuropsychological function in bipolar depression. The aim 
of this first empirical chapter is to present the results of the initial assessment of 
neuropsychological functioning in 20 patients with bipolar depression (compared to 
performance in 20 healthy controls) who subsequently entered the study of adjunctive 
antiglucocorticoid treatment.  
 
The selection of neuropsychological tests was informed by the results of the review presented 
in Chapter 1.3.2 with the objective of broadly covering the domains described. Specifically, the 
intention was to include measures of executive function and attention, verbal and visuo-
spatial memory and psychomotor speed. Many of the individual tests selected were 
characterised by large effect sizes in the pooled analyses and therefore increase statistical 
power in the present comparison. However, it is important to note that at this stage, the aim 
was to profile these functions broadly and not just to select those tests with the largest 
effects. To afford some protection against Type-I statistical error, a multivariate approach will 
be taken with the analysis and individual tests examined following significant global effects 
(see Stevens, 2002). 
 
The neuroendocrine assessment was based on the method proposed by Halbreich of sampling 
cortisol levels in plasma, every half-hour, from 1pm to 4pm. This sampling period correlates 
well with 24-hr levels and provides a reliable estimate of hypercortisolaemia (Halbreich et al., 
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1982). In addition, in a novel extension of this procedure, DHEA levels will also be measured in 
these samples to permit the estimation of cortisol-DHEA ratios (see General Introduction; 
1.4.1.3). 
 
2.2 Subjects and methods 
2.2.1 Ethical approval 
The study was approved by the Newcastle and North Tyneside LREC. After a full description of 
the study and all questions relating to the study had been answered, all subjects gave their 
written informed consent prior to inclusion. Subjects were free to leave the study at any point. 
 
 
2.2.2 Subjects 
2.2.2.1 Recruitment 
Patients were recruited by opportunity sampling through referring clinicians who first 
assessed their suitability for the study, based on their current clinical state. Most patients 
were referred via a tertiary mood disorders service in the North East of England. Expenses 
incurred for travel and subsistence were reimbursed.  
 
2.2.2.2 Matching of patient group to control reference sample 
A normative sample of healthy control data, matching the demographic profile of the patient 
sample, was collated from a large database on file. To avoid selection bias, the SAS ‘Match’ 
algorithm was used (Kosanke & Bergstralh, 1995). The macro is used to match one or more 
controls (from a total of M) for each of N cases. The control selected for a particular case(i) is 
the control(j) closest to the case in terms of Dij, where Dij is the weighted sum of the absolute 
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differences between the case and control matching factors. A maximum accepted difference 
(DMAXK) is used to define the largest possible absolute differences compatible with a valid 
match.  Cases are not matched to a control if any of the individual matching factor  differences 
are >DMAXK. The algorithm also offers a ‘greedy’ or ‘optimal’ matching method – in the case 
of the former, once a match between case and control is made it is never broken; in the case 
of the latter, the ‘PROC NETFLOW’ command is used to find the set of matches that minimizes 
the sum of Dij over all possible sets of matches. The optimal method was selected. The 
matching variable used were age, sex and NART estimated IQ (given the weighting 2:2:1 in the 
algorithm). The tolerance of the match was ±5 yrs in age, exact match in sex, and ±16 NART 
points. Although this range of NART scores is higher than would be expected for a ‘match’, as 
the program is producing case-control matches, the matching of the overall group is very 
similar to the mean and variance of the patient sample (see Appendix 9.2).  
 
2.2.2.3 Screening Assessment 
Bipolar patients underwent both physical examination and psychiatric assessment prior to 
inclusion.  
 
The physical examination was carried out to exclude significant medical illness, and past 
history of illness that may affect neuroendocrine or neurocognitive functioning. This included 
head-injury and neurological disorders. Further to this, some additional requirements 
pertaining to the antiglucocorticoid administration are described in chapter 3. 
 
The psychiatric assessment was performed as a structured clinical interview by experienced 
psychiatrists. Bipolar patients were required to fulfil DSM-IV SCID (First et al., 1995) criteria for 
a major depressive episode (MDE) and all general inclusion/ exclusion criteria set out in Table 
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2-1. Control subjects were required to have no current or past history of psychiatric illness, 
and no first degree relative with current or past history. Additional inclusion/ exclusion criteria 
are also set out in Table 2-1. 
 
During the screening interview, several rating scales were utilised to assess severity or 
subtype of depression in patients and to screen for depressive symptoms in controls. 
Descriptions of those used are presented below in Section 2.2.3. 
 
2.2.2.4 Inclusion / Exclusion criteria 
General inclusion/ exclusion criteria for the patient and control group are presented: 
 
 
Table 2-1. Inclusion/ Exclusion criteria for patients and control group 
BD patients Control group 
 Age 18 – 65 years  Aged 18 – 65 years 
 Fulfilling DSM-IV (SCID) 
criteria for bipolar disorder; 
current episode depressed (or 
with depressive symptoms) 
 No history of depression or psychiatric 
illness 
  No first-degree relatives with a  
history of depression or psychiatric 
illness 
  Beck < 8 
 No current alcohol 
dependence or abuse 
 Alcohol intake  28 units per week 
(female  21 units) 
 Physically healthy  Physically healthy 
 No ECT within the last 6 
months 
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2.2.3 Rating scales 
BD subjects were assessed using all rating scales described. Control subjects completed the 
Beck Depression Inventory only. 
 
2.2.3.1 Hamilton Depression Rating Scale (HAM-D) 
The HAM-D is a frequently used depression rating scale in experimental and clinical research. 
One limitation however, is that the scale was devised for use only on patients already 
diagnosed as suffering from affective disorder of the depressive type and as such, it is not 
suitable for administration to control subjects. 
 
The scale consists of 17 items (HAM-D17), some defined in terms of a series of categories of 
increasing intensity and others by a number of equal-valued terms . Eight items are scored 
from 0 to 4 (0 = absent, 1 = mild, 2-3 = moderate, 4 = severe) and 9 scored from 0 to 2 (0 = 
absent, 1 = slight or doubtful, 2 = clearly present). A 21-item version is available (HAM-D21) 
which includes 4 additional variables: diurnal variation, derealisation, paranoid symptoms and 
obsessional symptoms (see Appendix 9.3). Both versions were used in this study. The 
maximum score from the 17-item scale is 50, and from the 21-item the maximum is 62 
(Hamilton, 1960). 
 
2.2.3.2 Montgomery-Åsberg Depression Rating Scale (MADRS) 
The MADRS was designed as a rating scale for depression which was especially sensitive to 
change, and therefore is of particular use in clinical trials or in smaller cohorts. Sensitivity and 
accuracy of change estimates were the major criteria for the inclusion of items. The scale is 
useful as it can be used with any time interval between ratings (Montgomery & Asberg, 1979). 
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The scale consists of ten items: apparent sadness, reported sadness, inner tension, reduced 
sleep, reduced appetite, concentration difficulties, lassitude, inability to feel, pessimistic 
thoughts, suicidal thoughts. These are rated by the clinician on a six point scale, with 
descriptors provided for the defined scale steps 0, 2, 4 and 6. The maximum score for the 
scale is 60 (see Appendix 9.4). 
 
2.2.3.3 Beck Depression Inventory (BDI) 
This self-report scale provides an assessment of the intensity of depressive symptoms. The 
scale is suitable for use in both subjects with a confirmed diagnosis of depression and those 
without.  
 
The BDI consists of 21 categories, each one describing a specific behavioural manifestation of 
depression (see Appendix 9.5). For each category there is a graded series of 4 statements and 
each statement is assigned a score from 0 to 3. A description at the top of the BDI instructs 
the subject to read each statement in a category and to select the one which best represents 
how they have felt over the past week (Beck et al., 1961). The maximum score on the scale is 
63. 
 
2.2.3.4 Mania/hypomania 
The use of the SCID in the screening assessment meant that only patients meeting criteria for 
bipolar depression were included in the study. However, to assess low level manic symptoms, 
the Young scale was also administered (Young et al., 1978).  
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2.2.4 Neuropsychological Tests 
2.2.4.1 Design of the neurocognitive test battery 
The neurocognitive test battery was designed to test several broad cognitive domains, across 
several modalities (visuo-spatial and verbal/auditory). Full descriptions of each test are 
provided in the following section. 
 
Prior to administration of the main test battery, the NART (Nelson, 1982) was administered to 
estimate pre-morbid verbal IQ.  
 
 
Table 2-2. Neurocognitive test battery 
TEST DOMAIN 
1. NART General screening (estimated verbal IQ) 
2. Rey-AVLT Learning and memory (verbal) 
3. Vigil CPT Sustained attention / Executive  
4. Verbal fluency Executive 
5. Digit Span Immediate memory / Executive 
6. Rey-AVLT (Long-term) Learning and memory (verbal) 
7. SWM (CANTAB) Executive 
8. DSST Psychomotor 
9. PRec (CANTAB) Learning and memory (visuo-spatial) 
10. SRec (CANTAB) Learning and memory (visuo-spatial) 
11. SSp (CANTAB) Immediate memory  
12. Stroop Executive 
Computerised tests are shaded. Numbers represent order of administration. 
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2.2.4.2 Procedure 
For the neurocognitive assessment, all subjects were tested at 1300h, with the testing taking 
approximately 75 minutes to complete. The neurocognitive test battery was designed to 
assess a broad range of cognitive domains and included pen-and-paper and computerised 
tests. Pen-and-paper tasks were administered according to standardised instructions (Lezak, 
1995). Computerised tests were administered according to the CANTAB manual protocols, on 
a PC which was fitted with a colour touch-screen monitor fixed in a standardised position. 
Detailed descriptions of each test and details of their administration are given below. 
 
 
2.2.4.3 General Screening Tests 
2.2.4.3.1 National Adult Reading Test (NART) (Nelson, 1982) 
The NART was originally designed as a method of estimating pre-morbid verbal IQ in subjects 
with dementing conditions (Lezak, 1995). By using phonetically-irregular words, it is not 
possible for subjects to ‘sound out’ a word that is not already known to them. 
 
The version used in the present study consists of 50 such words (see Table 2-3) which the 
subject is required to pronounce correctly. The number of errors can then be converted to an 
estimate of pre-morbid verbal IQ. To ensure consistent administration of the test, a 
pronunciation guide is used by the experimenter in which the words are written using the 
International Phonetic Alphabet. 
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Table 2-3. Words from the National Adult Reading Test (NART) 
Chord Courteous Hiatus Facade Gauche 
Ache Rarefy Subtle Zealot Topiary 
Depot Equivocal Procreate Drachm Leviathan 
Aisle Naïve Gist Aeon Beatify 
Bouquet Catacomb Gouge Placebo Prelate 
Psalm Gaoled Superfluous Abstemious Sidereal 
Capon Thyme Simile Détente Demesne 
Deny Heir Banal Idyll Syncope 
Nausea Radix Quadruped Puerperal Labile 
Debt Assignate Cellist Aver Campanile 
     
 
2.2.4.4 Immediate (short-term) memory 
These tests are included separately as in theoretical terms they fit closely with current models 
of working memory architecture and are a good measure of phonological loop and visuo-
spatial sketchpad capacity (Baddeley & Hitch, 1974).  
 
2.2.4.4.1 Digit span (forwards) 
It this test, the participant is read a series of numbers and they are asked to repeat them in 
the same order as given. The length of the number sequence increases until 2 incorrect 
responses at any given level. The maximum span attainable is 9. 
 
2.2.4.4.2 Spatial span 
This is a computerised test from the CANTAB battery and is analogous to the Corsi blocks test. 
It is the spatial equivalent of the digit span test (above). Participants view a fixed array of 
boxes on the screen and these change colour in a random order. Participants are then asked 
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to tap out the same sequence on the computer touch-screen. The test terminates with three 
incorrect responses at any given level. The maximum attainable span is 9. 
 
2.2.4.5 Attention and Executive Function 
2.2.4.5.1 Vigil Continuous Performance Task 
This is a continuous performance test that measures the ability to sustain attention over a 
period of time (Cegalis & Bowlin, 1991). It is a computerised test lasting 8 minutes in which 
single letters are flashed on the screen for 85 milliseconds (ms), with a gap of 915ms from one 
letter to the next, during which time the screen is blank.  The subject is required to respond to 
the letter sequence of an ‘A’ followed by a ‘K’, and not to respond to any other stimuli. During 
the 8 minutes the subject is shown 480 trial stimuli (letters), among which there are 25 target 
stimuli (‘A-K’ sequences) in each 2 minute quarter of the test (100 in total). Response latency 
and errors of omission (where subjects fail to respond to an A-K sequence) and commission 
(where subjects respond to a stimulus other than the A-K sequence) are recorded. 
 
Figure 2-1. Vigil Continuous Performance Test 
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2.2.4.5.2 Spatial Working Memory (SWM) 
This is a self-ordered search task which places demands on spatial working memory and 
executive function. Subjects must search through an increasing number of “boxes” (two, 
three, four, six, or eight) for a hidden token. Once a token is found, it will not appear in the 
same box again. Subjects must continue the search without returning to a box which has 
already contained a token. Accuracy is measured as the number of between search errors (the 
number of times boxes which have already contained tokens on previous trials are searched) 
and within search errors (the number of times boxes which have already been examined on 
the current trial are searched).  
 
A strategy score is also computed, based on the use of a systematic search pattern on the 6 
and 8 box problems. Higher scores indicate less use of the strategy. 
 
Figure 2-2. CANTAB Spatial Working Memory test 
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2.2.4.5.3 Controlled Oral Word Association Test (Benton’s FAS) 
This is a test of verbal fluency which is sensitive to frontal lobe damage (Lezak, 1995). There 
are 3 trials, each lasting 60 seconds, in which subjects are required to list as many words as 
possible, beginning with the given letters – ‘F’, ‘A’ and ‘S’, excluding proper nouns, numbers or 
repetitions of the same word with a different suffix. Accuracy is measured as the overall 
number of legitimate correct words. 
 
2.2.4.5.4 Stroop 
There are many variants of the original Stroop test (for a review see MacLeod & MacDonald, 
2000). The version used here has 2 parts to it: in the first, participants must read aloud the 
printed names of colours as quickly as possible. Time to complete is recorded. In the second 
part, participants are required to inhibit this response and instead state the colour of the ink 
that each word is incongruously printed in. Number correctly completed in 120 sec is recorded 
(Trenerry et al., 1989).  
 
2.2.4.5.5 Digit span (reverse) 
This is the second part of the span task described above (section 2.2.4.4.1). Administration is 
identical with the exception that participants must repeat back the sequence of digits in 
reverse order, thus placing greater demands on the online maintenance of working memory.  
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2.2.4.6 Psychomotor Performance 
2.2.4.6.1 Digit Symbol Substitution Task (DSST) 
This is a test of psychomotor speed and selective sustained attention from the Wechsler Adult 
Intelligence Scale-Revised (WAIS-R; (Wechsler, 1981)). The test consists of four rows of 25 
blank squares, each with a random number between 1 and 9 associated with it. At the top of 
the page is a printed key in which each different number has been associated with an 
geometric symbol. Subjects are allowed to complete 7 samples which are not timed, and are 
then instructed to work as ‘quickly and as accurately as possible’ to work through each row/ 
square in order and draw the appropriate matched symbol in each of the squares given. The 
test is terminated after 90 seconds and the number correct in this time is recorded. 
 
 
2.2.4.7 Learning and memory (verbal) 
2.2.4.7.1 Rey – Auditory Verbal Learning Test (Rey – AVLT) 
This test measures immediate memory, provides a learning curve, elicits retroactive and 
proactive interference tendencies and tendencies to confusion or confabulation on memory 
tasks and measures both short-term and longer-term retention following interpolated activity 
(Rey, 1964; Lezak, 1995).  
 
It begins with a test of immediate word recall: for trial I, the examiner reads a list of 15 words 
(List A) at the rate of one per second. The subject is instructed to repeat back as many of the 
words as possible, in any order.  This is then repeated a total of five times, with recall of the 
list recorded after each one  (Trial I to V).  
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Immediately after trial V, the experimenter then reads out a different list of words (List B), 
instructing the subject to again repeat back as many words as possible. Following the B-list 
trial, the examiner asks the patient to recall as many words from the A-list as possible (trial VI) 
without further presentation of that list.  
 
After a 30 minute delay, recall of List A is again tested (trial VII). A recognition trial is normally 
given whenever a subject’s delayed recall is less than 13 words, however all subjects in the 
present study completed this trial. In testing recognition, the administrator asks the patient to 
identify as many words as possible from List A when shown a list of 50 words containing all 
the items from both the A and B lists as well as words that are semantically associated or 
phonemically similar to words on lists A or B. 
 
The number of words correctly recalled or recognised are recorded. As performance on the 
final 2 recall trials of List A depends upon how well the words were initially learned, these 
scores are calculated as a percentage of the maximum score from the first 5 recalls. 
Interference indices can also be derived: Proactive inhibition, where previously learned 
material interferes with the acquisition of new material, can be calculated by subtracting the 
first recall of List A from recall of List B and Retroactive inhibition, where material learned after 
the to-be-remembered list interferes with subsequent recall of that list, can be calculated by 
subtracting the fifth recall of List A from the sixth. 
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2.2.4.8 Learning and Memory (visuo-spatial) 
All tests of visuo-spatial learning and memory were from the CAmbridge Neuropsychological 
Test Automated Battery (CANTAB). 
 
2.2.4.8.1 Pattern Recognition (PRec) 
This is a test of visual recognition memory. A total of 24 visual patterns are presented in the 
centre of the screen (in 2 sets of 12) for three seconds each. These patterns are designed so 
that they cannot easily be give verbal labels. In the recognition phase, after a delay of five 
seconds, pairs of patterns are presented. Subjects are required to choose between a pattern 
they have already seen and a novel pattern. The test patterns are presented in the reverse 
order to the original order of presentation. Immediate auditory and visual feedback (a green 
tick or a red cross) is provided for accuracy of response. Accuracy measured as the total 
percentage correct. Speed of response is also recorded, measured as the latency between the 
pair of patterns appearing on the screen and the subject’s response. 
 
2.2.4.8.2 Spatial Recognition (SRec) 
This is a test of spatial recognition memory. The subject is presented with a white square that 
moves in sequence to five different locations on the screen. Each remains on the screen for a 
total of 3 seconds. In the recognition phase, after a 5 second delay, the subject sees a series of 
five pairs of squares, one of which is in a location not seen in the presentation phase. The 
subject must touch the box which is in exactly the same location as one of those in the initial 
presentation sequence. As with the pattern recognition test, locations are tested in the 
reverse of the presentation order. A total of four trials are completed. Total percentage 
correct and response latency are recorded. 
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Figure 2.1: CANTAB Pattern Recognition test 
 
 
Figure 2.2: CANTAB Spatial Recognition test 
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2.2.5 Neuroendocrine Testing 
In order to profile plasma cortisol and DHEA secretion, subjects were canulated in the 
antecubital fossa at 12:30 p.m. and blood samples (~5ml) collected at 30 minute intervals 
from 1:00 p.m. to 4:00 p.m. (Halbreich et al., 1982). Subjects fasted throughout this period, 
remained semi-supine and did not sleep. Following extraction of serum by centrifugation, 
samples were immediately frozen and stored at -20°C. This process was carried out by an 
experienced research nurse.  
 
All assays were performed by staff in the Psychiatry Research Laboratory, Newcastle 
University, under the supervision of senior technician. Sections 2.2.5.1/ 2.2.5.2 below are 
descriptions of the assay procedure provided by the senior technician. Details of plasma and 
saliva methods are presented here (saliva is used subsequently in Chapter 6.2). 
 
2.2.5.1 Cortisol assay 
Cortisol was measured using a commercial radioimmunoassay kit (corti-count, ICN).  For the 
determination of cortisol the manufacturer’s instructions were followed. Briefly, 25µl of 
plasma/plasma quality control (QC)/plasma std (27.6 to 1656nmol/l) were incubated at 37°C 
for 45mins with 500µl of cortisol 125I-tracer in cortisol antibody coated tubes. At the end of the 
incubation the liquid from each tube was decanted and the tubes inverted and left to drain on 
absorbent paper for 3mins. Tubes were counted for 1min in a gamma counter (Riastar 5410, 
Packard). Cortisol concentrations in the samples were determined by interpolation from the 
standard curve. 
 
QCs (plasma spiked with a known amount of cortisol) were included with each assay and QC 
rules were applied (Westgard et al., 1981). The mean cortisol values (nmol/l) for plasma (and 
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saliva) QCs spiked with cortisol were: 102.6 (4.0); 240.7 (21.5); 451.5 (60.8). Intra- and inter- 
assay CVs (%) for the above plasma (and saliva) QCs were: 5.9/5.6 (10.5%/9.6%); 8.1/8.5 
(6.8%/7.0%); 8.1/8.7 (6.2%/8.1%) respectively.   
 
2.2.5.2 DHEA assay 
DHEA was measured in extracted saliva/plasma using a modified DHEA tritium 
radioimmunoassay kit (ICN).   
 
DHEA was extracted from 500µl of saliva into 5ml ethyl-acetate:hexane (3:2 v/v).  For plasma, 
2ml of ethyl-acetate:hexane (3:2 v/v) was added to 200µl of sample.  Extraction QCs (sample 
spiked with a known quantity of 3H-DHEA) were included to assess extraction efficiency. 
Typically the recovery from the sample was >80%. The organic phase was removed and 
evaporated to dryness under a gentle stream of air.   
 
The dry saliva extract was reconstituted in 1.2ml steroid diluent (2.5 ml for plasma extract) 
and analysed in duplicate as follows. 100µl of 3H-DHEA tracer (ICN) and 100µl of antiserum 
(ICN) was added to 500µl of reconstituted sample/standard (0-0.5ng/500µl)/QC (steroid 
diluent spiked with DHEA) and incubated overnight at 4°C. The free ligand was separated from 
the bound fraction by the addition of 200µl of dextran/charcoal (ICN) which was incubated for 
20mins at 4°C before centrifuging at 2500RPM for 15mins at 4°C. The supernatant was 
decanted into scintillation vials and 3ml of scintillant (Fisher) added before counting for 2mins 
in a β-counter (Tri-Carb 2100TR, Packard). The cross reactivity of the antibody for DHEA-S was 
less than 1.2%. DHEA concentrations in the sample were calculated from the standard curve 
after correction for extraction efficiency.  QCs were included with each assay and QC rules 
applied (Westgard et al. 1981). The calculated values (ng/ml) for QC's used in the DHEA RIA 
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assay were 0.075, 0.2, 0.5.  Actual measured values were 0.06, 0.17, 0.47.  The intra- and 
inter-assay CVs for the entire procedure were 13.0% and 13.5% respectively for saliva; 18.0% 
and 12.2% for plasma. 
 
 
2.2.6 Statistical Analysis 
2.2.6.1 General data presentation and analysis approach 
Descriptive statistics are presented as mean, standard deviation (s.d.) and range. For graphical 
presentation of results, bar charts are presented as mean, with error bars representing  1 
standard error of the mean (SEM). The general approach to data analysis will be parametric. 
The distribution of the data will be assessed using the Shapiro-Wilk’s test and Levene’s test for 
normality and homogeneity of variance respectively. Data will further be visually inspected 
using histograms and box plots to identify outliers. Where possible, transformations will be 
applied to data or otherwise supported using the equivalent non-parametric test. 
 
2.2.6.2 Neuropsychological data analyses 
A frequent problem associated with studies of neuropsychological function is the number of 
comparisons that are made in the analysis, increasing the likelihood of committing a type I 
error. One approach which has been suggested to overcome this is to adopt a multivariate 
approach to confirm an overall effect of group, prior to examination of individual tests. Similar 
to all parametric analysis methods there are assumptions about the data underlying the use of 
this method which include independence, multivariate normality and equality of the 
population covariance matrices of the dependent variables. However, with respect to Type I 
error, the MANOVA is generally robust to the latter of these two assumptions (Stevens, 2002).  
Page | 110 
This method was therefore adopted to confirm that a significant multivariate statistic was 
present before univariate comparison and presentation of simple effect sizes (Cohen’s d). 
Effects sizes are presented with estimates of the 95%CI for d (Calculator available from the 
Centre for Evaluation and Monitoring: http://www.cemcentre.org). Further detailed analysis 
was carried out using analysis of variance (ANOVA) with group (BD or controls) as a between 
subjects factor. Where a test has more than one level (i.e. Rey-AVLT, learning trials; Vigil, time 
quarter; SWM, problem level) an additional within subject factor of ‘time’ or ‘level’ was added 
where appropriate. Where ANOVA sphericity was violated according to Mauchly’s Test, 
Huyhn-Feldt epsilon-adjusted significance levels (p|hf|) are reported although unadjusted 
degrees of freedom are reported for clarity (Field, 2000). Similarly, if homogeneity of variance 
was violated, the adjusted t and significance levels were reported.  
 
Crawford’s method was used to assess if differences qualified as true differential deficits 
(Crawford et al., 2000). (Also see discussion in section 1.3.1.2). 
 
2.2.6.3 Neuroendocrine data analyses 
Data were log (base 10) transformed prior to analysis (Bland & Altman, 1996). Untransformed 
data summaries are reported for clarity. Cortisol levels, DHEA levels and molar cortisol-DHEA 
ratios were examined in separate repeated measures ANOVAs with log10 transformed sample 
(the 7 time points from 1:00 p.m. to 4:00 p.m.) as a within subjects factor and diagnosis 
(bipolar or control) as a between subjects factor. Where sphericity was violated, within 
subject degrees of freedom were adjusted using the Huynh-Feldt correction. The adjusted 
significance values are reported, though the original degrees of freedom are reported for 
clarity. 
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Following the primary data analysis, a ROC (Receiver Operating Characteristics) analysis was 
performed to ascertain the discriminative utility of the endocrine markers i.e. the level at 
which the greatest separation between the BD and control groups occurred expressed as 
sensitivity and specificity (Altman et al., 2000).  
 
2.3 Results 
2.3.1 Demographic details of the bipolar sample 
Twenty bipolar patients (18 male, 2 female) participated in the study. Patients were aged 
between 26 and 63 years (mean=49 years, s.d.=11) and had no current diagnosis of substance 
abuse or dependence. There were no current psychotic features in the group. The average 
(median) age of onset in the group was 20 years (mean=25.5, s.d.=12.5). The median number 
of hospitalizations in the group was 3. Nine patients (45%) had previously attempted suicide 
and 7 (35%) had previously been treated with ECT (>12 months ago).  
 
All patients had persistent depressive symptoms, with 17 fulfilling SCID criteria for current 
depressive episode4. The median length of current depressive episode in the group was 7 
months (mean=13.5, s.d.=15.7). Depressive symptoms had a mean score of 23 (s.d.=10) on the 
Montgomery-Åsberg Depression Rating Scale (MADRS) and of 18 (s.d.=10) on the 17-item 
Hamilton Depression Rating Scale (HDRS17). The mean MADRS and HDRS17 scores of the three 
patients without a specific episode were 8 (s.d.=5) and 4 (s.d.=1) respectively. The average 
YMRS score in the whole group was 4 (s.d.=4). 
 
                                                          
4
 For brevity in description, the phrase ‘bipolar depression’ will be used when describing these patients as a group 
(n=20). 
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All patients were currently receiving medication at the time of testing which had been stable 
for at least 6 weeks.  
 
Seventeen patients (85%) were currently taking at least one mood stabilizer. Of the eleven 
(55%) taking lithium: four were on monotherapy, five were also taking lamotrigine, and two 
gabapentin (one with valproate, one with carbamazepine). Of the four (20%) taking valproate: 
three were on monotherapy, one was also taking lamotrigine. Of the two (10%) taking 
gabapentin: one was on monotherapy and one also taking carbamazepine.  
 
Twelve patients (60%) were currently taking at least one antidepressant: three were taking 
venlafaxine, three venlafaxine plus mirtazapine, one mirtazapine, one mirtazapine plus 
citalopram, one amitriptyline, one sertraline, two paroxetine.  
 
Ten patients (50%) were currently taking an antipsychotic: Olanzapine (n=3), Quetiapine (n=4), 
Risperidone (n=2), Sulpiride (n=1).  
 
2.3.2 Neuropsychological functioning 
The matching algorithm, as described in section 2.2.2.2, produced a sample of 20 healthy 
control participants who were very closely matched to the patient group. Eighteen males and 
2 females were selected, matched for age (patients: mean=48.6 years, s.d.=10.8; controls: 
mean=47.1 years, s.d.=9.3; t=0.488, df=38, p=0.628) and NART score (patients: mean=111, 
s.d.=6.9; controls: mean=110, s.d.=8.3; t=0.408, df=38, p=0.686). All participants had also been 
through a screening procedure at the time of testing to exclude anyone with a personal or 
family history (first-degree) of psychiatric illness, significant medical or neurological illness 
likely to affect neuropsychological functioning, or history of drug/alcohol abuse.  
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Initial analysis of the data was performed by MANOVA on the outcome measures from the 
overall tests battery. To reduce inter-correlation between outcome measures, if multiple 
possible outcomes were available, then the most commonly utilised measures were included. 
This resulted in a MANOVA with group (bipolar or control) as the fixed factor and 13 
dependent variables (see Table 2-4 for the measures included; note the Immediate Memory 
tests and Stroop were not included in this due to the reduced control sample available and 
were analysed separately. Also Rey-AVLT A7 was not included and the percentage A7 retaining 
measure used). Initially, age and NART were included as covariates although neither were 
significant and were therefore dropped in the main analysis. 
 
2.3.2.1 Primary analysis 
From the primary MANOVA, a main effect of group was observed (Pillai’s Trace=0.570; 
F=2.647, df=13,26, p=0.017) with bipolar patients performing globally worse than controls. 
The sub-analysis of Immediate Memory and Stroop measures also produced a significant 
MANOVA main effect of group (Pillai’s Trace=0.344; F=3.152, df=4,24, p=0.032). Therefore 
pairwise analyses were carried out on each of the individual measures (see Table 2-4).  
 
From the pairwise comparisons and examination of effect sizes it is clear that there is a broad 
impairment across all domains examined, with large effects (d>0.7) in immediate memory 
(corresponding to visual and spatial WM slave systems Baddeley & Hitch, 1974), executive 
functioning (spatial working memory, phonological fluency and sustained attention), spatial 
(but not visual) recognition memory, delayed verbal recall and recognition, and psychomotor 
speed. Due to the relatively small sample sizes, the distribution of some outcome measures 
was non-normal, particularly Rey-AVLT recognition and Vigil (in the case of the latter, outliers 
>3s.d. were also evident in the data). As transforming the data did not alter this, these results 
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were also examined non-parametrically. The total omission (U=74.0, p<0.001) and commission 
(U=124.5, p=0.040) errors were significantly greater in the patient group. For the Rey-AVLT 
recognition trial, the difference between the groups was not statistically significant (U=140.0, 
p=0.108).  
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Table 2-4. Neuropsychological data for bipolar patients (n=20) and their matched control group (n=20) 
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P values reported are adjusted for non-equality of variance following significant Levene’s test. 
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Figure 2-3. Effect sizes for all neuropsychological test measures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
n.b. alternate colouring of bars presented as visual aid only and are to separate neuropsychological domains. 
 
(data corrected so that negative effect sizes always reflect worse performance in the patient sample, relative to 
controls) 
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As several measures have multiple ‘levels’ to their design (i.e. of difficulty or time) these tests 
were examined in more detail. As the main effect of Spatial Working Memory between search 
errors was significant, this was examined by repeated measures ANOVA, adding level of 
difficulty (4, 6 and 8-boxes; see 2.2.4.5.2 for a description) as a within subjects factor. Data 
were square root transformed prior to analysis. 
 
Significant main effects of group (F=6.083, df=1,38, p=0.018), level (F=200.274, df=2,76, 
p<0.0001) and a group by level interaction (F=4.663, df=2,76, p=0.012) were observed. Post 
hoc pairwise comparison across each level revealed that there was no significant difference 
between the groups at level 4 (p=0.364) with a trend emerging at level 6 (p=0.075) and 
increasing further to a significant difference at level 8 (p=0.004). 
 
A similar analysis was performed for Vigil omission errors, including time (errors at 2, 4, 6 and 
8 minutes) as the within subjects factor. Although the main effect of group was significant 
there was no significant main effect of time (F=3.305, df=3,114, p|hf|=0.057) or interaction 
(F=0.977, df=3,114, p|hf|=0.361).  
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Figure 2-4. Spatial Working Memory between search errors across level of difficulty 
 
 
 
 
 
 
 
 
 
Figure 2-5. Vigil omission errors across each time-quarter of the test 
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For the Rey-AVLT, a repeated measures ANOVA was also used to examine the 5 repetitions of 
the list, retaining ‘group’ as the between subjects factor. The effect of ‘list’ was significant 
(F=89.020, df=4,152, p|hf|<0.0001) however there was no significant group by list interaction 
(F=1.612, df=4,152, p|hf|=0.187) suggesting that whilst recall improved with increased 
repetition, this learning/recall was similar across patients and controls. 
 
Figure 2-6. Rey-AVLT recall across each repetition of list A. 
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2.3.2.2 Exploratory analysis: differential deficit 
Examination of the profile of effect sizes revealed some interesting differences that were 
explored further to see if they represented true differential deficits (i.e. whether the 
difference or deficit on test A was significantly  greater than the deficit on test B).   
 
The first comparison subjected to this analysis was within the immediate memory domain, 
where a larger effect size was evident in spatial span than digit span. However, this difference 
did not qualify as a differential deficit (t=0.579, df=29, p=0.284).  
 
Secondly, within the visuo-spatial memory domain, the effect size observed in spatial 
recognition was larger than that in pattern recognition. This difference did qualify as a 
differential deficit (t=1.815, df=37, p=0.039)5.  
 
2.3.3 Neuroendocrine testing 
As the control participants in earlier neuropsychological studies had not completed the 1pm 
to 4pm blood-sampling protocol (and had only completed neuropsychological testing) a 
sample of 20 healthy controls were recruited from hospital staff and by local advert. All were 
physically healthy and were subject to the same inclusion/exclusion criteria as in section 2.3.2. 
The group was matched exactly for sex (18 males, 2 females) and were closely matched for 
age (mean=45.3 years, s.d.=12.4; t=0.897, df=38, p=0.375) with the patient sample.  
 
The DHEA level at a single time point (3:30 p.m.) was missing for one bipolar patient. This was 
replaced using the calculated midpoint between the 3:00 p.m. and 4:00 p.m. samples for this 
subject.  
                                                          
5 There is a potential issue of ceiling effects in the Pattern Recognition test and therefore this may be an artefact of a reduced 
potential effect size. A total of 8 participants (5 controls, 3 patients) achieved the maximum score of 24. 
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The repeated measures ANOVA on cortisol levels revealed a significant main effect of group 
(F=4.339, df=1,38, p=0.044) with patient having higher levels than controls. There was clear 
evidence of diurnal rhythm in a significant main effect of time (F=8.875, df=6,228, p<0.0001) 
with levels decreasing over the afternoon, although there was no group by time interaction 
(F=0.517, df=6,228, p=0.678).  
 
Figure 2-7. Plasma cortisol levels from 1pm to 4pm in patients and controls 
 
 
For DHEA, no significant main effects were observed for group (F=0.511, df=1,38, p=0.479), 
time (F=2.043, df=6,228, p=0.084) or in the group by time interaction (F=0.094, df=6,228, 
p=0.988). Similarly, for the molar cortisol-DHEA ratio analysis, there were no significant main 
effects of group (F=0.574, df=1,38, p=0.453) or group by time interaction (F=1.086, df=6,228, 
p=0.356) although there was a significant diurnal rhythm, reflected in the main effect of time 
(F=11.938, df=6,228, p<0.0001).  
50
100
150
200
250
300
350
1:00pm 1:30pm 2:00pm 2:30pm 3:00pm 3:30pm 4:00pm
C
o
rt
is
o
l (
n
m
o
l/
L)
BD
Controls
Page | 122 
Figure 2-8. Plasma DHEA levels from 1pm to 4pm in patients and controls 
 
 
 
Figure 2-9. Plasma Cortisol-DHEA ratios from 1pm to 4pm in patients and controls 
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2.3.3.1 ROC analysis 
The ROC analysis for cortisol, DHEA and cortisol-DHEA ratio is presented in the table below. 
Only cortisol levels had a 95%CI above 0.5 (random classification) and using a cortisol AUC 
level of 33,323.16 nmol/L/min gave good sensitivity with reasonable specificity. Although 
DHEA and the cortisol-DHEA ratio also gave high sensitivity, the specificity was poor and 
neither produced AUC values that indicated they were reliable discriminators of the patient 
and control groups. 
 
Table 2-5. ROC analysis for endocrine data 
 Cortisol DHEA Cortisol/DHEA ratio 
 
Bipolar vs. 
Control group 
 
AUC=0.72 
(95%CI=0.53 to 0.90) 
 
AUC=0.55 
(95%CI=0.35 to 0.80) 
 
AUC=0.58 
(95%CI=0.38 to 0.78) 
 
 
Sensitivity=0.90, 
Specificity=0.60 
 
 
Sensitivity=0.95, 
Specificity=0.20 
 
 
Sensitivity=0.90, 
Specificity=0.45 
 
 
 
2.3.3.2 Exploratory correlations 
To explore the relationship between endocrine measures and neuropsychological tests, 
Spearman’s correlations were performed. Only 2 of the 18 correlations performed were 
statistically significant using cortisol AUC and 1 of 18 using DHEA. None of these would remain 
significant with correction for multiple comparison with correlation coefficients (see Curtin & 
Schulz, 1998).  
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Table 2-6. Spearman’s correlation coefficients for endocrine measures and neuropsychological tests in bipolar 
patients (n=20) 
 
Cortisol AUC DHEA AUC 
Spatial span 0.549* -0.151 
Forward span -0.100 -0.249 
SWM between error  -0.141 0.309 
SWM within error 0.255 0.113 
SWM strategy score -0.201 -0.064 
FAS correct -0.313 -0.081 
Backward span 0.611** 0.170 
Vigil Omissions 0.103 -0.070 
Vigil Commissions -0.233 -0.239 
Stroop CW correct in 2min -0.074 -0.404 
SRec Correct -0.027 -0.194 
PRec Correct -0.089 -0.336 
Rey total A1-5 -0.036 -0.324 
Rey A7 0.056 -0.323 
Rey A7 % retained  0.179 -0.191 
Rey Recognition A -0.196 -0.634** 
DSST -0.095 -0.253 
Vigil Latency -0.006 -0.310 
* p<0.05, **p<0.005 (uncorrected for multiple comparison) 
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2.4 Discussion of Chapter 2 
In this chapter, data were presented from the assessment of neuropsychological and 
neuroendocrine functioning in 20 patients with bipolar depression and matched groups of 
healthy controls. From the neuropsychological assessment, there was evidence of broad 
impairment across all domains examined, with large effects in immediate memory 
(phonological and spatial), executive functioning (spatial working memory, phonological 
fluency and sustained attention), spatial (but not visual) recognition memory, delayed verbal 
recall and recognition, and psychomotor speed. With regard to the neuroendocrine 
assessment, significantly elevated cortisol levels were evident in patients compared to the 
control group, although there was no significant difference in DHEA or cortisol-DHEA ratio. 
Cortisol levels (AUC; 1pm to 4pm) were also showed moderate discriminatory value, yielding 
sensitivity of 0.90 and specificity of 0.60 in a ROC analysis. There was no evidence of a simple 
linear or monotonic relationship between neuropsychological and neuroendocrine 
parameters, with an absence of any meaningful statistically significant correlations.  
 
Comparing the profile of mean effect sizes obtained in this study with those of the pooled 
estimates of effects sizes from the literature in Chapter 1.3.2, several fall within the 95%CI 
including digit span forwards, Spatial Working Memory, and delayed verbal recognition. Tests 
that produced values lower than the pooled estimates were reverse digit span, Stroop 
(inhibition), Rey-AVLT immediate and delayed recall ; while those that produced higher values 
were Spatial Span, Spatial Working Memory, Spatial and Pattern Recognition and DSST. 
However, this does not account for a similar confidence parameter applied to the present 
data, which would result in some degree of overlap in all measures (see Figure 1-2; section 
1.3.8). One very important consideration is that we do not know the extent of biological 
dysfunction, specifically HPA axis function, in most studies. If HPA dysfunction is causal to 
neuropsychological impairment (perhaps, though, not monotonically as we have assessed 
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here), this factor may at least in part explain the discrepancy between the present findings 
and previous literature.  
 
It is of note that the majority of tests that produced effect sizes larger than those from the 
literature review involved spatial processing. As discussed in the introduction, several studies 
have indicated that certain clinical feature can exacerbate the profile and extent of 
neuropsychological impairment. For example, Glahn and colleagues (2006) reported that 
bipolar depressed patients with history of psychosis exhibited spatial memory deficits while 
those without did not. Unfortunately data is not available on history of psychosis in these 
patients in the present thesis, although those recruited for the study were through secondary 
care and a specialist tertiary referral service and therefore are likely to have more complex, 
chronic illnesses. However, this is unlikely to be the only reason for the profile of results 
obtained as it does not explain the occurrence of effect sizes lower than those obtained from 
the pooled literature search. 
 
With regard to the cortisol data, despite the high sensitivity and moderate specificity in 
separating the patient and control groups, levels did not correlate to any great extent with 
neuropsychological outcome measures. This highlights a potential difficulty in establishing a 
simple linear or monotonic relationship and the need for careful consideration of firstly, the 
known effects of corticosteroids on specific rather than general cognitive processes and 
secondly, the subtleties of HPA axis dysfunction. Given the potential complexity of these 
relationships, it is not surprising that it is difficult to establish a simple (and replicable) linear 
or monotonic model relating peripheral cortisol levels to broad neuropsychological functions. 
It is possible that the simple assessment of basal levels is not representative of the dynamic 
processes or the role of individual receptors in cognitive processes. Perhaps the linking of the 
‘activated’ HPA axis is a better method and may relate to neuropsychological functioning in a 
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more representative way. This includes the function of the GR specifically which plays an 
important role in memory (see section 1.4). Therefore assessment after activation or blockade 
of the GR may be a plausible  method.  
 
The next chapter of this thesis therefore reports the results of a study in the same patients in 
which a GR antagonist or placebo was administered for one week and neuropsychological and 
neuroendocrine functioning was assessed. It was hypothesised that administration of the drug 
would acutely raise cortisol levels but subsequently result in a reduction once treatment had 
ceased and that this change would selectively improve neuropsychological functioning. 
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Chapter III 
 
Effects of antiglucocorticoid treatment on 
neuropsychological functioning, mood and the 
HPA axis in bipolar depression  
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3. Effects of antiglucocorticoid treatment on neuropsychological 
functioning, mood and the HPA axis in bipolar depression 
 
3.1 Introduction to Chapter 3 
Although the co-occurrence of HPA axis dysfunction and neurocognitive impairment has 
frequently been described (see chapter 1.5), demonstrating a direct causal link has proved 
more difficult. As noted above, there are a number of possible reasons for this, not least of 
which may be that the complexity of the relationship centrally between the two phenomena 
may not be accurately modelled or measured by peripheral hypercortisolaemia. In this section 
studies that have used more direct probes of glucocorticoid receptor function to assess effects 
on learning and memory are examined. 
 
One opportunity lies in the novel use of GR antagonist drugs which are currently being 
explored for the treatment of severe mood disorders. The intention here is not to review this 
literature but to very briefly discuss this approach with relevance to the application in 
neuropsychological functioning in mood disorder, focussing specifically on one drug of interest 
– mifepristone. 
 
3.1.1 Mifepristone - background 
Mifepristone (or RU-486) is a synthetic steroid with both antiprogesterone and 
antiglucocorticoid properties. The compound is a 19-nor steroid with substitutions at positions 
C11 and C17 [                                                             
                             ] which antagonizes cortisol action competitively at 
the receptor level (Nieman et al., 1985). It was discovered in the early 1980s by the French 
pharmaceutical company Roussel–Uclaf (Herrmann et al., 1982; Jung-Testas & Baulieu, 1983). 
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At present it is licensed in the UK for the medical termination of pregnancy (trade name: 
Mifegyne®; marketing authorization holder: Exelgyn Laboratories). Mifepristone was the first 
antiprogestin to be developed and it has been evaluated extensively for its use as an 
abortifacient. The original target for the research group, however, was the discovery and 
development of compounds with antiglucocorticoid properties (Hazra & Pore, 2001), and it is 
these properties that are of greatest interest for their application in the treatment of severe 
mood disorders and psychosis.  
 
3.1.2 Pharmacokinetics and pharmacodynamic activity  
The pharmacokinetics of mifepristone are dose-dependent in humans (Ashok et al., 2002). 
Due to saturation of the serum-binding capacity, high dose mifepristone results in nonlinear 
kinetics, whereas lower doses show a linear pattern (Leminen et al., 2003). For example, 
following administration of doses from 50 to 800mg, after the absorption and distribution 
phase of approximately 4 to 6h, the serum concentration of mifepristone remains in the 
micromolar range for the next 24 to 48h. Within the dose range of 2 to 25mg, serum 
concentrations of mifepristone, as well as the areas under the concentration–time curves 
(AUC), increase according to dose (Sitruk-Ware & Spitz, 2003).  
 
Following a single oral dose of 600mg mifepristone, the binding equivalent is present in 
measurable concentrations 7 days after administration, only decreasing below assay detection 
limits >7 to 14 days (Foldesi et al., 1996). In this study, the concentration of the mifepristone 
binding equivalent reached a peak within approximately 2 hours (doses 200 to 600mg) 
indicating rapid absorption. Peak levels were significantly greater following the 600mg dose 
(Cmax=12.3µmol/L vs. 200mg: 6.30µmol/L), while the bioavailability as assessed by the AUC 
was significantly greater following 600mg dose than both 200 and 400mg. These were not, 
however, directly proportional to the dose increase (Foldesi et al., 1996).  
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In contrast to mifepristone plasma concentrations, plasma concentrations of its metabolites 
do increase in a dose-dependent manner when larger doses are administered, so that serum 
metabolite concentrations being close to, or even in excess of those of the parent compound 
(Lahteenmaki et al., 1987). These metabolites have some antiprogestin and antiglucocorticoid 
properties, and therefore may mediate some of the actions of mifepristone (Spitz & Bardin, 
1993a, 1993b). 
 
3.1.3 Side effects of chronic mifepristone administration 
Laue and colleagues reported that in healthy male normal volunteers who received 
mifepristone (10 mg/kg/day), 8 of 11 subjects developed generalized exanthem after 9 days. 
One subject developed symptoms and signs consistent with the diagnosis of adrenal 
insufficiency (Laue et al., 1990). With respect to immune function, it was reported that total 
white blood cell counts, absolute lymphocyte, neutrophil and eosinophil counts, erythrocyte 
sedimentation rate, and quantitative immunoglobulins did not change. Furthermore, 
functional evaluation of lymphocyte cytotoxicity and proliferation revealed no changes. 
 
A study using lower doses (200mg/day for 2 to >31months) in 14 patients with unresectable 
meningiomas reported milder side effects. Most commonly, fatigue was noted in 11 of the 14 
patients (Grunberg et al., 1991). However, in a study of mifepristone (200mg/day for up to 8 
weeks) in chronic depression, 1 of 4 patients discontinued treatment prematurely because of 
the appearance a rash (Murphy et al., 1993). In patients with psychotic depression receiving 
mifepristone (50 to 1200mg/day for 7 days), 2 of 10 patients in the 600-mg group and 1 of 9 in 
the 1200-mg group reported uterine cramping, while 1 of 11 patients in the 50-mg group and 
1 of 9 patients in the 1200-mg group (but none in the 600-mg group) reported a rash. In both 
cases, this had abated 1 to 2 months after study completion (Belanoff et al., 2002). 
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3.1.4 Antiglucocorticoid effects of mifepristone 
A large amount of human clinical data on the antiglucocorticoid actions of mifepristone has 
come from studies in Cushing’s disease (Sartor & Cutler, 1996). Nieman and colleagues 
administered mifepristone orally at increasing doses of 5, 10, 15, and 20 mg/kg/day for a 9-
week period to a patient with Cushing's syndrome due to ectopic ACTH secretion. Following 
treatment, the somatic features associated with Cushing's syndrome ameliorated and blood 
pressure normalized. Importantly, suicidal ideation and depression also resolved, and all 
biochemical glucocorticoid-sensitive parameters normalized (Nieman et al., 1985).  
 
Mifepristone has also been shown to rapidly reverse acute psychosis in Cushing syndrome 
(van der Lely et al., 1991). More recently, high-dose (up to 25 mg/kg/day), long-term 
mifepristone administration was shown to normalize all biochemical glucocorticoid-sensitive 
measurements, as well as significantly reverse psychotic depression in a patient with Cushing's 
syndrome caused by an ACTH-secreting pituitary macroadenoma (Chu et al., 2001). Although 
the adrenal axis also normalised, the 18 month-long mifepristone treatment course led to the 
development of severe hypokalemia (attributed to excessive cortisol activation of MRs), which 
responded to spironolactone administration. 
 
3.1.5 The use of mifepristone in mood disorders 
Early work highlighted the potential for antiglucocorticoid strategies in depression. Initially the 
focus of studies utilising mifepristone was on the effect on endocrine parameters (Kling et al., 
1989; Krishnan et al., 1992). In the first preliminary, open-label investigation of mifepristone 
treatment of major depression, Murphy and colleagues administered mifepristone (200mg 
each morning) for as long as it was tolerated, for up to 8 weeks to 4 patients with ‘drug-
resistant’ depression. Data were presented as a case-series and showed improvements of 
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between 16% and 66% on the Hamilton Depression Rating Scale (HDRS) (Murphy et al., 1993). 
The trial terminated, however, due to problems obtaining the trial medication.  
 
Recent studies have renewed interest in the potential therapeutic efficacy of GR-antagonists 
in the treatment of mood disorders and psychosis (for a review see Gallagher et al., 2008). 
There is considerable debate in the literature currently as to the true efficacy of this approach 
and some authors have questioned the methodology and analysis of these trials (Carroll & 
Rubin, 2006, 2008). However, this is outside the scope of specific interest for the present 
thesis and will not be discussed here. The key point is that mifepristone is a potent modulator 
of the HPA axis and GR, although no studies have examined the effect of this on 
neuropsychological functioning  in patients with mood disorders. Evidence does however exist 
on the effects of GR manipulation on cognitive functioning in other groups. 
 
3.1.6 Effects of GR manipulation on cognitive function 
3.1.6.1 Effects of GR agonists on memory 
Numerous studies have examined the effects of GR agonists on cognitive function, both in 
animal and human studies. Generally, two approaches have been adopted: the first is to use 
the cortisol response to specific GR agonists, such as dexamethasone, and the relationship of 
post-administration cortisol levels with memory; the second is to assess the direct effects of 
GR agonists/antagonists within the stages of information processing and memory formation.  
 
The use of dexamethasone (and the dexamethasone suppression test; DST)  as an assay of GR 
function has a long history in the assessment of patients with mood disorders (Carroll, 1982b, 
1982a; Ribeiro et al., 1993; Nelson & Davis, 1997; Raison & Miller, 2003). Relating this to 
memory function (Wauthy et al., 1991) has produced mixed results. In elderly depressed 
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patients, contrary to expectations a failure to dexamethasone-suppress was associated with 
better global cognitive performance (Adler & Jajcevic, 2001). In contrast, a study from our 
group found, in bipolar disorder, dexamethasone non-suppression was correlated with poorer 
working memory function (Watson et al., 2006b). Interestingly, in a series of three studies 
using the same verbal memory task, Wolkowitz and colleagues found performance deficits in 
healthy subjects following 5-days of prednisolone (a non-specific MR and GR agonist) 
administration, in healthy subjects following a single dose of dexamethasone, and in patients 
with major depression with dexamethasone non-suppression (Wolkowitz et al., 1990). 
Together these findings are consistent with the inverted “U”-shape relationship between 
serum glucocorticoid levels and cognitive function posited earlier. This was shown more 
clearly recently in patients with major depression using a verbal declarative memory task 
(paragraph recall) administered twice, with dexamethasone or placebo administered in-
between (Bremner et al., 2004). In healthy controls, memory improved from baseline to day 3 
with placebo but was unchanged with dexamethasone, whereas in MDD patients memory 
function showed a pattern of decreasing with placebo and improving with dexamethasone 
(Bremner et al., 2004).  
 
Studies in clinical populations using specific MR and GR probes would be of great interest in 
examining the hypothesis of MR/GR balance and optimal memory performance (Tytherleigh 
et al., 2004). 
 
3.1.6.2 Effects of GR antagonists on memory 
The recent therapeutic interest in anti-glucocorticoids for the treatment of mood disorders 
has provided a further valuable opportunity to examine the effects of GR manipulation on 
neuropsychological functioning (Gallagher et al., 2008). In this final section we will provide an 
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overview of the findings in the animal literature before examining the parallels in clinical 
studies in humans. 
  
3.1.6.2.1 Rodent studies 
 Douma and colleagues examined the effects of repeated MR- (RU28318), GR- (RU38486), or 
combined antagonism on aspects of spatial learning in the rat. Repeated administration of the 
MR-antagonist impaired reference memory (in the hole-board learning paradigm). Combined 
MR/GR-antagonism similarly reduced reference memory performance while GR-blockade 
alone had no effect. These results highlight the importance of MRs in this process. Working 
memory acquisition rates were also suppressed in the initial phase of the training period with 
MR-blockade, although they were impaired throughout the whole training period with 
combined MR/GR-blockade suggesting modulation by both (Douma et al., 1998). Such results 
highlight the importance of considering the specific processes within a cognitive domain when 
examining the relative contribution of receptor function.  
 
As with the human literature discussed above, the pattern of HPA interventions and the 
timing of assessment of memory processes are crucial. In a series of studies, Oitzl and 
colleagues have examined the effect of GR blockade on spatial memory function in the rat. 
Acute intracerebroventricular (i.c.v.) injection of the GR antagonist RU38486 was found to 
result in spatial memory impairment (Oitzl & de Kloet, 1992). However more localized 
administration (10 and 100 ng) intra hippocampally was found to improve performance in a 
water maze 24 h after treatment. This effect occurred following either unilateral or bilateral 
injection and appeared to be dose-related (Oitzl et al., 1998a). Interestingly the authors note 
that opposite effects on neuroendocrine regulation of pituitary ACTH release occur with 
RU38486. While i.c.v. administration increases plasma ACTH and corticosterone levels, 
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administration locally in the dorsal hippocampus suppresses the circadian rise of these 
hormones (van Haarst et al., 1997). Chronic administration also has effects that are dependent 
on the administration regimen. Phasic GR blockade (RU38486: 10 and 100ng/µL i.c.v. 
administered pre-training over 3 consecutive days) impaired spatial memory in a dose-
dependent fashion while continuous blockade (10 and 100ng/0.5µL per hour over 10 days) 
facilitated spatial performance, continuing several days after training in the case of the higher 
dose (Oitzl et al., 1998b).  
 
The use of such compounds in recent clinical trials offers an important avenue of research into 
the role of the GR in human memory. Of particular interest is in determining if effects seen in 
the non-human literature can be replicated. 
 
3.1.6.2.2 Human studies 
There is little information of the effects of GR antagonists on memory function in humans. 
Most data comes from treatment studies using RU38486 (mifepristone). Pomara and 
colleagues examined the use of mifepristone in the treatment of Alzheimer’s disease in a small 
randomized, placebo-controlled trial (Pomara et al., 2002). Some subtests of cognition were 
improved following RU486 on an intention-to-treat analysis. At 12 hours after the first dose, 
the change from baseline in the Alzheimer's Disease Assessment Scale–Cognitive subscale 
(ADAS-Cog)(Rosen et al., 1984) total score was not statistically different between the two 
groups. However, patients treated with mifepristone performed significantly better on the 
ADAS-Cog Word Recall subtest. At week 6, the mean change from baseline in ADAS-Cog total 
score among completers revealed that patients treated with mifepristone tended to improve 
(by 2.67 points) whereas patients treated with placebo tended to worsen (by 1.67 points).  
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It is important to consider the treatment regimen used in these trials. Although the 
administration of mifepristone was once daily, more chronic receptor occupancy was likely by 
the end of the treatment period because mifepristone, has rapid absorption, a long half-life 
(of 25 to 30 hours) and micromolar serum concentrations following typical doses 
(Heikinheimo et al., 2003a). This may explain the positive effects found in spatial memory 
processes, akin to those found in chronic (but not phasic) administration in rodents (see Oitzl 
et al., 1998).  
 
3.1.7 Summary and aims of the study 
From the literature reviewed, from healthy volunteer work through to clinical conditions and 
studies examining the direct effects of GR antagonists on memory in animals and humans, a 
common finding is for spatial memory functions and verbal declarative memory to be 
consistently altered. As was observed in the patient sample participating in the study reported 
in Chapter 2, large effects were observed for neuropsychological tasks within the spatial 
domain with some even reaching criteria to be considered a differential deficit (see 2.3.2.2). 
Given the extent of the HPA axis disturbance in the patient group, particularly in cortisol 
levels, then we can at this stage hypothesize that giving a drug that targets the GR and 
potentially reduces hypercortisolaemia will lead to improvements in spatial memory and 
verbal declarative memory. Therefore, the a priori selection of primary outcome measures 
were the spatial working memory test from CANTAB and verbal declarative memory, using the 
Rey-AVLT. The same neuropsychological test battery as in Chapter 2 was used. It is 
hypothesised that administration of the GR antagonist mifepristone would result in improved 
neuropsychological  functioning. 
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3.2 Methods 
3.2.1 Subjects 
The details of the 20 patients participating have been presented earlier (Chapter 2.2). Patients 
were aged 18 to 65 years with a diagnosis of bipolar disorder, confirmed using the Structured 
Clinical Interview for DSM-IV (SCID) (First et al., 1995), were recruited from services in North 
East of England. A specific attempt was made to recruit those with residual depressive 
symptoms. Illness characteristics, clinical ratings and medication history were determined by 
trained psychiatrists using full history, case-note and medication review and standardized 
rating scales. Patients’ medication had been unchanged for 6 weeks prior to participation and 
remained so throughout the study period. Seventeen were taking at least one mood stabilizer, 
with 13 taking at least one antidepressant and 11 taking an antipsychotic.  
After a complete description of the study, written informed consent was obtained from all 
participants; the study received full approval from the local ethics committee. 
 
3.2.2 Procedure 
Following an initial baseline assessment of neurocognitive function and mood, and basal 
neuroendocrine profiling (day 0), patients were randomly allocated to receive either 600mg 
mifepristone (taken orally at 8:00 a.m. once a day) or placebo for 7 days. Administration of 
medication was in a double-blind design. Mood ratings were taken after the week’s treatment 
(day +7) and then at weekly intervals (day +14 and day +21). At day 21, the groups crossed 
over and the alternative treatment (placebo or mifepristone) administered for 7 days, again 
with ratings taken following the week’s treatment (day +7) and at weekly intervals (day +14 
and day +21). Neurocognitive function was assessed on three occasions over the study period: 
at baseline and at day +21, after each treatment. Neuroendocrine profiling was performed at 
baseline, after the week’s treatment period (day +7) and then day +21.  
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Figure 3-1. Trial design 
 
 
 
3.2.3 Neurocognitive testing 
Based on previous research on the effects of corticosteroids on neurocognitive function 
(Lupien et al., 1999; Newcomer et al., 1999; Young et al., 1999; de Quervain et al., 2000; de 
Quervain et al., 2003), it was predicted that the principal cognitive domains which would be 
most sensitive to changes in HPA axis function were (spatial) working memory and verbal 
declarative memory. The primary neurocognitive battery therefore consisted of two tests: 
 
The Spatial Working Memory task. This computerized test of working memory from the 
Cambridge Neuropsychological Test Automated Battery (CANTAB; CeNeS Pharmaceuticals, 
Cambridge, U.K.) requires subjects to search through an increasing number of (three, four, six, 
and eight) boxes to locate hidden tokens. As the token is never located in the same box more 
than once, “between search errors” (BSE) are committed when the subject returns to search a 
box in which a token has previously been located.  
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 The Rey-Auditory Verbal Learning Test (Rey-AVLT). This test of verbal learning, includes 
indices of initial and delayed recall and recognition. A list of 15 words (List A) is read out to the 
subject 5 times. They are required to recall after each trial. A different list of 15 words (List B) 
is then read once, followed by recall of this list. Finally, after a 30 minute delay, recall of List A 
is again tested without an additional presentation of that list. This is followed by a recognition 
trial of words from List A. The number of words correctly recalled or recognized is recorded. 
Alternative forms of the test were used on each visit. 
 
A secondary battery was also included which examined a broader range of neurocognitive 
domains, incorporating additional measures of learning and memory, attention and executive 
function: 
Short-term memory span. This was tested across both phonological and spatial domains. The 
Wechsler forward digit span test requires subjects to repeat verbatim a string of digits which 
sequentially increases in length until the consecutive failure of two trials of the same digit 
span length. The CANTAB spatial span task was utilized to assess the subjects’ ability to 
remember a serial sequence of squares as they change colour. 
 
Visuo-spatial learning and memory. This was assessed using the CANTAB pattern and spatial 
recognition tests. The pattern recognition task requires the subject to learn a series of 12 
abstract patterns. Subjects are then presented with pairs of patterns and required to identify 
the familiar one. The test consists of two sets of 12 stimuli. For the spatial recognition test, the 
subject must learn the on-screen spatial position of 5 serially presented squares, with a 
subsequent forced-choice recognition between 2 locations. A total of four trials of five stimuli 
are completed. Alternative forms of both tests were used on each visit. 
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Executive function. This was tested using an established verbal fluency test (naming words 
beginning with one of three given letters; 60 seconds for each) with the overall total correct 
responses recorded. The Wechsler backward digit span, which requires the monitoring of 
information held in working memory, was also administered using the same method as the 
forward span test. Alternative forms of both tests were used on each visit. 
 
Attention/psychomotor speed. Psychomotor speed was assessed using the digit symbol 
subtest from the Wechsler Adult Intelligence Scale; a test requiring rapid copying of symbols 
paired with numbers in 90 seconds. Alternative forms of the test were used on each visit. 
Aspects of attention were measured using a computerized continuous performance task – 
Vigil (Cegalis & Bowlin, 1991). In this random-interval ‘A-K’ form, subjects are required to 
respond to the target letter ‘K’ only when it is preceded by the letter ‘A’ from amongst a 
stream of random letters over an 8 minute period. 
 
All pen-and-paper tasks were administered according to standardized instructions referenced 
under each test above and computerized tests from the CANTAB according to the manual 
protocols, on a personal computer fitted with a colour touch-screen monitor. For all subjects, 
testing began at 1:00 p.m. and took approximately 75 minutes to complete. 
 
3.2.4 Symptoms 
With respect to symptomatic improvement, the antidepressant effect of mifepristone was the 
principal focus, therefore the outcome measures of interest were the 17-item Hamilton 
Depression Rating Scale (HDRS17; (Hamilton, 1960) and the Montgomery-Åsberg Depression 
Rating Scale (MADRS; (Montgomery & Asberg, 1979). Other secondary scales consisted of the 
Brief Psychiatric Rating Scale (BPRS;  (Overall & Gorham, 1962) and the Young Mania Rating 
Scale (YMRS; (Young et al., 1978). 
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3.2.5 Neuroendocrine assessment  
To profile plasma cortisol secretion, subjects were canulated in the antecubital fossa at 12:30 
p.m. and blood samples collected at 30 minute intervals from 1:00 p.m. to 4:00 p.m. Subjects 
fasted throughout this period, remained semi-supine and did not sleep. Cortisol levels were 
determined by using Corti-cote radioimmunoassay kits (ICN Pharmaceuticals, Costa Mesa, 
Calif.). The inter-assay coefficient of variation for cortisol was less than 8%, and the intra-assay 
variation was less than 9% across the assay range. 
 
3.2.6 Statistical analysis 
Neurocognitive data were analyzed by repeated measures analysis of covariance (ANCOVA) 
with ‘treatment’ (mifepristone or placebo) and, where tests had more than one level, ‘level’, 
as the within subject factors. As differential learning effects may occur depending upon the 
order of treatment administration, ‘order’ (mifepristone first or placebo first) was entered as a 
between subjects factor and ‘baseline’ performance as a covariate. Main effects were further 
examined as the mean difference (and 95% confidence interval of the difference) between 
treatments (mifepristone or placebo), expressed as a change from baseline performance 
(Altman et al., 2000). Mood symptoms were also expressed as the mean change (95%CI) from 
baseline for each treatment and analyzed by paired t-test. All cited p values were two-tailed, 
with a significance level set at 0.05. Analyses were performed using SPSS (SPSS, 1998). 
 
 
3.3 Results 
One patient was excluded from the study because of self-discontinuation of lithium 
prophylaxis. Data from 19 patients were available for analysis. 
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3.3.1 Neuropsychological testing 
3.3.1.1 Primary outcome measures 
A significant ANCOVA main effect of treatment was found in the SWM between search error 
(BSE) rate (square root transformed) of the spatial working memory task. Subsequent analysis 
of this significant main effect revealed that, following mifepristone treatment, the error rate 
was significantly reduced from baseline (t=3.04, df=18, p=0.007). However no significant 
change occurred following placebo (t=1.24, df=18, p=0.232). Direct comparison of the 
treatments revealed a significant advantage of mifepristone over placebo in the percentage 
improvement (calculated for each individual subject) in error rate from baseline (mean 
difference=19.8%, 95%CI=4.3 to 35.2; t=2.69, df=18, p=0.015) (see Figure 3-2; upper). Order of 
treatment administration did not appear to be a confounding factor. The improvement 
following mifepristone was not significantly different in the group who received mifepristone 
first compared to the group who received it second. Again there was no difference in the 
response to placebo between these groups (p>0.2 for all). There was also no ANCOVA main 
effect of order or treatment by order interaction (see Figure 3-2; lower). There were no 
significant main effects of treatment on any outcome measure from the Rey-AVLT (total 
correct, long-term recall or recognition).  
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Table 3-1. Neuropsychological test results at baseline and following mifepristone and placebo 
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Figure 3-2. Improvement in SWM between search error rate overall (top) and by order (lower) 
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3.3.1.2 Secondary outcome measures 
ANCOVA main effects of treatment were found in both spatial recognition memory and verbal 
fluency (see Table 3-2).  
 
For verbal fluency, the number of words correctly produced was significantly greater than at 
baseline following mifepristone treatment (t=3.34, df=18, p=0.004) with no significant 
difference following placebo (t=1.57, df=18, p=0.133). Direct comparison of each treatment, 
expressed as a percentage improvement from baseline, did not significantly differ (mean 
difference=1.60%, 95%CI= -9.89 to 13.10; t=0.29, df=18, p=0.773). For the spatial recognition 
task, direct comparison of mifepristone versus placebo, expressed as a percentage change in 
error rate from baseline, revealed a trend towards a lower error rate following mifepristone 
(mean difference=27.2%, 95%CI= -1.81 to 56.17; t=1.97, df=18, p=0.064). 
 
3.3.2 Symptoms 
At +14 days, following treatment with mifepristone, depression rating scores from the HDRS17 
and MADRS had significantly improved from baseline levels (see Table 3-2). No significant 
change was observed at any time point following placebo. Direct comparison of the advantage 
of mifepristone over placebo at this time point (+14 days), however, failed to reach statistical 
significance for either HDRS17 scores (mean difference=2.32, 95%CI= -2.08 to 6.71; t=1.107, 
df=18, p=0.283) or MADRS scores (mean difference=2.26, 95%CI= -3.36 to 7.89; t=0.845, 
df=18, p=0.409).  
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Table 3-2. Symptom ratings in the group as raw scores and change from baseline with 95%CI 
 
M
e
an
 (
9
5
%
C
I)
 im
p
ro
ve
m
e
n
t 
fr
o
m
 b
as
e
lin
e
 
P
la
ce
b
o
 9
5
%
 C
I 
 
- 
-0
.3
7
 t
o
 6
.6
9
 
-2
.1
1
 t
o
 6
.7
7
 
-0
.8
6
 t
o
 7
.8
1
  - 
-0
.4
9
 t
o
 6
.1
8
 
-0
.4
2
 t
o
 8
.0
0
 
-2
.3
3
 t
o
 8
.7
5
  - 
-1
.0
0
 t
o
 5
.3
2
 
-1
.1
7
 t
o
 7
.0
6
 
-1
.4
6
 t
o
 7
.6
7
  - 
-2
.2
6
 t
o
 1
.1
0
 
-2
.7
9
 t
o
 1
.7
4
 
-1
.6
3
 t
o
 2
.3
7
 
M
ea
n
 
 
- 
3
.1
6
 
2
.7
9
 
3
.4
7
  - 
2
.8
4
 
3
.7
9
 
3
.2
1
  - 
2
.1
6
 
2
.9
5
 
3
.1
1
  - 
-0
.5
8
 
-0
.5
3
 
0
.3
7
 
M
if
ep
ri
st
o
n
e
 
9
5
%
 C
I 
 
- 
-1
.5
0
 t
o
 6
.7
6
 
0
.9
1
 t
o
 9
.3
0
 
-3
.2
3
 t
o
 5
.9
7
  - 
-2
.6
2
 t
o
 7
.4
6
 
0
.7
5
 t
o
 1
1
.3
6
 
-2
.9
3
 t
o
 8
.2
0
  - 
-1
.0
3
 t
o
 6
.7
2
 
0
.1
2
 t
o
 7
.9
9
 
-0
.7
3
 t
o
 6
.7
3
  - 
-1
.9
7
 t
o
 2
.3
9
 
-1
.3
7
 t
o
 2
.7
4
 
-0
.7
8
 t
o
 1
.9
4
 
M
ea
n
 
 
- 
2
.6
3
 
5
.1
1
 b
 
1
.3
7
  - 
2
.4
2
 
6
.0
5
 c
 
2
.6
3
  - 
2
.8
4
 
4
.0
5
 d
 
3
.0
0
  - 
0
.2
1
 
0
.6
8
 
0
.5
8
 
R
aw
 d
at
a
 
P
la
ce
b
o
 s
.d
. 
 
- 
8
.3
1
 
9
.3
3
 
7
.6
0
  - 
1
1
.0
8
 
1
0
.6
5
 
1
0
.1
7
  - 
6
.4
0
 
6
.0
3
 
6
.8
1
  - 
4
.0
5
 
4
.0
8
 
2
.9
7
 
M
ea
n
 
 
- 
1
4
.8
9
 
1
5
.2
6
 
1
4
.5
8
  - 
2
0
.1
6
 
1
9
.2
1
 
1
9
.7
9
  - 
2
7
.6
3
 
2
6
.8
4
 
2
6
.6
8
  - 
4
.1
6
 
4
.1
1
 
3
.2
1
 
M
if
ep
ri
st
o
n
e
 
s.
d
. 
 
9
.9
2
 
7
.4
2
 
6
.7
4
 
8
.2
7
  
1
0
.2
4
 
9
.9
6
 
1
0
.5
6
 
1
0
.8
9
  
7
.1
4
 
7
.3
8
 
7
.9
9
 
6
.4
4
  
3
.7
8
 
4
.6
2
 
3
.6
3
 
2
.4
7
 
M
ea
n
 
 
1
8
.0
5
 
1
5
.4
2
 
1
2
.9
5
 
1
6
.6
8
  
2
3
.0
0
 
2
0
.5
8
 
1
6
.9
5
 
2
0
.3
7
  
2
9
.7
9
 
2
6
.9
5
 
2
5
.7
4
 
2
6
.7
9
  
3
.5
8
 
3
.3
7
 
2
.8
9
 
3
.0
0
 
   H
D
R
S 1
7
 B
as
el
in
e 
a  
D
ay
 +
7
 
D
ay
 +
1
4
 
D
ay
 +
2
1
 
M
A
D
R
S 
B
as
el
in
e 
a  
D
ay
 +
7
 
D
ay
 +
1
4
 
D
ay
 +
2
1
 
B
P
R
S 
B
as
el
in
e 
a  
D
ay
 +
7
 
D
ay
 +
1
4
 
D
ay
 +
2
1
 
YM
R
S 
B
as
el
in
e 
a  
D
ay
 +
7
 
D
ay
 +
1
4
 
D
ay
 +
2
1
 
 
 
 
 
a
 Baseline for both treatments (mifepristone and placebo) 
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 Significant change from baseline (t=2.56, df=18, p=0.020)  
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 Significant change from baseline (t=2.40, df=18, p=0.028) 
d
 Significant change from baseline (t=2.16, df=18, p=0.044) 
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An independent samples t-test was used to confirm that the order of treatment 
administration was not a confounding factor. There was no significant difference in response 
to the active treatment, between the group receiving mifepristone first or the group receiving 
it second in either HDRS17 scores (t=0.054, df=17, p=0.958) or MADRS scores (t=0.554, df=17, 
p=0.587).  
 
Of the secondary scales, BPRS scores were also found to be significantly lower at +14 days 
following mifepristone treatment, with no significant change following placebo (see Table 
3-2). Again however, comparison of the advantage of mifepristone over placebo at this time 
point failed to reach statistical significance (mean difference=1.11, 95%CI= -3.00 to 5.22; 
t=0.564, df=18, p=0.579). YMRS scores did not significantly differ from baseline at any time 
point. A post hoc analysis was performed on all symptom effects, after the exclusion of the 
three patients who did not fulfil SCID criteria for a current depressive episode. The 
improvement from baseline at +7 days remained significant for all measures (p<0.05). 
 
3.3.3 Neuroendocrine measures 
A highly significant ANOVA main effect was observed (F=20.6, df=4,68, p<0.0001), with cortisol 
levels being significantly higher following mifepristone treatment (day +7)  compared to all 
other visits (see figure 3). A significant diurnal rhythm was evident in the effect of time 
(F=21.6, df=6,102, p<0.0001), although there was no interaction between visit and time 
(F=1.18, df=24,408, p=0.29). No other significant effects were observed. 
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Figure 3-3. Cortisol levels 1pm to 4pm at baseline and following mifepristone or placebo at day +7 and +21 
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Subjecting the data to the same analysis procedure as the neuropsychological tests (the 
method recommended byVickers & Altman, 2001), the AUC cortisol data from day +21 (the 
day of neuropsychological testing) was entered into a repeated measures ANCOVA with 
baseline and age as covariates. A significant main effect of treatment was observed, with 
cortisol levels being significantly lower after mifepristone treatment (mean AUC=40,673, 
s.d.=11,266) compared to placebo (mean AUC=44,046, s.d.=9,884; F=6.449, df=1,16, p=0.022).  
 
 
 
3.3.4 Exploratory analysis: relationship between cortisol and neuropsychological 
functions 
 
An exploratory post hoc analysis (see Figure 3-4 below) revealed that the area-under-the-
curve (AUC) cortisol output at baseline correlated positively with the percentage improvement 
in spatial working memory error rate following mifepristone administration (rs=0.460, 
p=0.048). No relationship was found between cortisol AUC and the error rate following 
placebo (rs=0.286,  p=0.235). 
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Figure 3-4. Correlation between baseline cortisol (AUC: 1pm to 4pm) and spatial working memory improvement 
following mifepristone 
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is associated with a greater improvement in neuropsychological function). From the table 
below, the correlation between the primary outcome measure of Spatial Working Memory 
was at trend level only (rs= -0.355, p=0.087), however consistent significant results were 
observed for Spatial Recognition Memory, delayed verbal recognition and psychomotor speed 
(DSST). All were consistent with the hypothesis that a great suppression of cortisol would be 
associated with a greater improvement in neuropsychological function (It should however be 
noted that one significant correlation – Vigil commission errors – went contrary to this 
prediction).  
 
Table 3-3. Spearman’s correlations between neuropsychological improvement and cortisol suppression in 
response to mifepristone (both examined as the percentage change) 
 
 
Mifepristone Placebo 
SWM between errors -0.335 -0.172 
Spatial Recognition -0.458* 0.104 
Verbal fluency (FAS)  0.120 0.251 
   DSST -0.459* -0.135 
Pattern Recognition 0.063 0.262 
SSP 0.270 0.050 
Digit span forward 0.137 -0.152 
Digit span reverse -0.238 -0.084 
Vigil omissions 0.344 -0.229 
Vigil commissions 0.572* 0.075 
Stroop CW -0.279 0.118 
Rey total A1 to A5 -0.158 -0.295 
Rey A7 -0.169 -0.292 
Rey A recognition -0.459* -0.093 
 
 * p<0.05; Directional hypothesis (one-tailed) 
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3.4 Discussion of Chapter 3 
These data suggest that administration of a drug with GR-antagonist properties – mifepristone  
– selectively improved neuropsychological functioning in bipolar depression. Spatial working 
memory function (between search errors) was significantly improved compared to placebo 
(measured 2 weeks after cessation of treatment). Changes in secondary measures of spatial 
recognition memory and verbal fluency were observed, but these improvements were not 
significant over those seen with placebo. Ratings of depression (HDRS17 and MADRS) and total 
BPRS scores were similarly reduced compared to baseline after treatment with mifepristone, 
but not after treatment with placebo (this occurred 7 days after cessation of treatment). 
There was no significant difference from baseline in mood ratings at the time of 
neuropsychological testing (14 days after cessation of treatment). Analysis of the 
neuroendocrine data revealed that cortisol levels in the group had significantly reduced from 
baseline at this point. Exploratory correlational analyses revealed that the extent of the 
reduction in cortisol levels correlated with the percentage improvement in some of the 
neuropsychological measures (see Table 3-3). While this was only at a trend-level with the 
primary outcome measure – SWM – it was found that cortisol levels at baseline correlated 
with the extent of the improvement in this measure (Figure 3-4). 
 
As noted in the introduction, animal work has shown that administration of a GR-antagonist 
can, under certain treatment protocols, improve spatial memory (Oitzl & de Kloet, 1992; Oitzl 
et al., 1998a; Oitzl et al., 1998b). Chronic administration was shown to improve spatial 
memory as did direct administration to the hippocampus. The relatively high dose of 
mifepristone used in the present study, along with the long half-life of the drug, may have 
resulted in chronic blockade by the end of the treatment period. However, because of the 
crossover design of the study and the delayed neuropsychological testing period (which was 2 
weeks after cessation of treatment) it is not possible to ascertain if the improved spatial 
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memory processes in the present study are directly attributable to this effect. An alternative 
possibility is that the improvement is related to the overall suppression or ‘normalisation’ of 
the HPA axis. One previous study has shown that a single dose of mifepristone (200mg) can 
lead to a reduction in glucocorticoid bioactivity for up to 2 weeks after the treatment 
(Heikinheimo et al., 2003b). The correlations (whilst being moderate and only obtained 
through exploratory analyses) between the extent of cortisol suppression after mifepristone 
and the degree of improvement in neuropsychological functioning may suggest that this direct 
link also contributes to the effect. It should however be noted that the actions of this class of 
drug are highly complex and may be attributable to other factors outside of those that can be 
ascertained from the data here. For example, although it is typically referred to as an 
antagonist, evidence indicates that mifepristone is a partial agonist at the GR (Bourgeois et al., 
1984; Laue et al., 1988). A recent paper has reported that mifepristone exerted partial 
agonistic effects, while blocking the effects of glucocorticoids, on mitochondrial GR 
translocation and mitochondrial membrane potential. These results are discussed the context 
of the biphasic (inverted “U”-shaped) effects of glucocorticoids on neural functions, including 
memory (Du et al., 2009). Interestingly, in  a recent animal study, of the series of GR 
antagonist examined, mifepristone was the only drug to increase both mineralocorticoid 
receptor (MR) and GR binding in the frontal cortex (Bachmann et al., 2003) which may lead to 
specificity in the effects on neuropsychological functions seen here (see next section 3.4.1). 
 
It is of course possible that the apparent incongruence in the results in other domains (such as 
verbal declarative memory) compared to previous studies may be attributable to 
methodological differences. For example, when examining the effects of corticosteroids in the 
healthy human literature, studies typically use paragraph recall (with its incorporated 
sentence structure) or other word lists with a larger number of items. The present study found 
no effects of mifepristone on verbal declarative memory which used the 15-item Rey-AVLT, 
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while subtle but positive effects were seen on word recall in the Pomara et al study (although 
it should be noted that the ‘trend’ described by the authors would not meet most definitions 
used by others) (Pomara et al., 2002). It is also important to consider that the tasks on which 
improvements were observed were associated with the largest effect sizes within their 
domain in Chapter 2. Verbal fluency and SWM between search errors were the largest effect 
sizes within the Executive domain, and Spatial Recognition the largest within the Visuo-spatial 
memory domain (and also met criteria to be classified as a differential deficit) and therefore it 
could be argued that effects were relative to the size of the deficit to begin with6. However, 
other processes such as psychomotor speed (DSST) were not affected and yet exhibited large 
effect sizes, so unless the effect is process specific and effect size sensitive, then this cannot 
explain the result wholly.  
 
 
3.4.1 Implications of the preceding findings for the subsequent direction of the 
thesis 
 
So as a starting point for the subsequent studies in this thesis, let us take the position that 
there may relative specificity for the effects of HPA axis manipulation on neuropsychological 
functioning. The tasks affected to the greatest extent following direct GR manipulation was 
CANTAB Spatial Working Memory (SWM), along with trends (i.e. significant change from 
baseline, but not over placebo) in Spatial Recognition and Verbal Fluency. Therefore it is worth 
considering in more detail the processes and brain structures underlying these tasks.  
 
                                                          
6 Although note that the notion of ‘regression towards the mean’ is not relevant here as the crossover design would make it 
equally as likely that the lower scores occur in the placebo arm of the study as in the active arm. 
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Focussing first on the CANTAB SWM test, a number of studies have developed variants of this 
paradigm such as the Executive Golf Test (Feigenbaum et al., 1996; Morris et al., 1996) and 
the boxes task (van Asselen et al., 2005; van Asselen et al., 2006). All involve self-ordered 
searching across fixed locations, with subjects having to remember accumulating locations of 
positions where targets have been found and avoid repetitious searching. Consequently, 
outcome measures include within search errors (returning to a location already searched 
within a given search sequence) and between search errors (returning to a location where a 
target was already found previously). It has been suggested that the latter reflects the 
maintenance of information held in memory over a longer time period, while the former can 
be considered to be more immediate and a measurement of the visuo-spatial sketchpad of 
working memory (Feigenbaum et al., 1996; van Asselen et al., 2005; van Asselen et al., 2006). 
Generally such tasks are considered to broadly tap executive and working memory processes, 
but may extend beyond this. Early work examining the underlying the underlying neural 
circuitry of these processes indicated that patients with unilateral or bilateral frontal lesions 
made significantly more of both types of error than matched controls and these increased 
with set-size (Owen et al., 1990). In a subsequent study these findings were extended to 
groups of patients with frontal lobe lesions, temporal lobe or following unilateral amygdalo-
hippocampectomy (AH) where it was reported that significant impairment in between search 
errors7 was not observed in the temporal group, but was in the other two, even at the lowest 
levels of task difficulty in the case of the frontal group  (Owen et al., 1995). However it should 
be noted that the temporal group did make more errors at trend level and in a subsequent 
study using the ‘Executive Golf’ variant of the task, significantly increased between search 
errors have been reported with both unstructured and structured (by eliminating the self-
ordered search element of the task) versions of the test in the absence of differences in 
within-search errors (Feigenbaum et al., 1996). Therefore, as has been suggested (see van 
                                                          
7 Within-search errors were not reported in this study. 
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Asselen et al. 2005, 2006), it does appear that the longer-term maintenance of spatial 
information, reflected in the between search error rate, is reliant upon structures like the 
temporal lobes and hippocampus, while within search processes are unaffected unless there is 
frontal lobe impairment. This general position was supported in a recent study in stroke 
patients (van Asselen et al., 2006) which looked in more detail at the brain areas underpinning 
spatial working memory performance, both in terms of lesion location and general 
hemispheric specialisation. Results indicated there were no differences in immediate spatial 
memory with the Corsi-blocks task, both in terms of specific location or hemispheric 
specialisation, although damage to the right DLPFC and the right PPC was correlated with 
performance. On the spatial working memory test (‘boxes task’), within search errors were 
significantly higher overall in right-hemisphere (RH) patients than controls while no 
differences were found between left hemisphere (LH) patients and the control group. Analysis 
of specific brain areas (dorsolateral prefrontal cortex, DLPFC; posterior parietal cortex, PPC; 
hippocampal formation, HF) revealed no significant difference between RH, LH and controls 
within any of these areas8. With respect to between search errors, again RH patients made 
significantly more than controls while there was no significant difference between LH and 
controls. Location specific analyses revealed that right DLPFC performed worse than controls, 
with no difference between left DLPFC patients and controls. A similar pattern emerged with 
regard to the PPC, where RH performed worse than controls. For the HF, both RH and LH 
patients performed worse than controls. Overall the results were indicative of a general 
involvement of the RH in spatial working memory processes; the authors suggested 
specifically that the DLPFC and the PPC may be essential for keeping spatial information in 
memory over short periods, while the HF is involved in the transfer of information from 
working memory into long-term memory or vice versa i.e. accessing long-term memory for 
transfer to working memory, to facilitate performance (van Asselen et al., 2006).  
                                                          
8 However, it should be noted that the overall rates of within search errors tend to be minimal compared to between search 
errors and therefore observing significant changes is often difficult. 
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The original question of why these tests specifically were improved by GR manipulation could 
perhaps be related to the actions of the drug or cortisol within these areas, especially if we 
tentatively consider as supportive the other tests that showed significant improvement from 
baseline. The Spatial Recognition Memory task was also examined in the study by Owen et al. 
(1995) and performance was found to be significantly worse in the ‘frontal lobe group’ only, 
with no significant effect in the AH or temporal groups (although it should be noted that the 
actual level of significance in the latter was p=0.075 and therefore a trend at least is 
suggested). With regard to verbal fluency, many studies have demonstrated the involvement 
of the frontal cortex in phonological fluency tasks (Davidson et al., 2008), particularly the LH 
(associated with semantic retrieval) with some temporal lobe activation (Cabeza & Nyberg, 
2000; Weiss et al., 2003). Again these tests are very sensitive to frontal damage but are also 
significantly impaired in many patients with temporal or hippocampal damage (Gleissner & 
Elger, 2001; Alessio et al., 2006). Therefore, is it the case that the tasks which are altered 
through HPA axis manipulation reflecting the direct, underlying actions of the drug or are they 
simply those that engage the broadest range of processes/systems?  
 
As discussed in section 3.1.6.2.1 above, administration of mifepristone in rodents can 
significantly improve spatial memory when administered chronically and when administered 
directly to the hippocampus. Also, we have noted the drug has been shown to increase 
corticosteroid receptor numbers in the frontal lobes. Therefore there is some face validity at 
least to this assertion although stronger evidence is needed, particularly as our understanding 
of the complexity of human memory functions (and underlying theoretical models) has 
developed. To some, especially within the human experimental psychology literature, we have 
moved away from equating and classifying tasks with specific brain regions. For example, this 
is illustrated well in the move away from discussing ‘frontal’ tasks and instead focussing on 
underlying executive processes (Baddeley & Wilson, 1988). And it is this ‘process’ approach 
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that is needed to continue the exploration of these results. To better understand the 
specificity of effects, especially the spatial aspect, we need first to examine the factor 
structure underlying the tests used: what are the shared factors or common processes 
involved? This is important for the SWM because whilst it has been used in some studies in 
bipolar depression (see section 1.3.2) and in those studies described above linking brain 
structure to the test measures, there is a lack of understanding of the neuropsychological 
processes underpinning performance on SWM. From this, we can examine a number of 
questions that have emerged from the data so far: what are the factors underpinning the 
SWM task, specifically the between search errors? Is the factor structure in the patients 
different to that of healthy controls i.e. are some processes scaffolded by others? 9  Secondly, 
to subsequently explore the spatial effect we first need to consider the processes 
underpinning the general concept of ‘spatial memory’ and attempt to utilise tests that allow 
fractionation of these. Thirdly, we should extend the measures of HPA axis function to include 
measures more closely related to the function of the GR receptor.  
 
This discussion above frames the subsequent three chapters of the thesis. In Chapter 4, 
Principal Component Analysis (PCA) will be employed to examine the factor structure of 
neuropsychological processes in a larger group of bipolar depressed patients and healthy 
controls. In Chapter 5, the results of a novel spatial (object-location) memory task will be 
reported which permits fractionation of distinct processes. Finally, in Chapter 6, the 
relationship between distinct spatial measures, general neuropsychological factors and newer 
more sensitive HPA axis measures are explored (specifically, the spatial measures of interest 
are those of the SWM, because of the findings in Chapter 3 where effects emerged in the 
between but not within search errors; and also the novel task described in Chapter 5), 
                                                          
9 This has been noted in many different contexts. For example, using PET imaging, very different patterns of activation have been 
observed in patients with Parkinson’s Disease who were able to maintain performance on an executive planning task through a 
shift to a declarative memory processing /’hippocampal’ activation (Dagher et al., 2001). The issue of executive scaffolding of 
visuospatial WM has also been demonstrated in euthymic bipolar patients (Thompson et al., 2006).  
Page | 160 
 
 
Chapter IV 
 
The component structure of neuropsychological 
processes in bipolar depression and healthy 
controls  
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4. The component structure of neuropsychological processes in bipolar 
depression and healthy controls 
 
4.1 Introduction to Chapter 4 
As outlined in the previous discussion the purpose of the present chapter is to analyse in 
detail the component structure 10 of neuropsychological processes in bipolar disorder. The 
tests examined will include those that have been used in chapters 2 and 3 of this thesis 
alongside some additional measures to tap specific processes not covered earlier or to address 
methodological issues that had arisen. These are briefly discussed below.  
 
4.1.1 Additional neuropsychological tests for PCA 
One issue that can occur with the use of some CANTAB tests in healthy or high-functioning 
participants is that of ceiling effects (see section 2.3.2.2). In Chapter 2, 8 participants (20%) 
achieved the maximum score of 24 on the Pattern Recognition (PRec) test and therefore the 
observed effect may have been an underestimate (as this occurred in 5 controls and 3 
patients). There are two likely explanations for this: firstly, the patterns used in the task in its 
present form are highly nameable and loosely resemble many concrete objects; and secondly, 
the test is administered in two blocks of twelve items. A modified PRec (PRec-m) test was 
therefore developed using the more abstract, black-and-white patterns (Vanderplas & Garvin, 
1959) and administered as a single block of 24. All other parameters remained the same as the 
original version. Although no participant achieved a maximum score on the Spatial 
Recognition (SRec) test, a number of people came close and therefore in addition to the 
standard test of four trials with 5 spatial locations to remember, two additional modified trials 
                                                          
10 This will be carried out using Principal Component Analysis (PCA). The specific methodology used here will be outlined 
subsequently. 
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with 7 locations (SRec-m7) and two with 9 locations (Srec-m9) were introduced for use with 
this larger cohort. 
 
In this study, the reverse version of the CANTAB Spatial Span test was also included to parallel 
the testing procedure used in the digit span test. The ‘forward’ versions of the digit and spatial 
span tests broadly tap the phonological loop and visuo-spatial sketchpad respectively, while 
the reverse versions place greater demands on the central executive component of working 
memory. A modified verbal fluency test (Crawford et al., 1995; Shores et al., 2006) was also 
included – the ‘Exclude-Letter’ Fluency Test (ELFT) – which again places greater demands on 
executive processes. Unlike the standard ‘FAS’ test in which subjects are required to produce 
as many words as possible beginning with a given letter, in the ELFT participants must produce 
as many words as possible that do not contain the given letters (vowels are typically used). To 
retain the characteristics of the FAS version the time for each letter was reduced to 60s 
(rather than the 90s as described in the original study). Lastly, an additional measure of speed 
of cognitive processing (SCOLP; Speed and Capacity of Language Processing) was included. 
This test more specifically measures slowing of language processing (Baddeley et al., 1992).  
 
Additional tests were included to tap specific aspects of (visuo-spatial) working memory and 
its executive control. The abstract design version (Petrides & Milner, 1982) of the Self-Ordered 
Pointing Test (SOPT) is a test of executive function/ visual working memory, requiring the 
ability to generate and monitor a sequence of responses. As the patterns used are abstract 
and change spatial position after each trial, participants must rely on visual-strategic 
processing in the task. The version used here consists of 3 trials at levels 4, 6, 8 and 10. A 
second visual memory test was included – the Visual Patterns Test (VPT) – which was designed 
to measure ‘short-term visual memory largely devoid of its spatio-sequential component’ 11 
                                                          
11 This is a direct contrast to the Corsi or Spatial Span test which is a purer measure of spatio-temporal processing. 
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(Della Sala et al., 1997; Della Sala et al., 1999). The version used in this study was 
computerised, with presentation of the stimuli on a PC but responses were recorded on paper 
as per the original test. In order to more closely parallel the spatial span test, the VPT allows 3 
attempts at each level before terminating the test.  
 
The addition of these tests will permit a more detailed interpretation of the factors that 
emerge from both the PCA and when used as composite scores in subsequent regression 
analysis. 
 
4.1.2 Aims of the PCA 
There are two broad aims of the present chapter and PCA. Firstly, using all the tests available 
(as outlined), a PCA will be carried out on a larger sample of patients with bipolar disorder and 
healthy control participants. The aim here is not to repeat the study reported in Chapter 2 (i.e. 
examining generic performance differences between patients and controls) but instead to 
explore the common factors onto which the different tests and processes load. Secondly, as 
already discussed, one of the aims of the subsequent chapters is to obtain a better 
understanding of the specificity of effects on spatial memory processes, therefore the PCA will 
also be run with a test of interest, such as the CANTAB Spatial Working Memory, removed in 
order to establish unique factor scores/unweighted composites that can be used in the 
analyses in the final empirical Chapter 6. In that final chapter, the composite scores derived 
from the results of this PCA and additional HPA axis measures will be used in regression 
analyses to explore the relationship with the primary spatial measures (namely, Spatial 
Working Memory and the Object-Location Memory paradigm in Chapter 5).  
 
 
Page | 164 
4.2 Methods 
For this and all subsequent chapters, a new cohort of patients and controls was recruited as 
part of an extended research programme into the effects of GR antagonists in bipolar 
depression funded by the Stanley Medical Research Institute (SMRI) and the Medical Research 
Council (MRC). 
 
4.2.1 Subjects 
Patients (n=53) aged 18 to 65 years with a diagnosis of bipolar disorder, confirmed using the 
Structured Clinical Interview for DSM-IV (SCID; First et al., 1995), were recruited from 
secondary and tertiary care services in North East of England. All were currently in a 
depressive episode. Patients were excluded if they met criteria for any other current axis I 
disorder, including anxiety disorder, schizophrenia or substance dependence/abuse. Illness 
characteristics, clinical ratings and medication history were determined by trained 
psychiatrists using full history, case-note and medication review and standardized rating 
scales. All patients were receiving medication at the time of testing which had remained stable 
for a minimum of 4 weeks.  
 
Healthy control subjects (n=47) were recruited by advertisement and from hospital/university 
staff. All controls had also been through a screening procedure prior to testing to exclude 
anyone with a personal or family history (first-degree) of psychiatric illness, significant medical 
or neurological illness likely to affect neuropsychological functioning, or history of 
drug/alcohol abuse. 
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After a complete description of the study, written informed consent was obtained from all 
participants. The study was approved by Newcastle and North Tyneside Research Ethics 
Committee. 
 
4.2.2 Neuropsychological tests 
As discussed in the introduction, in this part of the study an extended neuropsychological test 
battery was employed, with particular focus on additional tests of visual and spatial memory.  
These have been utilised in previous studies and are briefly listed below. 
 
CANTAB Spatial Working Memory (SWM): a self-ordered search task which requires subjects 
to search for hidden tokens within a spatial array. The number of between-search errors are 
recorded i.e. occasions when a subject returns to a square under which a token was already 
found, as well as a strategy measure, were a lower strategy score reflects a more systematic 
search strategy.  
CANTAB Spatial Recognition (SRec): a memory task in which subjects view 5 ‘squares’ 
presented in serial order and then are subsequently required to identify, from a choice of 2 
squares, the one that occupies one of the 5 locations shown previously. Subjects complete 4 
sets. The percentage of correct responses are recorded.  
CANTAB Spatial Recognition-modified (SRec-m): a modified version of the task was also 
administered which is identical to the standard version except two sets of 7 squares, then 2 
sets of 9 squares are used.  
CANTAB Spatial Span and Reverse Spatial Span (SSp/ rSSp): a test analogous to the Corsi Block 
task which is administered first in the standard format and then reverse, where subjects tap 
the sequence in the opposite order from presentation. The maximum span reached is 
recorded.  
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Visual Patterns Test (VPT): a test of short-term visual memory in which subjects are required 
to remember and reproduce increasingly complex ‘checkerboard’ patterns (Della Sala et al., 
1999). It is scored in the same way as the SSp task with the maximum set-size achieved being 
recorded.  
CANTAB Pattern Recognition (PRec): a test of visual recognition memory in which subjects 
view a series of 12 coloured patterns and must then select the patterns they have seen in a 2-
choice, forced-discrimination paradigm. Subjects complete 2 sets and the percentage correct 
is recorded. 
 Pattern Recognition-modified (PRec-m): due to the risk of ceiling effects in healthy controls, a 
modified pattern recognition task was constructed which was similar to the CANTAB version 
except the patterns were more abstract, black and white shapes and were more closely 
matched to their distracter during the recognition phase. These were taken from (Vanderplas 
& Garvin, 1959) and displayed using the Superlab program. One set of 24 patterns was 
administered.  
Self-Ordered Pointing Test (SOPT): a test of visual memory and strategic processing, using set 
sizes 4, 6, 8 and 10.  
 
The other tests included are: 
Rey-Auditory Verbal Learning Test (Rey-AVLT): a verbal learning and memory task which was 
administered according to standardised instructions (Rey, 1964; Lezak et al., 2004).  
Forward and Backward Digit Span (fDSp/ bDSp): a test of immediate verbal recall and working 
memory which was again administered according to standardised instructions (Lezak et al., 
2004).  
Verbal fluency (FAS) and Exclude-Letter Fluency test (ELFT): tests of executive function in which 
participants are required to produce as many words as possible beginning with, or not 
containing a given letter.  
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Digit Symbol Substitution Test (DSST): as a test of psychomotor speed and attention.  
Speed and Capacity of Language Processing (SCOLP): to test the speed and efficiency of 
cognitive processing. 
 
4.2.3 Statistical analysis procedure 
Due to the exploratory nature of this type of analysis procedure, the general methodology and 
data screening considerations are outlined in this section. The approach adopted follows 
closely the recommendations by Field and Stevens (Stevens, 2002; Field, 2009). 
 
4.2.3.1 Preliminary data cleaning 
A Principal Component Analysis (PCA) was performed on the neuropsychological tests 
described above. Of the tests included, on those that have multiple possible outcome 
measures associated with them only the most commonly used / most representative of 
specific cognitive processes were extracted: this resulted in 26 potential variables. These 26 
variables were then assessed along a number of criteria for inclusion in the analysis. First, as 
outlined in the introduction, a number of experimental measures were introduced to assess 
and overcome the issue of ceiling effects in the Pattern Recognition (PRec) and Spatial 
Recognition (SRec) tests. In the standard version of PRec, n=18 (22.2%) of participants 
achieved the maximum possible score on the task, therefore this variable was excluded in 
favour of the modified PRec test where only 2 participants (1.6%) scored the maximum. With 
the SRec, the standard version of the test was retained as only n=2 (1.6%) of participants 
achieved the maximum score and SRec 7 and 9 were excluded.   
 
Test variables were also assessed for missing values: all those retained had a maximum of n=5 
(5%) missing data points, which were replaced with the group mean (patient or control). 
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However the 3 variables from the Vigil test were excluded as, due to a technical error in the 
software, only n=75 (75%) valid data was available. 
 
Finally, as recommended by Field, the correlation matrix was examined for any extreme values 
i.e. variables correlating very highly or very weakly with others. For the Rey-AVLT, delayed 
recall of List A (trial A7) unsurprisingly correlated very highly with A7 percentage retained 
(r>0.9) therefore the latter variable was excluded in favour of the former which showed 
moderate, significant correlations with a greater number of other variables.  
 
By excluding these outcome measures/variables there are 19 potential for inclusion in the 
PCA. This results in around 5.3 cases per variable which falls just within the recommended 5 to 
10 per variable with samples n<300 (Kass & Tinsley, 1979). This is only a general guideline and 
more formal testing of the sample and the data will be performed through the iterative 
process of extracting stable factor solutions. The Kaiser-Mayer-Olkin measure of sampling 
adequacy (KMO) will be reported along with Haitovsky’s test for multicolinearity:  
Haitovsky’s χ2H = [  
       
 
   ]       | |  
 
Where p is the number of variables in the correlation matrix, N is the overall sample size and 
|R| is the determinant of the correlation matrix. The resulting Chi-squared statistic has  
degrees of freedom  
      
 
       (Haitovsky, 1969; Field, 2009). 
 
A significant result on this test indicates there is no severe multicolinearity (although it should 
be noted, that assumption is not necessary with PCA). As recommended by Stevens, with 
samples of around n=100 it is also recommended that a significant result on Bartlett’s test of 
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sphericity is obtained in order to reject the null hypothesis that the variables in the population 
correlation matrix are uncorrelated.  
 
4.2.3.2 Factor rotation selection 
Finally, an important consideration is the interpretation of the components which are 
extracted, which is done through the rotation of factors. There are numerous methods 
available, many of which are included in statistical analyses packages. However, there is 
considerable debate as to the method to use. The main consideration is whether to select 
Orthogonal (varimax) or Oblique (direct Oblimin) rotation 12 (Stevens, 2002; Field, 2009). 
Avoiding detailed discussion of the mathematics behind each of these, the main distinction is 
that orthogonal rotations produce factors that are uncorrelated while oblique rotations 
produce factors that will be correlated to a lesser or greater extent. The varimax method 
(Kaiser, 1960) is design to produce factors that are as independent as possible, with each 
factor loading as high as possible on a small number of variables and as little as possible with 
others, hence interpretation of the resulting factors in the component matrix is  easier than 
with other methods (Stevens, 2002). In contrast, the Oblimin method permits factors to 
correlate, determined to an extent by the delta value entered at the time. The result of this 
analysis produces two matrices – a pattern matrix which contains the loadings of each variable 
to the factor with the influence of the remaining variables partialled out; and a structure 
matrix which presents the simple factor loadings of each variable. Consequently, if the factor 
structure is orthogonal these two matrices are the same, however differences between the 
two (in terms of variable loadings) are of interest as these differences indicate those 
factors/variable loadings that are largely independent compared to those that load across 
                                                          
12
 There are many additional examples of rotation methods within these categories. Those discussed here are those 
recommended in each case, based on the consistency and predictability of results and ease of interpretation of the resulting 
factors. 
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several factors.  When dealing with components of human psychological processes it has been 
argued that it is unlikely that these are ever truly independent (Field, 2009).  
 
Therefore the approach adopted in the present study is to examine and compare the results 
of both rotation methods (as recommended by several authors Pedhauzur & Schmelkin, 1991; 
Stevens, 2002). This fits with the two broad aims of the present chapter; first, to understand 
the factor structure underlying the tests and processes employed, and second, to produce 
interpretable composite scores for use in subsequent regression analyses. As has been 
discussed, the varimax method of producing factors that are as unique as possible will create 
interesting theoretical distinctions between these components with the caveat that they may 
not be precisely representative of the complex inter-relationships between processes in 
human neuropsychology. In contrast, the Oblimin method will provide valuable information 
on the relative independence of each variable or shared component across the resulting 
factors, and through the iterative process of re-assessing the strength of these factors as those 
variables that are multiple-loading are removed, a set of independent factors can be produced 
(at which point the pattern and structure matrices will be the same and hence orthogonal; 
replicating the varimax model). 
 
One final point to note surrounds the labels given to the extracted components. These should 
be viewed as broad, general descriptions only, given the complexity of accurately describing 
the exact combination of tests or measures within any given component. 
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4.3 Results 
Fifty three bipolar patients (33 male, 20 female) participated in the study. Patients were aged 
between 22 and 63 years (mean=47 years, s.d.=10) and had a NART estimated IQ of 109 
(s.d.=2). There were no current psychotic features in the group and no current diagnosis of 
substance abuse or dependence. The average (median) age of onset13 in the group was 24 
years (mean=27, s.d.=13). The median number of hospitalizations14 in the group was 1. Twenty 
six patients (49%) had previously attempted suicide10 and 11 (22%) had previously been 
treated with ECT15 (>12 months ago).  
 
All patients had persistent depressive symptoms, with all fulfilling SCID criteria for current 
depressive episode. The median length of current depressive episode12 in the group was 26 
weeks (mean=61.5, s.d.=82.7). Depressive symptoms had a mean score of 28 (s.d.=8) on the 
Montgomery-Åsberg Depression Rating Scale (MADRS)16 and of 20 (s.d.=5) on the 17-item 
Hamilton Depression Rating Scale (HDRS17).  
 
The healthy control group (n=47) consisted of 28 males and 19 females. Controls were aged 
between 18 and 64 (mean=45 years, s.d.=14) and had a NART estimated IQ of 112.5 (s.d.=12). 
This group was matched to the patient group by sex (χ2=0.76, df=1, p=0.783), age (t=0.954, 
df=98, p=0.343) and NART score17 (t=1.586, df=93, p=0.116).  
 
 
 
 
                                                          
13 Data on 4 patients was missing. 
14 Data on 2 patients was missing. 
15 Data on 3 patients was missing. 
16 Data on 1 patient was missing. 
17 n.b. by accidental omission, the NART was not completed for 2 patients and 3 controls. 
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4.3.1 PCA #01: Total Sample 
The first step in the analysis was to further screen the data for variables for inclusion in the 
PCA. A correlation matrix was produced for all variables (see Table 4-1) and then sorted into 
order (Table 4-2), allowing exclusion of those variables that did not correlate strongly with 
others (shading indicates significant p<0.05)18.  
 
4.3.1.1 Initial model 
Although there is no fixed criteria for this screening procedure, for the purposes of the initial 
analysis, Field and others recommend that variables with low-loadings (r<0.3) be excluded. To 
attempt to improve the explained variance within the PCA a more stringent approach to initial 
data screening was adopted. Any variables with overall or multiple low-loadings (r<0.3) were 
excluded. Those with the lowest average loading were: SCOLP spot-the-word test (median 
r=0.118) , SWM within errors (median r=0.120), and SCOLP speed of comprehension (median 
r=0.222). These variables also had some of the lowest loadings with other individual variables: 
SWM had no individual correlations above r=0.28, for SCOLP spot-the-word test only 3 
individual values were 0.30<r<0.46); on this criteria Forward Digit Span was also excluded 
(median=0.233 and only 3 individual values 0.30<r<0.40). 
  
                                                          
18 The need to carry out this additional step is indicated as, if an attempt is made to run the PCA with all variables included, the 
determinant |R| of the correlation matrix is 0 indicating extreme multicolinearity and the rotated factor solution fails to converge 
(25 iterations; convergence=0.006). 
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Table 4-1. Overall correlation matrix 
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Table 4-2. Correlation matrix, ranked by magnitude (grey shading indicates median value) 
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No shading: variables with low-loadings (r<0.3); grey shading: average r value 
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This resulted in the initial entry of 15 variables into the PCA. The initial model, following factor 
rotation indicated that the modified Pattern recognition (PRec-m) test did not load onto any 
component above the pre-defined criteria (see below) and also displayed low communality 
(0.307). Therefore this variable was eliminated to produce the final PCA reported below using 
the 14 variables remaining. The factorability of the variables was confirmed using the criteria 
described above (section 4.2.3). All variables correlated with at least five others at r>0.30 (and 
less than r=0.77). The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy was 0.833 
(the cut-off for a ‘very good’ value is above 0.8) and Bartlett’s test of sphericity was significant 
(2=636.8, df=91, p<0.0001). The diagonals of the anti-image correlation matrix were all much 
greater than 0.5 (the lowest value was 0.744), justifying the inclusion of each item in the 
analysis. Although not required for PCA, Haitovsky’s test failed to reach significance (χ2H =0.09, 
df=91, p=0.99), however the determinant of the initial correlation matrix was |R|=0.001 (well 
above the recommended 0.00001) suggesting that multicolinearity is not an issue with these 
data. Finally, the communalities for the PCA ranged from 0.468 to 0.778, with a mean of 0.690 
(see Table 4-3 below). 
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Table 4-3. PCA #01 communalities (initial model) 
 Initial Extraction 
SWM between errors 1.000 0.746 
Spatial span 1.000 0.637 
Spatial span reversed 1.000 0.653 
Visual Patterns test span 1.000 0.644 
SWM strategy score 1.000 0.667 
SRec Correct 1.000 0.468 
SOPT total errors 1.000 0.641 
DSST 1.000 0.644 
Rey total A1-5 1.000 0.815 
Rey A7 1.000 0.827 
Rey Recognition A 1.000 0.778 
Digit Span (reverse) 1.000 0.637 
FAS correct 1.000 0.731 
ELFT correct 1.000 0.772 
 
 
 
Four factors were extracted, with each independently explaining 40.3%, 11.7%, 9.6% and 7.4% 
of the variance (cumulatively: 40.3, 52.0, 61.2 and 69.0%).  
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Table 4-4. PCA #01 unrotated component matrix  (initial model) a 
 Component 
 1 2 3 4 
SWM between errors
 b
 -0.777 -0.024 0.360 0.113 
Spatial span 0.659 0.132 -0.339 0.266 
Spatial span reversed 0.655 0.262 -0.237 0.315 
Visual Patterns test span 0.625 0.319 -0.367 0.131 
SWM strategy score 
b
 -0.676 -0.113 0.214 0.388 
SRec Correct 0.615 -0.023 0.015 -0.299 
SOPT total errors 
b
 -0.729 0.096 0.136 0.287 
DSST 0.608 0.120 0.159 0.485 
Rey total A1-5 0.690 -0.500 0.164 0.250 
Rey A7 0.648 -0.618 0.110 0.117 
Rey Recognition A 0.581 -0.592 0.144 -0.264 
Digit Span (reverse) 0.453 0.514 0.227 -0.341 
FAS correct 0.505 0.339 0.599 -0.050 
ELFT correct 0.596 0.239 0.588 0.117 
 
a. 4 components extracted. 
b. Note: although loadings are negative, these variables report error scores and therefore should be 
reversed for interpretation on component loading. 
 
 
 
 
In terms of which loadings should used for interpretation, Stevens recommends using a fixed 
criteria based on the sample size rather than a simple convention (such as >0.4). As the 
loading is effectively a Pearson correlation coefficient between each variable and the factor 
(the linear combination of the variables), the cut-off adopted should be the coefficient at a 
given significance level for the particular sample size. Therefore with n=100 and p<0.01, the 
critical value for a 2-tailed correlation coefficient is >2*(0.256)= 0.512 
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Table 4-5. PCA #01 Varimax rotated component matrix  (initial model) a 
 
 Component 
 1 2 3 4 
SWM between errors
 b
 -0.547 -0.259 -0.616 -0.021 
Spatial span 0.733 0.178 0.258 0.049 
Spatial span reversed 0.754 0.100 0.199 0.189 
Visual Patterns test span 0.706 -0.021 0.370 0.095 
SWM strategy score 
b
 -0.286 -0.127 -0.742 -0.135 
SRec Correct 0.153 0.275 0.560 0.234 
SOPT total errors 
b
 -0.273 -0.359 -0.650 -0.124 
DSST 0.598 0.311 -0.088 0.427 
Rey total A1-5 0.303 0.828 0.084 0.178 
Rey A7 0.187 0.871 0.171 0.062 
Rey Recognition A -0.086 0.764 0.427 0.067 
Digit Span (reverse) 0.110 -0.206 0.491 0.584 
FAS correct 0.083 0.094 0.168 0.829 
ELFT correct 0.208 0.246 0.080 0.814 
Rotation Method: varimax with Kaiser Normalization.  Shaded values are below the recommended critical value of 0.512 
a. Rotation converged in 7 iterations. b. Note: although variable loadings on each component are negative, these variables report 
error scores and therefore should be reversed for interpretation of true component loading. 
 
 
From Table 4-5 above there are four components after varimax factor rotation. The clustering 
of variables suggests that component 2 represents verbal learning and memory and 
component 4 (verbal) executive function and working memory. The remaining two 
components appear to represent differing aspects of visuo-spatial processing: component 1 a 
short-term visuo-spatial memory measure and component 3 a self-ordered/strategic visuo-
spatial processing measure.  
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Of great interest is the fact that SWM between search errors is the only variable to load 
significantly across these two measures. Of the remaining measures, although not significant, 
it is of note that the DSST loads moderately onto components 2 and 4, possibly representing 
the contribution of general psychomotor speed in many different components. Similarly, 
reverse digit span also loads moderately onto the strategic component 3, possibly reflecting 
the WM manipulation component to the test.  
 
4.3.1.2 Optimised model 
Resulting from the discussion previously on the differences between orthogonal and oblique 
factor rotation, the direct Oblimin pattern and structure matrices were also generated and 
compared to the rotated model in section 4.3.1. These also provide additional information on 
the variables which may load onto multiple components, allowing generation of ‘cleaner’ 
composite scores. From the component correlation matrix there does appear to be some 
degree of correlation between the factors. This is more clearly evident when comparing the  
loadings of individual variables. 
 
Table 4-6. PCA #01 component correlation matrix  (optimised model) a 
 
Component 1 2 3 4 
1 1.000 -0.354 0.378 -0.230 
2 -0.354 1.000 -0.243 0.151 
3 0.378 -0.243 1.000 -0.164 
4 -0.230 0.151 -0.164 1.000 
   
 Rotation Method: Oblimin with Kaiser Normalization.  
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Table 4-7. PCA #01 Oblimin rotated pattern and structure matrices (optimised model) 
Oblimin Pattern Matrix 
Component 
 
1 2 3 4 
SWM between errors
 b
 -0.607 0.216 0.075 0.389 
Spatial span 0.794 -0.074 -0.073 0.000 
Spatial span reversed 0.798 0.028 0.080 0.068 
Visual Patterns test span 0.795 0.130 -0.002 -0.146 
SWM strategy score 
b
 -0.324 0.118 -0.100 0.593 
SRec Correct 0.119 -0.279 0.215 -0.413 
SOPT total errors 
b
 -0.267 0.362 -0.072 0.467 
DSST 0.521 -0.186 0.342 0.374 
Rey total A1-5 0.172 -0.816 0.083 0.181 
Rey A7 0.066 -0.898 -0.025 0.054 
Rey Recognition A -0.203 -0.845 0.035 -0.289 
Digit Span (reverse) 0.073 0.258 0.634 -0.395 
FAS correct -0.079 -0.026 0.876 0.000 
ELFT correct 0.032 -0.162 0.827 0.146 
 
Oblimin Structure Matrix 
Component 
 1 2 3 4 
SWM between errors
 b
 -0.744 0.471 -0.271 0.549 
Spatial span 0.793 -0.338 0.246 -0.183 
Spatial span reversed 0.802 -0.263 0.363 -0.125 
Visual Patterns test span 0.782 -0.173 0.291 -0.309 
SWM strategy score 
b
 -0.540 0.346 -0.349 0.702 
SRec Correct 0.394 -0.436 0.396 -0.518 
SOPT total errors 
b
 -0.530 0.544 -0.338 0.595 
DSST 0.630 -0.397 0.523 0.169 
Rey total A1-5 0.451 -0.870 0.317 0.004 
Rey A7 0.361 -0.907 0.209 -0.092 
Rey Recognition A 0.176 -0.825 0.211 -0.375 
Digit Span (reverse) 0.313 0.018 0.664 -0.477 
FAS correct 0.262 -0.211 0.852 -0.130 
ELFT correct 0.368 -0.352 0.854 -0.022 
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From the Oblique rotation reported above, it is clear that three of the components are 
identical to the orthogonal solution 19. The pattern matrix shows the cluster of factor loadings 
in components 1, 2 and 3 are identical to components 1, 2 and 4 respectively of the varimax 
solution. The fourth component in the structure matrix also shows identical loadings to the 
varimax solution, although as can be seen from the pattern matrix, these load less cleanly due 
to moderate loadings with other factors. Loadings in the pattern matrix further show that 
Spatial Recognition and SOPT do not load uniquely onto any of the four components for the 
same reason.  
 
Therefore, this model was revisited after excluding variables that were not loading sufficiently 
uniquely onto individual components. Exclusion was done one variable at a time until a 
suitable, unique factor rotation was obtained within a PCA that met all criteria described 
previously. After the exclusion of SOPT, DSST and SRec, the final model was achieved. The 
factorability of the variables was again confirmed using the criteria described above (section 
4.2.3). The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy was 0.802 (the cut-off 
for a ‘very good’ value is above 0.8) and Bartlett’s test of sphericity was significant (2=476.9, 
df=55, p<0.0001). The diagonals of the anti-image correlation matrix were all much greater 
than 0.5 (the lowest value was 0.719), justifying the inclusion of each item in the analysis. The 
determinant of the initial correlation matrix was |R|=0.006 (well above the recommended 
0.00001) suggesting that multicolinearity is not an issue with these data. Finally, the 
communalities for the PCA ranged from 0.536 to 0.772, with a mean of 0.675 (see Table 4-8 
below). 
 
 
 
                                                          
19 For clarity, cells are coloured red if the factor loadings are no longer significant, while those in green are loadings 
that have entered the component. 
Page | 182 
Table 4-8. PCA #01 communalities (optimised model) 
 Initial Extraction 
SWM between errors
 
 1.000 0.744 
Spatial span 1.000 0.611 
Spatial span reversed 1.000 0.571 
Visual Patterns test span 1.000 0.622 
SWM strategy score  1.000 0.536 
Rey total A1-5 1.000 0.762 
Rey A7 1.000 0.836 
Rey Recognition A 1.000 0.689 
Digit Span (reverse) 1.000 0.542 
FAS correct 1.000 0.772 
ELFT correct 1.000 0.744 
 
Three components were now extracted, with each independently explaining 40.7%, 14.8%, 
and 12.0% of the variance (cumulatively: 40.7, 55.5, and 67.5%).  
 
Table 4-9. PCA #01 unrotated component matrix  (optimised model) 
 Component 
 1 2 3 
SWM between errors
 
 -0.788 0.040 0.349 
Spatial span 0.684 -0.134 -0.354 
Spatial span reversed 0.661 -0.258 -0.259 
Visual Patterns test span 0.620 -0.329 -0.360 
SWM strategy score  -0.701 0.142 0.157 
Rey total A1-5 0.690 0.523 0.112 
Rey A7 0.660 0.628 0.079 
Rey Recognition A 0.571 0.584 0.147 
Digit Span (reverse) 0.435 -0.519 0.288 
FAS correct 0.523 -0.316 0.631 
ELFT correct 0.611 -0.197 0.576 
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After direct Oblimin rotation, the factor loadings of the pattern and structure matrices 
matched (in terms of individual variables loading to a component), indicating orthogonal 
factors.  
Table 4-10. PCA #01 Oblimin rotated pattern and structure matrices (optimised model) 
Pattern Matrix 
 Component 
 1 2 3 
SWM between errors
 b
 -0.797 -0.213 0.072 
Spatial span 0.776 0.080 -0.065 
Spatial span reversed 0.731 -0.024 0.074 
Visual Patterns test span 0.821 -0.132 0.000 
SWM strategy score 
b
 -0.622 -0.126 -0.128 
Rey total A1-5 0.116 0.809 0.073 
Rey A7 0.084 0.887 -0.015 
Rey Recognition A -0.011 0.825 0.042 
Digit Span (reverse) 0.233 -0.236 0.639 
FAS correct -0.086 0.073 0.894 
ELFT correct -0.034 0.210 0.813 
Structure Matrix 
 Component 
 1 2 3 
SWM between errors
 b
 -0.837 -0.452 -0.273 
Spatial span 0.776 0.313 0.247 
Spatial span reversed 0.752 0.222 0.350 
Visual Patterns test span 0.779 0.128 0.290 
SWM strategy score 
b
 -0.711 -0.346 -0.390 
Rey total A1-5 0.401 0.860 0.267 
Rey A7 0.360 0.911 0.180 
Rey Recognition A 0.266 0.829 0.189 
Digit Span (reverse) 0.403 -0.045 0.685 
FAS correct 0.280 0.210 0.874 
ELFT correct 0.344 0.348 0.839 
b. Note: although variable loadings on each component are negative, these variables report error scores and therefore should be 
reversed for interpretation of true component loading. 
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To confirm this, an orthogonal varimax rotation was also performed and produced the 
expected identical cluster of loadings. 
 
Table 4-11. PCA #01 Varimax rotated component matrix (optimised model)a 
 
 Component 
 1 2 3 
SWM between errors
 b
 -0.788 -0.337 -0.090 
Spatial span 0.750 0.203 0.085 
Spatial span reversed 0.719 0.107 0.206 
Visual Patterns test span 0.776 0.007 0.143 
SWM strategy score 
b
 -0.645 -0.241 -0.248 
Rey total A1-5 0.243 0.826 0.142 
Rey A7 0.206 0.889 0.054 
Rey Recognition A 0.116 0.817 0.089 
Digit Span (reverse) 0.315 -0.131 0.652 
FAS correct 0.099 0.145 0.861 
ELFT correct 0.154 0.281 0.801 
Rotation Method: varimax with Kaiser Normalization. a. Rotation converged in 5 iterations. b. Note: 
although variable loadings on each component are negative, these variables report error scores and 
therefore should be reversed for interpretation of true component loading. 
 
 
From these loadings the three components are clearly evident as: visuo-spatial memory in 
component 1, verbal learning and memory in component 2, and (verbal) executive function 
and working memory in component 3. These latter two are identical to the initial models, 
however through the removal of tests that exhibit a  broader profile of loadings, the visuo-
spatial components have collapsed into a single factor.  
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4.3.2 PCA #02: Total Sample (for SWM sub-analysis) 
4.3.2.1 Initial model 
As discussed earlier, one of the aims of the subsequent chapters is to reduce the 
neuropsychological variables into composites that can be used to examine the relationship 
with specific spatial tests and processes. To this end, the PCA was re-run after excluding SWM 
entirely in order to use this test as the dependent variable.  
 
Interestingly, the pattern of excluded variables followed closely that of PCA #01 in that PRec-
m, SRec and also DSST did not load significantly after factor rotation (and also exhibited low 
communality) and were therefore excluded. The Kaiser-Meyer-Olkin (KMO) measure of 
sampling adequacy was 0.784 (the cut-off for a ‘good’ value is between 0.7 and 0.8) and 
Bartlett’s test of sphericity was significant (2=398.5, df=45, p<0.0001). The diagonals of the 
anti-image correlation matrix were all much greater than 0.5 (the lowest value was 0.696), 
justifying the inclusion of each item in the analysis. The determinant of the initial correlation 
matrix was |R|=0.015 (well above the recommended 0.00001) suggesting that 
multicolinearity is not an issue with these data. Finally, the communalities for the PCA ranged 
from 0.546 to 0.839, with a mean of 0.690 (see Table 4-12 below). 
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Table 4-12. PCA #02 communalities (initial model) 
 Initial Extraction 
Spatial span 1.000 0.649 
Spatial span reversed 1.000 0.668 
Visual Patterns test span 1.000 0.659 
SOPT total errors 1.000 0.574 
Rey total A1-5 1.000 0.760 
Rey A7 1.000 0.839 
Rey Recognition A 1.000 0.706 
Digit span (reverse) 1.000 0.546 
FAS correct 1.000 0.768 
ELFT correct 1.000 0.727 
 
 
Three components were extracted explaining 40.5%, 16.2% and 12.3% of the variance (40.5, 
56.7, 69.0% respectively).  
 
 
Table 4-13. PCA #02 unrotated component matrix (initial model) a 
 Component 
 1 2 3 
Spatial span 0.653 0.153 -0.445 
Spatial span reversed 0.653 0.296 -0.392 
Visual Patterns test span 0.591 0.333 -0.446 
SOPT total errors -0.743 0.051 0.141 
Rey total A1-5 0.738 -0.460 0.055 
Rey A7 0.707 -0.581 0.051 
Rey Recognition A 0.599 -0.558 0.189 
Digit span (reverse) 0.439 0.549 0.229 
FAS correct 0.554 0.394 0.552 
ELFT correct 0.623 0.278 0.511 
   a. 3 components extracted. 
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After varimax rotation, the same 3 components were evident: a verbal learning and memory 
component (1); a visuo-spatial memory component (2); and a verbal executive/WM 
component (3). 
 
Table 4-14. PCA #02 Varimax rotated component matrix (initial model) a 
 Component 
 1 2 3 
Spatial span 0.228 0.768 0.085 
Spatial span reversed 0.130 0.782 0.199 
Visual Patterns test span 0.054 0.795 0.154 
SOPT total errors -0.490 -0.534 -0.223 
Rey total A1-5 0.827 0.244 0.131 
Rey A7 0.896 0.184 0.047 
Rey Recognition A 0.833 0.030 0.104 
Digit span (reverse) -0.094 0.305 0.667 
FAS correct 0.149 0.091 0.859 
ELFT correct 0.273 0.120 0.799 
 Rotation Method: varimax with Kaiser Normalization. a. Rotation converged in 5 iterations. 
 
4.3.2.2 Optimised model 
Again, as before, although not significant above the defined cut-off for interpretation it is 
evident that SOPT also loads onto component 1. Therefore when comparing this to the 
oblique rotation method, SOPT did not load uniquely onto any component. Once removed, 
the Oblimin method produced an identical pattern and structure matrix which was confirmed 
through orthogonal rotation. 
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This new PCA contained 9 variables. The KMO statistic was 0.758 and Bartlett’s test was 
significant (2=334.0, df=36, p<0.0001). The diagonals of the anti-image correlation matrix 
were all much greater than 0.5 (the lowest value was 0.682), justifying the inclusion of each 
item in the analysis. The determinant of the initial correlation matrix was |R|=0.030 (well 
above the recommended 0.00001). Finally, the communalities for the PCA ranged from 0.547 
to 0.848, with a mean of 0.711 (see Table 4-15). 
 
Table 4-15. PCA #02 communalities (optimised model) 
 Initial Extraction 
Spatial span 1.000 0.688 
Spatial span reversed 1.000 0.706 
Visual Patterns test span 1.000 0.641 
Rey total A1-5 1.000 0.786 
Rey A7 1.000 0.848 
Rey Recognition A 1.000 0.691 
Digit span (reverse) 1.000 0.547 
FAS correct 1.000 0.763 
ELFT correct 1.000 0.731 
 
 
 
Three components were extracted explaining 39.6%, 18.0% and 13.5% of the variance 
(cumulatively; 39.6, 57.6, 71.1%). 
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Table 4-16. PCA #02 unrotated component matrix (optimised model) a 
 
 Component 
 1 2 3 
Spatial span 0.660 0.146 -0.481 
Spatial span reversed 0.664 0.287 -0.428 
Visual Patterns test span 0.574 0.333 -0.449 
Rey total A1-5 0.749 -0.475 0.011 
Rey A7 0.705 -0.593 0.018 
Rey Recognition A 0.582 -0.565 0.182 
Digit span (reverse) 0.429 0.546 0.256 
FAS correct 0.581 0.377 0.532 
ELFT correct 0.667 0.257 0.469 
 
a. 3 components extracted. 
 
 
 
 
After direct Oblimin rotation, 3 components were evident in the pattern and structure 
matrices: 1) a visuo-spatial memory component; 2) a verbal learning and memory component; 
and 3) a verbal executive/WM component.  
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Table 4-17. PCA #02 Oblimin rotated pattern and structure matrices (optimised model) a 
 
Pattern Matrix 
a
 
 Component 
 1 2 3 
Spatial span 0.804 -0.141 -0.062 
Spatial span reversed 0.809 -0.028 0.062 
Visual Patterns test span 0.802 0.064 0.034 
Rey total A1-5 0.168 -0.818 0.038 
Rey A7 0.098 -0.899 -0.039 
Rey Recognition A -0.099 -0.838 0.065 
Digit span (reverse) 0.166 0.206 0.685 
FAS correct -0.077 -0.071 0.882 
ELFT correct -0.023 -0.212 0.797 
   Rotation Method: Oblimin with Kaiser Normalization.  a. Rotation converged in 7 iterations. 
 
 
Structure Matrix 
 Component 
 1 2 3 
Spatial span 0.817 -0.333 0.252 
Spatial span reversed 0.838 -0.246 0.355 
Visual Patterns test span 0.798 -0.147 0.307 
Rey total A1-5 0.390 -0.869 0.261 
Rey A7 0.314 -0.917 0.175 
Rey Recognition A 0.137 -0.826 0.197 
Digit span (reverse) 0.358 0.028 0.703 
FAS correct 0.255 -0.227 0.869 
ELFT correct 0.314 -0.364 0.830 
  Rotation Method: Oblimin with Kaiser Normalization. 
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As can be seen from the convergence of the pattern and structure matrices, the factors are 
now orthogonal and are identical to the varimax rotated solution. 
 
 
Table 4-18. PCA #02 Varimax rotated component matrix (optimised model) a 
 
 Component 
 1 2 3 
Spatial span 0.240 0.789 0.092 
Spatial span reversed 0.141 0.803 0.205 
Visual Patterns test span 0.047 0.781 0.170 
Rey total A1-5 0.837 0.262 0.131 
Rey A7 0.900 0.190 0.049 
Rey Recognition A 0.824 0.008 0.112 
Digit span (reverse) -0.111 0.258 0.684 
FAS correct 0.152 0.086 0.856 
ELFT correct 0.290 0.140 0.792 
   Rotation Method: varimax with Kaiser Normalization.   a. Rotation converged in 5 iterations. 
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4.3.3 PCA #03: Control participants 
4.3.3.1 Initial model 
In order to examine any differences in the structure of the models between patients and 
controls, the PCA was re-run for each group separately. To allow for differences to emerge, 
the analyses were performed from the point of initial data screening. Examination of the 
correlation matrix led to the exclusion of the digit span forward and both SCOLP measures. 
From this analysis it emerged that SWM within search errors and SRec did not load 
significantly into the rotated solution and the modified PREC exhibited low communality; all 
were excluded.   
 
This final model contained 13 variables. The Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy was 0.738 and Bartlett’s test of sphericity was significant (2=281.9, df=78, 
p<0.0001). The diagonals of the anti-image correlation matrix were all greater than 0.5 
justifying the inclusion of each item in the analysis. The determinant of the initial correlation 
matrix was |R|=0.001 suggesting that multicolinearity is not an issue with these data. Finally, 
the communalities for the PCA ranged from 0.610 to 0.870, with a mean of 0.733 (see Table 
4-19 below). 
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Table 4-19. PCA #03 communalities (initial model) 
 
 Initial Extraction 
SWM between errors 1.000 0.720 
Spatial span 1.000 0.694 
Spatial span reversed 1.000 0.621 
Visual Patterns test span 1.000 0.700 
SWM strategy score 1.000 0.756 
SOPT total errors 1.000 0.758 
DSST 1.000 0.610 
Rey total A1-5 1.000 0.823 
Rey A7 1.000 0.870 
Rey Recognition A 1.000 0.751 
Digit Span (reverse) 1.000 0.675 
FAS correct 1.000 0.766 
ELFT correct 1.000 0.789 
 
 
Four components were extracted explaining 35.6%, 15.1%, 13.1%, 9.5% (cumulatively, 35.6, 
50.7, 63.8, 73.3%) of the variance.  
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Table 4-20. PCA #03 unrotated component matrix (initial model) a 
 
 Component 
 1 2 3 4 
SWM between errors -0.778 0.139 0.303 0.056 
Spatial span 0.687 -0.259 -0.218 0.327 
Spatial span reversed 0.568 0.035 -0.185 0.513 
Visual Patterns test span 0.547 -0.117 -0.611 0.117 
SWM strategy score -0.661 -0.039 0.365 0.429 
SOPT total errors -0.749 -0.002 0.093 0.433 
DSST 0.521 0.175 0.088 0.549 
Rey total A1-5 0.608 -0.284 0.601 0.103 
Rey A7 0.695 -0.252 0.570 -0.008 
Rey Recognition A 0.627 -0.267 0.452 -0.288 
Digit Span (reverse) 0.521 0.574 -0.131 -0.239 
FAS correct 0.236 0.805 0.242 -0.059 
ELFT correct 0.298 0.799 0.189 0.163 
a. 4 components extracted. 
 
 
After varimax rotation, the criteria for significance of the loadings were again calculated for 
the obtained sample size. At an alpha level of p<0.05 and n=47, the cut-off for interpretation 
was  >2*(0.2876)= 0.575 20 
 
  
                                                          
20 Note that this is more stringent than the cut-off with the overall sample, hence the use of p<0.05 rather than 0.01. 
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Table 4-21. PCA #03 Varimax rotated component matrix (initial model) a 
 
 Component 
 1 2 3 4 
SWM between errors
 b
 0.677 -0.240 -0.451 0.022 
Spatial span -0.355 0.254 0.697 -0.135 
Spatial span reversed -0.151 0.096 0.757 0.123 
Visual Patterns test span -0.595 -0.146 0.554 -0.131 
SWM strategy score 
b
 0.851 -0.110 -0.095 -0.101 
SOPT total errors
 b
 0.765 -0.380 -0.065 -0.154 
DSST 0.045 0.229 0.678 0.310 
Rey total A1-5 -0.005 0.871 0.251 0.025 
Rey A7 -0.139 0.895 0.212 0.067 
Rey Recognition A -0.322 0.805 -0.015 0.008 
Digit Span (reverse) -0.522 0.015 0.079 0.629 
FAS correct -0.041 0.048 -0.040 0.872 
ELFT correct 0.022 0.019 0.186 0.868 
a. Rotation converged in 6 iterations. 
b 
n.b. for these measures, higher scores equate to worse performance.  
 
After rotation, there are four components that emerge. Component 2 and 4 are identical to 
those seen in the overall group analysis, and represent verbal learning and memory and 
(verbal) executive function/WM respectively. For component 1, it appear that in controls this 
represents more generically an executive function/WM factor which seems to be domain non-
specific, including both verbal and visuo-spatial elements. Component 3 appears to relate 
more closely to the visuo-spatial sketchpad and executive control of this slave system, as tests 
that assess the processing of the inner eye (VPT) and inner scribe (SSP) are included.  
 
However, it is also noted that a number of measures load across multiple components, 
therefore an optimised model was sought to produce more independent factors. 
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4.3.3.2 Optimised model 
Using an oblique rotation method it was noted that the VPT loaded heavily onto 2 
components; removal of this factor produced a model in which reverse digit span did not load 
uniquely in the pattern matrix (due to shared variance with other components). Removal of 
this led to the final model below.  
  
The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy was 0.705 and Bartlett’s test of 
sphericity was significant (2=228.7, df=55, p<0.0001). The diagonals of the anti-image 
correlation matrix were all greater than 0.5 justifying the inclusion of each item in the analysis. 
The determinant of the initial correlation matrix was |R|=0.004 suggesting that 
multicolinearity is not an issue with these data. Finally, the communalities for the PCA ranged 
from 0.605 to 0.882, with a mean of 0.764 (see Table 4-22 below). 
 
 
Table 4-22. PCA #03 communalities (optimised model) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Initial Extraction 
SWM between errors 1.000 0.745 
Spatial span 1.000 0.678 
Spatial span (reverse) 1.000 0.690 
SWM strategy score 1.000 0.805 
DSST 1.000 0.605 
SOPT total errors 1.000 0.755 
Rey total A1-5 1.000 0.823 
Rey A7 1.000 0.882 
Rey Recognition A 1.000 0.755 
FAS correct 1.000 0.827 
ELFT correct 1.000 0.838 
Extraction Method: Principal Component Analysis. 
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Table 4-23. PCA #03 unrotated component matrix (optimised model) a 
 
 Component 
 1 2 3 4 
SWM between errors -0.748 0.135 0.403 0.063 
Spatial span 0.678 -0.172 -0.267 0.342 
Spatial span (reverse) 0.549 0.110 -0.328 0.518 
SWM strategy score -0.607 0.060 0.483 0.446 
DSST 0.519 0.317 -0.018 0.486 
SOPT total errors -0.722 0.048 0.170 0.450 
Rey total A1-5 0.701 -0.126 0.547 0.132 
Rey A7 0.772 -0.136 0.516 0.034 
Rey Recognition A 0.697 -0.197 0.399 -0.268 
FAS correct 0.197 0.844 0.118 -0.250 
ELFT correct 0.261 0.877 0.025 -0.033 
Extraction Method: Principal Component Analysis.    a. 4 components extracted. 
 
 
From this model, 4 components were again extracted explaining 37.8%, 15.6%, 12.2% and 
10.7% (37.8, 53.5, 65.7, and 76.4% cumulatively). 
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Table 4-24. PCA #03 Oblimin rotated pattern and structure matrices (optimised model) 
 
Pattern Matrix 
a
 
 Component 
 1 2 3 4 
SWM between errors -0.665 0.080 -0.052 -0.377 
Spatial span 0.261 -0.202 0.132 0.653 
Spatial span (reverse) 0.087 0.009 -0.067 0.822 
SWM strategy score -0.917 -0.057 0.097 -0.022 
SOPT total errors -0.758 -0.117 -0.252 0.070 
DSST -0.137 0.249 0.157 0.675 
Rey total A1-5 -0.136 -0.014 0.900 0.131 
Rey A7 -0.014 0.004 0.915 0.082 
Rey Recognition A 0.251 -0.007 0.796 -0.175 
FAS correct 0.083 0.910 0.022 -0.103 
ELFT correct 0.018 0.888 -0.049 0.159 
 
Structure Matrix 
 Component 
 1 2 3 4 
SWM between errors -0.776 0.015 -0.384 -0.552 
Spatial span 0.466 -0.111 0.401 0.736 
Spatial span (reverse) 0.274 0.099 0.211 0.825 
SWM strategy score -0.891 -0.075 -0.224 -0.232 
SOPT total errors -0.828 -0.150 -0.496 -0.211 
DSST 0.093 0.334 0.334 0.715 
Rey total A1-5 0.201 0.071 0.893 0.366 
Rey A7 0.317 0.088 0.936 0.355 
Rey Recognition A 0.476 0.045 0.827 0.128 
FAS correct 0.088 0.902 0.093 0.028 
ELFT correct 0.065 0.902 0.077 0.250 
a. Rotation converged in 8 iterations. 
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Again, the factor loadings above were compared to the varimax rotated model and an 
identical pattern of loading was observed between this and the Oblimin pattern matrix. 
 
 
Table 4-25. PCA #03 Varimax rotated component matrix (optimised model) 
 
 Component 
 1 2 3 4 
SWM between errors -0.193 0.707 -0.454 0.048 
Spatial span 0.240 -0.357 0.685 -0.154 
Spatial span (reverse) 0.049 -0.173 0.809 0.059 
SWM strategy score -0.047 0.886 -0.117 -0.063 
SOPT total errors -0.352 0.781 -0.067 -0.129 
DSST 0.223 0.024 0.684 0.295 
Rey total A1-5 0.868 -0.042 0.258 0.029 
Rey A7 0.896 -0.159 0.228 0.045 
Rey Recognition A 0.787 -0.367 -0.014 0.016 
FAS correct 0.052 -0.079 -0.045 0.903 
ELFT correct 0.005 -0.034 0.193 0.895 
Rotation Method: Varimax with Kaiser Normalization.   a. Rotation converged in 5 iterations. 
 
 
This four component solution retains the verbal memory and learning factor in component 1, 
and component 2 appears to be a strategic, visuo-spatial self-ordered search component, 
while 3 includes the immediate spatial span measures with psychomotor speed. In component 
4 the digit span was not included in the model leaving a verbal fluency/executive component 
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4.3.4 PCA #04: Control participants (for SWM sub-analysis) 
4.3.4.1 Initial model 
Again, a series of components was sought that could be used to produce a composite score 
that could be used to predict SWM performance. After removal of the SWM variables, the 
initial analysis revealed that SRec did not load onto any component and was removed to 
produce the model below. All criteria were met as before regarding a significant Bartlett’s test 
(2=223.0, df=66, p<0.0001), and acceptable KMO of 0.691 and the diagonals of the anti-
image correlation matrix were all greater than 0.5. The determinant of the initial correlation 
matrix was |R|=0.004 suggesting that multicolinearity is not an issue with these data. Finally, 
the communalities for the PCA ranged from 0.487 to 0.880, with a mean of 0.716 (see Table 
4-26 below). 
 
Table 4-26. PCA #04 communalities (initial model) 
 
 Initial Extraction 
PRec modified  1.000 0.487 
Visual Patterns test 1.000 0.716 
Spatial span  1.000 0.750 
Spatial span reversed  1.000 0.624 
Rey total A1-5 1.000 0.813 
Rey A7 1.000 0.880 
Rey Recognition A 1.000 0.765 
Digit span (reverse) 1.000 0.583 
FAS correct 1.000 0.775 
ELFT correct 1.000 0.782 
DSST 1.000 0.631 
SOPT v2 total errors 1.000 0.783 
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From the four components extracted, the proportion of variance explained was 32.7, 16.2, 
13.0, and 9.6% (32.7, 48.9, 61.9, and 71.6% respectively).  
 
 
Table 4-27. PCA #04 unrotated component matrix (initial model) a 
 Component 
 1 2 3 4 
PRec modified  0.414 0.054 -0.253 -0.498 
Visual Patterns test 0.474 -0.073 -0.694 -0.058 
Spatial span  0.681 -0.264 -0.414 0.209 
Spatial span reversed  0.587 0.037 -0.385 0.360 
Rey total A1-5 0.665 -0.354 0.470 0.155 
Rey A7 0.749 -0.330 0.451 0.080 
Rey Recognition A 0.656 -0.323 0.396 -0.269 
Digit span (reverse) 0.493 0.560 -0.047 -0.154 
FAS correct 0.313 0.775 0.252 -0.116 
ELFT correct 0.358 0.768 0.185 0.172 
DSST 0.533 0.164 -0.015 0.565 
SOPT total errors -0.726 0.021 0.112 0.492 
 a. 4 components extracted. 
 
 
After varimax rotation, there were four distinct factors extracted.  
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Table 4-28. PCA #04 Varimax rotated component matrix (initial model) a 
 
 Component 
 1 2 3 4 
PRec modified  0.065 0.105 0.087 0.681 
Visual Patterns test -0.122 -0.083 0.647 0.525 
Spatial span  0.278 -0.105 0.761 0.287 
Spatial span reversed  0.114 0.150 0.759 0.109 
Rey total A1-5 0.879 0.030 0.198 -0.025 
Rey A7 0.908 0.071 0.211 0.079 
Rey Recognition A 0.803 0.019 -0.011 0.345 
Digit span (reverse) 0.044 0.656 0.174 0.347 
FAS correct 0.035 0.866 -0.096 0.118 
ELFT correct 0.029 0.870 0.136 -0.070 
DSST 0.271 0.349 0.619 -0.229 
SOPT total errors -0.385 -0.179 -0.183 -0.754 
  Rotation Method: varimax with Kaiser Normalization.    a. Rotation converged in 6 iterations. 
 
 
Of interest is that again the same two initial components, verbal learning and memory, and 
verbal executive function/WM emerge, as they have done in the overall sample. The 
remaining two components are close to the initial model prior to removing SWM, with 
component 3 being an executive/spatial sketchpad component, and 4 being a visual memory 
component.  
 
4.3.4.2 Optimised model 
As with previous models, the PCA was also examined using an Oblimin rotation method. Using 
the same variables as in the initial model indicated that DSST and SOPT did not produce 
significant unique loadings onto a single component (from the pattern matrix) and were 
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therefore excluded. PRec-m exhibited a very low communality (0.244) and was also excluded 
leaving 9 variables for inclusion. 
 
Criteria were met as before regarding a significant Bartlett’s test (2=161.2, df=36, p<0.0001), 
and acceptable KMO of 0.654 and the diagonals of the anti-image correlation matrix were all 
greater than 0.5. The determinant of the initial correlation matrix was |R|=0.022. Finally, the 
communalities for the PCA ranged from 0.565 to 0.884, with a mean of 0.723 (see Table 4-29 
below). 
 
Table 4-29. PCA #04 communalities (optimised model) 
 
 Initial Extraction 
Visual Patterns Test 1.000 0.663 
Spatial span 1.000 0.777 
Spatial span (reverse) 1.000 0.604 
Rey total A1-5 1.000 0.807 
Rey A7 1.000 0.884 
Rey Recognition A 1.000 0.680 
Digit Span (reverse) 1.000 0.565 
FAS correct 1.000 0.775 
ELFT correct 1.000 0.753 
 
 
 
From the PCA, three components were extracted explaining 34.1%, 21.4%, and 16.8% of the 
variance (cumulatively 34.1%, 55.5%, 72.3%).  
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Table 4-30. PCA #04 unrotated component matrix (optimised model) 
 
 Component 
 1 2 3 
Visual Patterns Test 0.400 -0.080 0.705 
Spatial span 0.687 -0.237 0.499 
Spatial span (reverse) 0.599 0.058 0.492 
Rey total A1-5 0.749 -0.288 -0.404 
Rey A7 0.826 -0.252 -0.372 
Rey Recognition A 0.669 -0.260 -0.406 
Digit Span (reverse) 0.438 0.600 0.113 
FAS correct 0.277 0.811 -0.203 
ELFT correct 0.340 0.793 -0.092 
 a. 3 components extracted. 
 
 
From the pattern and structure matrices produced after Oblimin rotation it can be seen that 
the two converge with the same pattern of loadings, again indicating an orthogonal structure 
which can be confirmed by entering the variable into a varimax rotated model. 
 
The three components represent a verbal learning and memory component, a verbal 
executive/WM component and a visuo-spatial memory (or more specifically the visuo-spatial 
sketchpad and executive control). It is also clear from these components that the variables 
included in each one load very highly onto those components, with negligible loadings onto 
the others. 
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Table 4-31. PCA #04 Oblimin rotated pattern and structure matrices (optimised model) 
 
Pattern Matrix 
a
 
 Component 
 1 2 3 
Visual Patterns Test -0.156 -0.050 0.842 
Spatial span 0.240 -0.095 0.801 
Spatial span (reverse) 0.071 0.165 0.718 
Rey total A1-5 0.899 -0.014 0.002 
Rey A7 0.918 0.038 0.062 
Rey Recognition A 0.834 -0.010 -0.040 
Digit Span (reverse) 0.000 0.688 0.230 
FAS correct 0.016 0.884 -0.161 
ELFT correct -0.006 0.871 -0.027 
a. Rotation converged in 5 iterations. 
 
 
Structure Matrix 
 Component 
 1 2 3 
Visual Patterns Test 0.041 0.035 0.798 
Spatial span 0.423 0.030 0.847 
Spatial span (reverse) 0.262 0.260 0.755 
Rey total A1-5 0.898 0.086 0.217 
Rey A7 0.937 0.148 0.288 
Rey Recognition A 0.823 0.079 0.160 
Digit Span (reverse) 0.133 0.716 0.314 
FAS correct 0.077 0.867 -0.049 
ELFT correct 0.085 0.867 0.077 
  
 Rotation Method: Oblimin with Kaiser Normalization. 
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Table 4-32. PCA #04 Varimax rotated component matrix (optimised model) 
 Component 
 1 2 3 
Visual Patterns Test -0.059 -0.011 0.812 
Spatial span 0.327 -0.036 0.818 
Spatial span (reverse) 0.162 0.209 0.731 
Rey total A1-5 0.891 0.034 0.112 
Rey A7 0.919 0.090 0.177 
Rey Recognition A 0.821 0.033 0.063 
Digit Span (reverse) 0.062 0.699 0.269 
FAS correct 0.043 0.873 -0.104 
ELFT correct 0.036 0.867 0.025 
  Rotation Method: varimax with Kaiser Normalization.  a. Rotation converged in 4 iterations. 
 
4.3.5 PCA #05: Bipolar patients  
For the PCA including patients only, the correlation matrix was used to screen data for any 
variables that did not correlate strongly or consistently with other variables. At this stage, 
SWM within errors, PRec-m, Digit span (forward), and the SCOLP measures were excluded.  
4.3.5.1 Initial model 
This first model showed that the ELFT did not load significantly onto any component and was 
removed, then the DSST was removed from the subsequent model for the same reason 
leaving 12 variables in the final model. The Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy was 0.773 and Bartlett’s test of sphericity was significant (2=264.6, df=66, 
p<0.0001). The diagonals of the anti-image correlation matrix were all greater than 0.5 
justifying the inclusion of each item in the analysis. The determinant of the initial correlation 
matrix was |R|=0.004 suggesting that multicolinearity is not an issue with these data. Finally, 
the communalities for the PCA ranged from 0.442 to 0.811, with a mean of 0.645 (see Table 
4-33). 
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Table 4-33. PCA #05 communalities (initial model) 
 Initial Extraction 
SWM between search errors 1.000 0.765 
Spatial span 1.000 0.699 
Spatial span (reverse) 1.000 0.604 
Visual Patterns test span 1.000 0.537 
SWM strategy score 1.000 0.607 
SRec Correct  1.000 0.694 
SOPT total errors 1.000 0.597 
Rey total A1-5 1.000 0.680 
Rey A7 1.000 0.811 
Rey Recognition A 1.000 0.680 
Digit span (reverse) 1.000 0.626 
FAS correct 1.000 0.442 
 
 
Table 4-34. PCA #05 unrotated component matrix (initial model) 
 Component 
 1 2 3 
SWM between search errors -0.839 -0.007 0.248 
Spatial span 0.642 0.291 -0.450 
Spatial span (reverse) 0.691 0.354 0.021 
Visual Patterns test span 0.647 0.333 0.083 
SWM strategy score -0.711 -0.064 0.311 
SRec Correct  0.502 0.161 0.645 
SOPT total errors -0.732 0.141 -0.203 
Rey total A1-5 0.652 -0.497 0.091 
Rey A7 0.544 -0.715 -0.064 
Rey Recognition A 0.509 -0.589 0.272 
Digit span (reverse) 0.284 0.595 0.437 
FAS correct 0.561 0.299 -0.196 
 a. 3 components extracted. 
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Three components were extracted, explaining 39.0%, 16.0% and 9.5% of the variance 
(cumulatively, 39.0, 55.0, 64.5%).  
 
After varimax rotation, the loadings onto each factor suggested that there was a much 
broader loading onto the first factor which covered executive control (as well as strategic 
aspects) and visuo-spatial memory. In component 2 the verbal learning and memory measures 
were included along with SOPT, possibly suggesting that this test was being approached in a 
different way compared to controls. The final component includes SRec and a verbal WM 
measure. This last point is of note as all the components include a mixture of verbal and 
visual/spatial measures.  
 
Table 4-35. PCA #05 Varimax rotated component matrix (initial model) a 
 Component 
 1 2 3 
SWM between search errors -0.761 -0.416 -0.112 
Spatial span 0.835 0.035 0.013 
Spatial span (reverse) 0.632 0.113 0.438 
Visual Patterns test span 0.557 0.118 0.462 
SWM strategy score -0.724 -0.284 -0.042 
SRec Correct  0.070 0.293 0.777 
SOPT total errors -0.375 -0.569 -0.364 
Rey total A1-5 0.245 0.784 0.076 
Rey A7 0.170 0.863 -0.191 
Rey Recognition A 0.004 0.815 0.125 
Digit span (reverse) 0.188 -0.220 0.736 
FAS correct 0.636 0.036 0.190 
  Rotation Method: varimax with Kaiser Normalization. a. Rotation converged in 5 iterations. 
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4.3.5.2 Optimised model 
To optimise the model, the same series of procedures were completed as above. The ELFT, 
SOPT and then DSST variables were excluded due to high multiple loadings across factors. The 
final model contained 11 variables. The Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy was 0.731 and Bartlett’s test of sphericity was significant (2=235.4, df=55, 
p<0.0001). The diagonals of the anti-image correlation matrix were all greater than 0.5 
justifying the inclusion of each item in the analysis. The determinant of the initial correlation 
matrix was |R|=0.007 suggesting that multicolinearity is not an issue with these data. Finally, 
the communalities for the PCA ranged from 0.436 to 0.810, with a mean of 0.657 (see Table 
4-36). 
 
Table 4-36. PCA #05 communalities (optimised model) 
 Initial Extraction 
SWM between search errors 1.000 0.768 
Spatial span 1.000 0.689 
Spatial span (reverse) 1.000 0.600 
Visual Patterns test 1.000 0.519 
SWM strategy score 1.000 0.602 
SRec Correct 1.000 0.760 
Rey total A1-5 1.000 0.678 
Rey A7 1.000 0.810 
Rey Recognition A 1.000 0.725 
Digit span (reverse) 1.000 0.636 
FAS correct 1.000 0.436 
 
 
 
Three components were extracted, explaining 38.2%, 17.3% and 10.1% of the variance 
(cumulatively, 38.2, 55.5, 65.7, and 73.8%). 
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Table 4-37. PCA #05 unrotated component matrix (optimised model) 
 
Component Matrix (unrotated) 
a
 
 Component 
 1 2 3 
SWM between search errors -.849 .031 .215 
Spatial span .674 .250 -.415 
Spatial span (reverse) .700 .333 .004 
Visual Patterns test .644 .322 .043 
SWM strategy score -.735 -.023 .248 
SRec Correct .505 .150 .695 
Rey total A1-5 .630 -.517 .116 
Rey A7 .520 -.734 -.037 
Rey Recognition A .490 -.606 .343 
Digit span (reverse) .290 .596 .443 
FAS correct .584 .269 -.150 
 a. 3 components extracted. 
 
 
After rotation, the same components were observed with the exception of the exclusion of 
the SOPT. As the pattern and structure matrices converged in terms of their loadings, an 
orthogonal structure could be assumed, which was confirmed by varimax rotation. 
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Table 4-38. PCA #05 Oblimin rotated pattern and structure matrices (optimised model) 
 
Pattern Matrix 
a
 
 Component 
 1 2 3 
SWM between search errors -0.766 0.296 0.048 
Spatial span 0.880 0.092 -0.164 
Spatial span (reverse) 0.658 0.014 0.270 
Visual Patterns test 0.585 0.013 0.292 
SWM strategy score -0.724 0.191 0.081 
SRec Correct -0.017 -0.305 0.817 
Rey total A1-5 0.188 -0.753 0.036 
Rey A7 0.117 -0.850 -0.215 
Rey Recognition A -0.103 -0.853 0.189 
Digit span (reverse) 0.168 0.264 0.708 
FAS correct 0.646 0.056 0.076 
  Rotation Method: Oblimin with Kaiser Normalization. a. Rotation converged in 7 iterations. 
 
Structure Matrix 
 Component 
 1 2 3 
SWM between search errors -0.826 0.486 -0.172 
Spatial span 0.811 -0.123 0.081 
Spatial span (reverse) 0.730 -0.154 0.454 
Visual Patterns test 0.664 -0.138 0.456 
SWM strategy score -0.748 0.369 -0.125 
SRec Correct 0.288 -0.316 0.818 
Rey total A1-5 0.384 -0.800 0.103 
Rey A7 0.267 -0.875 -0.166 
Rey Recognition A 0.162 -0.831 0.177 
Digit span (reverse) 0.301 0.209 0.750 
FAS correct 0.653 -0.106 0.256 
  Rotation Method: Oblimin with Kaiser Normalization. 
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Table 4-39. PCA #05 Varimax rotated component matrix (optimised model) a 
 Component 
 1 2 3 
SWM between search errors -0.774 -0.403 -0.079 
Spatial span 0.829 0.033 -0.019 
Spatial span (reverse) 0.673 0.080 0.376 
Visual Patterns test 0.605 0.070 0.386 
SWM strategy score -0.718 -0.292 -0.039 
SRec Correct 0.115 0.302 0.810 
Rey total A1-5 0.270 0.775 0.070 
Rey A7 0.181 0.861 -0.191 
Rey Recognition A 0.016 0.833 0.175 
Digit span (reverse) 0.220 -0.237 0.729 
FAS correct 0.634 0.036 0.181 
  Rotation Method: varimax with Kaiser Normalization. a. Rotation converged in 6 iterations. 
 
 
4.3.6 PCA #06: Bipolar patients (for SWM sub-analysis) 
Finally, the PCA for use as a predictor of SWM performance was obtained. After screening the 
variables, the ELFT was excluded as it did not load significantly onto any component and then 
the DSST was excluded with a low communality (0.378). The pattern of loadings in the final 
model was identical to the overall model above (PCA #05) but with SWM omitted. 
 
4.3.6.1 Initial analysis 
In brief, all conditions as laid out were met: the Kaiser-Meyer-Olkin (KMO) measure of 
sampling adequacy was 0.734 and Bartlett’s test of sphericity was significant (2=180.9, df=45, 
p<0.0001). The diagonals of the anti-image correlation matrix were all greater than 0.5 
justifying the inclusion of each item in the analysis. The determinant of the initial correlation 
Page | 213 
matrix was |R|=0.023 suggesting that multicolinearity is not an issue with these data. Finally, 
the communalities for the PCA ranged from 0.468 to 0.824, with a mean of 0.663 (see Table 
4-40). 
 
Table 4-40. PCA #06 communalities (initial model) a 
 Initial Extraction 
SRec Correct 1.000 0.711 
Visual Patterns test span  1.000 0.570 
Spatial span  1.000 0.703 
Spatial span (reverse)  1.000 0.636 
Rey total A1-5  1.000 0.724 
Rey A7  1.000 0.824 
Rey Recognition A  1.000 0.718 
Digit span (reverse)  1.000 0.664 
FAS correct  1.000 0.468 
SOPT total errors 1.000 0.607 
 
 
 
Three components were extracted explaining 36.6%, 19.2% and 10.5% of the variance 
(cumulatively 36.6, 55.7, and 66.3%). 
 
As discussed above, these components parallel the earlier analysis, but have the SWM 
loadings removed. 
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Table 4-41. PCA #06 unrotated component matrix (initial model) a 
 Component 
 1 2 3 
SRec Correct 0.557 0.180 0.607 
Visual Patterns test span  0.663 0.352 -0.082 
Spatial span  0.596 0.295 -0.510 
Spatial span (reverse)  0.694 0.372 -0.128 
Rey total A1-5  0.701 -0.478 -0.059 
Rey A7  0.558 -0.704 -0.131 
Rey Recognition A  0.523 -0.578 0.332 
Digit span (reverse)  0.304 0.606 0.451 
FAS correct  0.558 0.306 -0.250 
SOPT total errors -0.767 0.120 -0.070 
  a. 3 components extracted. 
 
 
Table 4-42. PCA #06 Varimax rotated component matrix (initial model) a 
 Component 
 1 2 3 
SRec Correct 0.287 0.136 0.781 
Visual Patterns test span  0.135 0.668 0.325 
Spatial span  0.083 0.831 -0.077 
Spatial span (reverse)  0.133 0.724 0.307 
Rey total A1-5  0.800 0.290 0.000 
Rey A7  0.875 0.124 -0.209 
Rey Recognition A  0.814 -0.095 0.215 
Digit span (reverse)  -0.219 0.248 0.745 
FAS correct  0.084 0.667 0.128 
SOPT total errors -0.582 -0.433 -0.285 
  Rotation Method: varimax with Kaiser Normalization.   a. Rotation converged in 5 iterations. 
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4.3.6.2 Optimised model 
From the above PCA, it can be seen that the SOPT loaded moderately onto a second 
component. When the Oblimin rotation was performed on the variables, SOPT was excluded 
as is did not load independently onto any component in the pattern matrix. Again the final 
model is identical to the optimised overall patient model but with SWM omitted. 
 
The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy was 0.671 and Bartlett’s test of 
sphericity was significant (2=151.2, df=36, p<0.0001). The diagonals of the anti-image 
correlation matrix were all greater than 0.5 justifying the inclusion of each item in the analysis. 
The determinant of the initial correlation matrix was |R|=0.043 suggesting that 
multicolinearity is not an issue with these data. Finally, the communalities for the PCA ranged 
from 0.476 to 0.829, with a mean of 0.678 (see Table 4-43). 
 
Table 4-43. PCA #06 communalities (optimised model) a 
 
 Initial Extraction 
SRec Correct 1.000 0.748 
Visual Patterns test span 1.000 0.557 
Spatial span 1.000 0.710 
Spatial span (reverse) 1.000 0.637 
Rey total A1-5  1.000 0.736 
Rey A7  1.000 0.829 
Rey Recognition A  1.000 0.745 
Digit span (reverse)  1.000 0.665 
FAS correct  1.000 0.476 
 
 
The three components extracted explained 35.0%, 21.1% and 11.7% of the variance (35.0, 
56.1, and 67.8% cumulatively). 
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Table 4-44. PCA #06 unrotated component matrix (optimised model) a 
 Component 
 1 2 3 
SRec Correct 0.580 0.142 0.625 
Visual Patterns test span 0.669 0.318 -0.091 
Spatial span 0.642 0.246 -0.487 
Spatial span (reverse) 0.715 0.330 -0.128 
Rey total A1-5  0.680 -0.521 -0.042 
Rey A7  0.520 -0.738 -0.118 
Rey Recognition A  0.495 -0.611 0.356 
Digit span (reverse)  0.328 0.593 0.454 
FAS correct  0.598 0.262 -0.223 
 a. 3 components extracted. 
 
After Oblimin rotation, the pattern and structure matrices were again identical indicating an 
orthogonal solution which was confirmed with a subsequent varimax rotated model.  
 
 
Table 4-45. PCA #06 Oblimin rotated pattern and structure matrices (optimised model) a 
Pattern Matrix 
a
 
 Component 
 1 2 3 
SRec Correct 0.044 -0.266 0.795 
Visual Patterns test span 0.660 -0.030 0.203 
Spatial span 0.872 -0.010 -0.203 
Spatial span (reverse) 0.721 -0.035 0.185 
Rey total A1-5  0.257 -0.778 -0.032 
Rey A7  0.101 -0.877 -0.220 
Rey Recognition A  -0.173 -0.837 0.262 
Digit span (reverse)  0.189 0.281 0.718 
FAS correct  0.674 -0.022 0.040 
  Rotation Method: Oblimin with Kaiser Normalization. a. Rotation converged in 7 iterations. 
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Structure Matrix 
 Component 
 1 2 3 
SRec Correct 0.305 -0.311 0.820 
Visual Patterns test span 0.720 -0.154 0.382 
Spatial span 0.819 -0.152 0.033 
Spatial span (reverse) 0.777 -0.170 0.381 
Rey total A1-5  0.383 -0.822 0.074 
Rey A7  0.195 -0.884 -0.152 
Rey Recognition A  0.043 -0.819 0.255 
Digit span (reverse)  0.333 0.214 0.755 
FAS correct  0.689 -0.141 0.223 
   Rotation Method: Oblimin with Kaiser Normalization. 
 
Table 4-46. PCA #06 Varimax rotated component matrix (optimised model) a 
 Component 
 1 2 3 
SRec Correct 0.163 0.286 0.800 
Visual Patterns test span 0.677 0.095 0.299 
Spatial span 0.835 0.087 -0.072 
Spatial span (reverse) 0.736 0.106 0.290 
Rey total A1-5  0.311 0.799 0.019 
Rey A7  0.143 0.879 -0.189 
Rey Recognition A  -0.071 0.823 0.249 
Digit span (reverse)  0.252 -0.247 0.735 
FAS correct  0.670 0.086 0.140 
  Rotation Method: varimax with Kaiser Normalization.    a. Rotation converged in 5 iterations. 
 
As seen previously, this model is identical to the overall patient model with the SWM removed 
from the variable list. 
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4.4 Discussion of Chapter 4 
The series of PCA above highlight the profile of neuropsychological tests/processes from the 
sample as a whole and individually for patients and controls. The approach to this analysis was 
to first examine the initial model which involved PCA with subsequent orthogonal (varimax) 
rotation. This was done in order to produce independent factors from which the composite 
scores can be derived. However, as discussed earlier, this approach may not be consistent 
with the real-life situation where it is entirely possible that these components of human 
neuropsychological functioning are indeed related. Therefore an optimised PCA was also 
performed using oblique rotation (oblimin) in order to examine variables on an item by item 
basis, excluding any that did not load uniquely or sufficiently onto an individual component. 
Once the pattern and structure matrices of these analyses converged, an orthogonal structure 
could be assumed and was confirmed by a return to a varimax method of rotation.  
 
All analyses were also re-run from the initial data screening stage after excluding the variables 
from the CANTAB spatial working memory test. From the previous chapters, SWM is of 
particular interest given the results of Chapter 3 with the GR-antagonist mifepristone. One 
aim is therefore to examine the relationship between specific spatial tests (including SWM and 
the OLM test reported in the next chapter), composite neuropsychological factors and 
measures of HPA axis function.  
 
4.4.1 Comparison of initial models (full variable set) 
The initial varimax rotated models show a broadly consistent result between controls and the 
group as a whole. Two of the extracted components were identical – verbal learning and 
memory (component 2), and verbal executive function and WM (component 4). The 
remaining two components, containing different aspects of visuo-spatial memory processes, 
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were largely consistent although the order of extraction (and therefore proportion of variance 
explained) was reversed. The other difference was that in controls, the SRec variable was 
dropped from the model as it did not load significantly and consequently VPT which loaded 
across the two components reached the required level for inclusion in the strategic 
component only. SWM between search errors which loaded across both components in the 
overall sample only loaded onto one in controls, interestingly, with SOPT (another strategic 
self-ordered search task) and the SWM strategy score. Therefore this component in controls 
appears to be a ‘cleaner’, more distinct strategic processing factor. It is also worth noting that 
in the controls’ PCA, the spatial span measures cluster with psychomotor speed in a separate 
component to the VPT. These tests are theoretically derived to tap different elements of the 
visuo-spatial sketchpad in Baddeley’s WM model (Della Sala et al., 1999) – the inner-scribe 
and inner-eye respectively – and appear to cluster separately in healthy controls.  
 
In contrast, a different profile of variable clusters emerged in the bipolar sample. Only three 
components were extracted and one of these (component 3) was somewhat weak, including 
only SRec and digit span (reverse)21. Moderate loadings were evident in this component, but 
did not reach the threshold for inclusion, from spatial span (reverse) and VPT. Therefore this 
method of orthogonal rotation may be less suitable for the patient sample due to a less 
independent structure underlying their neuropsychological processes. Component 1 
contained a combination of visuo-spatial measures as well as verbal executive. The separation 
of the visuo-spatial sketchpad measures did not occur as it did in control participants and in 
component 2, the SOPT loaded along with the verbal learning and memory measures, possibly 
suggesting this task was being approached in a different way to controls, relying on verbal 
‘scaffolding’ of performance. In fact, all three components included a combination of verbal 
                                                          
21 It should be noted that reverse digit span has been shown to be impaired in visual neglect patients and although there is debate 
as to the underlying cause of this, both reduced general attentional processes and/or impaired spatial imagery have been 
suggested (Robertson, 1990; Rapport et al., 1994). Therefore the loading to a component with the spatial recognition task may 
represent an additional spatial component. 
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elements alongside visuo-spatial measures. Again, although not reaching the criteria for 
inclusion, SWM between errors did load moderately into the verbal learning and memory 
component (-0.416).  
 
4.4.2 Comparison of optimised models (full variable set) 
The next stage of the PCA analysis strategy was to look to optimise these models, comparing 
the pattern and structure matrices from an oblique rotation method and attempting to 
achieve equivalence between the two, a point at which an orthogonal structure can be 
assumed. The relative stability of the initial solutions was demonstrated by this approach as 
other than the exclusion of some variables that loaded across several components (sometimes 
not sufficiently to cross the cut-off for inclusion, but nevertheless showing moderate factor 
loading) the models remained largely unaltered with respect to the remaining variables.  
 
In the total sample, three variables that appeared in the initial model (SRec, SOPT and the 
DSST) were excluded in the optimised model due to moderate loadings with multiple 
components. Consequently, the two visuo-spatial components collapsed together producing a 
simple three component solution for the optimised model, consisting of visuo-spatial 
processing (where CANTAB SWM measures loaded together with spatial span measures and 
the VPT), verbal learning and memory (containing verbal learning and delayed recall and 
recognition), and verbal executive function/WM (containing reverse digit span and verbal 
fluency measures). The optimised models for the separate groups also closely resembled the 
initial solutions: aside from the exclusion of VPT and reverse digit span in controls and the 
exclusion of SOPT in the bipolar sample, all resulting from shared variance with other 
components, the models remained the same. Although the changes are subtle, these 
consequent optimised models are of particular interest – in the bipolar sample, the SWM 
loads together with components of the visuo-spatial WM system that have been proposed to 
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be separable, namely the spatio/temporal and visual components (Della Sala et al., 1999), 
while in controls these WM components remained distinct. Therefore looking more closely at 
these visuo-spatial components and attempting a more detailed exploration of processes 
within is of interest (see chapter 5). 
 
4.4.3 Comparison of models following SWM exclusion 
 In order to allow the compilation of composite scores that can be used as predictors of spatial 
working memory function, the SWM variables were removed from those available to the 
initial model and the PCA process was repeated. The initial model for the total sample 
produced a three component solution – two of these were identical to those produced in the 
models described above: a verbal learning and memory component and a verbal executive. 
The remaining factor was a general visuo-spatial component; this contrast with the two visuo-
spatial components evident in the initial model with SWM included. Although variables such 
as DSST and SRec also dropped from the model, it is possible that the loading of SWM 
between search errors across both visuo-spatial components in the initial overall model (PCA 
#01) was the feature that kept these components separate and by removing it, the two 
collapsed together.  
 
After separating by diagnostic group, the initial models with SWM removed again retained 
components identical to the initial PCA #03 and #05 models with respect to verbal memory 
and verbal executive although some changes occurred within the visuo-spatial components. In 
controls for example, with the SWM removed, the VPT incorporated with the component 
including spatial span and DSST, while the SOPT formed a new unique component with 
Pattern Recognition – a purer ‘visual’ component than had been seen. In patients, there were 
no changes to the components other than omitting SWM. Comparing the (SWM omitted) 
optimised with initial models, for the total sample and the patients, the only minor change to 
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occur was the removal of SOPT for loadings onto other components. In controls, the 
additional removal of the measures that formed the ‘visual’ component resulted in a 
reduction to a three component solution.   
 
 
4.4.4 Summary 
Overall, one of the most prominent features of the PCA models was the relative consistency 
between the components extracted, particularly the verbal learning and memory and verbal 
executive components. More variation was evident in some of the visuo-spatial components, 
with variables loading slightly differently when those exhibiting some degree of shared 
variance were removed. After separating by diagnostic group, the visuo-spatial components in 
controls remained divided into a more executive/strategic/cognitively-demanding element, 
and a shorter-term, immediate element. In patients, it was notable that overall only three 
components were ever produced and these showed a much greater overlap between verbal 
and visuo-spatial variables, with at least one verbal measure being evident in every 
component.  
 
Very few studies have adopted a factor analytical or PCA approach to the assessment of 
neuropsychological processes in bipolar disorder. A study by Czobor and colleagues compared 
the neuropsychological factor structure of patients with bipolar disorder with patients with  
schizophrenia and reported a common six factors in both samples: attention, working 
memory, ideational fluency, verbal knowledge, non-verbal functions and learning (Czobor et 
al., 2007). However, within these factors there were some significant differences in the 
profiles of impairment between the diagnostic groups (patients with schizophrenia performing 
worse in the attention and non-verbal domains).  
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It is important to note the distinction between the PCA approach employed here and factor 
analysis. Factor analysis derives a mathematical model from which factors are estimated 
whereas PCA decomposes the available data into sets of linear variables. As such it has been 
argued that only factor analysis can truly estimate the underlying factors, with PCA simply 
examining the strength of the relationship between a given variable within each linear 
component, although the two approaches can lead to similar results when communalities are 
high (>0.7) (Field, 2000). As can be seen in the present analysis, a number of variables  were 
excluded at the initial data screening stage and further removed from the model due to 
insufficient or multiple component loadings.  
 
Finally, it is of particular interest to note the components that emerged from the optimised 
model in PCA#05 (the bipolar group). The first component, explaining the greatest proportion 
of variance in this model (38.2%), was a visuo-spatial memory/executive component. This 
included the variables: SWM BSE and strategy, spatial span forwards and reverse, VPT, and 
FAS verbal fluency. It is worth considering these in terms of the variables that were improved 
in the study in Chapter 3 following treatment with the GR antagonist mifepristone (SWM BSE, 
and improved from baseline, FAS and spatial recognition).  Therefore, it is not simply the case 
that this general component and variables subsumed within were improved (although it is 
noted that not all tests from this component were used in Chapter 3). It may be that some 
process, separate from that which led to the clustering of variables within the PCA 
component, which is key to explaining which processes are changed by GR manipulation. As 
already mentioned above, it is also worth noting that in the bipolar sample, the SWM BSE 
loads together with components of the visuo-spatial WM system that have been proposed to 
be separable, namely the spatio/temporal and visual components (Della Sala et al., 1999).  
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Therefore looking more closely at visuo-spatial functioning and attempting a more detailed 
exploration of processes within this type of memory is important; firstly from the general 
point of view of gaining a better understand visuo-spatial memory processes in bipolar 
depression (see Chapter 5), and secondly, as a means of establishing the relationships 
between fractionated visuo-spatial memory processes, broader neuropsychological 
composites, and specific measures of HPA axis function related to the GR (see Chapter 6). 
Prior to this, the results of a novel memory paradigm which permits the fractionation of 
different spatial memory processes is reported. This task was administered to a sub-group of 
participants from the n=100 that took part in the present chapter. 
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Chapter V 
 
Fractionation of spatial memory processes in 
bipolar depression 
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5. Fractionation of spatial memory processes in bipolar depression 
 
5.1 Introduction to Chapter 5 
Human spatial memory is far from being a unitary construct (for an overview see Schacter & 
Nadel, 1992). As already discussed in the case of the CANTAB SWM paradigm for example, 
there seems to be a clear distinction between the holding of spatial information ‘online’ over 
short periods of time and longer term maintenance (viz. within- and between-search errors). 
This can been seen both in behavioural processes and in underlying neural circuitry (see 
section 3.4.1). Within the working memory (WM) theory literature there is also increasing 
understanding of the independence of sub-processes within some WM slave systems, such as 
the fractionation of spatial/sequential components from a visual component within non-
verbal short-term memory (Della Sala et al., 1997; Baddeley, 2000). One specific aspect of this 
latter component (i.e. memory for spatial layout/relationships between elements) has been 
further fractionated with reference to object-location memory where exact, metric (or 
‘coordinate’) processes have been separated from relative relations between objects (or 
‘categorical’ processes). A number of studies have now been carried out in healthy 
participants as well as patients with brain damage examining the separation of these 
processes using the same test paradigm – the Object Relocation test (ORT) program (Kessels 
et al., 1999)22 – which can assess several discrete aspects of spatial memory and object 
binding, as well as their integration. As discussed in previous chapters, there are many 
hypothetical links between spatial memory, the HPA axis and mood disorders. However, to 
date, the assessment of these fractionated processes has not been explored in patients with 
bipolar disorder or depression.  
 
                                                          
22 This paper is the first report of the paradigm as a complete computer program/software, in the form that was utilised in the 
present study. However, it should be noted that elements of the task were used in earlier papers as discussed subsequently.  
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The ORT program itself was developed as a standardised method of assessing different 
components of this specific form of spatial memory, namely the processes underpinning 
memory for spatial configurations and the localisation of objects within space (Kessels et al., 
1999). The background to this task was developed through a series of studies by Postma and 
de Haan in healthy subjects, which sought to establish the independence of these processes. 
The initial study (Postma & de Haan, 1996) reported a series of three experiments in which 
participants were required to remember (from an initial 30 second exposure) and then 
relocate (as accurately as possible) 4, 7 or 10 objects into a 10.5cm x 10.5cm square frame on 
the screen. The objects were either verbal (i.e. letters), non-verbal (nonsense stimuli) or all 
identical, and these were recalled under two different task conditions – silently (AS-) or with 
articulatory suppression (AS+; counting backwards in ‘ones’ from 100). The main findings were 
that displacement error was lowest when all objects were identical (‘position-only’ condition) 
and just the spatial locations had to be remembered. Interestingly, performance on this 
condition was affected to only a limited extent by an increase in set size: after a slight 
decrease in performance from set-size 4 to 7, there was no subsequent difference when 
increasing to 10 and there was also no effect of AS+. Of the other two stimulus types, 
performance was very different – while accuracy was better overall for the placement of 
letters than nonsense objects, performance with both types was impaired by increasing set 
size and importantly, also by AS+ (i.e. the interference effect was not restricted to stimuli that 
were specifically verbal). From this data, there is the initial suggestion that a different process 
underlies memory for overall spatial layout compared to the relocation of objects within that 
space. In a second experiment, the spatial relocation phase was altered so that the exact 
positions in which objects had been located were given to the participant through the 
presentation of pre-marked locations. As before, the binding of letters to a location was easier 
than nonsense stimuli, and both set size and AS+ significantly impaired performance with both 
stimulus sets.  
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In one final experiment, the task was administered in a form very similar to that of the 
computerised version, with three conditions – the reconstruction of positions only (POM; 
position-only memory), the placement of objects to remarked locations (OLB; object-location 
binding), and a final condition that integrated both processes i.e. required participants to 
locate individual objects into a free space (COM; the combined condition). For this 
experiment, only set size 7 and 10 were used, the object stimuli used were a series of different 
punctuation marks (thereby falling somewhere between letters and nonsense stimuli in 
difficulty) and the articulatory suppression task was made less difficult in order to place fewer 
demands on overall cognitive resources (and now involved repeating the syllable ‘blah’). 
Again, the relative independence of the POM process was demonstrated, with neither set size 
nor AS+ having any significant effect on performance. With both OLB and COM, both set size 
and AS+ significantly impaired relocation accuracy (although for COM, the AS+ only had an 
effect at set size 7).  
 
Through this work, Postma and de Haan established preliminary evidence for a dissociation of 
(at least) two separable spatial processes in short term object location memory – the encoding 
of positions per se and object-to-position binding. Interestingly, the binding of objects to 
positions was shown to be sensitive to the effects of verbal articulatory suppression, even 
when non-verbal stimuli were used. One potential theoretical explanation for the separation 
of these processes was taken from the earlier work of Kosslyn and colleagues on spatial 
relationships used in visual perception and visuospatial imagery (Kosslyn et al., 1989; Kosslyn 
et al., 1992)23 . Kosslyn had proposed that two types of processes underlying spatial 
representation exist – co-ordinate, which are involved in fine-grain, exact metric location, and 
categorical, which deal with more gross, relative relations between objects. It was also 
                                                          
23 It should be noted that some authors have disputed the simple transfer of categorical/co-ordinate coding distinctions onto this 
form of short term visuo-spatial memory (Dent, 2009), specifically with regard to the fractionated processes. However, even here 
it is conceded that the debate is not over the independence of the processes but of the application of a categorical/co-ordinate 
distinction to them. 
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proposed that there was relative hemispheric specialisation for these processes, with 
categorical judgments being faster when stimuli are initially presented to the left cerebral 
hemisphere, compared to evaluations of distance, which are faster when initially presented to 
the right hemisphere. There was further suggestion that these categorical representations 
developed with practice and therefore the possibility of verbal coding of such relations was 
suggested, although it is noted throughout this work that it is unlikely to be verbal/linguistic 
labelling per se but a commonality of process behind coding of information in a categorical or 
modular way (Kosslyn et al., 1989). In work conducted earlier to Postma and de Haan (1996) it 
had been proposed that this distinction between categorical and co-ordinate processes may 
extend from early perceptual systems and apply also to long-term memory (McNamara, 
1991). The work by Postma and de Haan had extended this to processes within short-term 
visuo-spatial memory which led to a series of subsequent studies exploring this phenomena in 
healthy participants and those with brain lesions or diffuse impairment, as well as examining 
some of the neurobiological modulators of these processes (e.g. the role of sex hormones).  A 
brief overview of this work is now presented. 
 
5.1.1 Effects of sex hormones on the ORT paradigm 
An extensive literature exists exploring sex differences in spatial abilities and the underlying 
neurobiology (Geary, 1995; Halpern & Wright, 1996; Cahill, 2006). The ORT has been used in a 
number of studies to examine overall differences in fractionated processes as well as the 
effect of AS+ on performance (Postma et al., 1998; Postma et al., 1999). In both these studies, 
males were found to be more accurate at POM, with no sex difference in OLB or COM 
performance (although in the earlier study, using a ‘best-fit’ error score rather than absolute 
error yielded a male superiority). In both studies, contrary to expectations, AS+ reduced 
performance in all conditions (which the authors suggested may be the result of a 
combination of factors such as stimulus set size and overall frame size - 15 cm  x 15 cm was 
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used). In the 1999 study, the role of hormonal factors was also examined and it was found 
that POM performance was significantly worse in females at the point of the menstrual cycle 
when oestrogen levels are lower (Postma et al., 1999). In a follow-up study, the effect of 
testosterone administration (sublingually 0.5 mg testosterone or placebo with cyclodextrin as 
carrier) was examined in female healthy volunteers (Postma et al., 2000). This study included 
both an immediate and a delayed recall version of the task (using a 3 min retention interval). It 
was found that for delayed recall of the COM condition, performance was significantly 
improved by testosterone.  
 
Although tentative, the effects of these hormones at the level of the hippocampus was 
suggested as a potential mechanism through which these effects emerged. This has 
implications for the use of the task in the present study as it has been shown that some of the 
effects of sex hormones on memory function may be via interactions with corticosteroids 
(Symonds et al., 2004) and there is increasing understanding of these interactions of 
hippocampal morphology and function (for a review see McEwen, 2010).  
 
5.1.2 Effects of brain injury on the ORT paradigm 
A further important source of information on the brain structural underpinnings of spatial 
memory processes is from a series of studies examining performance on the ORT paradigm in 
patients with brain damage. One of the first studies (Kessels et al., 2000a) assessed 10 
patients after intracranial tumour resection (compared to 24 healthy controls). Five patients 
showed no impairment and one was impaired on all experimental levels of the task. 
Interestingly of the remaining patients a double dissociation was observed, with two patients 
being impaired on POM only and two on OLB and COM, but not POM.  These latter two 
patients who were impaired on OLB and COM were also significantly impaired on the object 
memory control task. Although it was suggested that these general memory deficits cannot 
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fully explain the selective spatial memory findings, as it is especially spatial mnemonic 
processing that is tested, rather than memory for object identity (i.e. patients do not have to 
recall the objects), it has been shown in several studies that damage to the parietal lobes can 
cause impairments in visual discrimination and visual-manual exploration which may have 
affected performance (Eacott & Gaffan, 1991; Hinkley et al., 2009).  
 
Due to the varying extent and localisation of the surgery in the patients in the above study, it 
was not possible to be precise about the underlying neural circuitry of the spatial processes 
examined although overall spatial memory impairment was more frequent in right 
hemispheric patients than in left hemispheric patients and was more often found in patients 
with posterior (parietal or occipital) lesions than in patients with anterior (temporal or frontal) 
lesions (Kessels et al., 2001). In a larger follow up study (Kessels et al., 2002) in patients who 
had suffered a stroke with left hemisphere infarct (LH; n=28), right hemisphere infarct (RH; 
n=16) or bilateral (BIL; n=6) similar left-right distinctions were observed with RH patients being 
(statistically) significantly impaired at POM only (immediate and delayed recall) compared to 
controls, while LH patients only were impaired at OLB (immediate and delayed recall) and 
COM (immediate recall).  
 
In subsequent studies, it has been possible to characterise and group patients more precisely 
in terms of lesion location. Kessels et al (2004) administered the ORT to twenty five patients 
who had suffered from medically refractory temporal-lobe epilepsy caused by mesiotemporal 
sclerosis and had undergone a unilateral selective amgygdalohippocampectomy (16 left side 
AH, 9 right side AH). The task included an additional condition – a categorical POM trial – in 
which a grid was included in the relocation phase of identical stimuli. Overall, right AH 
patients were selectively impaired on POM while left AH patients were impaired on COM, 
compared to controls. There was no significant difference on the categorical POM trial, 
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although for the OLB condition, a trend was observed in the group effect, with left AH patients 
making more errors.   
 
In two final studies (van Asselen et al., 2008; van Asselen et al., 2009), recently conducted in 
stroke patients with LH (n=13) or RH (n=12) damage, van Asselen and colleagues tested more 
specific hypotheses using the ORT paradigm, focussing more on the categorical/co-ordinate 
distinction in memory for exact spatial locations versus the binding of objects to those 
locations. Effects were observed on positional memory only, with LH patients being impaired 
on the categorical process while RH patients were impaired on coordinate processes (van 
Asselen et al., 2008). Using a lesion-localisation method in a larger group of patients they then 
went on to demonstrate that the area of maximal lesion overlap for the POM task condition 
was in the right hemisphere (including the insula, the superior/middle temporal cortex, the 
posterior parietal cortex and the inferior frontal gyrus); for OLB the area of maximum overlap 
involved the left posterior parietal cortex and the right hippocampus, putamen and 
fusiform/lingual gyrus; and for COM the overlap also involved the left posterior parietal cortex 
(van Asselen et al., 2009).  
 
5.1.3 Implications for the subsequent study 
Although there are some minor differences in which processes are affected by lateralised 
brain damage (most likely due to differences in the cause and type of damage), the overall 
profile is relatively consistent. As discussed previously, some authors have questioned the 
direct application of categorical and coordinate processing explanations to the binding of 
objects to spatial locations, although this disagreement relates only to the mechanism and not 
to the dissociation of memory for positions from memory for object-location binding (Dent, 
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2009)24. In general it appears that there are three components to this form of visuo-spatial 
memory – memory for objects, spatial locations, and the binding of objects to those locations 
(Postma et al., 2008). Focussing on the latter two spatial processes, it appears that memory 
for exact metric locations is dependent upon the RH, especially posterior parietal cortex. The 
binding of objects to locations seems to be dependent on the LH with an important role for 
the hippocampus bilaterally (Piekema et al., 2006; Postma et al., 2008; van Asselen et al., 
2009)25. Along with the evidence from healthy volunteer studies that some of these processes 
can be modulated by changes in some exogenous and endogenous steroids, the ability to 
dissociate these components using the ORT paradigm provides an important method to 
explore visuo-spatial memory in more detail in the context of the present research. To date, 
the paradigm has not been used in patients with depression or bipolar disorder (although in 
schizophrenia, the COM process has been examined in isolation and found to be impaired, but 
only when stimuli with threatening content were used  van 't Wout et al., 2007). 
 
The aim of this chapter is therefore to examine the performance of patients with bipolar 
depression and healthy controls on a this novel visuo-spatial memory task – the ORT 
paradigm. The participants were part of the initial cohort (sequentially recruited) from those 
taking part in Chapter 4 therefore all additional secondary neuropsychological measures are 
available to compare performance on the fractionated ORT processes with.  
  
                                                          
24 However, there are many differences between the paradigm used by Dent (2009) and the ORT paradigm which leaves this 
debate open, such as the use of only 4 stimuli-location pairings per trial, the use of colours rather than nameable objects and the 
use of a rapid change detection methodology. Other work has shown a clear time-course effect whereby LH categorical 
advantage increases over retention interval suggesting that the maintenance of representation in this way may be linked to 
efficiency of coding over fine-grain detail (Postma et al., 2006).  
25 However it is important to note that aspects of these distinctions may be relative, for example in their review Postma and 
colleagues note that there are frontal and hippocampal contributions to memory for exact metric locations which are time-
dependant i.e. greater hippocampal involvement when longer term maintenance is required (Postma et al., 2008). 
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5.2  Methods 
As stated previously, these participants were a sub-set of those included in chapter 4 (n=100). 
The following methods have been previously outlined and are therefore presented only in 
brief. 
 
5.2.1 Subjects 
Patients aged 18 to 65 years with a diagnosis of bipolar disorder, confirmed using the 
Structured Clinical Interview for DSM-IV (SCID; First et al., 1995), were recruited from 
secondary and tertiary care services in North East of England. All were currently in a 
depressive episode. Patients were excluded if they met criteria for any other current axis I 
disorder, including anxiety disorder, schizophrenia or substance dependence/abuse. Illness 
characteristics, clinical ratings and medication history were determined by trained 
psychiatrists using full history, case-note and medication review and standardized rating 
scales. All patients were receiving medication at the time of testing which had remained stable 
for a minimum of 4 weeks.  Healthy control subjects were recruited by advertisement and 
from hospital/university staff. All were physically healthy and had no personal or family 
history of psychiatric illness. After a complete description of the study, written informed 
consent was obtained from all participants. The study was approved by Newcastle and North 
Tyneside Research Ethics Committee. 
 
5.2.2 Neuropsychological tests 
5.2.2.1 Object Location Memory 
To assess memory for the locations of objects, the Object Relocation program was used 
(Kessels et al., 1999). The program presents stimulus displays on a PC fitted with a touch-
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screen monitor. A number of variations of the task parameters are possible within the 
program (e.g.; Kessels et al., 2004); here we ran the program using the immediate memory 
conditions from (Kessels et al., 2000a).  
 
First, subjects completed two control tasks that assessed object identity memory; and 
visuospatial construction and perception. In the object identity task subjects viewed 10 
different objects for 30s which had to be remembered and subsequently recognised from a 
set of 20 objects, containing the ones that were shown previously and 10 distracters. In the 
visuospatial construction task subjects had to copy a frame containing 10 different objects at 
different locations without a memory  component. Each task condition consisted of an 
example containing only 4 objects/positions, followed by two different test displays. 
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Figure 5-1. Control conditions for the OLM task (upper figure shows the object identity trial and lower the 
visuospatial reconstruction) 
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Following these control tasks, subjects completed 3 experimental task conditions:  
 
(i) position-only memory (POM) - subjects viewed an array containing 10 identical objects and 
were required to remember their precise locations. After 30s the array disappeared and the 
objects appeared along the top of the screen. Subjects were then required to move the 
objects down into the empty frame and recreate the exact positions of the array as accurately 
as possible.  
(ii) object-location binding (OLB) – subjects viewed an array of 10 different objects and were 
required to remember where they were located within the frame. After 30s the array 
disappeared and the objects appeared along the top of the screen. Subjects were then 
required to move the objects down into the frame and recreate the array, although the 
precise positions that had been occupied were indicated by pre-marked by black dots.  
(iii) combined memory condition (COM) – which was identical to the OLB condition except for 
the relocation stage where there were no pre-marked black dots i.e. subjects were required to 
remember and relocate the 10 different objects as precisely as possible to their exact previous 
locations.  
 
 Again, each task condition consisted of an example containing only 4 
objects/positions, followed by two different test displays. Performance measures were 
percentage incorrect items in the object identity control condition and OLB conditions, and 
deviation error (millimetres; mm) in the visuospatial construction and perception control 
condition, and POM and COM tasks. In the case of the POM task, as all objects are identical, it 
is impossible to specify which location any given object is relocated to and consequently the 
best-fit error is used (Kessels et al., 2000a). All other tasks use the absolute error score. 
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Figure 5-2. POM; position-only memory condition (upper figure shows the learning phase and the lower figure 
the test phase) 
 
 
 
 
Nb. Figures not to scale 
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Figure 5-3. OLB; object location binding condition (upper figure shows the learning phase and the lower figure 
the test phase) 
 
 
 
 
Nb. Figures not to scale 
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Figure 5-4. COM; combined condition (upper figure shows the learning phase and the lower figure the test 
phase) 
 
 
 
Nb. Figures not to scale 
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5.2.2.2 Secondary neuropsychological tests 
Additional secondary neuropsychological tests (with a main focus on visual and spatial 
processes) were also administered. These have been outlined  in previous chapters (chapter 4) 
and are only briefly listed below.  
 
CANTAB Spatial Working Memory (SWM): a self-ordered search task which requires subjects 
to search for hidden tokens within a spatial array. The number of between-search errors are 
recorded i.e. occasions when a subject returns to a square under which a token was already 
found, as well as a strategy measure, were a lower strategy score reflects a more systematic 
search strategy. CANTAB Spatial Recognition (SRec): a memory task in which subjects view 5 
‘squares’ presented in serial order and then are subsequently required to identify, from a 
choice of 2 squares, the one that occupies one of the 5 locations shown previously. Subjects 
complete 4 sets. The percentage of correct responses are recorded. CANTAB Spatial 
Recognition-modified (SRec-m): a modified version of the task was also administered which is 
identical to the standard version except two sets of 7 squares, then 2 sets of 9 squares are 
used. CANTAB Spatial Span and Reverse Spatial Span (SSp/ rSSp): a test analogous to the Corsi 
Block task which is administered first in the standard format and then reverse, where subjects 
tap the sequence in the opposite order from presentation. The maximum span reached is 
recorded. Visual Patterns Test (VPT): a test of short-term visual memory in which subjects are 
required to remember and reproduce increasingly complex ‘checkerboard’ patterns (Della Sala 
et al., 1999). It is scored in the same way as the SSp task with the maximum set-size achieved 
being recorded. CANTAB Pattern Recognition (PRec): a test of visual recognition memory in 
which subjects view a series of 12 coloured patterns and must then select the patterns they 
have seen in a 2-choice, forced-discrimination paradigm. Subjects complete 2 sets and the 
percentage correct is recorded. Pattern Recognition-modified (PRec-m): due to the risk of 
ceiling effects in healthy controls, a modified pattern recognition task was constructed which 
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was similar to the CANTAB version except the patterns were more abstract, black and white 
shapes and were more closely matched to their distracter during the recognition phase. These 
were taken from (Vanderplas & Garvin, 1959) and displayed using the Superlab program. One 
set of 24 patterns was administered. Self-Ordered Pointing Test (SOPT): a test of executive 
function/ visual working memory, requiring the ability to generate and monitor a sequence of 
responses. The version used here consists of 3 trials at levels 4, 6, 8 and 10.  
 
Rey-Auditory Verbal Learning Test (Rey-AVLT): a verbal learning and memory task which was 
administered according to standardised instructions (Rey, 1964; Lezak et al., 2004). Forward 
and Backward Digit Span (fDSp/ bDSp): a test of immediate verbal recall and working memory 
which was again administered according to standardised instructions (Lezak et al., 2004). 
Verbal fluency (FAS and ELFT): tests of verbal fluency with difference executive demands. Digit 
Symbol Substitution Test (DSST): testing psychomotor speed. Lastly, speed of cognitive 
processing (SCOLP; Speed and Capacity of Language Processing) was included.  
 
5.2.3 Statistical analysis 
Descriptive statistics are presented as mean, standard deviation (s.d.) and range. For graphical 
presentation of results, bar charts are presented as mean, with error bars representing  1 
standard error of the mean (SEM). Where estimates effect sizes are presented Cohen’s d is 
used (Cohen, 1988), calculated using the formula ( X patients minus X controls)/Spooled). Where 
necessary the signs of the effect sizes were reversed so that negative values always represent 
impairment in the patient group compared to the controls. For the primary analyses, a 
parametric approach was again adopted. The secondary battery was subjected to an overall 
multivariate analysis first for consistency (see section 2.2.6) however the primary aims of this 
chapter was to examine the performance of participants on the ORT and examine the 
relationship to the secondary measures. Correlation and hierarchical regression (entry 
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method) were adopted. Differential deficit in ORT measures was examined using the program 
developed by Crawford and colleagues (‘diffdef’), which can be used to test whether the 
deficit exhibited by a clinical sample on one measure is significantly greater than the deficit 
exhibited on another through the application of William's (1959) test for non-independent 
correlations (Crawford et al., 2000). Statistical analyses were carried out using SPSS version 17 
(SPSS, 2008). 
 
 
5.3 Results 
Twenty-five patients (n=17 male) and 25 healthy controls (n=19 male) took part in the study 
(these were sequentially the first participants from the n=100 from chapter 4). The two groups 
were well matched by sex (chi-squared=0.97, df=1, p=0.529), age (BD: mean=46.1 years, 
s.d.=10.9; controls: mean=44.2 years, s.d.=15.1; t=0.515, df=48, p=0.609), years of education 
(BD: mean=13.9 years, s.d.=2.5; controls: mean=14.5 years, s.d.=2.3; t= -0.829, df=48, 
p=0.411) and NART estimated full-scale IQ (BD: mean=110.9, s.d.=9.9; controls: mean=112.0, 
s.d.=13.2; t= -0.329, df=48, p=0.744). 
 
Patients had a mean age of illness onset of 30.2 years (s.d.=13.1) and a current median length 
of illness episode of 18 weeks (mean=51, s.d.=74). Severity of depression in the group at 
screening using the HAM-D17 was 19 (s.d.=4.4) and on the day of testing (using MADRS) was 
26 (s.d.=8.5). The median number of hospitalizations in the group was 3. 
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5.3.1 Object Location Memory 
On the experimental conditions, patients with BD performed significantly worse than controls 
on all 3 measures: OLB (t=2.611, df=48, p=0.012; d= -0.70), POM (t=4.169, df=48, p<0.0001; d= 
-1.02) and COM (t=2.987, df=48, p=0.004; d= -0.78). Application of Crawford’s calculator did 
not reveal evidence of a differential deficit between any of these processes (POM vs. OLB: 
t=1.181, df=47, p=0.243; POM vs. COM: t=0.846, df=47, p=0.402; OLB vs. COM: t=0.380, df=47, 
p=0.706). 
 
Examination of the control conditions revealed that while performance of object identity 
memory did not differ significantly between groups (t=1.063, df=48, p=0.293; d= -0.30), 
patients with BD performed significantly worse than controls at the visuo-spatial construction 
task (t=3.120, df=48, p=0.003; d= -0.81).  
 
 
 
Table 5-1. Mean (s.d.) errors for patients and controls on the Object Location Memory test 
 Patients (n=25) Controls (n=25) 
 Mean s.d. Mean s.d. 
Control tasks      
Object identity (% errors) 4.4 (9.3) 2.2 (4.6) 
Visuospatial construction (error, mm) 107.2 (51.2) 69.8 (31.2) 
Experimental measures     
OLB (errors, %)  34.0 (22.9) 17.8 (21.0) 
POM (error a, mm) 200.5 (49.7) 150.5 (33.5) 
COM (error, mm) 310.7 (83.1) 239.2 (86.3) 
a
 in the case of POM, the best-fit error was used (see methods section). 
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An ANCOVA was therefore used to examine the group differences on each of the experimental 
measures, with the inclusion of visuospatial construction as a covariate (this method has been 
utilised in previous studies, see van Asselen et al., 2008). Sex was also added as a between 
subjects factor. Patients were significantly impaired on the POM measure (F=6.733, df=1,45, 
p=0.013). However performance on the OLB measure (F=1.918, df=1,45, p=0.173) and COM 
measure (F=3.635, df=1,45, p=0.063) did not significantly differ between groups. The visuo-
spatial reconstruction task was a significant covariate in all 3 models. On the OLB measure, a 
significant sex difference was observed with females performing significantly better than 
males (F=5.351, df=1,45, p=0.025). 
 
Although there was no differential deficit, examination of the relationship between the three 
measures revealed that performance on the OLB and COM measures was significantly 
correlated for patients (rs=0.521, p=0.008) and controls (rs=0.550, p=0.004), but there was no 
significant correlation between POM and either of these measures in patients (POM vs. OLB: 
rs=0.334, p=0.103; POM vs. COM: rs=0.251, p=0.227) or controls (POM vs. OLB: rs=0.085, 
p=0.688; POM vs. COM: rs=0.192, p=0.359). This suggests that POM may tap different 
underlying processes than OLB and COM.  
 
5.3.2 Secondary neuropsychological tests 
As discussed in chapter 4.1.1, ceiling effects were observed in the standard CANTAB PRec test 
therefore only the modified PRec is included in the multivariate analysis. For the SRec, the 
standard version was used (5 stimuli). Also, as the groups were intentionally matched on pre-
morbid estimated verbal IQ, the spot the word test from the SCOLP was not included in 
between group comparisons. 
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 From the primary MANOVA, a overall main effect of group was observed (Pillai’s Trace=0.573; 
F=1.945, df=20,29, p=0.050) with patients performing worse than controls. Examination of 
individual tests is presented in Table 5-2 indicating statistical differences across the majority of 
measures included.  
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Table 5-2. T-test for between group differences for patients and controls 
 
 Patient Control t-test ES a 
 mean s.d. mean s.d. t p d 
Visual Patterns test         
span 7.9 (1.6) 9.3 (2.2) -2.584 0.013 -0.69 
SOPT        
total errors 13.5 (5.5) 10.0 (6.3) 2.096 0.041 -0.57 
Pattern Recognition        
correct (standard)b 21.3 (2.8) 22.3 (2.2) -1.409 0.168 -0.40 
correct (modified 24) 17.1 (3.0) 18.9 (2.5) -2.285 0.027 -0.62 
Spatial span        
forward span 5.2 (1.0) 6.0 (1.2) -2.470 0.017 -0.66 
reverse span 5.2 (1.1) 6.2 (1.4) -2.865 0.006 -0.76 
Spatial Working Memory        
between errors 31.6 (20.1) 22.7 (18.8) 1.701 0.092 -0.45 
within errors 2.7 (7.5) 1.3 (1.8) 0.897 0.374 -0.25 
strategy score 33.4 (6.4) 30.7 (6.2) 1.552 0.127 -0.43 
Spatial Recognition        
correct (standard) 13.7 (3.0) 14.6 (3.1) -1.060 0.294 -0.30 
correct (modified 7) b 9.1 (2.2) 10.4 (2.2) -2.010 0.050 -0.55 
correct (modified 9) b 11.1 (2.3) 11.3 (2.0) -0.390 0.698 -0.11 
Rey-AVLT        
correct (total A1 to A5) 38.7 (8.6) 46.0 (8.6) -3.025 0.004 -0.79 
correct (A7) 6.0 (3.4) 8.4 (3.5) -2.459 0.018 -0.66 
correct (recognition A) 11.5 (2.6) 12.1 (2.6) -0.732 0.468 -0.21 
Digit span        
forward span 6.2 (1.1) 7.3 (1.1) -3.644 0.001 -0.92 
reverse span 4.7 (1.2) 5.2 (1.3) -1.465 0.149 -0.41 
Verbal fluency        
‘FAS’ correct 37.8 (9.2) 44.4 (10.9) -2.299 0.026 -0.62 
‘exclude letter’ correct 34.9 (8.6) 45.1 (10.7) -3.726 0.001 -0.94 
DSST        
Correct 46.6 (10.2) 56.0 (9.8) -3.330 0.002 -0.86 
SCOLP        
Speed of Comprehension 55.2 (15.3) 71.9 (15.8) -3.810 <0.001 -0.95 
 
a Effect sizes (ES) are Cohen’s d, corrected so that negative values always represent impairment 
in patients compared to controls. 
b these are included for information only. 
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5.3.3 Relationship between the ORT and secondary neuropsychological tests 
Presented below are the (Spearman’s) correlation matrices for controls and patients 
separately, for the ORT task and the tests from the wider secondary battery (statistically 
significant correlations are highlighted in red; p<0.05).   
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Table 5-3. Correlation matrix for ORT measure with the secondary battery (Controls) 
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Table 5-2. Correlation matrix for ORT measure with the secondary battery (Patients) 
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Overall it can been seen that there appears to be a greater extent of inter-correlation 
between secondary tests in control subjects compared to patients, especially within the visuo-
spatial tasks (rows a to i). When examining the relationship between the ORT paradigm 
outcome measures and the secondary measures, it is clear that a very different profile 
characterises each group. Aside from the PRec-m measure, there are no shared areas of 
significance of correlations between  patient and control groups. With regard to the ORT 
measures, there are two areas are of particular note. Firstly, in controls, there are multiple 
significant correlations between the POM and the visuo-spatial tasks, including the spatial 
span and VPT measures, PRec-m and SRec, and SWM (between errors). There are numerically 
fewer in patients (although of note is the correlation between COM and SWM between 
errors). Secondly, in patients, there are significant correlations between verbal learning (Rey-
AVLT total) and the ORT measures of OLB and COM, but not POM. Comparing the strength of 
these ORT/Rey-AVLT correlations between patients and controls revealed that there was no 
significant difference for POM (z=0.33, p=0.741) or COM (z=-0.15, p=0.881) measures, but the 
OLB correlation was significantly larger in patients than controls (z=-2.05 p=0.040).  
 
Using a hierarchical multiple regression method, each of the ORT variables was examined 
separately, entering visuospatial reconstruction (VSR), Rey-AVLT total, and group as 
independent predictors. Four models were examined; Models 1 and 2 examined the individual 
effects of Rey-AVLT total and visuospatial reconstruction respectively by entering each of 
these variables first followed by group. Models 3 and 4 examined the order of entry. 
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Table 5-4. POM hierarchical regression (whole group, with Rey-AVLT total and VSR) 
 R2 R2 change F for R2 change p 
Model 1     
Rey-AVLT total 0.090 0.090 4.755 0.034 
Group: BD vs. control 0.276 0.186 12.094 0.001 
     
Model 2     
VS reconstruction 0.227 0.227 14.056 <0.001 
Group: BD vs. control 0.350 0.123 8.913 0.004 
     
Model 3     
Rey-AVLT total 0.090 0.090 4.755 0.034 
VS reconstruction 0.253 0.163 10.261 0.002 
Group: BD vs. control 0.353 0.100 7.082 0.011 
     
Model 4     
VS reconstruction 0.227 0.227 14.056 <0.001 
Rey-AVLT total 0.253 0.027 1.679 0.210 
Group: BD vs. control 0.353 0.100 7.082 0.011 
 
 
From the regression analysis of the POM measure, entry of either variable (Rey-AVLT total  or 
VSR) individually  predicted a significant proportion of the variance, although the entry of 
group membership also explained significant additional variance (18.6% and 12.3% 
respectively). Importantly, when both variables were entered, the order of entry had a 
significant impact on the resulting models and although both explained a significant 
proportion of the variance (model 3), when VSR was added first (25.3%), the addition of the 
Rey-AVLT did not result in a significant increase (2.7%). Again, entering the group variable was 
significant. 
 
A different pattern emerged for both the OLB and COM measures, with a greater proportion 
of the variance being explained by the verbal learning measure. 
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Table 5-5. OLB and COM hierarchical regression (whole group, with Rey-AVLT total and VSR) 
OLB R2 R2 change F for R2 change p 
Model 1     
Rey-AVLT total 0.186 0.186 10.953 0.002 
Group: BD vs. control 0.224 0.039 2.341 0.133 
     
Model 2     
VS reconstruction 0.119 0.119 6.478 0.014 
Group: BD vs. control 0.172 0.054 3.042 0.088 
     
Model 3     
Rey-AVLT total 0.186 0.186 10.953 0.002 
VS reconstruction 0.236 0.050 3.101 0.085 
Group: BD vs. control 0.253 0.017 1.034 0.315 
     
Model 4     
VS reconstruction 0.119 0.119 6.478 0.014 
Rey-AVLT total 0.236 0.117 7.216 0.010 
Group: BD vs. control 0.253 0.017 1.034 0.315 
 
 
COM R2 R2 change F for R2 change p 
Model 1     
Rey-AVLT total 0.270 0.270 17.795 <0.001 
Group: BD vs. control 0.312 0.042 2.872 0.097 
     
Model 2     
VS reconstruction 0.092 0.092 4.864 0.032 
Group: BD vs. control 0.181 0.089 5.081 0.029 
     
Model 3     
Rey-AVLT total 0.270 0.270 17.795 <0.001 
VS reconstruction 0.294 0.023 1.548 0.220 
Group: BD vs. control 0.321 0.027 1.815 0.185 
     
Model 4     
VS reconstruction 0.092 0.092 4.864 0.032 
Rey-AVLT total 0.294 0.202 13.424 0.001 
Group: BD vs. control 0.321 0.027 1.815 0.185 
 
  
Page | 254 
For the OLB measure, entry of the Rey-AVLT first explained 18.6% of the variance, with VSR 
not producing a significant increase (5.0%). However, even when entering VSR first, the 
subsequent addition of Rey-AVLT total produced a significant increase (11.7%). In the case of 
COM, the same pattern emerged, with entry of the Rey-AVLT first explaining 27.0% of the 
variance while the subsequent entry of VSR was not significant (2.3%). Entering VSR first 
explained 9.2% of the variance, with the subsequent entry of Rey-AVLT significantly increasing 
the proportion explained (20.2%). In both analyses of OLB and COM, the final entry of the 
group variable was not significant, explaining only an additional 1.7% and 2.7% respectively.  
 
 
5.3.4 Is the effect group-specific? 
In order to examine the specificity of this effect to the individual groups, a similar series of 
analyses was performed for each group independently.  
 
Table 5-6. POM hierarchical regression (separate groups, with Rey-AVLT total and VSR) 
 Controls Patients 
POM  
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 3         
Rey-AVLT total 0.001 0.001 0.031 0.861 0.032 0.032 0.764 0.391 
VS reconstruction 0.255 0.253 7.471 0.012 0.106 0.074 1.817 0.191 
         
Model 4         
VS reconstruction 0.231 0.231 6.908 0.015 0.079 0.079 1.961 0.175 
Rey-AVLT total 0.255 0.024 0.694 0.414 0.106 0.027 0.676 0.420 
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Table 5-7. OLB and COM hierarchical regression (separate groups, with Rey-AVLT total and VSR) 
 Controls Patients 
OLB 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 3         
Rey-AVLT total 0.028 0.028 0.656 0.426 0.246 0.246 7.522 0.012 
VS reconstruction 0.159 0.132 3.448 0.077 0.262 0.016 0.469 0.501 
         
Model 4         
VS reconstruction 0.159 0.059 4.352 0.048 0.022 0.022 0.528 0.475 
Rey-AVLT total 0.159 <0.001 0.010 0.922 0.262 0.240 7.148 0.014 
         
 
 Controls Patients 
COM 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 3         
Rey-AVLT total 0.168 0.168 4.656 0.042 0.203 0.203 5.841 0.024 
VS reconstruction 0.203 0.035 0.953 0.340 0.206 0.003 0.087 0.771 
         
Model 4         
VS reconstruction 0.106 0.106 2.723 0.133 0.006 0.006 0.141 0.711 
Rey-AVLT total 0.203 0.097 2.678 0.116 0.206 0.200 5.527 0.028 
         
Significance of entry indicated by shading. 
 
It is clear from the above analyses that a very consistent pattern emerges in the results of the 
hierarchical regression. In controls, VSR explained a significant proportion of the variance in 
POM, irrespective of the order of entry into the model. For OLB, VSR was also significant but 
only when entered first into the model, similarly for COM, although the Rey-AVLT explained a 
significant proportion of the variance in COM when entered first, this was not significant in 
model 4 when entered after VSR  (explaining <10% additional variance).  
 
In patients, the results were very different. For POM, neither variable was significant. 
However, for OLB and COM, the Rey-AVLT explained a significant proportion of the variance 
irrespective of the order of entry (≥20% for all) while the addition of VSR was non-significant 
for all (≤2.2% variance explained).   
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5.4 Discussion of Chapter 5 
In this chapter, the results of the first use of the ORT paradigm in patients with bipolar 
depression and healthy controls are presented. Initial univariate analyses demonstrated large 
effect sizes on all three primary outcome measures from the task: OLB (d= -0.70), COM 
(d= -0.78) and POM (d= -1.02). One of the control tasks (VSR) also showed a between group 
difference. When the results of this task were covaried, only the group difference in POM 
remained significant. Analysis of the secondary neuropsychological tests revealed a broad 
pattern of performance impairment in the bipolar patients. Correlational analysis of the 
relationships between the secondary battery and ORT measures suggested a different pattern 
of significant relationships between patients and controls. Given the results of the earlier 
chapters it is of note for example that in controls POM correlates significantly with SWM 
between errors, while in patients it is COM which correlated most strongly with SWM 
between errors. 
 
There was a significant impairment in verbal learning in the patient group (Rey-AVLT total; 
d= -0.79). In patients, performance on this measure correlated significantly with the OLB and 
COM measures, but not with POM (no equivalent significant relationships were found in 
controls). Subsequent hierarchical multiple regression revealed that all but a trivial proportion 
of variance in OLB and COM measures (over and above that explained by control variables i.e. 
VSR) can be explained by verbal learning with ‘group’ explaining only a trivial amount of 
variance. In the equivalent analysis of POM, the addition of ‘group’ still explained significant 
additional variance (~10%). 
 
Similar to the effect reported in many of the previous studies using the ORT paradigm (see 
section 5.1), we see here an apparent separation between the POM process and the 
OLB/COM processes. Although this did not meet criteria for a differential deficit, the pattern 
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of correlation, subsequent ANCOVA and results of the multiple regression analyses shows an 
apparent difference in the mediating effect of verbal learning between patients and controls 
(this will be discussed in detail in sections 5.4.1 and 7.3 below).  
 
5.4.1 Theoretical implications of the ORT findings 
In a study specifically designed to examine the role of verbal memory processes and object-
location memory, Kessels and Postma (2002) examined the effect of articulatory suppression 
(AS+; counting 1 to 5 recurrently) or silence (AS-) during either the encoding or maintenance 
phase of the three ORT processes. Performance was significantly worse with AS+ on the OLB 
and COM conditions, but there was no effect on POM. Also, the effect only occurred during 
the encoding phase; there was no effect on any measure when AS+ was applied during 
maintenance. These results were discussed in terms of the earlier findings of Postma and de 
Haan (1996), that the effect of AS+ appears to occur even with stimuli that are not readily 
nameable and therefore that it may not be a direct verbal effect per se, but possibly a 
disruption in underlying categorical information processing.  
 
The implications of the above discussion can be outlined in a number of hypothesis, although 
it is again noted that these are purely speculative as they were not tested directly in the 
present study.  
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5.4.1.1 What underpins the link between some ORT measures and Rey-AVLT total learning? 
It is first important to again consider precisely what traits or capacities underlie the verbal 
learning measure (Rey-AVLT total) and also the ORT measures, OLB and COM26. In terms of the 
former, there is a great deal of work in the hemispheric preponderance literature highlighting 
the close relationship between language processing and categorization or the ability to 
process information in a categorical manner (Kosslyn et al., 1989; Parrot et al., 1999). 
Therefore, whilst the Rey-AVLT is clearly a verbal memory measure, it may also be viewed to 
some degree as measure of categorical learning or processing. Furthermore, when referring to 
categorical relations of objects, linguistic and perceptual/cognitive representations of space 
are at least partially distinct (although it has been noted that language can modify both 
perceptual sensitivity and cognitive style- for a review see Kemmerer, 2006). For example, 
evidence from a seminal paper by Kemmerer and Tranel (2000) reports a double dissociation 
in two brain-damaged subjects between linguistic representation of spatial relationships and 
perceptual representations, especially those of a categorical nature. Jager & Postma (2003) 
summarise this as evidence of a “tripartion [sic] between perceptual-coordinate spatial codes, 
perceptual-categorical codes and verbal-categorical spatial codes”. 
 
Therefore, within the tripartition described by Jager and Postma above and the consideration 
of what is being measured by the Rey-AVLT total verbal learning measure (i.e. Rey-AVLT being 
foremost a verbal memory measure, but possibly also tapping some element of general 
categorical processing) a number of hypotheses can be considered to explain the pattern of 
results from the regression analyses. These are outlined below as individual potential 
hypotheses although it should be noted that they may not be mutually exclusive, but may in 
fact overlap. 
                                                          
26
 It is noted that COM is a complex measure which may be considered to include both categorical and coordinate 
processes. Here, for the purposes of the discussion, it is included along with OLB due to the correlation between 
OLB and COM in both groups, and a similar pattern/relationship of both measures to predictor variables in the 
regression analyses. 
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The first hypothesis is that the relationship between verbal learning and OLB/COM is because 
language processing in general overlaps (as regards the processes involved) the binding and 
relational aspect of memory for spatial arrays in that both can involve a form of categorical 
processing. This would explain the loss of the significant group effect in OLB/COM when 
factoring verbal learning into the statistical model. However, the proportion of the variance in 
OLB/COM measures explained by verbal learning was greater in patients than controls. 
Considering this, a second hypothesis could be that patients preferentially attempt to verbally 
encode items (“the chair was top/left, the car was bottom/right ...”), while controls 
perceptually encode items with either no or minimal support from other (verbal) processes. 
This would also explain the results of the regression analyses where a larger proportion of the 
variance of the group difference in OLB/COM was explained by verbal learning. In this context, 
when the groups are examined separately, the greater proportion of variance explained by 
verbal learning in patients is because the verbal learning measure has much greater loading to 
verbal-categorical processes. A third related hypothesis is that patients having visuospatial 
(perceptual) memory impairment, including an impairment of visuospatial metric processing, 
draw more on verbal/verbal-categorical processes to attempt to maintain or ‘scaffold’ 
performance on tasks which are amenable to such a strategy i.e. when objects are unique. 
However, performance on the verbal learning measure is statistically worse in patients (see 
section 5.3.2) therefore it is unclear why patients would use such a process, unless, despite 
being impaired, it is relatively ‘less impaired’ than other processes that could be used. This 
perhaps also explains the arithmetically larger effect size for the group difference in POM 
compared to OLB/COM.  
 
In terms of the POM measure, memory for exact metric/coordinate locations is likely to be 
highly demanding of cognitive resources. Moreover, retention of exact spatial location is 
critically time-dependent with a rapid decay function. Some distortions in precise location are 
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evident after retention intervals in the order of hundreds of milliseconds or less (Werner & 
Diedrichsen, 2002) and these distortions increase over time (Postma et al., 2006).  Recent 
work by van der Ham et al. (2007) examining the time-course of hemispheric specialisation for 
categorical and co-ordination spatial relations revealed that whilst the predicted relative 
hemispheric differences occurred at very brief retention intervals (500ms), the co-ordinate 
specialisation of the right hemisphere was not present when durations were 2 seconds or 
more (in fact there appeared to be a shift to LH advantage). It was reported that, subjectively, 
participants described the attempted use of verbal encoding strategies at longer intervals. The 
effect was summarised thus: “it is very well possible that in the long interval, the coordinate 
strategy failed completely, because the exact, metric information had decayed in memory. A 
verbal approach could replace the coordinate strategy, which would result in a lower level of 
performance, because the coordinate trials were not perfectly solvable without knowing the 
total number of possible positions. A verbal, more categorical strategy, using words like ‘near’, 
‘in the middle’, and ‘far’, could well have caused the left hemispheric advantage found, 
because of the use of categories and verbal memorization”.  
 
5.4.1.2 Summary 
Together the results of these studies suggest that it may be the rapid and accurate encoding 
of spatial configural information which may be at the heart of the performance on the ORT in 
the present study. It has been suggested that the formation of some categorical coding must 
occur very rapidly to maintain anything close to an accurate representation of the original 
locations (Werner & Diedrichsen, 2002). For the POM condition, the large effect size and 
statistical difference between groups – which remained after factoring in the variance 
explained by the control or verbal learning tasks – may result from an impairment in rapid 
encoding of precise spatial locations. Because all items are identical in this condition, as 
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discussed above, any switch to / or support from a more verbal strategy is unlikely to 
adequately scaffold performance.  
 
These data raise an important empirical question for the final chapter in this thesis, namely, 
what is the interrelationship between spatial memory processes, broader neuropsychological 
components and the HPA axis? Also, do these processes operate differently in patients 
compared to healthy controls? Given the findings in this Chapter with regard to the 
differences in ORT measures and the contributions of other processes to task performance 
(e.g. the verbal memory findings), one primary aim is to ascertain if similar effects occur with 
the SWM task (i.e. are there differences in the processes underlying the between and within 
search errors). The aim of the subsequent chapter is to integrate the findings from the 
previous two chapters and introduce additional measures of HPA axis functioning which may 
be more specific or sensitive in order to examine these relationships.  
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Chapter VI 
 
Neuropsychological and HPA axis correlates of 
spatial memory processes  
Page | 263 
6. Neuropsychological and HPA axis correlates of spatial memory 
processes  
 
6.1 Introduction to Chapter 6 
In this final chapter the relationships among spatial memory processes, neuropsychological 
composites and HPA axis measures will be examined in a series of multiple regression 
analyses. This will be completed in the overall sample of patients and controls as described in 
chapter 4 (n=100 total) and also in the sub-set of participants who completed the ORT 
paradigm as described in the preceding Chapter 5.  
 
As discussed in the introduction to Chapter 1, there are many methods which can be used to 
assess HPA axis function in humans. Also, as identified in Chapters 2 and 3, to fully explore the 
role of the HPA axis as a mediator of neuropsychological performance, measures beyond 
peripheral cortisol secretion should be considered. Here, three different measures are 
included: salivary cortisol-DHEA ratio, the cortisol awakening response and the degree of 
dexamethasone non-suppression (using the DST). These three were selected to provide a 
more comprehensive assessment than any of the measures can individually, particularly as has 
been noted in earlier discussion, there are examples in patients with bipolar disorder where 
‘activating’ tests (which more closely assess functional alterations at the receptor level) have 
demonstrated differences in HPA activity in the absence of basal salivary changes (e.g. Watson 
et al., 2004) and conversely, examples of instances where CAR abnormalities have been 
detected in the absence of abnormal DST responses (Deshauer et al., 2003). Of particular 
interest are the CAR and the DST which are more closely linked to the functioning of the GR – 
in the case of the CAR, because it assesses levels during the maximal waking surge and the 
DST, a GR agonist (see General introduction, section 1.4.1) 
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The neuropsychological measures used will be composite scores derived from the 
components extracted from the series of PCA analyses in Chapter 4. Initially, a general analysis 
will examine the relationship between the spatial memory measures and HPA axis measures. 
Subsequently, a more detailed analysis will be conducted with the SWM and the ORT task in 
order to examine the relationship of the neuropsychological composites to the different task 
processes. This analysis will also draw on individual variables of theoretical interest in order to 
examine their relationship to the visuo-spatial processes examined. With regard to the SWM, 
it is expected that a different pattern of loadings will be observed across the two error types: 
BSE and WSE. Based on the results of Chapter 5 from the Object Location Memory task, a 
specific confirmatory hypothesis can be put forward that along with visuospatial composites, 
(in patients) the verbal memory composite will predict significant variance in selected OLM 
measures – OLB and COM.  
 
6.2 Methods 
6.2.1 Subjects 
Details of the subjects included in this chapter have been described previously (see section 
4.2). General demographic and clinical information for this sample is also reported earlier 
(section 4.3). 
 
6.2.2 HPA axis measures 
For the assessment of HPA axis function, two saliva sampling methods and one plasma 
sampling method was adopted. Saliva sampling took place on separate days, prior to 
completion of neuropsychological testing. Due to the administration of dexamethasone during 
the plasma sampling protocol, this was completed after neuropsychological testing.  
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The first saliva sampling method was 8am/8pm cortisol, DHEA, and cortisol-DHEA (CD) ratio. 
Saliva was collected by a passive drool method at the two time points over a single day. 
Samples were analysed to measure cortisol, DHEA and the CD ratio. The second saliva method 
utilised was the cortisol awakening response (CAR). Five saliva samples were taken (again 
using the passive drool method) from the time of awakening, then at 15-minute intervals 
thereafter for one hour. All saliva samples were assayed for cortisol and DHEA. Details of the 
assay procedures are presented previously (section 2.2.5).  
 
For the dexamethasone (dex) suppression test (DST), a blood sample (5ml) was taken after 
neuropsychological testing to serve as a baseline. One mg dex was taken orally at 11pm the 
same evening and the participant returned for a repeat blood sample the next day at the 
same time as the baseline had been assessed.  The blood sample was assayed for cortisol and 
the extent of suppression (DST Δ) assessed by subtracting the post-dex level from the pre-dex 
level.  
 
6.2.3 Statistical analysis 
Due to the iterative nature of this chapter, specific details of each analysis will be given 
throughout the results section. The general approach adopted will be to utilised multiple 
regression with forced entry. The principal steps of interest will be the R2 change for each 
variable/composite entry within the model. Where tests have relevant control tasks 
associated with them (for example, the VSR of the ORT) in exploratory models these variables 
will be entered first in order to examine the additional variance explained by the true 
variables of interest. In general, one of the main aims of these analyses will be to examine the 
contribution of verbal memory measures to the performance of the spatial tasks described in 
the previous chapters of the thesis. Also, although the initial analyses of the separate groups 
will all be performed using the control-derived PCA composites, the analyses will be repeated 
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in the patient group using their own PCA derived composites in order to examine any 
differences. In effect, this will establish if any absence of  significant relationships between the 
composite predictors and dependent variable are true and not a consequence of the 
underlying neuropsychological variable loadings being different in the patient group and 
therefore that composite being unrepresentative of that given factor in the patients).  
 
6.3 Results 
Presented first is a brief summary of the results of the additional HPA axis assessments. 
 
6.3.1 Additional neuroendocrine measures 
6.3.1.1 Data summary 
Of the total sample of n=100, not all participants completed the HPA axis assessments. Due to 
the issue of artificially reducing variance when large numbers of data points are imputed, the 
analysis was carried out on observed data only. The only exception was that for the CAR, 
where a data point was missing in between two valid observations, the missing point was 
imputed as the midpoint between the two. Where the first or last sample was missing, it was 
replaced using the group mean. Replacement of this type was only performed where more 
than half the data was present i.e. for only those participants with 2 or fewer missing 
observations. 
 
For the 8am/8pm cortisol and DHEA data, full datasets were available for 27 patients (51%)  
and 35 controls (74%). For the remaining 26 patients: 16 had provided no samples, 1 had a 
missing 8am sample, 3 had 8pm cortisol sample missing, 2 had 8am DHEA missing, 2 had 8pm 
DHEA missing, 1 had cortisol analysed but no DHEA available, and 1 had the 8pm cortisol and 
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all DHEA missing. For the remaining 12 controls: 7 had provided no saliva samples, 3 had 
cortisol analysed but no DHEA was available, 1 had a the 8am cortisol sample missing, and 1 
the 8pm DHEA sample missing. The reasons for missing data are varied, however instances 
where samples are provided but measures of either DHEA or cortisol are missing are generally 
the result of insufficient sample remaining to complete both assays.  
 
For the CAR, full data sets were available for 36 patients (68%) and 34 controls (72%). Of the 
remaining patients, 1 had provided no samples, 8 had single missing samples (0mins, four at 
30mins, two at 45mins, 60mins), 5 had two missing samples (0mins, 15mins / 0mins, 45mins / 
15mins, 45mins / 30mins, 45mins / 30mins, 60mins), 1 had three missing samples (15mins, 
45mins, 60mins), and two had all samples after 0mins missing. Of the remaining 13 controls: 8 
had provided no samples, 2 had single missing samples (0mins/45mins), 1 had two missing 
samples (0mins, 45mins), and 2 had three missing samples (0mins, 15mins, 60mins / 30mins, 
45mins, 60mins). Using the method of handling missing data described above resulted in the 
data of an additional 3 controls and 13 patients being available giving usable data for 49 (92%) 
patients and 37 (79%) controls.  
 
For the DST, 29 patients (55%) and 30 controls (64%) provided full data sets. Of the remainder, 
only 5 patients and 10 controls did not provide any blood samples. Seventeen patients and 6 
controls provided pre-dex samples but no post-dex sample, while 2 patients and 1 control had 
only the post-dex sample available. The main reason for instances where the pre-dex sample 
only was available was because a more detailed blood analysis was performed for the overall 
program of research of which this study was part, therefore participants agreed to this sample 
but either declined to take dexamethasone or could not attend the following day to provide 
an additional sample, so dexamethasone was not dispensed.    
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6.3.1.2 Analysis of neuroendocrine data 
Salivary cortisol and DHEA data were examined separately in a repeated measures ANOVA 
with time as the within subjects factor. For cortisol, there was a significant effect of time 
(F=67.326, df=1,66, p<0.0001) but no significant main effect of group (F=0.109, df=1,66, 
p=0.743) or time by group interaction (F=0.240, df=1,66, p=0.626). Similarly, for DHEA, there 
was a significant effect of time (F=51.067, df=1,67, p<0.0001) but no significant main effect of 
group (F=0.277, df=1,67, p=0.277) or time by group interaction (F=0.077, df=1,67, p=0.782). 
Consequently, there was no difference between the groups in the molar cortisol-DHEA ratio. 
 
Table 6-1. Summary data for the endocrine measures. 
 Controls Patients   
 mean s.d. mean s.d. t p 
Cortisol-DHEA a       
8am cortisol 11.0 6.3 11.3 8.5   
8pm cortisol 2.9 5.4 2.2 1.7   
8am DHEA 4.5 4.1 3.9 2.9   
8pm DHEA 1.7 1.3 1.3 0.9   
8am CD ratio 4.3 3.9 4.3 4.4 0.041 0.986 
8pm CD ratio 2.1 4.4 2.7 3.3 1.000 0.321 
CAR a       
AUC 735.9 374.8 779.7 636.3 0.373 0.710 
DST a       
Pre-dex cortisol 266.0 85.9 247.7 107.2   
Post-dex cortisol 46.2 102.5 51.0 54.4   
Δ cortisol -229.5 80.6 -199.8 106.3 1.212 0.230 
a
 All values in nmol/L or nmol/L/min for AUC. 
 
 
Individual time points for the CAR are presented in Figure 6-1 below. Again there was a 
significant effect of time (F=5.545, df=4,336, p=0.006) but no significant main effect of group 
(F=0.106, df=1,84, p=0.745) or time by group interaction (F=0.389, df=4,36, p=0.655). 
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Figure 6-1. The cortisol awakening response (CAR) 
 
 
 
 
Finally, for the DST, as can be seen in Table 6-2 there was no significant difference in the 
degree of cortisol suppression between the groups following dexamethasone. However, the 
DST typically uses a cut-off to define non-suppression and reduces the data to categorical 
values (i.e. suppressor vs. non-suppressor). The historical value based on the original paper 
(Carroll et al., 1981) was 5µg/dl (138nmol/L) although this value was based on the optimum 
cut-off for sensitivity and specificity. Therefore an ROC analysis was performed on the Δ 
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cortisol values in patients and controls. The AUC of the ROC was 0.654 (95%CI=0.502 to 
0.806). An optimum cut-point of -178.9 nmol/L produced a sensitivity of 0.55 and specificity of 
0.77. Examination of the cross-tabulation of patient and controls by DST suppression status 
was significant (χ2=6.284, df=1, p=0.017).  
 
 
Table 6-2. Number of patients and controls classified as DST non-suppressors 
 Patients Controls 
Non-suppressor 16 (55.2%) 7 (23.3%) 
Suppressor 13 (44.8%) 23 (76.7%) 
Percentage with reference to proportions within diagnostic group. 
 
 
6.3.2 Neuroendocrine measures as predictors of spatial memory 
From the additional HPA axis measures, four principal outcome measures were examined in 
relation to the spatial memory tasks: 8am CD ratio, 8pm CD ratio, CAR AUC, DST Δ cortisol. 
The spatial memory outcomes were restricted to SWM between and within search errors, and 
Object Relocation Test  POM, OLB and COM. 
 
Table 6-3. Correlation between spatial memory measures and HPA axis measures 
Whole group SWM ORT 
 Between Within POM OLB COM 
8am CD ratio -0.029 0.122 0.045 -0.415* -0.183 
8pm CD ratio -0.137 -0.059 0.204 -0.187 -0.159 
CAR AUC -0.019 0.035 0.200 -0.090 0.151 
DST Δ cortisol -0.036 -0.173 -0.117 -0.047 -0.020 
*p<0.05 
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 SWM ORT 
 Between Within POM OLB COM 
Patients      
8am CD ratio -0.091 0.086 -0.156 -0.496 -0.358 
8pm CD ratio -0.133 0.064 0.253 -0.086 -0.187 
CAR AUC 0.103 -0.055 0.166 0.060 0.422* 
DST Δ cortisol -0.060 -0.254 -0.293 -0.442 -0.393 
    
Controls    
8am CD ratio 0.038 0.154 0.319 -0.507* -0.114 
8pm CD ratio -0.134 -0.192 0.232 -0.347 -0.082 
CAR AUC -0.135 0.162 0.086 -0.490* -0.228 
DST Δ cortisol -0.008 0.006 -0.400 0.221 -0.059 
*p<0.05 
 
As can be seen in the table, there is little evidence of any consistent relationship between HPA 
measures and spatial tests. Between the groups, the only significant correlations were for the 
CAR to be associated with poorer COM performance in patients and for both CAR and the 8am 
CD ratio to be associated with better OLB performance in controls. Individual composites were 
also examined but again there were no meaningful significant correlations for any measure 
(see Appendix 9.6, p.376). 
 
As the only measure to show significance in the whole group was CAR AUC for the OLB 
measure, a regression was performed with entry of this measure followed by group. From the 
analysis below the initial entry adds only 3% of variance. However subsequent entry of group 
adds significant additional variance (~10%).   
 R2 R2 change F for R2 change p 
OLB     
     
CAR AUC 0.003 0.003 0.141 0.709 
Group: BD vs. control 0.106 0.106 5.211 0.027 
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Finally, to examine the effect of DST suppression status, independent t-tests were used to 
examine for differences in spatial memory processes between suppressors and non-
suppressors (diagnostic group was not considered in this analysis). There were no significant 
differences between groups (suppression status) for SWM BSE (t=0.641, df=57, p=0.524), WSE 
(t=0.443, df=57, p=0.660), ORT POM (t=0.029, df=28, p=0.977), OLB (t=0.054, df=28 p=0.957) 
or COM (t=0.120, df=28, p=0.906). There were also no significant differences in any of the 
composite measures (p>0.1; data not shown).  
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6.3.3 Neuropsychological composites as predictors of spatial memory performance 
 
Table 6-4. Mean composite scores (derived from individual variable z scores) for each component of the PCA 
analysis 
 
Bipolar (n=53) Controls (n=47)  
  
Mean s.d. SEM Mean s.d. SEM t p 
  
Optimised model 
      
(df=98)  
TOTAL_c1 (visuo-spatial; VS) 
a
 -0.205 0.735 0.101 0.229 0.762 0.111 -2.900 0.005 
TOTAL_c2 (verbal memory) 
b
 -0.297 0.847 0.116 0.335 0.796 0.116 -3.828 <0.001 
TOTAL_c3 (verbal exec) 
c
 -0.298 0.649 0.089 0.336 0.833 0.122 -4.274 <0.0001 
control_c1 (verbal memory)
 b
 -0.297 0.847 0.116 0.335 0.796 0.116 -3.828 <0.001 
control_c2 (VS complex) 
d
 -0.165 0.818 0.112 0.186 0.851 0.124 -2.098 0.038 
control_c3 (VS immediate) 
e
 -0.268 0.713 0.098 0.301 0.781 0.114 -3.808 <0.001 
control_c4 (verbal exec) 
f
 -0.357 0.724 0.099 0.402 0.928 0.135 -4.587 <0.0001 
patient_c1 (VS) 
g
 -0.220 0.698 0.096 0.247 0.660 0.096 -3.424 0.001 
patient_c2 (verbal memory)
 b
 -0.297 0.847 0.116 0.335 0.796 0.116 -3.828 <0.001 
patient_c3 (digit srec) 
h
 -0.162 0.817 0.112 0.182 0.774 0.113 -2.153 0.034 
       
  
Optimised SWM model 
      
  
TOTAL_c1 (verbal memory)
 b
 -0.297 0.847 0.116 0.335 0.796 0.116 -3.828 <0.001 
TOTAL_c2 (VS)
  i
 -0.238 0.740 0.102 0.266 0.835 0.122 -3.200 0.002 
TOTAL_c3 (verbal exec) 
 c
 -0.298 0.649 0.089 0.336 0.833 0.122 -4.274 <0.0001 
control_c1 (verbal memory)
 b
 -0.297 0.847 0.116 0.335 0.796 0.116 -3.828 <0.001 
control_c2 (verbal exec)
 c
 -0.298 0.649 0.089 0.336 0.833 0.122 -4.274 <0.0001 
control_c3 (VS)
 i
 -0.238 0.740 0.102 0.266 0.835 0.122 -3.200 0.002 
patient_c1 (VS)
 j
 -0.253 0.688 0.094 0.283 0.676 0.099 -3.915 <0.001 
patient_c2 (verbal memory)
 b
 -0.297 0.847 0.116 0.335 0.796 0.116 -3.828 <0.001 
patient_c3 (digit srec)
 h
 -0.162 0.817 0.112 0.182 0.774 0.113 -2.153 0.034 
Key to z-score variables that constitute each composite: 
a 
SWM between errors, strategy; 
Spatial span forward, reverse; VPT.  
f
 FAS; ELFT 
 
b
 Rey-AVLT total, A7, recognition.  
g
 SWM between errors, strategy; Spatial span forward, reverse; VPT; FAS. 
c 
FAS, ELFT, Digit Span reverse. 
h 
Digit span reverse; SRec 
d
 SWM between errors, strategy; SOPT. 
i 
Spatial span forward, reverse; VPT. 
e 
Spatial span forward, reverse; DSST 
j 
Spatial span forward, reverse; VPT; FAS. 
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Table 6-4 above summarises the composite scores for each of the PCA analyses from Chapter 
4. As can be seen, all composites indicate significantly worse scores in patients compared to 
controls. All values are included although it should be noted that there are several repetitions 
included in the table (e.g. the verbal memory composite) where several models produced the 
same solutions in terms of the individual variables constituting each.  
 
Given the findings in Chapter 3 of specific changes in SWM (BSE not WSE), these two error 
types are examined first in order to explore any differences in underlying composite loadings. 
 
6.3.3.1 Spatial Working Memory 
6.3.3.1.1 Between search errors 
In order to restrict the number of contrasts performed, an initial analysis was performed on 
the whole dataset (n=100) with concurrent forced entry of the three total composite 
measures (from the Optimised SWM model). The dependent variable was square root 
transformed prior to analysis. 
 
The overall model was highly statistically significant (F=31.02, df=3,96, p<0.0001) with 49.2% 
of the variance explained (R=0.702). Examination of the individual composite coefficients 
revealed that the verbal executive composite (TOTAL_c3) was not statistically significant 
(B=-0.038, standard error, SE=0.229; β=-0.13; t=-0.165, p=0.869), therefore only the verbal 
memory (c1) and visuospatial memory (c2) composites were used further in the hierarchical 
models.  
 
For each model, group (patient or control) was entered after the entry of the composites to 
assess the additional variance explained. Model 1 entered the c1 then c2, while in Model 2 the 
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order was reversed. For the remaining analyses, the group variable was removed and patients 
any controls were examined separately. The first set of models used the composites derived 
from the healthy controls’ PCA analysis (SWM optimised; control c1 and c3). The last set of 
models examined patients only, using the composites derived from their own PCA analysis 
(SWM optimised; patients c1 and c2).  
Table 6-5. SWM between search errors (TOTAL group) 
 R2 R2 change F for R2 change p 
     
Model 1     
TOTAL c1 (verbal) 0.232 0.232 29.656 <0.001 
TOTAL c2 (VS) 0.492 0.260 49.579 <0.001 
Group: BD vs. control 0.505 0.013 2.467 0.120 
     
Model 2     
TOTAL c2 (VS) 0.418 0.418 70.389 <0.001 
TOTAL c1 (verbal) 0.492 0.074 14.135 <0.001 
Group: BD vs. control 0.505 0.013 2.467 0.120 
 
Table 6-6. SWM between search errors (groups separated; control derived composites) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 3         
control c1 (verbal) 0.208 0.208 11.816 0.001 0.214 0.214 13.914 <0.001 
control c3 (VS) 0.467 0.259 21.351 <0.001 0.517 0.302 31.283 <0.001 
         
Model 4         
control c3 (VS) 0.390 0.390 28.755 <0.001 0.415 0.415 36.241 <0.001 
control c1 (verbal) 0.467 0.077 6.342 0.015 0.517 0.101 10.481 0.002 
         
         
Model 5         
patient c2 (verbal) - - - - 0.214 0.214 13.914 <0.001 
patient c1 (VS) - - - - 0.481 0.267 25.751 <0.001 
         
Model  6         
patient c1 (VS) - - - - 0.382 0.382 31.566 <0.001 
patient c2 (verbal) - - - - 0.481 0.099 9.556 0.003 
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As can be seen in all of the above models, irrespective of the order of entry, additional 
variance was explained by both the visuospatial and verbal composites. This occurred for the 
group as a whole and for patients and controls separately. Overall it appeared that 
arithmetically the visuospatial composite may be the greater predictor as R2 values were 
always higher and when it was entered first (model 4 and 6) around 40% of the variance was 
explained by this variable. Nevertheless, entry of the verbal composite always explained 
significant additional variance (around 20% when entered first, and around 10% when entered 
second).  
 
6.3.3.1.2 Within search errors 
The same analyses were also performed (Models 1 to 6) for the SWM within search error rate. 
Again, the square root transformed values were utilised (however, it should be noted that the 
high number of zero error scores on this variable meant that while the distribution was 
improved, it did not achieve normality).  
 
Table 6-7. SWM within search errors (TOTAL group) 
 R2 R2 change F for R2 change p 
     
Model 1     
TOTAL c1 (verbal) 0.057 0.057 5.967 0.016 
TOTAL c2 (VS) 0.116 0.059 6.468 0.013 
Group: BD vs. control 0.143 0.027 3.009 0.086 
     
Model 2     
TOTAL c2 (VS) 0.097 0.097 10.528 0.002 
TOTAL c1 (verbal) 0.116 0.019 2.119 0.149 
Group: BD vs. control 0.143 0.027 3.009 0.086 
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Table 6-8. SWM within search errors (groups separated; control derived composites) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 3         
control c1 (verbal) 0.123 0.123 6.318 0.016 0.044 0.044 2.373 0.130 
control c3 (VS) 0.248 0.125 7.319 0.010 0.091 0.047 2.576 0.115 
         
Model 4         
control c3 (VS) 0.198 0.198 11.081 0.002 0.068 0.068 3.711 0.060 
control c1 (verbal) 0.248 0.051 2.961 0.092 0.091 0.023 1.290 0.262 
         
         
Model 5         
patient c2 (verbal) - - - - 0.044 0.044 2.373 0.130 
patient c1 (VS) - - - - 0.117 0.073 4.132 0.047 
         
Model  6         
patient c1 (VS) - - - - 0.099 0.099 5.623 0.022 
patient c2 (verbal) - - - - 0.117 0.018 1.024 0.316 
         
 
 
In comparison to the between search errors, the regression models on within search errors 
indicated minimal involvement of the verbal composite. In the total sample and in controls, 
while initial entry of verbal memory was significant, when the visuospatial composite was 
entered first no significant additional variance was explained by the entry of the verbal 
composite (models 1 to 4). Interestingly, in patients, when the composites derived from the 
control participants PCA solutions were used, entry of neither composite was significant. 
However, when composites derived from their own PCA solution were used, an even clearer 
pattern was observed with verbal memory explaining no significant additional variance, 
irrespective of the order of entry. Only the visuospatial composite explained significant 
variance (models 5 and 6).  
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6.3.3.2 Object Relocation Task 
6.3.3.2.1 Whole sample 
An initial analysis was performed on the whole sample who had completed the ORT (n=50). 
Due to the number of variables (with the inclusion of group), the hierarchical regression was 
simply performed using entry of the optimised composites in order. This order reflects the 
overall loadings from the original PCA analysis in chapter 4 i.e. the relative contribution of 
each component to the overall PCA model. All components were used as the aim was to 
establish not just loadings of each but to examine the effect of final entry of ‘group’. 
 
Table 6-9. ORT task (TOTAL group) 
 R2 R2 change F for R2 change p 
POM     
     
TOTAL c1 (VS) 0.205 0.205 12.396 0.001 
TOTAL c2 (verbal) 0.212 0.007 0.422 0.519 
TOTAL c3 (verbal exec) 0.218 0.006 0.336 0.565 
Group: BD vs. control 0.377 0.159 11.460 0.001 
     
OLB     
     
TOTAL c1 (VS) 0.063 0.063 3.228 0.079 
TOTAL c2 (verbal) 0.206 0.143 8.489 0.005 
TOTAL c3 (verbal exec) 0.252 0.045 2.776 0.103 
Group: BD vs. control 0.276 0.025 1.530 0.222 
     
COM     
     
TOTAL c1 (VS) 0.126 0.126 6.918 0.011 
TOTAL c2 (verbal) 0.364 0.138 8.777 0.005 
TOTAL c3 (verbal exec) 0.282 0.018 1.162 0.287 
Group: BD vs. control 0.316 0.034 2.264 0.139 
     
 
While aspects of this initial analysis replicate what was established in chapter 5, it is 
interesting to note that the pattern of the variance explained by the composites is different 
for POM than for OLB and COM. POM is the only process for which the final entry of group 
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into the model explains significant additional variance (~16%) compared with OLB and COM 
(~3%). Also, while the initial entry of the visuospatial composite is significant in all 3 models 
(trend with OLB), subsequent entry of the verbal composite is only significant for OLB and 
COM. 
 
The remaining analyses are all performed on the groups separately. Following a similar 
procedure as above, the regression models will use the control-derived composite scores and 
then the patients models will be re-calculated using patient-derived scores. Due to the 
number of permutations that are possible with the entry of five variables in a hierarchical 
fashion, the models will be constructed systematically to focus primarily on the  visuospatial 
versus verbal contribution to each of the three ORT variables. Later models in each section will 
begin with the inclusion of the visuo-spatial reconstruction (VSR) measure to remove this 
source of variance (see section 5.3.1) and then examine the additional unique contribution of 
verbal memory. 
 
6.3.3.2.2 Position-only memory (POM) 
Based on the whole sample analysis, the visuospatial (VS) measures are of particular interest 
in these initial POM analyses. Both control derived VS composites (optimised model: c2 and 
c3; a complex visuospatial measure, consisting of SWM between search errors and strategy 
and the SOPT, and a more immediate one27, consisting of spatial span forward and reverse 
and the DSST), were entered first in the initial model, followed by the remaining composites 
(note, the visuospatial and verbal composites were always sequential to each other, in order 
to allow for the maximum chance of additional variance to be explained by one or the other). 
Then this was repeated with the VS measures last. 
                                                          
27 Note that these are fairly general identifying labels only; the individual variables that constitute each composite were in some 
instances difficult to classify under a single term. These will be discussed in greater detail in section 6.4. 
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Table 6-10. POM (groups separated; control derived composites) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 1         
control c2|c3 (both VS) 0.349 0.349 5.893 0.009 0.285 0.285 4.376 0.025 
control  c1 (verbal) 0.404 0.055 1.937 0.179 0.350 0.065 2.106 0.161 
control  c4 (verbal exec) 0.406 0.002 0.075 0.786 0.427 0.077 2.698 0.116 
         
         
Model 2         
control  c1 (verbal) 0.018 0.018 0.416 0.525 0.024 0.024 0.565 0.460 
control  c4 (verbal exec) 0.046 0.028 0.654 0.427 0.061 0.037 0.874 0.260 
control c2|c3 (both VS) 0.406 0.360 6.061 0.009 0.427 0.366 6.390 0.007 
         
 
Table 6-11. POM (patients only; patient- derived composites) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 1         
patient  c1 (VS) - - - - 0.002 0.002 0.040 0.844 
patient  c2 (verbal) - - - - 0.024 0.022 0.501 0.486 
patient  c3 (digit srec) - - - - 0.025 0.001 0.021 0.885 
         
         
Model 2         
patient  c2 (verbal) - - - - 0.024 0.024 0.565 0.460 
patient  c1 (VS) - - - - 0.024 <0.001 <0.001 0.999 
patient  c3 (digit srec) - - - - 0.025 0.001 0.021 0.885 
         
 
From the above models it is clear that the only composites that predict a significant 
proportion of the variance in POM are the visuospatial measures. It is of note that even entry 
at the end of the model explains around 36% in both patients and controls.  Interestingly, 
when re-examining the patient group using the composite scores derived from their own PCA, 
there were no significant entry steps in any model. This may suggest that as a consequence of 
the ‘blurred boundaries’ of the composites in patients (i.e. the mixture of verbal and 
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visuospatial variables, as discussed in section 5.4) these have poorer predictive ability than the 
‘purer’ control-derived measures which follow more circumscribed theoretical divisions.  
The final analysis conducted was in order to examine the effect of initially entering the VSR 
control task variable into the model  followed by the remaining control derived composites, 
with the visuospatial measures entered last in order to assess the additional variance 
explained.  
 
Table 6-12. POM (groups separated; control derived composites with initial VSR entry) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 1         
VSR 0.231 0.231 6.908 0.015 0.079 0.079 1.961 0.175 
control  c1 (verbal) 0.240 0.009 0.262 0.614 0.089 0.010 0.250 0.622 
control  c4 (verbal exec) 0.257 0.017 0.470 0.501 0.138 0.049 1.203 0.285 
control c2|c3 (both VS) 0.457 0.200 3.505 0.051 0.439 0.300 5.080 0.017 
         
 
From this analysis it is clear that even with prior entry of the VSR and all remaining 
composites,  the final entry of the visuospatial composites adds a substantial proportion of 
additional variance (30% for patients and 20% for controls, although it is noted that this 
marginally fails to reach conventional significance in controls). 
 
6.3.3.2.3 Object-location binding (OLB) 
As with the previous analysis of POM, the initial models compare the hierarchical entry of the 
control derived PCA composites. Due to the emergence of a significant entry of the verbal 
executive composite in one of the models, one additional model was included with initial 
entry of this measure. 
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Table 6-13. OLB (groups separated; control derived composites) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 1         
control c2|c3 (both VS) 0.173 0.173 2.308 0.123 0.077 0.077 0.917 0.414 
control c1 (verbal) 0.190 0.017 0.433 0.518 0.282 0.206 6.015 0.023 
control  c4 (verbal exec) 0.324 0.134 3.955 0.061 0.364 0.082 2.571 0.124 
         
         
Model 2         
control c1 (verbal) 0.083 0.083 2.077 0.163 0.231 0.231 6.913 0.015 
control c4 (verbal exec) 0.246 0.163 4.761 0.040 0.263 0.032 0.955 0.339 
control c2|c3 (both VS) 0.324 0.078 1.152 0.336 0.364 0.101 1.590 0.229 
         
         
Model 3         
control c4 (verbal exec) 0.195 0.195 5.572 0.027 0.008 0.008 0.183 0.673 
control c2|c3 (both VS)  0.320 0.125 1.938 0.169 0.184 0.176 2.268 0.128 
control c1 (verbal) 0.324 0.003 0.101 0.754 0.364 0.180 5.665 0.027 
         
 
 
From the above analysis it is clear that there are consistent but different key composite 
loadings between the groups – the verbal executive composite (consisting of the verbal 
fluency measures) in controls and the verbal memory composite (consisting of Rey-AVLT total 
and delayed recall and recognition) in patients. In the case of the patients, even entering the 
verbal composite last in the model contributes to a significant increase in variance explained 
(~18%). In the case of the controls, although final entry of the verbal executive measure just 
fails to reach statistical significance, an additional 13.4% of the variance is explained, and in 
other models initial or second entry positions are significant (n.b. model 2 above was repeated 
with c2|c3 first and this second entry step of c4 is also significant; R2 change=14.7%).  
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The next series of models was performed in order to repeat the analysis in patients using 
composites derived from their own PCA analysis. As can be seen in the table below, the profile 
of results was identical to that achieved using the control derived composites, with the entry 
of the verbal memory composite adding at least 21%, irrespective of the position within the 
model. 
Table 6-14. OLB (patients only; patient- derived composites) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 1         
patient c1 (VS) - - - - 0.018 0.018 0.410 0.528 
patient   c2 (verbal) - - - - 0.231 0.214 6.112 0.022 
patient  c3 (digit srec) - - - - 0.232 0.001 0.019 0.891 
         
         
Model 2         
patient   c2 (verbal) - - - - 0.231 0.231 6.913 0.015 
patient  c3 (digit srec) - - - - 0.232 0.001 0.021 0.887 
patient c1 (VS) - - - - 0.232 <0.001 <0.001 0.997 
         
         
Model 3         
patient  c3 (digit srec) - - - - 0.006 0.006 0.129 0.723 
patient c1 (VS) - - - - 0.020 0.014 0.319 0.578 
patient   c2 (verbal) - - - - 0.232 0.212 5.797 0.025 
         
 
The final analysis conducted was in order to examine the effect of initially entering the VSR 
control task variable into the model  followed by the remaining control derived composites. 
From the previous analyses it was identified that the verbal executive was the strongest 
predictor  in control participants, while it was the verbal memory composite in patients. 
Therefore, these variables were entered last in order to assess the additional variance 
explained.  
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Table 6-15. OLB (groups separated; control derived composites with initial VSR entry) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 1         
VSR 0.159 0.159 4.352 0.048 0.022 0.022 0.528 0.475 
control c2|c3 (both VS) 0.231 0.072 0.987 0.389 0.082 0.060 0.684 0.516 
control  c4 (verbal exec) 0.385 0.153 4.981 0.037 0.189 0.107 2.640 0.120 
control  c1 (verbal) 0.385 0.001 0.020 0.889 0.364 0.175 5.231 0.034 
         
Model 2         
VSR 0.159 0.159 4.352 0.048 0.022 0.022 0.528 0.475 
control c2|c3 (both VS) 0.231 0.072 0.987 0.389 0.082 0.060 0.684 0.516 
control  c1 (verbal) 0.241 0.010 0.266 0.612 0.283 0.200 5.587 0.028 
control  c4 (verbal exec) 0.385 0.144 4.445 0.049 0.364 0.082 2.440 0.138 
         
 
 
From this analysis it is clear that even with prior entry of the VSR and all remaining 
composites,  the final entry of the verbal executive composite in the case of controls or the 
verbal memory composite in the case of patients adds a substantial proportion of additional 
variance explained. 
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6.3.3.2.4 Combined condition (COM) 
Finally, as with OLB and COM, the initial models compare the hierarchical entry of the control 
derived PCA composites. For comparison, these are presented as they were with the OLB 
analysis. 
 
Table 6-16. COM  (groups separated; control derived composites) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 1         
control c2|c3 (both VS) 0.213 0.213 2.981 0.071 0.081 0.081 0.975 0.393 
control  c1 (verbal) 0.293 0.080 2.366 0.139 0.149 0.068 1.670 0.210 
control  c4 (verbal exec) 0.303 0.010 0.292 0.595 0.149 <0.001 <0.001 0.998 
         
         
Model 2         
control  c1 (verbal) 0.250 0.250 7.657 0.011 0.106 0.106 2.732 0.112 
control  c4 (verbal exec) 0.258 0.008 0.233 0.634 0.117 0.010 0.257 0.617 
control c2|c3 (both VS) 0.303 0.045 0.652 0.532 0.149 0.033 0.383 0.687 
         
         
Model 3         
control  c4 (verbal exec) 0.026 0.026 0.609 0.443 0.025 0.025 0.596 0.488 
control c2|c3 (both VS)  0.236 0.211 2.895 0.078 0.082 0.057 0.649 0.533 
control  c1 (verbal) 0.303 0.067 1.916 0.182 0.149 0.067 1.577 0.224 
         
 
From the models above it is apparent that overall the pattern of results with COM is less clear-
cut. In patients, there are no steps in the models which add significant variance. In controls, 
although the entry of the verbal composite in model 2 is the only significant effect, it should 
be noted that the combined entry of the VS adds almost 15% variance in model one, and adds 
an additional 21% in model three, although both just fail to reach significance. 
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The next series of models was performed in order to repeat the analysis in patients using 
composites derived from their own PCA analysis. Again, as can be seen in the table below, the 
profile of results was similar with respect to the control derived composites, with no steps 
adding significant variance. 
 
Table 6-17. COM (patients only; patient- derived composites) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 1         
patient c1 (VS) - - - - 0.047 0.047 1.125 0.300 
patient  c2 (verbal) - - - - 0.124 0.078 1.947 0.177 
patient  c3 (digit srec) - - - - 0.133 0.008 0.206 0.655 
         
         
Model 2         
patient   c2 (verbal) - - - - 0.106 0.106 2.732 0.112 
patient  c3 (digit srec) - - - - 0.110 0.004 0.102 0.752 
patient c1 (VS) - - - - 0.133 0.022 0.541 0.470 
         
         
Model 3         
patient  c3 (digit srec) - - - - 0.001 0.001 0.023 0.881 
patient c1 (VS) - - - - 0.053 0.052 1.207 0.284 
patient   c2 (verbal) - - - - 0.133 0.080 1.930 0.179 
         
         
Model 4         
patient   c2 (verbal) - - - - 0.106 0.106 2.732 0.112 
patient c1 (VS) - - - - 0.124 0.018 0.451 0.509 
patient  c3 (digit srec) - - - - 0.133 0.008 0.206 0.655 
         
 
 
The final analysis conducted was in order to examine the effect of initially entering the VSR 
control task variable into the model  followed by the remaining control derived composites.  
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Table 6-18. COM (groups separated; control derived composites with initial VSR entry) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 1         
VSR 0.106 0.106 2.723 0.113 0.006 0.006 0.141 0.711 
control c2|c3 (both VS) 0.215 0.109 1.458 0.255 0.081 0.075 0.861 0.437 
control  c4 (verbal exec) 0.238 0.024 0.618 0.441 0.082 0.001 0.012 0.912 
control  c1 (verbal) 0.303 0.065 1.768 0.199 0.151 0.069 1.554 0.228 
         
Model 2         
VSR 0.106 0.106 2.723 0.113 0.006 0.006 0.141 0.711 
control c2|c3 (both VS) 0.215 0.109 1.458 0.255 0.081 0.075 0.861 0.437 
control  c1 (verbal) 0.293 0.078 2.209 0.153 0.151 0.070 1.649 0.214 
control  c4 (verbal exec) 0.303 0.010 0.280 0.603 0.151 <0.001 <0.001 0.995 
         
 
From this analysis it is clear that with prior entry of the VSR , there are no significant effects 
with entry of all remaining composites. However, it is possible that multiple resources are 
being employed in such a demanding task as COM. So one additional exploratory model was 
examined, with simultaneous entry of several composites. 
 
Table 6-19. COM (groups separated; control derived composites simultaneous entry, with initial VSR entry) 
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
Model 1         
VSR 0.106 0.106 2.723 0.113 0.006 0.006 0.141 0.711 
control  c1|c4 (verbal &  0.272 0.166 2.391 0.116 0.117 0.110 1.312 0.290 
verbal exec)         
Model 2         
VSR 0.106 0.106 2.723 0.113 0.006 0.006 2.723 0.113 
control c2|c3 (both VS) 0.215 0.109 1.458 0.255 0.081 0.075 1.458 0.255 
control  c1|c4 (verbal &  0.303 0.088 1.205 0.322 0.151 0.070 1.205 0.322 
verbal exec)         
 
As can be seen, the simultaneous entry of these variables was not statistically significant.  
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6.3.3.2.5 Comparison of phonological with verbal learning 
One final exploratory analysis was performed to examine the verbal contribution to the three 
measures of the ORT. Specifically, hierarchical regression was used to compare the variance 
added by a phonological loop measure (digit span forward) with a verbal learning measure 
(Rey-AVLT total). These two measures were added following the VSR control task. 
 
As can be seen from the analysis below, in patients, it was only the verbal learning measure 
which added significant variance to the OLB and COM models (models 3 to 6), irrespective of 
the order of entry. In controls, entry of neither measure was significant. This analysis was also 
repeated replacing the Rey-AVLT total with the A1 immediate recall measure and no entry 
step was significant (all R2 change values <5.5%).  
 
Finally, one additional comparison was made in patients to compare the entry of Rey-AVLT 
total with the delayed recall measure (A7). This was included to specifically examine the 
variance explained be the ‘learning’ aspect of the measure compared to the delayed recall 
component. For both OLB and COM, initial entry of the ‘total’ measure added significant 
variance while the subsequent entry of A7 did not (<3%). With initial entry of the A7 measure, 
entry was not statistically significant however subsequent entry of ‘total’ explained additional 
variance (OLB: 6.1% and COM: 17.7%).  
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Table 6-20. Comparison of a the Rey-AVLT total with digit span forward (all ORT measures)  
 Controls Patients 
 
R2 
R2 
change 
F for R2 
change 
p R2 
R2 
change 
F for R2 
change 
p 
POM         
Model 1         
VSR 0.231 0.231 6.908 0.015 0.079 0.079 1.961 0.175 
Rey-AVLT total 0.255 0.024 0.694 0.414 0.106 0.027 0.676 0.420 
Digit span forward 0.257 0.002 0.069 0.795 0.125 0.019 0.465 0.503 
         
Model 2         
VSR 0.231 0.231 6.908 0.015 0.079 0.079 1.961 0.175 
Digit span forward 0.231 <0.001 0.006 0.938 0.099 0.021 0.502 0.486 
Rey-AVLT total 0.257 0.026 0.728 0.403 0.125 0.026 0.631 0.436 
         
OLB         
Model 3         
VSR 0.159 0.159 4.352 0.048 0.022 0.022 0.528 0.475 
Rey-AVLT total 0.159 <0.001 0.010 0.922 0.262 0.240 7.148 0.014 
Digit span forward 0.179 0.019 0.498 0.488 0.269 0.007 0.207 0.654 
         
Model 4         
VSR 0.159 0.159 4.352 0.048 0.022 0.022 0.528 0.475 
Digit span forward 0.178 0.018 0.494 0.490 0.032 0.009 0.215 0.648 
Rey-AVLT total 0.179 0.001 0.035 0.852 0.269 0.237 6.825 0.016 
         
COM         
Model 5         
VSR 0.106 0.106 2.723 0.113 0.006 0.006 0.141 0.711 
Rey-AVLT total 0.203 0.097 2.678 0.116 0.206 0.200 5.527 0.028 
Digit span forward 0.203 <0.001 0.006 0.940 0.258 0.052 1.478 0.238 
         
Model 6         
VSR 0.106 0.106 2.723 0.113 0.006 0.006 0.141 0.711 
Digit span forward 0.118 0.012 0.296 0.592 0.064 0.058 1.351 0.258 
Rey-AVLT total 0.203 0.085 2.250 0.148 0.258 0.194 5.498 0.029 
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6.4 Discussion of Chapter 6 
6.4.1 Summary of findings 
This final empirical chapter presents the results of a series of regression analyses examining 
the relationship between spatial memory measures (SWM and ORT) and the composite 
measures derived from the PCAs in Chapter 4. Additional HPA axis assessments are also 
presented and their relationship to the above measures.  
 
The PCA composites from Chapter 4 were used in regression models to predict separately 
SWM between search errors (BSE) and within search errors (WSE). There were clear and 
interpretable differences in the set of PCA composites which predict BSE and WSE. As regards 
BSE, in the whole group, and also in the control and patient groups separately, the 
visuospatial composite and the verbal memory composite both explained significant 
additional variance, irrespective of the order of entry (although the visuospatial always 
explained numerically more). As regards WSE, in the whole group, entry of the verbal 
composite was significant when entered first, but not when entered following the visuospatial 
composite. In controls separately, exactly the same pattern emerged, while for patients, the 
pattern was even more clear in that the verbal composite was not significant in any model. 
Interestingly, the visuospatial composite was significant only when it was derived from the 
patients’ own PCA analysis result within this WSE analysis suggesting that, for this measure at 
least, the use of the more tightly defined control-derived  composite was not appropriate. 
 
As discussed earlier, the ORT yields three measures: POM, OLB and COM. With regard to 
POM, controls and patients showed an almost identical pattern of loading for POM in each of 
the analyses, with the visuospatial composite explaining a significant proportion of the 
variance. As regards OLB, in controls it was the verbal executive measure (verbal fluency tests) 
which provided the significant entry in the models, while for patients it was the verbal 
Page | 291 
composite which explained additional variance wherever it was included in the model. Due to 
the complexity of COM, the pattern of loadings within the models was less clear.  
 
In patients, the pattern of loadings between SWM WSE and BSE was similar to that seen 
between ORT POM and OLB measures, with WSE and POM having high visuospatial loading 
and BSE and OLB having high verbal composite loadings. However, the visuospatial composite 
made a significant contribution to BSE, but not to OLB.  
 
Finally, some exploratory analyses were included to look at specific aspects of the Rey-AVLT 
and the relationship with the ORT measures. It seems that specifically it was the total learning 
measure which related to the OLB/COM processes – neither immediate or delayed recall 
measures (single list) from the Rey-AVLT nor forward digit span predicted significant variance. 
The implications of this specificity are discussed in section 7.3.2 below.  
 
As outlined in the introduction, with regard to the neuroendocrine assessment in this chapter, 
the aim was to provide a more comprehensive assessment with a focus on measures which 
have been shown to be sensitive and linked more closely to the function of the GR than simple 
peripheral measures. In Chapter 2, the assessment of levels through the afternoon resulted in 
a significant group difference but there was little relationship with neuropsychological 
functions. However, in Chapter 3, using a GR antagonist there was a clear change in 
neuropsychological function (specifically CANTAB SWM BSE), therefore the aim here was to 
attempt to examine the relationship between specific spatial processes and these more 
selective HPA/GR measures. Although there were no differences between the groups in 
salivary cortisol or DHEA measures, the proportion of patients characterised as DST non-
suppressors fits exactly with that described in the original work on the development of the 
DST: Carroll (1982a) described sensitivity of 50-65%, although specificity was higher than that 
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seen here. When examining the relationship between these measures and the spatial tests, 
there was little evidence of any strong relationships. The only measure which was significant 
in the whole group (CAR AUC vs COM) explained some variance in the regression model but 
this was not sufficient to render the subsequent entry of the group variable non-significant.  
 
To avoid repetition, more detailed discussion of this final empirical chapter, especially with 
regard to the implications of these findings, will be covered in the General Discussion (see 
section 7.3 below). However, some methodological issues will be briefly outlined here. 
 
6.4.2 Methodological issues 
It was noted in Section 6.3.3.2.2 that the labels used to describe each of the composites was 
only for general descriptive purposes only. For some, for example verbal memory, the 
variables loading to this composite were very consistent and well defined. However others, 
such as the ‘visuospatial immediate’ or ‘visuospatial complex’ the boundaries defining these 
are less clear, the former for example contained both spatial span measures (forward and 
reverse), but also the DSST (a test of psychomotor speed and attention). It should also be 
noted that the measures within composites (e.g. visuospatial) often cover a range of 
processes from memory measures to those falling broadly under the executive function 
domain. Therefore the processes represented or measured by a composite can be broad. A 
further note on the loading of the variables within each composite is that while these 
produced orthogonal solutions, some potentially interesting tests may have been lost to the 
composites through multiple loading. As discussed already, this overlap of processes may 
reflect the norm in human neuropsychology, therefore removing such tests to achieve 
independent composites may be somewhat artificial.  
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It should also be noted that some of the analyses performed in this last chapter were on 
relatively small samples, especially the sub-group of patients and controls who completed the 
ORT and also the numbers completing the HPA axis assessments. Some moderate R2 change 
values may not therefore have reached statistical significance, although it is the case that the 
relative comparison of the pattern of loadings between the measures from the ORT is 
equivalent. The issue with missing or incomplete neuroendocrine samples was outlined in 
section 6.3.1. While some values can reasonably be imputed (e.g. CAR – estimation of the 
midpoint between two valid samples), other sampling protocols which involved less frequent 
sampling are not amenable to this without artificially decreasing the variance in the sample 
(e.g. replacement with the group mean).  
 
 
In the last chapter of the thesis, a general discussion is presented to summarise the principal 
findings of the thesis and to highlight the main strengths and weaknesses, as well as outline 
the implications and future directions for research. 
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Chapter VII 
 
General Discussion 
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7. General discussion 
 
In this final chapter, the results and principal findings of Chapters 1 to 6 will be summarised 
before discussing the major strengths and weaknesses of these and establishing directions for 
future research. 
 
7.1 Summary of principal findings in the thesis 
In Chapter 1, a general background to the thesis was presented along with an overview of 
bipolar disorder outlining the key areas of interest to the present work, namely that patients 
with mood disorder often exhibit neuropsychological impairment and HPA axis dysfunction. It 
was noted that there was relatively little data specifically examining neuropsychological 
function in bipolar depression. Chapters 2 and 3 reported the results from an initial sample of 
20 patients with bipolar depression. In Chapter 2, a broad profile of neuropsychological 
impairment was observed in patients within all the general neuropsychological domains 
examined, with large effects in immediate memory (phonological and spatial), executive 
functioning (spatial working memory, phonological fluency and sustained attention), spatial 
(but not visual) recognition memory, delayed verbal recall and recognition, and psychomotor 
speed. Sampling of cortisol and DHEA levels in plasma showed that hypercortisolaemia was 
evident in patients, but with no significant difference in DHEA or cortisol-DHEA ratios. 
However, there were no meaningful significant correlations between the extent of HPA axis 
disturbance and neuropsychological functioning, despite the acceptable (ROC) sensitivity and 
specificity of one of the HPA axis measures (plasma cortisol AUC; 1pm to 4pm). In Chapter 3, 
these patients entered into a double-blind, randomized crossover treatment study of the GR 
antagonist mifepristone which was administered adjunctively to concurrent medication. At 
the primary endpoint for the study (two weeks after cessation of treatment) a significant 
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improvement in CANTAB Spatial Working Memory (SWM)28 between search errors was 
observed. At this point there was also a significant reduction in cortisol levels from baseline in 
the active arm of the study. There was no significant difference in symptoms between 
treatment arms of the study at this point. Significant relationships were observed between the 
primary neuropsychological and HPA axis measures in that the percentage improvement in 
SWM correlated significantly with the cortisol area-under-the-curve at baseline. There were 
also selective correlations between the degree of cortisol reduction and the extent of 
neuropsychological improvement in some measures.  
 
At this point, several questions had emerged from the data, especially the improvement in 
one aspect of spatial working memory in response to a manipulation of the HPA axis.  In order 
to explore these findings in more detail, a larger cohort of participants was recruited and a 
more comprehensive analysis of neuropsychological functioning was performed. In view of 
the SWM result mentioned above, this focussed particularly on additional executive and 
visuo-spatial memory measures. In Chapter 4, a principal components analysis (PCA) was 
carried out to examine the component loadings of the neuropsychological measures for the 
whole group and for patients and controls separately. Although the primary aim of this 
chapter was to generate independent components from which composites could be derived 
for use in later analyses, two important facets became apparent in the data. Firstly, some of 
the individual variables (especially visuospatial ones) loaded onto more than one composite, 
suggesting both that multiple interdependent processes may underpin such variables; and 
also, while it may be possible to extract independent orthogonal solutions from 
neuropsychological variables, this may not be the true ‘structure’ underlying some tests. The 
implication is that results on any one of these tests cannot be attributed to a single 
component. Secondly, it appeared from the general profile of these composites that while in 
                                                          
28
 For the remainder of this discussion, SWM will be used to refer specifically to the CANTAB test. Any other 
reference to spatial memory refers to the general concept or process. 
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controls the pattern followed clear, expected distinctions (i.e. verbal memory, verbal 
executive, visuospatial etc.), in patients the pattern of loadings was less clear with most 
components containing at least one ‘verbal’ measure. In Chapter 5, a more detailed analysis of 
spatial memory processes was performed through the administration of the novel Object 
Relocation Task (ORT) paradigm which permits the fractionation of independent aspects of 
memory: exact positional information (POM), object-to-location binding (OLB) and a 
combined condition (COM). Through the administration of the secondary battery of tests, 
relationships were observed between verbal memory and both OLB and COM processes, 
which along with other analyses suggested that these latter ORT measures formed a 
component of visuospatial memory (distinct from POM) which was processed differently in 
patients compared to controls.  
 
Finally, in Chapter 6, using composites derived from the PCA solutions in Chapter 4, a series of 
hierarchical regression models were employed to examine their relationship with the principal 
spatial memory measures. Also included in this section were a number of additional measures 
of HPA axis function and their relationship with the spatial measures was also examined. In 
terms of between group differences, saliva measures did not reveal differences between 
patients and controls although the proportion of patients characterised as DST non-
suppressors was consistent with expectations. However, little evidence of a relationship 
between these measures and any measure from either SWM and ORT was found. With regard 
to the neuropsychological composites, regression analyses produced consistent results for 
SWM with both patients and controls relying on both visuospatial and verbal processes for 
BSE, but visuospatial only for WSE. For the ORT there were interesting differences between 
the groups. Controls relied on visuospatial measures for POM, but verbal executive measures 
for OLB; while patients, although similar to controls for POM, relied much more on verbal 
measures for OLB. Overall, the large between group effect seen in POM remained significant 
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after accounting for the variance explained by multiple different composites. As discussed in 
section 5.4.1 this, along with the similar profile of composite loadings in the separate groups, 
may suggest that either that patients have a core deficit in perceptual-coordinate spatial 
processing or they are unable to support or maintain a precise spatial representation by some 
other means (either verbal/categorical coding or accurate perceptual-categorical recoding).  
 
7.2 Methodological strengths and limitations 
With regard to the neuropsychological aspects of the thesis, there are several notable 
strengths. Many previous studies have utilised generic test batteries to examine broad 
neuropsychological processes in bipolar disorder. In the present work, after establishing 
effects using tests which examine broad functions, more specific, novel tasks (such as the first 
use of ORT in bipolar disorder) were used to focus on spatial processes in more detail. This 
was accompanied by statistical approaches that go beyond those which are usually applied in 
order to understand the processes underlying each of the measures of interest. The derivation 
of composite scores based on the outcome of principal component analysis to aid in this 
interpretation was also a particular strength, going beyond the treatment of tests as individual 
measures and instead examining more integrated processes. However, as noted previously, 
one aspect of this is also a potential weakness – composite scores could be derived from 
oblique solutions but by deriving fully orthogonal solutions in order to achieve the greatest 
degree of independence between composite predictors, a certain degree of artificiality may 
have resulted with some tests failing to be included through loadings to multiple composites. 
This situation (of greater dependence between components) may be more representative of 
the norm with regard to complex neuropsychological tasks drawing on and tapping multiple 
underlying processes. It should also be noted that some of the composites represent a 
somewhat broad, complex range of processes, especially in the example of the visuo-spatial 
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composites, they were entered together into the regression models. In this latter example, the 
measures loading into these composites represent a range of immediate memory, longer term 
memory and executive/attentional processes.  
 
One additional issue to consider is that of sensitivity to change of the neuropsychological tests 
used. The specificity of any observed deficit needs to be considered not just in terms of the 
magnitude of differences (as discussed regarding the differential deficit analysis) but also in 
terms of the ‘discriminating power’ of a test as reflected in its reliability, the shape and 
distribution of scores and item difficulty (Chapman & Chapman, 1973; Chapman & Chapman, 
1978). This same argument could be applied to sensitivity of a test (or measure) to change, 
although it should be noted that SWM BSE was not the largest effect size (between patients 
and controls) found at baseline therefore it does not appear to be the case that this measure 
changed because had the greatest chance of improvement. Also the crossover design of the 
study meant that comparisons were made within subject, including treatment conditions.  
 
With regard to the neuroendocrine tests, general issues around sample size and missing data 
were highlighted at the end of Chapter 6. To focus first on these particular methods of HPA 
axis assessment, in Chapter 2 a multi-time point blood sampling method was adopted which 
was taken over the period of neuropsychological assessment. In the later studies in the thesis, 
other methods were utilised, including salivary 8am/8pm cortisol-DHEA ratio, salivary CAR and 
the DST which have been described as sensitive measures in the literature. However, it is not 
known why these alternative saliva methods did not reveal any between group differences 
despite a high proportion of patients being DST non-suppressors (of course it is noted that in 
the case of the latter, the group difference is unsurprising since it is based on a cut-point 
which is specifically derived to maximise the difference between patients and control groups). 
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There are examples in the literature where one type of sampling methodology has failed to 
find statistical differences between groups while another has, within the same individuals. For 
example, differences in CAR have been described in individuals with no evidence of DST non-
suppression (Deshauer et al., 2003), while in other studies pronounced DST and dex/CRH 
abnormalities have been found in individuals with no differences in salivary cortisol levels (e.g. 
Watson et al., 2004). In this case, several different methodological issues may have 
contributed to the discrepancy. Firstly, the first sample used plasma levels over multiple 
afternoon time-points and the second, single point saliva levels. Secondly, the initial sample 
was recruited from patients in a tertiary referral service who presumably had more complex 
long-standing illnesses, while the latter sample also recruited directly from secondary care. 
Thirdly, it may have been a result of switching from the precision of collecting samples in the 
laboratory to participants collecting their own at home. CAR for example is affected by the 
actual awakening time (Federenko et al., 2004). In a recent meta-analysis which assessed 
twenty case-control studies where salivary cortisol was examined, including 1354 patients 
with depression (unipolar and bipolar) and 1052 controls, concluded that although there were 
very small increases in morning and evening cortisol levels in patients, overall it was a poor 
discriminator. In this meta-analysis, substantial overlap in levels between the groups was 
observed as well as high heterogeneity in morning sampling. Factors such as higher intra-assay 
coefficients of variation in cortisol kits and mean age were associated with a higher mean 
difference in morning salivary cortisol between depressed and controls, while the variables 
‘gender’ and ‘depression severity’ were not (Knorr et al., 2010). 
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7.3 Implications of the primary findings 
In the next section, a number of key implications of the present work are discussed and 
compared to previous work. 
 
7.3.1 What is the relationship between the HPA axis and spatial memory? 
The results of the present thesis provide little evidence of a simple relationship between 
peripheral HPA axis measures and spatial memory. While such measures are certainly useful 
to establish if neuroendocrine abnormalities are present on a group level, the variability 
inherent from the pulsatility of the HPA axis to the methodological issues discussed make it 
difficult to reliably use such indices to assess the link. However, clear effects on SWM were 
seen when the HPA axis was directly targeted by the GR antagonist mifepristone. This is in line 
with previous animal work showing effects of mifepristone on spatial memory (Oitzl et al., 
1998a).  
 
One feature of the results of Chapter 3 which is of particular note (and will be discussed in 
more detail below) is that while SWM BSE was improved, there was no significant change in 
verbal memory as assessed by the Rey-AVLT. This of course may simply be due to differences 
in test sensitivity to change. However it may also be due to the processes underpinning SWM 
BSE. One speculative explanation is that avoiding SWM BSE may be a somewhat ‘categorical’ 
process (or at least either overlaps with the same processes as categorical-type measures or 
becomes so as the test proceeds and participants form more accurate spatial categories 
relevant to the successful execution of the search sequence) in that all the spatial locations on 
the screen are fixed and the participant must search through these for the target, which 
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involves a (cognitively demanding) updating of each target location29. This explains the high 
visuospatial composite loading but also the verbal composite contribution (section 6.3.3.1). As 
has been discussed, the ‘verbal’ loading in this context may not be attributable to linguistic 
properties of the test, but to a categorical aspect. Therefore it may be that categorical spatial 
processes are sensitive to the effects of the GR antagonist i.e. SWM BSE were affected but not 
WSE. And the lack of effect of the drug on the Rey-AVLT may support the contention that it is 
not the verbal/linguistic elements of the task which is related to the BSE but in fact the 
categorical facets underpinning it. This may be similar for ORT OLB/COM measures (see 
section 7.4 below). 
 
7.3.2 Verbal scaffolding of visuospatial measures in bipolar depression? 
There have been a small number of studies that have examined the effects of verbal 
mediation on object-location memory processes, including some utilising similar paradigms to 
the present study (see Sections 5.1 and 5.4). In his seminal paper, Kosslyn suggests a relative 
hemispheric specialisation for categorical and co-ordinate spatial relations. Following initial 
experiments to establish the basic principle of a left hemisphere advantage for categorical and 
right hemisphere advantage for co-ordinate processes, explores the effects of repetition, 
difficulty and categorical dimension (i.e. on/off, above/below) on performance. With repeated 
presentation, the initial right hemisphere advantage reduced. It was argued that this was 
because practice allowed the development of new finer grained categories able to capture 
these spatial relations. Once these new categories were formed it was possible for the metric 
judgment task to be resolved using categorical processing and the encoding of spatial 
information with respect to fine grained metric distance would be diminished. However, a 
corresponding left hemisphere advantage did not develop. It was argued, therefore, that that 
                                                          
29
 Of course the temporal aspect of this type of error monitoring is also noted i.e. to avoid BSE, target locations are 
retained over longer periods of time than required to avoid WSE. 
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this may not be a direct verbal/semantic effect per se, but possibly a disruption in underlying 
categorical information processing (Kosslyn et al., 1989). 
 
The earlier discussion in Chapter 5 outlines comparable thinking with regard to the mediation 
of the ORT OLB and COM measures i.e. that the mediation may not be specifically linguistic. 
The original Postma and de Haan (1996) paper reported that articulatory suppression (AS+) 
had effects on tasks using stimuli that are not readily nameable and suggested that this may 
not be due to disruption of verbal processing per se, but possibly a disruption in underlying 
categorical information processing. One important feature of the studies examining the effect 
of verbal mediation of processes within the ORT is that they all used AS+ (either counting or 
repetition of a nonsense syllable) as the concurrent task. The aim of this is to interfere with 
the functioning of the phonological loop, without placing demands on executive processes 
(which can occur if the task is too complex). In the present thesis, one exploratory analysis 
was added to section 6.3.3.2.5 to compare the variance explained by a ‘phonological loop (PL) 
measure’ (digit span) compared to verbal learning. In patients, while neither measure was 
significant in the POM analysis, both OLB and COM measures had significant variance 
explained by the entry of verbal learning30, but not the PL measure. Although these two 
methods (i.e. comparing the effects of a direct interference task with the relationship in 
regression models) are of course very different, together they may further strengthen the 
argument that it may not be the verbal/linguistic element, but in fact the learning or 
categorical coding of information that is key. Of course, although the previous work described 
suggests that it is not the linguistic element per se that is responsible for the results observed, 
it cannot be completely ruled out that it is a simple verbal coding method that is being 
attempted by the patients. One final point to note is that the evidence for AS+ effects are not 
                                                          
30 n.b. this analysis was also repeated, replacing Rey-AVLT total with immediate verbal recall (trial A1 of the Rey-AVLT) or delayed 
recall (recall of list A7) and no significant entry steps were evident for either measure suggesting that this is not the mediating 
factor. 
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always consistent in terms of which ORT processes are affected (see section 5.1), therefore 
this argument remains speculative in the context of the present data. 
 
Considering the above discussion in the context of Kemmerer and Tranel’s (2000) work on the 
dissociation between linguistic and perceptual representations of categorical spatial 
relationships, it could be hypothesised that there is a dissociation between patients and 
healthy controls in the relative importance of the two, with patients either having greater 
dependence on the linguistic (verbal-categorical) or else using this to scaffold performance. If 
this is the case, then the explanation for the pattern of impairment seen in the patients in the 
ORT (i.e. arithmetically larger effects for POM over OLB/COM and the removal of the group 
effect in the latter when factoring in verbal measures, as well as the pattern of regression 
loadings) is that all measures essentially involve encoding and maintaining a complex spatial 
representation. Achieving this through linguistic representation is obviously less precise than 
through perceptual processes, therefore whilst the former may to some degree aid OLB 
performance – and to a lesser extent – COM,  it cannot match the precision of the latter. In 
the case of POM where all items are identical, linguistic processes cannot aid performance in 
the same way. It may be that patients do not use verbal processes at all for precise co-
ordinate tasks, or that they use them, but to no effect. In either case verbal processes will not 
relate to or explain significant variance in POM task performance. 
 
7.3.3 Stability of co-ordinate representations – an inefficiency of categorical coding 
in bipolar patients? 
The POM measure (from the ORT) yielded large effect sizes between patients and controls. 
For both groups, this measure had a strong association with the visuospatial composites (see 
section 6.3.3.2.2). In multiple regression models to predict POM, ‘group’ continued to be a 
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significant predictor of POM even after PCA-derived composites had been entered. As 
discussed previously, the maintenance of precise, fine-grain representation, as assessed by 
POM, stands apart from other spatial location measures. Such representation appears to be 
highly sensitive to retention duration and exhibits a rapid decay profile. Several authors have 
argued that the fragility of these representations require a rapid re-coding into categorical 
representation to facilitate maintenance over time (see discussion in Section 5.4, p.256). It is 
possible that such a recoding process is impaired in BD and leads to the large impairment in 
POM observed in these bipolar patients relative to controls.  
 
It is worth noting that the level of performance in patients does not approach anywhere near 
floor effects (i.e. the level of accuracy determined as chance- Kessels et al., 2000b; Postma et 
al., 2000). Therefore, as discussed at the end of Section 5.4, this deficit may represent a failure 
to rapidly process and integrate into alternative categorical coding. It would be expected that 
such processes would have significant executive contributions and as was observed in the 
composite loadings, both visuospatial composites would together predict significant variance. 
These composites included visuospatial executive measures such as SWM strategy (the 
efficiency of deriving and employing a spatial search strategy), SOPT (the ability to generate 
and monitor a sequence of responses i.e. executive control of WM), reverse spatial span 
(executive control of visuospatial WM) and DSST (rapid visuospatial processing/ psychomotor 
speed). Interestingly in the hierarchical regression models, the relationship of the composites 
to POM was similar in patients and controls, perhaps leading to the size of the between group 
difference, as alternative categorical processes could not be relied upon as they were in 
OLB/COM.  
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7.4 Future directions and further research 
Several important and interesting areas for future research have been identified, based on the 
present work. Some of these findings can lead straight to direct, testable hypotheses. 
One area relates to the effects of GR antagonists on spatial memory. In Chapter 3, results 
indicated that at the point where the improvement in spatial working memory was observed 
there was no significant difference in mood therefore minimizing this potential confound to 
interpretation. In the study, the neuropsychological assessment was performed 2 weeks after 
cessation of treatment to avoid the acute effects of elevated cortisol levels. However, it is 
important to understand the full timeframe of the effects of the GR antagonist. For example, 
there may be multiple mechanisms at work leading to the effect – from the animal work 
discussed in Section 1.5, GR antagonists are seen to have a direct effect on spatial memory, 
therefore at this point it is unknown if the SWM improvement was the result of the drug 
effect at the GR (which due to its long half-life would still be present) or an alteration in HPA 
axis function and lowering of cortisol levels. One final alternative explanation is based on the 
notion many antidepressant drugs have actions on blood-brain barrier steroid transporters 
(such as multidrug resistance p-glycoprotein). Plasma cortisol cannot freely enter the brain by 
passive diffusion because its access is limited by such membrane steroid transporters which 
actively expel cortisol from the brain. It has been suggested that by inhibiting membrane 
steroid transporters at the blood–brain barrier and in neurones, more cortisol is able to enter 
the brain (Pariante, 2004; Pariante et al., 2004b), thereby restoring glucocorticoid-mediated 
negative feedback of the HPA axis (Pariante et al., 2004b). Hypercortisolaemia is therefore 
argued to be a possible compensatory adaptive response to a central hypocortisolemic state 
(Pariante, 2003). Considering mifepristone: the antagonist action of mifepristone on GR 
causes a robust (2- to 3-fold) elevation in cortisol levels and this may facilitate HPA axis 
negative feedback. 
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As highlighted in Chapter 4, the patients who were recruited for this latter section of the 
thesis (Chapters 4 to 6) were part of a program of research further examining the effects of GR 
antagonists in bipolar disorder. This research used the same drug protocol as in Chapter 3, but 
a more simple parallel group design was used. As part of this, all neuropsychological tests, 
including the ORT paradigm, were administered at the point of cessation of treatment as well 
as 2 weeks later. Therefore there is the opportunity to study the timeframe of the effects on 
memory. Specific hypotheses can be made regarding the role of cortisol, for example, the high 
cortisol levels at the point of cessation of treatment would be expected to impair 
performance. However, if it is a direct drug effect which is important, improvements could be 
expected immediately. Further interesting hypotheses can be made regarding the specific 
processes which will be affected. For instance, as it was the SWM BSE which was improved 
(this is the measure with verbal loadings, in contrast to WSE) it can be hypothesised that OLB 
and COM measures of the ORT should be similarly improved. It would also be of interest to 
further examine these effects in euthymic patients as well as in healthy subjects, to see what 
effect GR manipulation produced on tasks where identical patterns of composite loadings 
were observed between patients and controls (e.g. SWM and POM) compared with those 
where differences were observed (e.g. OLB).  
 
As a next step, understanding the precise brain structures involved in these processes 
following HPA axis manipulation is important. Throughout this thesis, the role of structures 
like the PFC, hippocampus and parietal lobes have been mentioned with respect to both the 
effects of cortisol and structures that mediate performance on the spatial memory processes 
of interest. The effects of the GR antagonists are particularly related to this – as discussed, the 
animal work has shown mifepristone to have effects on hippocampus as well as prefrontal 
cortex corticosteroid receptor levels (Bachmann et al., 2003). Returning to the earlier 
discussion of the brain structures underpinning different spatial memory processes (e.g. 
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Section 3.4.1 and 5.1.3) it may be hypothesised that specific aspects of some tests will be 
affected by GR manipulation, for example, we could expect that SWM between search errors 
and ORT OLB (perhaps COM) would be affected if actions at the level of the hippocampus are 
important. Imaging and electroencephalogram studies may well prove invaluable in this 
respect. A number of studies using these techniques to explore categorical and co-ordinate 
processes within WM have been conducted (e.g. van der Lubbe et al., 2006; van der Ham et 
al., 2009) and these may be of interest if applied to bipolar disorder or following HPA axis 
manipulation.  
 
With regard to future experimental neuropsychology studies, exploring the effects of verbal 
interference on the SWM and ORT measures in bipolar patients is of great interest. While 
some studies have shown effects of AS+ on OLB/COM processes but not POM (e.g. Postma & 
de Haan, 1996; Kessels & Postma, 2002), results of other studies have suggested that 
unexpected inconsistencies can occur with concurrent AS+ (Postma et al., 1998; Postma et al., 
1999), possibly as a result of interaction with other methodological factors (see section 5.1.1). 
Therefore, either more work is needed to first optimise the AS+ task to avoid placing demands 
on executive resources, or the use of such tasks are inherently problematic due to the reasons 
discussed earlier on the relative contribution of linguistic and perceptual representations of 
visuospatial arrays and the executive demands of exact, metric detail (see sections 7.3.2 and 
7.3.3 above). Exploring alternative ways of interfering with different elements of the 
linguistic/perceptual representations may therefore offer a novel method of examining this 
phenomenon. 
 
A final area which should be further explored is the temporal aspect of visuospatial 
representation, specifically with the ORT task. As has been discussed, questions remain such 
as whether it is the case that because exact coordinate representation is so resource-
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demanding it is quickly reduced to a categorical representation? Is it the case that controls 
have a better ability to recode the coordinate to categorical and therefore do better or have  
more accurate categorical representation? Adopting methodologies such as those used by 
McNamara et al. (1992) or Werner & Diedrichsen (2002) to examine memory for precise 
location and temporal decay, and comparing patients and controls, would prove interesting. 
One related planned analysis using the data from the present study is to examine time vs. 
accuracy plots for the ORT paradigm data to examine the decay curve in the healthy controls 
(to ascertain if a limited number of items are very accurately located then the remainder of 
the array is more grossly arranged around these reference points) and then compare these 
results to the data from the bipolar group.  
 
Carrying out these additional studies will further our knowledge of the integration among the 
biological mechanisms underlying neuropsychological impairment in mood disorders and 
should develop our understanding of integration between cognitive processes in general. 
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9.1 Effect size plots from Chapter 1.3.2 
Effect size plot for RVIP latency 
 
 
 
Effect size plot for executive functioning (working memory monitoring) 
 
 
Cochrane effect size plot (fixed effects)
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Holmes, M. K., et al. 2008 (medicated)
Holmes, M. K., et al. 2008 (unmedicated)
Roiser, J. P., et al. 2009
  0  
pooled effect s ize = -0.011151  (95% CI = -0.253703 to 0.231402)
Cochrane effect size plot (fixed effects)
-2.0 -1.5 -1.0 -0.5 0.5
Taylor Tavares 2007 (SWM Between error)
Holmes 2008 (SWM Between error)
Holmes 2008 (SWM Between error)
Popescu 1991 (Sternberg)
Glahn 2006 (Digit span reverse)
Glahn 2006 (Digit span reverse)
Martinez-Aran 2004 (Digit span reverse)
Fossati 2004 (Digit span reverse)
  0  
pooled effect s ize = -0.681666  (95% CI = -0.874582 to -0.488749)
Page | 355 
Effect size plot for executive functioning (Set shifting/ rule formation and reversal) 
 
 
 
 
 
 
Effect size plot for executive functioning (Planning, reasoning and strategy) 
 
 
Cochrane effect size plot (fixed effects)
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Martinez-Aran 2004 (Trails B)
Basso 2002 (Trails B)
Fossati 2004 (WCST categories)
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Taylor Tavares 2007 (IDED errors)
Sweeney 2000 (IDED errors ED)
Rubinsztein 2006 (IDED errors ED)
Roiser 2009 (IDED errors ED)
Sweeney 2000 (Big circ le)
  0  
pooled effect s ize = -0.415915  (95% CI = -0.58672 to -0.245111)
Cochrane effect size plot (fixed effects)
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Sweeney 2000 (SOC min. moves)
Rubinsztein 2006 (TOL prop. correct)
Taylor Tavares 2007 (SWM strategy)
Sweeney 2000 (SWM strategy)
Roiser 2009 (SWM strategy)
Holmes 2008 (SWM strategy)
Holmes 2008 (SWM strategy)
Dixon 2004 (Cognitive estimation)
  0  
pooled effect s ize = -0.35885  (95% CI = -0.533446 to -0.184254)
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Effect size plot for executive functioning (Inhibition) 
 
 
 
 
 
Effect size plot for executive functioning (Verbal fluency) 
 
 
 
Cochrane effect size plot (fixed effects)
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Martinez-Aran 2004 (WCST perseverations)
Popescu 1991 (Stroop interference)
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Kerr 2005 (Stroop colour-w ord)
Dixon 2004 (HSCT error anom.)
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pooled effect s ize = -1.074484  (95% CI = -1.304828 to -0.844139)
Cochrane effect size plot (fixed effects)
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Dixon 2004 (Phonological fluency)
Martinez-Aran 2004 (Phonological fluency)
Basso 2002 (Phonological fluency)
Dixon 2004 (Category fluency)
Neu 2001 (Category fluency)
Martinez-Aran 2004 (Category fluency)
  0  
pooled effect s ize = -0.842878  (95% CI = -1.069258 to -0.616498)
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Effect size plot for digit span forwards 
 
 
Effect size plot for spatial span forwards 
  
Cochrane effect size plot (fixed effects)
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pooled effect s ize = -0.62165  (95% CI = -0.917441 to -0.325858)
Cochrane effect size plot (fixed effects)
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Taylor Tavares, J. V., et al 2007
Sweeney, J. A., et al. 2000
Roiser, J. P., et al. 2009
  0  
pooled effect s ize = -0.470044  (95% CI = -0.74838 to -0.191708)
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Effect size plot for total immediate free-recall 
 
 
 
Effect size plot for initial immediate free-recall 
 
Cochrane effect size plot (fixed effects)
-2.0 -1.5 -1.0 -0.5 0.5
Martinez-Aran, A., et al. 2004 (WMS logical; immed
Fossati, P., et al. 2004 (free recall)
Deptula, D., et al. 1991 (total recall)
Martinez-Aran, A., et al. 2004 (CVLT total)
Basso, M. R., et al. 2002 (CVLT total)
  0  
pooled effect s ize = -0.995233  (95% CI = -1.254079 to -0.736387)
Cochrane effect size plot (fixed effects)
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Fossati P et al. 2004 (Free recall 1)
Neu, P., et al. 2001 (RAVLT list 1)
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  0  
pooled effect s ize = -0.644326  (95% CI = -0.936787 to -0.351865)
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Effect size plot for delayed  free-recall 
 
 
 
Effect size plot for delayed  recognition 
 
Cochrane effect size plot (fixed effects)
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Martinez-Aran A et al. 2004 (logical mem. delayed)
Neu, P., et al. 2001 (Rey-AVLT delayed)
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  0  
pooled effect s ize = -1.064252  (95% CI = -1.332276 to -0.796229)
Cochrane effect size plot (fixed effects)
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Martinez-Aran A et al. 2004 (CVLT recog. hits)
Basso MR et al. 2002 (CVLT recog. hits)
Deptula, D., et al. 1991 (recog.)
  0  
pooled effect s ize = -0.956774  (95% CI = -1.309557 to -0.603991)
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Effect size plot for simultaneous match-to-sample (accuracy) 
 
 
 
 
 
 
Effect size plot for simultaneous match-to-sample (latency) 
 
 
Cochrane effect size plot (fixed effects)
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Roiser 2009 (SMTS; % correct)
Rubinsztein 2006 (SMTS; proportion correct)
Sweeney 2000 (MTS; accuracy)
  0  
pooled effect s ize = -0.207007  (95% CI = -0.476944 to 0.062931)
Cochrane effect size plot (fixed effects)
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Sweeney 2000 (SMTS; latency)
Sweeney (MTS; latency)
  0  
pooled effect s ize = -0.320848  (95% CI = -0.629209 to -0.012487)
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Effect size plot for delayed match-to-sample (latency) 
 
 
 
 
 
Effect size plot for visual memory (immediate recall) 
 
 
 
 
Cochrane effect size plot (fixed effects)
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pooled effect s ize = -0.007074  (95% CI = -0.254783 to 0.240636)
Cochrane effect size plot (fixed effects)
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Deptula 1991 (Non-verbal recall)
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Neu, P 2001 (WMS; correct)
  0  
pooled effect s ize = -0.769049  (95% CI = -1.110958 to -0.42714)
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Effect size plot for visual memory (recognition) 
 
 
 
 
 
Effect size plot for visual memory (CANTAB PREC accuracy) 
 
 
 
Cochrane effect size plot (fixed effects)
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pooled effect s ize = -0.167043  (95% CI = -0.355975 to 0.021889)
Cochrane effect size plot (fixed effects)
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Taylor Tavares 2007
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Holmes 2008 (medicated)
Holmes 2008 (unmedicated)
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pooled effect s ize = -0.128118  (95% CI = -0.321135 to 0.0649)
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Effect size plot for visual memory (CANTAB PREC latency) 
 
 
 
 
Effect size plot for spatial memory (accuracy) 
   
Cochrane effect size plot (fixed effects)
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Cochrane effect size plot (fixed effects)
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pooled effect s ize = -0.222224  (95% CI = -0.422943 to -0.021504)
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Effect size plot for psychomotor tests (motor skills or dexterity) 
 
 
Effect size plot for psychomotor tests (reaction time) 
 
  
Cochrane effect size plot (fixed effects)
-2 -1 1
Burdick 2009 (Pegboard)
Basso 2002 (Pegboard)
Burdick 2009 (finger tapping total 10s)
Popescu 1991 (tapping speed; 15s)
Neu 2001 (trails A)
Martinez-Aran 2004 (trails A)
Basso 2002 (trails A)
  0  
pooled effect s ize = -0.794185  (95% CI = -1.000567 to -0.587802)
Cochrane effect size plot (fixed effects)
-2.0 -1.5 -1.0 -0.5 0.5
Popescu 199 (Simple RT)
Burdick 2009 (Simple RT)
Popescu 1991 (Motor RT)
Sweeney 2000 (Five stage RT)
Popescu 1991(Choice RT; single)
Burdick 2009 (Choice RT)
  0  
pooled effect s ize = -0.606881  (95% CI = -0.833344 to -0.380417)
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9.2 SAS matching of patients and controls (Chapter 2) 
 
Data listing for matched Cases and Controls 
  UNID UNID Control Distance Age Sex NART Age Age Sex Sex NART NART 
Obs Case Control id D_IJ 
Abs. 
Diff. 
Abs. 
Diff. 
Abs. 
Diff. Case Control Case Control Case Control 
                            
1 128 91 1 9 1 0 7 45 44 1 1 110 117 
2 129 29 1 12 5 0 2 54 49 1 1 120 118 
3 130 100 1 5 2 0 1 57 55 1 1 106 105 
4 131 2 1 11 4 0 3 57 53 1 1 124 121 
5 132 86 1 11.813 5 0 2 56 51 1 1 111 113 
6 133 28 1 0.813 0 0 1 38 38 1 1 111 112 
7 134 55 1 12 4 0 4 61 57 1 1 126 122 
8 135 35 1 4 2 0 0 33 35 1 1 106 106 
9 136 36 1 15 2 0 11 63 61 2 2 100 89 
10 137 41 1 5 2 0 1 35 33 1 1 112 111 
11 138 88 1 18.188 5 0 8 58 53 1 1 111 103 
12 139 98 1 4 0 0 4 42 42 1 1 108 112 
13 140 87 1 4 2 0 0 49 47 1 1 110 110 
14 141 80 1 1.188 0 0 1 41 41 2 2 111 110 
15 142 44 1 5 2 0 1 26 28 1 1 100 101 
16 143 58 1 7 2 0 3 62 60 1 1 113 110 
17 144 61 1 5 0 0 5 50 50 1 1 121 126 
18 145 73 1 5 2 0 1 59 57 1 1 107 106 
19 146 3 1 3 1 0 1 41 40 1 1 108 107 
20 147 95 1 7 2 0 3 45 47 1 1 108 105 
        ========                   
        145                   
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match macro: case=CASES control=CONTROLS idca=UNID idco=UNID mvars=AGE SEX NART   
wts=2 2 1 dmaxk=5 0 12 dmax= ncontls=1 method=optimal  seedca=  seedco= 
out=MTCH   outnmca=__NMCA  outnmco=__NMCO 
 
The SAS System                        16:51 Friday, September 5, 2008   8 
 
Obs    Variable Label N Mean  Sum Minimum  Maximum 
              
DIJ DISTANCE/D_IJ 20 7.25 145 0.8125 18.1875 
DIF1 AGE/ABS. DIFF 20 2.15 43 0 5 
DIF2 SEX/ABS. DIFF 20 0  0 0  0 
DIF3 NART/ABS. DIFF 20 2.95 59 0  11 
CA1 AGE/CASE 20 48.6 972 26 63 
CA2 SEX/CASE 20 1.1 22 0 1 
CA3 NART/CASE 20 111.1875  2223.75 100 126 
CO1 AGE/CONTROL 20 47.05 941 28 61 
CO2 SEX/CONTROL 20 1.1 22 1 2 
CO3 NART/CONTROL 20 110.2  2204 89 126 
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9.3 Hamilton Rating Scale for Depression (HAM-D21) 
 
To rate the severity of depression in patients who are already diagnosed as depressed, 
administer this questionnaire. The higher the score, the more severe the depression. 
 
For each item, write the correct number on the line next to the item. (Only one response per 
item) 
 
1. DEPRESSED MOOD (Sadness, hopeless, helpless, worthless) 
0= Absent 
1= These feeling states indicated only on questioning 
2= These feeling states spontaneously reported verbally 
3= Communicates feeling states non-verbally—i.e., through facial expression, posture, voice, 
and tendency to weep 
4= Patient reports VIRTUALLY ONLY these feeling states in his spontaneous verbal and 
nonverbal communication 
 
2. FEELINGS OF GUILT 
0= Absent 
1= Self reproach, feels he has let people down 
2= Ideas of guilt or rumination over past errors or sinful deeds 
3= Present illness is a punishment. Delusions of guilt 
4= Hears accusatory or denunciatory voices and/or experiences threatening visual 
hallucinations 
 
3. SUICIDE 
0= Absent 
1= Feels life is not worth living 
2= Wishes he were dead or any thoughts of possible death to self 
3= Suicidal ideas or gesture 
4= Attempts at suicide (any serious attempt rates 4) 
 
4. INSOMNIA EARLY 
0= No difficulty falling asleep 
1= Complains of occasional difficulty falling asleep—i.e., more than 1/2 hour 
2= Complains of nightly difficulty falling asleep 
 
5. INSOMNIA MIDDLE 
0= No difficulty 
1= Patient complains of being restless and disturbed during the night 
2= Waking during the night—any getting out of bed rates 2 (except for purposes of voiding) 
 
6. INSOMNIA LATE 
0= No difficulty 
1= Waking in early hours of the morning but goes back to sleep 
2= Unable to fall asleep again if he gets out of bed 
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7. WORK AND ACTIVITIES 
0= No difficulty 
1= Thoughts and feelings of incapacity, fatigue or weakness related to activities; work or 
hobbies 
2= Loss of interest in activity; hobbies or work—either directly reported by patient, or indirect 
in listlessness, indecision and vacillation (feels he has to push self to work or activities) 
3= Decrease in actual time spent in activities or decrease in productivity 
4= Stopped working because of present illness 
 
8. RETARDATION: PSYCHOMOTOR (Slowness of thought and speech; impaired ability to 
concentrate; decreased motor activity) 
0= Normal speech and thought 
1= Slight retardation at interview 
2= Obvious retardation at interview 
3= Interview difficult 
4= Complete stupor 
 
9. AGITATION 
0= None 
1= Fidgetiness 
2= Playing with hands, hair, etc. 
3= Moving about, can’t sit still 
4= Hand wringing, nail biting, hair-pulling, biting of lips 
 
10. ANXIETY (PSYCHOLOGICAL) 
0= No difficulty 
1= Subjective tension and irritability 
2= Worrying about minor matters 
3= Apprehensive attitude apparent in face or speech 
4= Fears expressed without questioning 
 
11. ANXIETY SOMATIC: Physiological concomitants of anxiety, (i.e., effects of autonomic 
overactivity, “butterflies,” indigestion, stomach cramps, belching, diarrhoea, palpitations, 
hyperventilation, paresthesia, sweating, flushing, tremor, headache, urinary frequency).  
Avoid asking about possible medication side effects (i.e., dry mouth, constipation) 
0= Absent 
1= Mild 
2= Moderate 
3= Severe 
4= Incapacitating 
 
12. SOMATIC SYMPTOMS (GASTROINTESTINAL) 
0= None 
1= Loss of appetite but eating without encouragement from others. Food intake 
about normal 
2= Difficulty eating without urging from others. Marked reduction of appetite and 
food intake 
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13. SOMATIC SYMPTOMS GENERAL 
0= None 
1= Heaviness in limbs, back or head. Backaches, headache, muscle aches. Loss of energy and 
fatigability 
2= Any clear-cut symptom rates 2 
 
14. GENITAL SYMPTOMS (Symptoms such as: loss of libido; impaired sexual performance; 
menstrual disturbances) 
0= Absent 
1= Mild 
2= Severe 
 
15. HYPOCHONDRIASIS 
0= Not present 
1= Self-absorption (bodily) 
2= Preoccupation with health 
3= Frequent complaints, requests for help, etc. 
4= Hypochondriacal delusions 
 
16. LOSS OF WEIGHT 
A. When rating by history: 
0= No weight loss 
1= Probably weight loss associated with present illness 
2= Definite (according to patient) weight loss 
3= Not assessed 
 
17. INSIGHT 
0= Acknowledges being depressed and ill 
1= Acknowledges illness but attributes cause to bad food, climate, overwork, virus, need for 
rest, etc. 
2= Denies being ill at all 
 
 
 
SCORE FOR HAM-D 17: __________ 
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Additional items for HAMD-21 
 
 
18. DIURNAL VARIATION 
A. Note whether symptoms are worse in morning or evening. If NO diurnal variation, mark 
none 
0= No variation 
1= Worse in A.M. 
2= Worse in P.M. 
 
B. When present, mark the severity of the variation. Mark “None” if NO variation 
0= None 
1= Mild 
2= Severe 
 
 
19. DEPERSONALIZATION AND DEREALIZATION (Such as: Feelings of unreality; 
Nihilistic ideas) 
0= Absent 
1= Mild 
2= Moderate 
3= Severe 
4= Incapacitating 
 
 
20. PARANOID SYMPTOMS 
0= None 
1= Suspicious 
2= Ideas of reference 
3= Delusions of reference and persecution 
 
 
21. OBSESSIONAL AND COMPULSIVE SYMPTOMS 
0= Absent 
1= Mild 
2= Severe 
 
 
Total Score (HAM-D 21) ______________ 
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9.4 Montgomery and Åsberg (MADRS) Depression Rating Scale 
 
The rating should be based on a clinical interview moving from broadly phrased questions 
about symptoms to more detailed ones which allow a precise rating of severity. The rater 
must decide whether the rating lies on the defined scale steps (0, 2, 4, 6) or between them (1, 
3, 5). 
It is important to remember that it is only on rare occasions that a depressed patient is 
encountered who cannot be rated on the items in the scale. If definite answers cannot be 
elicited from the patient all relevant clues as well as information from other sources should be 
used as a basis for the rating in line with customary clinical practice. 
The scale may be used for any time interval between ratings, be it weekly or otherwise but 
this must be recorded. 
 
Item List 
1. Apparent sadness 
2. Reported sadness 
3. Inner tension 
4. Reduced sleep 
5. Reduced appetite 
6. Concentration difficulties  
7. Lassitude 
8. Inability to feel 
9. Pessimistic thoughts 
10. Suicidal thoughts 
 
 
 
 
1. Apparent Sadness 
Representing despondency, gloom and despair, (more than just ordinary transient low spirits) 
reflected in speech, facial expression, and posture. Rate by depth and inability to brighten up. 
 
0 No sadness.  
1  
2  Looks dispirited but does brighten up without difficulty. 
3  
4 Appears sad and unhappy most of the time.  
5  
6  Looks miserable all the time. Extremely despondent. 
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2. Reported sadness 
Representing reports of depressed mood, regardless of whether it is reflected in appearance 
or not. Includes low spirits, despondency or the feeling of being beyond help and without 
hope. 
Rate according to intensity, duration and the extent to which the mood is reported to be 
influenced by events. 
 
0 Occasional sadness in keeping with the circumstances. 
1  
2  Sad or low but brightens up without difficulty. 
3   
4 Pervasive feelings of sadness or gloominess. The mood is still influenced by external 
circumstances. 
5  
6  Continuous or unvarying sadness, misery or despondency. 
 
 
 
3. Inner tension 
Representing feelings of ill-defined discomfort, edginess, inner turmoil, mental tension 
mounting to either panic, dread or anguish. 
Rate according to intensity, frequency, duration and the extent of reassurance called for. 
 
0  'Placid. Only fleeting inner tension. 
1  
2  Occasional feelings of edginess and ill¬defined discomfort. 
3  
4 Continuous feelings of inner tension or intermittent panic which the patient can only 
master with some difficulty. 
5  
6 Unrelenting dread or anguish. Overwhelming panic. 
 
 
4. Reduced sleep 
Representing the experience of reduced duration or depth of sleep compared to the subject's 
own normal pattern when well. 
 
0 Sleeps as usual. 
1  
2  Slight difficulty dropping off to sleep or slightly reduced, light or fitful sleep. 
3  
4 Sleep reduced or broken by at least two hours. 
5  
6. Less than two or three hours sleep.  
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5. Reduced appetite 
Representing the feeling of a loss of appetite compared with when well. Rate by loss of desire 
for food or the need to force oneself to eat. 
 
0 Normal or increased appetite. 
1  
2 Slightly reduced appetite. 
3  
4 No appetite. Food is tasteless.  
5  
6 Needs persuasion to eat at all. 
 
 
 
6. Concentration difficulties 
Representing difficulties in collecting one's thoughts mounting to incapacitating lack of 
concentration. Rate according to intensity, frequency, and degree of incapacity produced. 
 
0 No difficulties in concentrating. 
1  
2  Occasional difficulties in collecting one's thoughts. 
3  
4  Difficulties in concentrating and sustaining thought which reduces ability to read or 
hold a conversation. 
5  
6  Unable to read or converse without great difficulty. 
 
 
 
7. Lassitude 
Representing a difficulty getting started or slowness initiating and performing everyday 
activities. 
 
0  Hardly any difficulty in getting started. No sluggishness. 
1  
2 Difficulties in starting activities. 
3  
4 Difficulties in starting simple routine activities which are carried out with effort. 
5  
6  Complete lassitude. Unable to do anything without help. 
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8. Inability to feel 
Representing the subjective experience of reduced interest in the surroundings, or activities 
that normally give pleasure. The ability to react with adequate emotion to circumstances or 
people is reduced. 
 
0  Normal interest in the surroundings and in other people. 
1  
2 Reduced ability to enjoy usual interests. 3 
4 Loss of interest in the surroundings. Loss of feelings for friends and acquaintances. 
5  
6 The experience of being emotionally para¬lysed, inability to feel anger, grief or 
pleasure and a complete or even painful failure to feel for close relatives and friends. 
 
 
9. Pessimistic thoughts 
Representing thoughts of guilt, inferiority, self¬-reproach, sinfulness, remorse and ruin. 
 
0 No pessimistic thoughts. 
1  
2 Fluctuating ideas of failure, self-reproach or self depreciation. 
3  
4  Persistent self-accusations, or definite but still rational ideas of guilt or sin. 
Increasingly pessimistic about the future. 
5  
6 Delusions of ruin, remorse or unredeemable sin. Self-accusations which are absurd 
and unshakable. 
 
10. Suicidal thoughts 
Representing the feeling that life is not worth living, that a natural death would be welcome, 
suicidal thoughts, and preparations for suicide. 
Suicidal attempts should not in themselves influence the rating. 
 
0 Enjoys life or takes it as it comes. 
1  
2 Weary of life. Only fleeting suicidal thoughts.  
3  
4 Probably better off dead. Suicidal thoughts are common, and suicide is considered as 
a possible solution, but without specific plans or intention. 
5  
6 Explicit plans for suicide when there is an opportunity. Active preparations for suicide. 
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9.5 Beck Depression Inventory (BDI) 
On this questionnaire are groups of statements.  Please read each group of statements carefully, then pick out the one 
statement in each group which best describes the way you have been feeling over the PAST WEEK.  Circle the 
number beside the statement you picked.  If several statements in the group seem to apply equally well then circle each 
one.  Be sure to read all the statements in each group before making your choice. 
 
1) 0 I do not feel sad. 11) 0 I am no more irritated by things than I ever am. 
 1 I feel sad.  1 I get annoyed or irritated more easily than I used to. 
 2 I am sad all the time and can't snap out of it.  2 I feel irritated all the time now. 
 3 I am so sad or unhappy that I can't stand it.  3 I don’t get irritated at all by things that used to irritate me. 
      
2) 0 I am not particularly discouraged about the future. 12) 0 I have not lost interest in other people. 
 1 I feel discouraged about the future.  1 I am less interested in other people than I used to be. 
 2 I feel I have nothing to look forward to.  2 I have lost most of my interest in other people. 
 3 I feel the future is hopeless and that things cannot  3 I have lost all of my interest in other people. 
  improve.    
                           
3) 0 I do not feel like a failure. 13) 0 I make decisions about as well as I ever could. 
 1 I feel I have failed more than the average person.  1 I put off making decisions more than I used to. 
 2 As I look back on my life, all I can see is a lot of  2 I have greater difficulty in making decisions than before. 
  failures.  3 I can't make decisions at all anymore. 
 3 I feel I am a complete failure as a person.    
      
4) 0 I get as much satisfaction out of things as I used to. 14) 0 I don't feel that I look any worse than I used to. 
 1 I don't enjoy things the way I used to.  1 I am worried that I am looking old or unattractive. 
 2 I don't get real satisfaction out of anything anymore.  2 I feel that there are permanent changes in my 
 3 I am dissatisfied or bored with everything.   appearance that make me look unattractive. 
    3 I believe that I look ugly. 
      
5) 0 I don't feel particularly guilty. 15) 0 I can work about as well as before. 
 1 I feel guilty a good part of the time.  1 It takes an extra effort to get started at doing something. 
 2 I feel quite guilty most of the time.  2 I have to push myself very hard to do anything. 
 3 I feel guilty all of the time.  3 I can't do any work at all. 
      
6) 0 I don't feel I am being punished. 16) 0 I can sleep as well as usual. 
 1 I feel I may be punished.  1 I don't sleep as well as I used to. 
 2 I expect to be punished.  2 I wake up 1-2 hours earlier than usual and find it  
 3 I feel I am being punished.   hard to get back to sleep. 
    3 I wake up several hours earlier than I used to  
     and cannot get back to sleep. 
                   
7) 0 I don't feel disappointed in myself. 17) 0 I don't get tired more than usual. 
 1 I am disappointed in myself.  1 I get tired more easily than I used to. 
 2 I am disgusted with myself.  2 I get tired from doing almost anything. 
 3 I hate myself.  3 I am too tired to do anything. 
      
8) 0 I don't feel I am worse than anybody else. 18) 0 My appetite is no worse than usual. 
 1 I am critical of myself for my weaknesses or mistakes.  1 My appetite is not as good as it used to be. 
 2 I blame myself all the time for my faults.  2 My appetite is much worse now. 
 3 I blame myself for everything bad that happens.  3 I have no appetite at all anymore. 
      
9) 0 I don't have any thoughts of killing myself. 19) 0 I haven't lost any weight recently. 
 1 I have thoughts of killing myself, but I would not   1 I have lost more than five pounds. 
  carry them out.  2 I have lost more than ten pounds. 
 2 I would like to kill myself.  3 I have lost more than fifteen pounds. 
 3 I would kill myself if I had the chance.   I am purposefully trying to lose weight by eating less. 
      
10) 0 I don't cry any more than usual. 20) 0 I am no more worried about my health than usual. 
 1 I cry more now than I used to.  1 I am worried about physical problems such as aches  
 2 I cry all the time now.   or pains, or upset stomach, or constipation. 
 3 I used to be able to cry, but now I can't even   2 I am very worried about physical problems and it's  
  cry even though I want to.   hard to think of much else. 
    3 I am so worried about my physical problems  
     that I cannot think about anything else. 
      
                        21) 0 I have not noticed any recent change in my  
     interest in sex. 
    1 I am less interested in sex than I used to be. 
    2 I am much less interested in sex now. 
    3 I have lost interest in sex completely. 
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9.6 Correlations between HPA axis measures and composites 
 
Whole group Salivary C_D 
ratio 8am 
Salivary C_D 
ratio 8pm 
Waking 
CORT AUC 
DST CORT 
change 
Salivary C_D ratio 8pm 0.199 
   
Waking CORT AUC 0.299
*
 -0.146 
  
DST CORT change (2-1) 0.068 0.072 -0.269 
 
Optimised model_TOTAL_c1 (VS)  -0.049 0.000 -0.002 0.063 
Optimised model_TOTAL_c2 (verbal 
memory)  
0.100 0.020 0.042 -0.181 
Optimised model_TOTAL_c3 (verbal 
exec)  
0.023 0.058 0.042 -0.106 
Optimised SWM model_TOTAL_c1 
(verbal memory)  
0.100 0.020 0.042 -0.181 
Optimised SWM model_TOTAL_c2 
(VS)  
-0.055 -0.137 -0.001 .082 
Optimised SWM model_TOTAL_c3 
(verbal exec)  
0.023 0.058 0.042 -0.106 
* p<0.05  
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By group  
Group 
Salivary C_D 
ratio 8am 
Salivary C_D 
ratio 8pm  
Waking 
CORT AUC 
DST CORT 
change (2-1)  
Salivary C_D ratio 8pm Patient 0.169    
Control 0.229    
Waking CORT AUC  Patient 0.202 -0.488
*
   
Control 0.373
*
 0.083   
DST CORT change (2-1) Patient 0.383 -0.150 -0.220  
Control 0.007 0.216 -0.197  
Optimised model_control_c1 
(verbal memory) 
Patient 0.022 0.125 -0.056 -0.084 
Control 0.278 0.022 0.072 0.046 
Optimised model_control_c2 (VS 
complex) 
Patient 0.028 0.168 -0.111 -0.043 
Control 0.074 0.188 0.144 -0.017 
Optimised model_control_c3 (VS 
immediate) 
Patient 0.263 -0.174 -0.076 0.420
*
 
Control -0.279 -0.168 -0.049 0.112 
Optimised model_control_c4 
(verbal exec) 
Patient 0.033 0.097 -0.201 0.168 
Control 0.271 0.257 0.219 -0.145 
Optimised model_patient_c1 (VS) Patient 0.092 -0.038 -0.112 0.103 
Control -0.126 0.023 0.044 0.083 
Optimised model_patient_c2 
(verbal memory) 
Patient 0.022 0.125 -0.056 -0.084 
Control 0.278 0.022 0.072 0.046 
Optimised model_patient_c3 (digit 
srec) 
Patient -0.055 0.148 -0.290 -0.147 
Control 0.161 0.019 0.180 -0.053 
Optimised SWM model_control_c1 
(verbal memory) 
Patient 0.022 0.125 -0.056 -0.084 
Control 0.278 0.022 0.072 0.046 
Optimised SWM model_control_c2 
(verbal exec) 
Patient 0.011 0.025 -0.199 0.124 
Control 0.165 0.152 0.179 -0.101 
Optimised SWM model_control_c3 
(VS) 
Patient 0.157 -0.197 -0.084 0.194 
Control -0.255 -0.132 -0.012 0.160 
Optimised SWM model_patient_c1 
(VS) 
Patient 0.102 -0.184 -0.098 0.176 
Control -0.126 -0.018 0.021 0.178 
Optimised SWM model_patient_c2 
(verbal memory) 
Patient 0.022 0.125 -0.056 -0.084 
Control 0.278 0.022 0.072 0.046 
Optimised SWM model_patient_c3 
(digit srec) 
Patient -0.055 0.148 -0.290 -0.147 
Control 0.161 0.019 0.180 -0.053 
* p<0.05  
 
 
 
